TW381093B - 2-phenyl-1-benzyl indole compounds as estrogenic agents - Google Patents

2-phenyl-1-benzyl indole compounds as estrogenic agents Download PDF

Info

Publication number
TW381093B
TW381093B TW86104919A TW86104919A TW381093B TW 381093 B TW381093 B TW 381093B TW 86104919 A TW86104919 A TW 86104919A TW 86104919 A TW86104919 A TW 86104919A TW 381093 B TW381093 B TW 381093B
Authority
TW
Taiwan
Prior art keywords
scope
methyl
phenyl
benzyl
item
Prior art date
Application number
TW86104919A
Other languages
Chinese (zh)
Inventor
Chris P Miller
Michael D Collini
Bach D Tran
Arthur A Santilli
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24541937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW381093(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of TW381093B publication Critical patent/TW381093B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to new 2-phenyl-1-[4-2-aminoethoxy]-benzyl]-indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures I or II in which: R1 is selected from H, OH, or C1-C6 alkyl ester (straight chain or side chain), C1-C6 alkyl ( straight chain or side chain or cycloparaffin) ether, or halogen or C1-C4 halogen ether containing trifluoride methyl ether and trichloride methyl ether; R2 is H; R3 and R4 are selected from H, OH, or C1-C6 alkyl ester ( straight chain or side chain ), C1-C6 alkyl ( straight chain or side chain or cycloparaffin ) ether, benzyloxyl, halogen or C1-C4 halogen ether containing trifluoride methyl ether and trichloride methyl ether, C1-C6 alkyl ( straight chain or side chain ), or trifluoride methyl, but with the condition that when R1 is H, R2 is not OH; R5 is methoxyl or H; R6 is H; X is selected from H, C1-C6 alkyl, cyano, halogen; n is 2 or 3; Y is selected from : -N-R7R8 wherein R7 and R8 are selected from hydroxyl, halogen, C1-6 alkyl and cyclohexane; or R7 and R8 together form piperidine, acriheptine, acribicyclicheptine, acribicyclicaprylic, piperazine, acricaprylic and pyrrolidine and the piperidine can be optionally substituted by C1-6 alkyl or hydroxyl and acribycyclicaprylic can be optionally substituted by C1-6 alkyl and the pharmaceutically acceptable salts.

Description

A7 五、發明说明(幻 ρ^ι η 製造此化合物之反應類似於該製造编號1 OU; 'Η NMR(DMSO) 7.50 - 7.29 (m , 11 Η), 7.17 (d , 1 H , J (d, 1 H, J = 2.4Hz), 7.02 (d , 1H, J = 2.4Hz), 6.93 - 6.85 (in, 2 4H), 5.14 (s , 2H), 5.13 (s , 2H), 5.07 (m , 2 H), 3.92 (t, 2 H , (t, 2H , J = 5.9Hz), 2.42 - 2.29 (m , 4 H), 1.94 (s , 3H), 1.44 --1.34 (m , 2H). 實施例编號133 3-氣- 2- (4-猙某-苯基)-1- 7者。 :8.4Hz), 7.05 Η), 6.75 - 6.65 (m J = 5.9Hz), 2.55 1.40 (m ,4 H), 1.38 Γ 4-(2- 毗咯啶-卜基-乙氣基)-苄基)-1H-吲哚-5 淳(HCL) 如實施例编號134所合成A7 V. Description of the invention (The reaction for making this compound is similar to the production number 1 OU; 'Η NMR (DMSO) 7.50-7.29 (m, 11 Η), 7.17 (d, 1 H, J ( d, 1 H, J = 2.4Hz), 7.02 (d, 1H, J = 2.4Hz), 6.93-6.85 (in, 2 4H), 5.14 (s, 2H), 5.13 (s, 2H), 5.07 (m , 2 H), 3.92 (t, 2 H, (t, 2H, J = 5.9Hz), 2.42-2.29 (m, 4 H), 1.94 (s, 3H), 1.44 --1.34 (m, 2H). Example No. 133 3-Gas 2- 2- (4-fluorene-phenyl) -1--7.: 8.4Hz), 7.05 Η), 6.75-6.65 (m J = 5.9Hz), 2.55 1.40 (m , 4 H), 1.38 Γ 4- (2-Pyrrolidine-b-yl-ethoxy) -benzyl) -1H-indole-5 (HCL) Synthesized as in Example No. 134

Mp = 233-235°C; lH NMR (DMSO) 10.50 (s, 1 H), 9.88 (s, 1 H|, 9.01 (s, 1 H), 7.30 -7.20 (m, 3 H), 6.90 * 6.80 (m, 7 H), 6.68 (dd, 1 H, J = 2.4, Hz, 8.8 Hz), 5.20 (s, 2 H), 4.22 (t, 2 H, J = 4.8 Hz), 3.47 (t, 2 H, J = 4.8 Hz), 3.1(1 (bm, 4 H), 1.90 (s, 4 H); IR (KBr) 3400,1625, 1475, 825 cm'1; MS el m/z 462 (M+); C27H77C1N2 〇b +1 HC1+.75H2 0 之 CHN 計算 實施例编號1 3 4除去苄酯以産生3 -氛- 2- U- 筠甚-荣甚) 1 Η - ί 引 11¾ (請先閱讀背面之注意事項再填寫本頁) 裝. 訂 經濟部中央橾隼局貝工消費合作社印製 -h-m (ηc η 類似於概述於方法7之3 -甲基吲呤之步驟 基醚。此化合物然後如前述方法8所述轉變 Ηρ= 207- 209 °C ; 1 H NHR(DMS0)10.10 概要除去苄 成鹽酸鹽; ,7.22 (d, 1 H, J : (bs . 1 Η), 9.86 (s , 1H), 9.07 (s , 1 H), 7.26 (d, 2 H, J = 8.6 Hz), 8.8 Hz), 6.87 (d , 2 H , J = 8.6Hz), 6.81 - 6.78 (m , 5 H), 6.65 (cd , 1 H, J = 8.8 Hz, J = 2.2 Hz), 5.20 (s, 2 H), 4.27 (t, 2H, J = 5.0Hz), 3.44 - 3:M (m , 4 H), 3.00 -2.85 (m , 2 H), 1.81-1.60 (m , 5H), 1.41 - 1.26 (m ,1 H); IR (KB ·) 3350, 1470 89- 本紙張尺度適用中國國家標準(CNS ) A4说格(210> 297公ft ) A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明 ( 1 ) 1 1 本 發 明 % 有 關 新 穎 2 - 苯 基 -1 - C 4 -( 2 - 胺 1氧 基 )- 苄 基〕 1 1 吲 化 合 物 > 其 傜 作 為 雌 激 素 > 以 及 和 利 η 該 等 化 合 物 1 | 之 m 學 組 合 物 治 療 方 法 〇 請 1 I ϋ_ 明 背 景 先 閱 1 I 1 | 使 用 激 素 替 代 療 法 預 防 停 經 後 婦 女 之 骨 % i流 失 已 有 許 背 面 1 I 之 1 多 前 例 可 循 〇 一 般 雌 激 素 補 充 之 治 療 像 使 拜 含 分 離 白 天 意 1 | 然 來 源 之 雌 _ t 雌 酵 > 乙 炔 基 二 醇 或 共 朝 i雌 激 素 配 事 項 1 I 再 1 方 (P r e ma r i η得自惠氏藥廠)。 在 某 病 人 4 由 於 雌 激 填 裝 本 素 對 於 子 宮 組 織 之 增 生 效 果 役 有 對 抗 力 量 ( 雌激素未合 頁 1 I 併 使 用 黃 體 素 )故禁忌此種療法。 增生伴隨 箸子宮内膜 1 1 異 位 及 / 或 子 宮 内 膜 癌 之 風 險 增 高 〇 未 經 % 抗 之 雌 激 素 1 1 對 乳 房 組 /Ah 繊 的 影 礬 不 清 楚 > 但 也 令 人 擔 憂 〇 需 要 雌 激 素 1 1 訂 1 維 持 骨 質 彈 性 9 同 時 減 少 對 子 宮 及 乳 房 之 增 |生 作 用 的 需 求 明 顯 〇 某 非 類 固 酵 抗 雌 激 素 曾 顯 示 可 用 於 卵 巢 切 除 1 I 大 鼠 模 式 及 人 類 臨 床 試 驗 維 持 骨 質 〇 例 如 堵 :摩 思 芬 1 1 (Τ a οι 0 X i f e η 由 Ze n e c a 製 藥 » 德 拉 威 州 * 威 頓 > 以 1 No v a d e X®品牌販賣之塔摩思芬檸檬酸鹽)為 用 於 乳 癌 之 各V I 緩 解 治 療 及 用 於 人 體 對 骨 質 産 生 雌 激 素 作 用 劑 類 似 的 效 1 1 果 ο 但 對 子 宮 亦 為 部 份 作 用 劑 9 故 也 造 成 a 慮 〇 瑞 羅 思 1 | 芬 (R a 1 0 X if e η ), 苯駢喀盼抗雌激素, _顯 承用於卵« 1 | 切 除 大 鼠 剌 激 子 宮 生 長 程 度 比 塔 摩 思 芬 更 低 同 時 可 維 1 1 持 保 護 骨 質 能 力 〇 組 織 選 擇 性 雌 激 素 之 適 售 綜 覽 參 見 論 1 | 文 : T i S S u e -S el e c t i v e A c t i 〇 n s 0 f Es t r 0 1 e η A na 1 〇 gs ", 1 Bo n e V 0 1 .1 7 , N 〇 . 4 ,1 9 9 5年1 3 - 〇月, 1 8 1 s- 1 30S 〇 1 1 1 1 1 1 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 經濟部中央標準局貝工消費合作社印製 A7 B7五、發明説明(2 ) 使用吲昤做為雌激素拮抗劑己報告於Von 化學摘要(Chenical Abstracts),第 99卷 ,摘要编號5 3 88U。亦參見,J· Med. Chee 2635-2 84 0 ; J. Med. Chen . 1 9 8 7 , 3 0 , 1 3 1 Ger.0ffen.,DE 3821148 A1 891228和 WO 96/03375。該 等先前技術化合物與本發明化合物共有一巧結構相似 性,但官能不同《對於包含鹸性胺之化合物,没有苯基 做為倒鐽。該等化合物之被報告的數據指出:其具有比 本發明化合物弱之對雌激素受體的結合且所報告之包 括鹼性餹鏈之化合物顯示顯示大鼠子宮之4宮治療效果 ^ W0 96/03375號中所列之化合物家族之 有苄基,但不具有鹹性側鐽《該等化合物+多數落於最 佳特擞為”純抗雌激素”之化合物的類別。多數目前所描 述之化合物,由於它們特定的側_,於子宮作為純抗雌 激素,於骨賂及心與血管条統顯示強的動衍作用》本文 所述之相關之先前技藝的化合物沒有被證明有該作用Mp = 233-235 ° C; lH NMR (DMSO) 10.50 (s, 1 H), 9.88 (s, 1 H |, 9.01 (s, 1 H), 7.30 -7.20 (m, 3 H), 6.90 * 6.80 (m, 7 H), 6.68 (dd, 1 H, J = 2.4, Hz, 8.8 Hz), 5.20 (s, 2 H), 4.22 (t, 2 H, J = 4.8 Hz), 3.47 (t, 2 H, J = 4.8 Hz), 3.1 (1 (bm, 4 H), 1.90 (s, 4 H); IR (KBr) 3400, 1625, 1475, 825 cm'1; MS el m / z 462 (M +) ; C27H77C1N2 〇b +1 HC1 + .75H2 0 CHN calculation Example No. 1 3 4 Remove the benzyl ester to produce 3-ambient-2- U- 筠--Rong even) 1 Η-引 引 11¾ (Please read the back first Please note that you need to fill in this page again.) Packing. Ordered by the Central Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperative, printed -hm (ηc η is similar to the step-based ether of 3-methylindolin outlined in Method 7. This compound is then as The transformation described in the aforementioned method 8 ρ = 207- 209 ° C; 1 H NHR (DMS0) 10.10 to remove benzyl hydrochloride; 7.22 (d, 1 H, J: (bs. 1 Η), 9.86 (s, 1H), 9.07 (s, 1 H), 7.26 (d, 2 H, J = 8.6 Hz), 8.8 Hz), 6.87 (d, 2 H, J = 8.6Hz), 6.81-6.78 (m, 5 H) , 6.65 (cd, 1 H, J = 8.8 Hz, J = 2.2 Hz), 5.20 (s, 2 H), 4.27 (t, 2H, J = 5.0Hz), 3.44-3 M (m, 4 H), 3.00 -2.85 (m, 2 H), 1.81-1.60 (m, 5H), 1.41-1.26 (m, 1 H); IR (KB ·) 3350, 1470 89- This paper size Applicable to China National Standard (CNS) A4 standard (210 > 297 ft) A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (1) 1 1 This invention is related to novelty 2-phenyl-1- C 4-(2 -Amine 1oxy) -benzyl] 1 1 indene compound > its estrogen as an estrogen > and Heli η these compounds 1 | the m-synthetic composition treatment method 〇 Please 1 I ϋ_ 明Background Read First 1 I 1 | Use of hormone replacement therapy to prevent bone loss in women after menopause. I have lost a lot of back. 1 I 1 more previous examples can be followed. General treatment of estrogen supplementation is like separating the daytime meaning 1 | The female _ t female leaven > ethynyl glycol or co-challenge estrogen 1 1 re 1 side (P r e ma r i η was obtained from Wyeth Pharmaceuticals). In a patient 4 due to estrogen filling, the proliferative effect of the hormone on the uterine tissue has a resistive amount (estrogen is not page 1 I and the use of lutein) is contraindicated. Hyperplasia is associated with endometrium 1 1 ectopic and / or increased risk of endometrial cancer. Estrogen without 1% anti-estrogen 1 1 is unclear for breast group / Ah 繊 > but it is also worrying Estrogen 1 1 Order 1 Maintain bone elasticity 9 Simultaneously reduce the need for uterine and breast growth | There is a clear need for a non-steroidal anti-estrogens once used in ovariectomy 1 I rat model and human clinical trials to maintain bone 〇For example: Mosfene 1 1 (T a οι 0 X ife η by Ze neca Pharmaceuticals »Dravid State * Witton > Tasmofen Citrate sold under the 1 No vade X® brand) Relief treatment of breast cancer by various VIs and similar effects for estrogen-producing agents on bone in the human body 1 1 Fruit ο but also a part of the agent in the uterus 9 It also causes a concern. 瑞罗思 1 | Fen (R a 1 0 X if e η), phenanthrene and anti-estrogens, _showed in eggs «1 | The degree of growth of the stimulated uterus of the resected rats is lower than that of tamoxifen, while maintaining the ability to protect bone mass. 0 For a comprehensive overview of the marketability of tissue-selective estrogen, see Discussion 1 | Article: T i SS ue -S el ective A cti 〇ns 0 f Es tr 0 1 e η A na 1 〇gs ", 1 Bo ne V 0 1 .1 7, N 〇 4, 195 1 3-〇, 1 8 1 s- 1 30S 〇1 1 1 1 1 1 This paper size applies to Chinese National Standard (CNS) A4 (2 丨 0297mm) Printed by A7 B7, Shellfish Consumer Cooperative, Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (2)昤 As an estrogen antagonist has been reported in Von Chemical Abstracts, Vol. 99, Abstract No. 5 3 88U. See also, J. Med. Chee 2635-2 84 0; J. Med. Chen. 1 987, 3 0, 13 1 Ger. 0ffen., DE 3821148 A1 891228 and WO 96/03375. These prior art compounds share the same structural similarity as the compounds of the present invention, but with different functionalities. For compounds containing amidines, there is no phenyl group as the perylene. The reported data for these compounds indicate that they have a weaker binding to the estrogen receptor than the compounds of the invention and that the reported compounds including a basic fluorene chain have shown a 4th house treatment effect in rat uterus The family of compounds listed in 03375 has a benzyl group, but does not have a salty side. "These compounds + most of them fall into the category of compounds with the best characteristics of" pure antiestrogens ". Most of the currently described compounds, because of their specific side, act as pure anti-estrogens in the uterus, and show strong dynamical effects in bone and heart and blood vessel systems. The related prior art compounds described in this article have not been Prove it

Angerer, ,第 7 號( 1 9 8 3 ) .1 9 9 0,33 ,-1 36«亦參見 艇化合物具 鏈之吲》朵抗 述具有合併 本 Otsuka,製 文式I和11 該具有與本 WO A 95 17383(Kar Bio AB)敘迷具長直 tt激素。另一相關之專利W〇 A 9 3 1 0 7 4 1描 其他側鐽的5-羥基吲W0 9 3 / 2 3 3 7 4 (日 藥)描述不同於本發明之結構的化合物,下 中之R3定義為硫烷基及參考資料沒有掲示 發明所提供者相同結構之得自吲昤之具倒$化合物,其 中側鐽要求與本文所述相似,該等化合物為醱胺;於本 發明中沒有申請醯基化吲11朵。 本紙張尺度適用中國國家標季(CNS ) A4規格(210X297公釐) — I I I I I 裝— I I I I I 訂 I I ―― ^― 1" (請先閲讀背面之注意事項再填寫本頁) P引呜為用 劑/拮抗劑 。於活體外 染分析,顯 的抗雌激素 _,同時, 子宮剌激作 大鼠中可抑 。該等化合 及減少總膽 A7 B7 五、發明説明(3 ) 發明^説明 式(U及(II)所示之一般結構類型之2 -苯 於治療雌激素缺乏之相關疾病的雌激素作用 。本發明化合物顯示對雌激素受體之強結含 分析中,包括石川鹸性璘酸酶分析及ERE轉 示該等化合物為極少具有固有雌激素特性 ,且其已證明可完全拮抗1 7办-雌二醇之作 在大鼠子宮分析單獨劑量時顯示很少或沒有 用。此外,該等化合物有一些在卵巢切除之 制骨質流失而顯示很少或没有子宮刺激作用 物一般在卵巢切除之動物亦減少重量增加以 固醇含量。 本發明包括式I或I I之化合物: (請先閱讀背面之注意事項再填寫本頁) 裝_ 、?τ X R3Angerer,, No. 7 (198 3). 1 9 9 0, 33, -1 36 «See also the indole of a boat compound with chain" The anti-statement has a consolidated version of Otsuka, the formulae I and 11 have the same as This WO A 95 17383 (Kar Bio AB) has a long straight hormone. Another related patent WOA 9 3 1 0 7 4 1 describes 5-hydroxyindole WO 9 3/2 3 3 7 4 (Japanese medicine) describing other compounds with different structures. R3 is defined as a sulfanyl group and the reference materials do not show the same structure provided by the invention with the indole compounds with the same structure, in which the side requirements are similar to those described herein, these compounds are amidine; in the present invention there is no Apply 11 fluorinated indole. This paper size applies to China National Standard Season (CNS) A4 specification (210X297 mm) — IIIII packaging — IIIII order II —— ^ ― 1 " (Please read the precautions on the back before filling this page) / Antagonist. In vitro staining analysis showed anti-estrogen _, and at the same time, uterine irritation caused suppression in rats. The combination and reduction of total bile A7 B7 V. Description of the invention (3) Invention ^ Illustrative formula (U and (II) of the general structure type 2-Benzene in the treatment of estrogen deficiency related diseases. Estrogen effect. The compounds of the invention show a strong binding analysis of estrogen receptors, including the analysis of Ishikawa's peptidase and ERE. These compounds have very few inherent estrogen properties and have been proven to completely antagonize Glycol production has shown little or no use in the analysis of individual doses of rat uterus. In addition, some of these compounds have been shown to have little or no uterine stimulatory effect on bone loss during ovariectomy, and are generally also found in ovariectomized animals. Reduce the weight and increase the sterol content. The present invention includes compounds of formula I or II: (Please read the precautions on the back before filling out this page) Packing _,? Τ X R3

(CH2)n_Y 或(CH2) n_Y or

(CH2)n-Y (Π) 線 經濟部中央標準局員工消費合作社印製(CH2) n-Y (Π) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

(D 其中:(D where:

Ri傷選自Η、-C12_ (直鍵或支#)或其Ci -C12 (直鏈或支鏈或環)烷醚、或鹵素;或包括与氟甲基醚及 三氣甲基醚之Ci -C4齒化醚; -5 -本紙張尺度適用中國國家標準(CNS〉A4規格(210X297公釐) 經 濟 部 中 央 標 準 局 員 工 消 f 合 作 社 印 製 Α7 Β7 五、發明説明(4 ) R2 ,R3 ,R4 ,Ri3及紀6分別選自H, 0H或【 1 _ C 12 酯( 直鍵或支鏈)或其Ci -Cw (直鐽或支鍵或環) 烷醚、鹵素 、或包括三氟甲基醚及三氯甲基醚之Ci -C, t鹵化醚、 氣基、Ci-Ce烷基(直鋪或支鍵)、或三氟E P基,但條 件為,當Ri為Η時,R2不為0Η; X傜選自H、Ci-Ce烷基、氣基、硝基、 三氟甲基、 鹵素; η為2或3 ; Υ像選自: a )該部份 、/R7 、N \ Re 其中R?及Rs分別選自H、Cl -Ce烷基、 或視需要經 CN、Ci-Cs烷基(直鍵或支鏈)、鹵素、-OH ,-C F 3 . -〇 C F 3取代之苯基; b)—種五員飽和、不飽和或部分飽和之雜 環,其僳包 含至多二個選自包括-〇-、-NH-、-N(Ci-Cz 院基)_、 -N=、及- S(0)m-之雜原子,其中hi為0-2 = [整數,視 需要地以1-3個分別選自包括氫、羥基、鹵3 ㊁、C 1 - C 4 烷基、三鹵甲基、Cl -C4烷氧基、三鹵甲萄 ί 基、C 1 -C 4 醯氣基、Ci -iU烷硫基、Ci-Cd烷亞磺醯 基、C 1 - C 4 烷磺醯基、經基(Ci -C4 )烷基、-C02 H-、 -CN' C0NHR 1 - 、——NH2-、Ci-C4 烷胺基、二(C1-C4)烷 -6 - 胺基、 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 广, 請 先 閲 % 背 ιδ 之 注 意 事 項 再 填 寫 本 頁 裝 訂 經 濟 部 中 央 標 準 員 X. 合 作 社 印 製 Α7 Β7 五、發明説明(,) -NHSO 2 R 1 -、 - NHCOR 1 -、 -N 0 2 -及視需要 經1-3悃 (Ci -C4 )烷基取代之苯基之取代基取代;ί g c) 一種六員飽和、不飽和或部分飽和之雜 環,其傜包 含至多二個選自包括- 〇-、-ΝΗ-、-MC!. -C- 院基)_、 -N=、 及- S(0)m-之雜原子,其中m為0-2之整數, 視需要地 以1 - 3個分別選自包括氫、羥基、鹵素、( 1 - C 4院基 、三鹵甲基、Cl -C4烷氣基、三鹵甲氧基、 C 1 ~ C 4 酸 氧基、Cl -C4院硫基、Ci _C4院亞礎醯基 、C 1 -C 4 綜礎酸基、經基(Ci -C4 )院基、-COsH-、 -CN' -C0NHR 1 -、-NH 2 Ci -C4 烷胺基、二(C 1 - C 4 )院 胺基.-NHS0 2 R 1 -、 -NHC0R 1 -、 -N0 2 -及 視需要經1 -3個(Ci -C4 )烷基取代之苯基之取代基取 代;或 d)—種t員飽和、不飽和或部分飽和之雜 環,其僳包 含至多二個選自包括-0 -、- N Η -、- N ( C 1 - Cz 烷基)-、-N =、 及- S(0)m -之雜原子,其中in為0-2之整數, 視需要地 以1 -3個分別選自包括氫、羥基、鹵素、C 1 - C 4院基 、三鹵甲基、Ci-C4烷氧基、三鹵甲氧基、 ci - c 4 m 氧基、Ci-C4烷硫基、C:1-C4烷亞磺醯基 、Cl - C 4 烷磺醯基、羥基(“ -C4 )烷基、-C02 H-、 -C N - x -C0NHR 1 - . -N H 2 -、C 丄-C 4 烷胺基、二(C i - C 4 )院 胺基、-NHS0 2 R a -、-NHC0R ! ' -N 0 2 -及 視需要經1 -3個(Ci -C4 >烷基取代之苯基之取代基取 代;或 e) —種包含6-12個磺原子之架橋或稠合之 雙環雜環, 其傜包含至多二個選自包括- 0-、-NH' -N( -7 - C 1 -C 4 烷 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 請 先 閲 讀 背 Λ 之 注 意 事 項 再 填 寫 本 頁 裝 訂 嫁 經 濟 部 中 央 標 準 員 工 消 費 合 作 社 印 裝 A7 B7 五、發明説明(知) 基)-、-N =、及- S(0)m-之雜原子,其中B為 > 0-2之整數 ,視需要地以1 -3锢分別選自包括氫、羥1丨 •、鹵素、 Cl-C4院基、三_甲基、Cl-C4院氣基、 三鹵甲氧基 、C1-C4醏氧基、Ci-C4烷硫基、Ci-C< 烷亞磺醯 基、Ci-C*烷磺醯基、羥基(Ci-fU)烷基 、-CO 2 H' -CN' - C 0 N H R 1 ' - ΝΗ 2 ' C i -C 4 烷胺 基,二(C!-C4) 烷胺基、-NHSO 2 R 1 -、-NHCOR 1 ' -NO 2 - 及視需要經 1 -3個(Ci -C4 )烷基取代之苯基之取代基 取代; 及其藥學上可接受鹽。 本發明之更佳化合物為該等具有上逑一般 結構I或I I 者,其中: Kl·像選自H、0H或Ci-C12酯或其烷醚、虐 f素; R2 ,ϋ3 ,R4 ,RS及“分別選自Η、 0H或C 1 - C 12酯或 其院醚、齒素、氣基、Ci -Cs院基,或三虐 甲基,較 佳為三氟甲基,但條件為,當Ri為Η時,R 2不為0H ; X像選自H、Ci-Cs烷基,気基,硝基, 三氟甲基, 鹵素; Y為該部份: wR7 \ Re 其中R7及R8分別選自H、Ci -C6烷基, 或與-(CH 2 ), 合併,其中P為2至6之整數,以致形成一 環,該環視 需要地以至多3値選自包括氫、羥基、鹵素 Ci - C 4 -8 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閲 讀 背 之 注 意 事 項 再 填 寫 本 頁 裝Ri is selected from Η, -C12_ (straight or branched #) or its Ci -C12 (straight or branched or cyclic) alkyl ether, or halogen; or Ci including fluoromethyl ether and trimethyl ether -C4 toothed ether; -5-This paper size applies to Chinese National Standards (CNS> A4 specification (210X297 mm). Employees of the Central Standards Bureau of the Ministry of Economic Affairs printed by the cooperative. A7 B7. 5. Description of the invention (4) R2, R3, R4, Ri3 and Ji 6 are respectively selected from H, 0H or [1 _ C 12 ester (straight or branched chain) or Ci-Cw (straight or branched or cyclic) alkyl ether, halogen, or trifluoromethyl Ci-C, t-halogenated ether, trialkyl, Ci-Ce alkyl (straight- or branch-bonded), or trifluoroEP based on triethyl ether and trichloromethyl ether, provided that when Ri is Η, R2 Is not 0Η; X 傜 is selected from H, Ci-Ce alkyl, alkyl, nitro, trifluoromethyl, halogen; η is 2 or 3; Υ image is selected from: a) the part, / R7, N Re where R? And Rs are selected from H, Cl-Ce alkyl, or optionally CN, Ci-Cs alkyl (straight or branched), halogen, -OH, -CF 3. -〇CF 3 Substituted phenyl; b)-a five-membered saturated And or partially saturated heterocycles, which contain at most two heterocycles selected from the group consisting of -0-, -NH-, -N (Ci-Cz), -N =, and -S (0) m- Atom, where hi is 0-2 = [Integer, if necessary, 1-3 are selected from the group consisting of hydrogen, hydroxyl, halogen 3 ㊁, C 1 -C 4 alkyl, trihalomethyl, Cl -C4 alkoxy Base, trihalomethyl, C 1 -C 4 fluorenyl, Ci -iU alkylthio, Ci-Cd alkylsulfinyl, C 1 -C 4 alkylsulfonyl, Ci-C4 ) Alkyl, -C02 H-, -CN 'C0NHR 1-,-NH2-, Ci-C4 alkylamino, bis (C1-C4) alk-6-amino, This paper size applies to Chinese national standards (CNS ) A4 specification (210X 297mm) wide, please read the note of% Back δ before filling in this page. Binding standard standard member of the Ministry of Economic Affairs X. Printed by the cooperative A7 Β7 V. Description of invention (,) -NHSO 2 R 1- ,-NHCOR 1-, -N 0 2-and optionally substituted with 1-3 苯基 (Ci -C4) alkyl substituted phenyl substituents; lg g) a six-membered saturated, unsaturated or partially saturated hetero A ring whose 傜 contains at most two selected from the group consisting of -〇-,- ΝΗ-, -MC !. -C- Yuanji) _, -N =, and -S (0) m- heteroatoms, where m is an integer from 0-2, and 1 to 3 are selected as needed Including hydrogen, hydroxyl, halogen, (1-C4 alkyl, trihalomethyl, Cl-C4 alkanoyl, trihalomethoxy, C1-C4 acidoxy, Cl-C4 alkylthio, Ci _C4 courtyard sub-base, C 1 -C 4 comprehensive base, Ci-C4 base, -COsH-, -CN '-C0NHR 1-, -NH 2 Ci -C4 alkylamino group, Di (C 1 -C 4) amino group. -NHS0 2 R 1-, -NHC0R 1-, -N0 2-and substituents of phenyl substituted with 1-3 (Ci -C4) alkyl groups if necessary Substitution; or d) —a t-membered, unsaturated, or partially saturated heterocyclic ring, wherein 僳 contains up to two members selected from the group consisting of -0, -N,-, -N (C1-Cz alkyl)-, -N =, and -S (0) m-heteroatom, where in is an integer of 0-2, and optionally 1-3 are selected from the group consisting of hydrogen, hydroxyl, halogen, C 1 -C 4 , Trihalomethyl, Ci-C4 alkoxy, trihalomethoxy, ci-c 4 moxy, Ci-C4 alkylthio, C: 1-C4 alkenesulfinyl, Cl-C 4 alkane Sulfonyl, hydroxyl ("-C 4) Alkyl, -C02 H-, -CN-x -C0NHR 1-. -NH 2-, C 丄 -C 4 alkylamino, di (C i-C 4) amino, -NHS0 2 R a -, -NHC0R! '-N 0 2-and optionally substituted with 1-3 (Ci -C4 > alkyl-substituted phenyl substituents; or e)-a bridge containing 6-12 sulfonic atoms Or condensed bicyclic heterocyclic ring, whose 傜 contains at most two selected from the group consisting of -0-, -NH '-N (-7-C 1 -C 4 alkanes. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (21 OX 297 mm) Please read the precautions for backing Λ before filling out this page. Binding and printing on the central standard of the Ministry of Economic Affairs, Consumer Co-operative Printing A7 B7 V. Description of the Invention (Knowledge)-, -N =, and-S (0 ) m-heteroatom, where B is an integer from 0 to 2, and optionally 1 to 3, respectively, selected from the group consisting of hydrogen, hydroxy 1 丨 •, halogen, Cl-C4, trimethyl, Cl-C4 alkyl group, trihalomethoxy group, C1-C4fluorenyl group, Ci-C4 alkylthio group, Ci-C < alkylsulfinyl group, Ci-C * alkylsulfonyl group, hydroxyl group (Ci- fU) alkyl, -CO 2 H '-CN'-C 0 NHR 1 '-ΝΗ 2' C i -C 4 Alkylamino, di (C! -C4) alkylamino, -NHSO 2 R 1-, -NHCOR 1 '-NO 2-and optionally phenyl substituted with 1-3 (Ci -C4) alkyl groups Substituent substitution; and pharmaceutically acceptable salts thereof. The better compounds of the present invention are those having a general structure I or II, wherein: K1 · is selected from the group consisting of H, 0H or Ci-C12 esters or their alkyl ethers, and Fs; R2, R3, R4, RS And "respectively selected from the group consisting of fluorene, 0H, or C 1 -C 12 esters or their ethers, dentines, gas groups, Ci -Cs groups, or trimethyl, preferably trifluoromethyl, provided that, When Ri is Η, R 2 is not 0H; X is selected from H, Ci-Cs alkyl, fluorenyl, nitro, trifluoromethyl, halogen; Y is this part: wR7 \ Re where R7 and R8 Respectively selected from H, Ci-C6 alkyl, or combined with-(CH2), where P is an integer from 2 to 6 so as to form a ring, and the ring is optionally selected from up to 3, including hydrogen, hydroxyl, halogen Ci-C 4 -8-This paper size applies to China National Standard (CNS) A4 (210X 297 mm) Please read the precautions on the back before filling in this page.

線 經 濟 部 中 央 準 % 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(7 ) 烷基,三鹵甲基,Cl -C4烷氣基,三鹵甲1 1 基,C 1 -C 4 烷硫基,Ci-C4烷磺醯基,C1-C4烷亞磺 醯基,羥基 (C i - C 4 )烷基,-C 0 2 Η,- C N,- C 0 N H ( C 1 - C 4 ) , -NH 3 ,Ci-tU烷胺基,Ci-C4二烷胺基,-HHS 〇 2 (C ! -C 4 ) ,-N H C 0 ( C i - C 4 ),及-N 0 a,取代基取代 及其藥學上可接受鹽。 如前所述,和r8 —起形成之環可包括 (但非限制 於)氮丙啶,吖丁啶,吡咯啶,六氳吡啶,f 5亞甲基胺 環或t亞甲基胺環β 本發明之最佳化合物為該等具有上逑一般 結構I或I I 者,其中Ri為〇H; R2 -Re如上所定義;X 傜選自C1, N 0 2,C N , C F 3或C Η 3之基;及Y為該部份 、尸7 \ Re · 及R7及R8共同為-(CH2 )r -,其中r為4 至6之整數 ,以形成一環,其視需要經至多三個選自包 括氫,羥基 ,鹵素,Cl -C4烷基,三鹵甲基,Cl-C4 院氧基,三 鹵甲氣基,Ci-C4烷硫基,Ci-tU烷磺醯 基,C 1 - C 4 烷亞磺醯基,羥基(Cl -C4 )烷基,-C02 Η ,-CN , -CONH(Ci -C4 )烷基,-ΝΗ3 , Ci -C4 烷胺 5 —* (Ci -C4 )烷胺基,-NHS02 (Ci -C4 )烷基, -N H C 0 ( C i - C 4 )烷基,及-N 0 2之取代基取代 9 及其藥學組成物。 -9 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閲 讀 背 之 注 意 事 項 再 填 寫 本 頁 裝 訂 A7 B7五、發明説明(ί ) 於本發明之另一具髏實施例中,其中R7 -(CH2 )P -,其中p為2至6之整數,較佳 形成環視需要經1-3個選自包含Ci -( 經濟部中央標準局員工消費合作社印製 如此所 氟甲基 代。 本發 酸鹽可 三乙胺 鹽可藉 基或二 由自由 而製得 酸鹽之 製得。 亞磷酸 所要的 本發 可接受 碘酸, 酸,檸 二酸, 酸。已 和非質 以酸加 和R 8 —起呈 為4至6 , 3烷基,三 鹵素、氫、苯基、硝基、-CN之基的取代基取 明包括酚基之硫酸鹽、胺基磺酸鹽、 藉由自由酚化合物與和胺(例如吡啶, 等)複合之三氣化硫反應而迅速製得。 由在適當鹼例如吡啶存在下以所要的 烷胺基胺磺醯基氛化物處理而製得》 酚與所要的烷磺醯基氣化物於適合鹼 。再者,本發明包括含於酚之磷酸鹽 化合物。磷酸鹽可藉由酚與適當氯磔 二烷基磷酸鹽可水解産生自由磷酸鹽 鹽,其中酚與所要的二烷基瞵氮化物 酚之二烷基隣酸鹽。 明包括從與無機酸或有機酸之加成反 鹽形式。可使用無機酸例如氫氣酸, 硫酸,磷酸,硝酸,以及有機酸例如 檬酸,順丁烯二酸,蘋果酸,酒石酸 甲烷磺酸,甲苯磺酸,莆磺酸,樟腦 知具有鹼性氮之化合物可與許多不同 子酸二者)複合,且其通常較佳本發明 硫酸酯、硫 三甲胺, 胺基磺酸 胺基或烷胺 硫酸酯可藉 存在下反應 以二烷基磷 酸鹽反應而 ,亦可申請 反應以産生 應而形成之 氫溴酸,氫 乙酸,丙 ,酞酸,丁 溝酸,苯磺 強(質子酸 之化合物 成鹽形式授予。再者,本發明包括化合物之四级 10 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) A.衣. 訂 A7 B7 五、發明説明(9 ) 銨鹽。該等可藉由惻鍵之親核性胺與適合反 如鹵化烷基或鹵化苄基反應而製得。 本發明之化合物可根據以下流程圖1合成 應烷化劑例 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 -1 1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製Central quasi-% of the Ministry of Economic Affairs printed A7 B7 printed by consumer cooperatives V. Description of the invention (7) Alkyl, trihalomethyl, Cl-C4 alkane, trihalo 1 1 group, C 1-C 4 alkylthio group , Ci-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, hydroxy (C i -C 4) alkyl, -C 0 2 fluorene, -CN, -C 0 NH (C 1 -C 4), -NH 3, Ci-tU alkylamino, Ci-C4 dialkylamino, -HHS 〇 2 (C! -C 4), -NHC 0 (Ci-C 4), and -N 0 a, substituents Substitutions and pharmaceutically acceptable salts thereof. As previously mentioned, the ring formed with r8 may include, but is not limited to, aziridine, azetidine, pyrrolidine, hexapyridine, f 5 methyleneamine ring or t methyleneamine ring β The best compounds of the present invention are those having the general structure I or II, wherein Ri is 0H; R2-Re is as defined above; X 傜 is selected from C1, N 0 2, CN, CF 3 or C Η 3 Base; and Y is the part, corpse 7 \ Re · and R7 and R8 together are-(CH2) r-, where r is an integer from 4 to 6 to form a ring, which can be selected from up to three if necessary Including hydrogen, hydroxy, halogen, Cl-C4 alkyl, trihalomethyl, Cl-C4 alkyloxy, trihalomethyl, Ci-C4 alkylthio, Ci-tU alkylsulfonyl, C 1-C 4 alkanesulfinyl, hydroxy (Cl -C4) alkyl, -C02 Η, -CN, -CONH (Ci -C4) alkyl, -NΗ3, Ci -C4 alkylamine 5 — * (Ci -C4) alkane Amino group, -NHS02 (Ci -C4) alkyl group, -NHC 0 (C i -C 4) alkyl group, and -N 0 2 substituents are substituted for 9 and its pharmaceutical composition. -9-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297mm) Please read the precautions before filling in this page to bind A7 B7 V. Description of the invention (ί) Another crossbones of the invention In the embodiment, where R7-(CH2) P-, where p is an integer from 2 to 6, it is preferred to form a look around 1-3 selected from the group including Ci-(printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Fluoromethyl. This acid salt can be obtained from triethylamine salt by free radicals or dibasic acid salts. The desired acid of phosphorous acid can accept iodic acid, acid, citric acid, acid. Substitute the acid and R 8 together to form a 4 to 6, 3 alkyl, trihalo, hydrogen, phenyl, nitro, -CN substituents including phenolic sulfate, amine Sulfonates are rapidly prepared by reacting free phenolic compounds with triple gaseous sulfur complexed with amines (e.g., pyridine, etc.). They are produced from the desired alkylamino amine sulfohydrazine in the presence of a suitable base such as pyridine. Prepared by processing "Phenol and the desired sulfonyl sulfonyl group gas are suitable for alkali. The invention includes phosphate compounds containing phenols. Phosphates can be hydrolyzed to produce free phosphate salts by the hydrolysis of phenols with appropriate chlorophosphonium dialkyl phosphates, in which the phenol is the dialkyl of the desired dialkylphosphonium nitride phenol O-acid salts. Includes inverse salt forms from additions with inorganic or organic acids. Inorganic acids such as hydrogen acid, sulfuric acid, phosphoric acid, nitric acid, and organic acids such as citric acid, maleic acid, malic acid, etc. Tartrate methanesulfonic acid, toluenesulfonic acid, sulfonic acid, camphor compounds known to have basic nitrogen can be compounded with many different acid acids), and they are generally preferred. The sulfate ester, thiotrimethylamine, aminosulfonic acid of the present invention Amine or alkylamine sulfates can be reacted with dialkyl phosphates in the presence of a reaction, or a reaction can be applied to produce the hydrobromic acid, hydroacetic acid, propyl, phthalic acid, butanoic acid, benzenesulfonate (Protonic acid compounds are granted in salt form. Furthermore, the present invention includes Grade 4 of the compounds. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm). (Please read the precautions on the back before (Fill this page) A. Clothing. Order A7 B7 5. Invention Description (9) Ammonium salts. These can be prepared by reacting a nucleophilic amine with a hydrazone bond with a suitable halogenated alkyl or benzyl halide. The compound of the invention can be synthesized according to the following flow chart. Example 1 (Please read the notes on the back before filling this page) Printed by the Consumers' Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -1 1 This paper applies Chinese national standards (CNS ) A4 size (210X297mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

I--------裝-- (請先閱讀背面之注意事項再填寫本頁)I -------- install-(Please read the precautions on the back before filling this page)

、1T -12 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) A7 B7 -溴酮(b)與 後産物以氣 氣化苄基(e ) 護製得。當 的。較佳保 五、發明説明(") 起始吲呤合成偽藉由加熱適當經取代之《 所要之一起加熱於DMF中以形成吲昤(c)。然 化苄基(e )烷基化以産生經取代之吲昤(f )。 可如所示之2步驟從醛(d)迅速製得。産物(g)可藉由酯 之還原作用從(f)醇轉化成溴,在適當溶劑^THF或DMF 中以所要胺取代溴,及最後若需要的話去保 R 1或R 2或二者以酯保護時,去保護是需要 護基為苄基,其可以數種習知方法(持別是窠解)方便地 除去。 ----------裝-- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 物。溴 3 一置位 t 化著亞士 合的N-之由位3-al基接以人 化佳,得藉3-之 S 氡酯由之 之較胺所,於擇U1B3-酸藉藉 。 基為醯 。質 。選,nl,^0^0^^__0 硝成二成先I)可B1者異物該路 ,合 丁完之(I或 i 或基合熟他 基擇氯地物汞用yl。醯化諳其 氰選N-易合基作rffl腈磺之一用 ,可如容化甲化fo成氛基任利 基之以劑基氟氱1(氫與硝。可 甲示易試甲三性^1去B*為得亦 氟所容之氟雙核®r後吲置製且 三 2 可胺三及親 — 隨之位而制 1 ,匾成醯 3 劑由^1及代3-昤限 素程形二為化M^ 肟取。蚓不 齒流的丁 作催可top成經成理並 ,如素碘可耙物:5變未合處徑 =H種鹵N-物用合(#1轉3-而酸路 X 一之或合利化化基由應乙等 具,置胺化應之醯醯藉反和該 於成位醯哚反基甲甲可胺納 , 至合3-二吲合氣可後物乙酸解 的於丁碘偶具置然合三硝了 ,11 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製、 1T -12 This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 X 297 mm) A7 B7-bromoketone (b) and the after product are prepared by gasification of benzyl (e). When. Better guarantee 5. Invention description (") The initial indine synthesis is heated in DMF to form indene (c) by heating appropriately substituted "desired". Natural benzyl (e) is alkylated to produce a substituted indene (f). It can be quickly prepared from the aldehyde (d) in the two steps shown. The product (g) can be converted from (f) alcohol to bromine by reduction of the ester, replacing bromine with the desired amine in a suitable solvent ^ THF or DMF, and finally protecting R 1 or R 2 or both if necessary. In the case of ester protection, deprotection requires benzyl as the protecting group, which can be easily removed by several conventional methods (specifically, hydrolysis). ---------- Outfit-(Please read the precautions on the back before filling out this page) The Central Consumers Bureau of the Ministry of Economic Affairs's consumer co-operative prints. The bromine 3 is set to t and the N-site of the ash group is connected with the 3-al group. It is better to borrow the S-ester of 3- than the amine, and to borrow U1B3-acid. The basis is 醯. Quality. Election, nl, ^ 0 ^ 0 ^^ __ 0 Nitrogen is two into the first I) B1 can be a foreign body, and Ding Wanzhi (I or i or Jishutaiji selects the chlorine chloride, mercury, yl.) Its cyanoselective N-easy group is used as one of rffl nitriles. It can be used as a solvent for methylation fo to form an aryl group. It can be used as a fluorinated fluorene 1 (hydrogen and nitrate. It can be shown as easy-to-test trisine ^ 1) B * is made of fluorinated dual-core®r, which can be obtained by fluorid, and it is made of triamine and triammonium — it is made in the same position. The second is to take M ^ oxime. Ding Zuo of earthworms can be topped up, such as plain iodine can be raked: 5 change the unreachable diameter = H kinds of halogen N-physical combination (# 1 转 3 -And the acid group X or the synthesizing group is provided by Ying B, etc., and the amidation reaction should be reversed and the indole transyl methylmethoxamine can be formed to the 3-diindene compound. The acetic acid hydrolysate of acetonitrile is compatible with trinitrate, 11 paper sizes are applicable to China National Standard (CNS) A4 (210X 297 mm). Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs.

(請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製(Please read the notes on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

裝 訂 键 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標隼局員工消費合作社印製Binding key (Please read the precautions on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs

(請先閱讀背面之注意事項再填寫本頁) -u^·. 、?τ if 五、發明説明(u A7 B7 流程圖4中所示合成步驟可使用於類似於 之實施例编號97之具2偏磺鏈之化合物。此 施例编號1 2 7之流程圖4 9。 流程圖4 a(Please read the notes on the back before filling out this page) -u ^ ·. 、? Τ if V. Description of the invention (u A7 B7 The synthesis steps shown in the flow chart 4 can be used for the similar example number 97 Compound with 2 partial sulfonic chain. This example number 1 2 7 of the flow chart 4 9. Flow chart 4 a

NH3+CI-NH3 + CI-

DMF. EtaN OBn CBn ΟΑβ#[20886·03<η CAS #(51388-20-61DMF. EtaN OBn CBn ΟΑβ # [20886 · 03 < η CAS # (51388-20-61

CAS# [99847-87-71 實施例编號127 流程圖3中 示於用於實CAS # [99847-87-71 Example No. 127

+實施例縝號P+ Example 缜 号 P

NaHNaH

DMF 經濟部中央樣準局員工消費合作社印製Printed by DMF Employees' Cooperatives

OBn K施例編號50 於吲呤之3-位置具有可選擇之取代基(CN, 的合成二者利用3 -未經取代吲呤編號141作^ 時傣藉由費雪(F i s h e r )法·,利用衍生自4 -苄 CAS编號[5 4 636-05-8〕和4-节氣基苯基阱 -58-5]之縮合作用之腺。腙编號140然後於乙 C 1 )之吲呤 前質。H引 _基苯乙_ C A S编號丨5 1 1 4 5 酸中使用 I- ! n I^I I I __ —訂 I I I I 髮 (請先閱讀背面之注意事項再填寫本頁) 17- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) A7 經濟部中央標準局員工消費合作社印製OBn K Example No. 50 has an optional substituent at the 3-position of indrine (CN, both of which are synthesized using 3 -unsubstituted indine No. 141) ^ By Fisher method · , Using the condensing gland derived from 4-benzyl CAS number [5 4 636-05-8] and 4-solenyl phenyl well-58-5]. 腙 number 140 and then B C 1) Indolin precursor. H__phenylphenylethyl_ CAS number 丨 5 1 1 4 5 Use of I-! N I ^ III __ — Order IIII hair (please read the precautions on the back before filling this page) 17- This paper size applies China National Standard (CNS) A4 specification (210X297 mm) A7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閲讀背面之注意事項再填寫本頁) 五、發明説明(π ) A7 B7 經濟部中央標隼局員工消費合作社印製(Please read the notes on the back before filling out this page) V. Invention Description (π) A7 B7 Printed by the Staff Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs

----------一裝-- (請先閲讀背面之注意事項再填寫本頁) 訂 叙 A7 B7 經濟部中央標準局員工消費合作社印製---------- One Pack-(Please read the precautions on the back before filling out this page) Order A7 B7 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閱讀背面之注意事項再填寫本頁) 、1Τ Μ Β7 經濟部中央標準局員工消費合作社印製 五、發明説明 ( ί1 ) 1 1 由 於 該 等 化 合 物 之 組 饑 選 擇 性 9 其 可 用 於 療 或 預 防 哺 1 1 乳 類 之 因 雌 激 素 缺 乏 (在某些組鏃如骨或心 輿血管中)或 1 1 有 關 之 疾 病 狀 態 或 症 候 群 〇 其 亦 可 使 用 於 η 療 由 子 宮 内 請 1 膜 異 位 或 以 子 宮 内 膜 異 位 紐 織 的 增 生 » 異 發 展 作 用 或 先 閲 1 1 1 | 生 長 的 方 法 中 〇 背 面 1 I 之 1 本 發 明 化 合 物 藉 由 降 低 膽 固 醇 之 類 似 雌 绣 素 作 用 雨 之 意 1 | 能 力 及 可 預 防 骨 質 流 失 〇 該 等 化 合 物 可 用 % 治 療 許 多 由 事 項 1 I 再 1 雌 激 素 效 果 及 雌 激 素 過 量 或 缺 乏 所 造 成 之 包 括 骨 疏 寫 本 裝 鬆 病 前 列 腺 肥 大 » 不 孕 症 » 乳 癌 9 子 宮 膜 癌 * 心 ϋ 頁 1 I 血 管 疾 病 9 避 孕 阿 玆 海 黙 氏 病 及 黑 素 瘤 〇 此 外 該 等 化 1 1 合 物 可 用 於 更 年 期 後 婦 女 或 其 他 必 須 補 充 Μ 激 素 之 雌 激 1 I 素 缺 乏 狀 態 做 為 激 素 替 代 療 法 0 1 1 訂 本 發 明 化 合 物 亦 可 用 於 骨 質 流 失 之 治 療 和 預 防 中 9 骨 1 質 流 失 可 能 由 個 體 新 骨 組 鐵 的 生 成 及 老 舊 組 織 的 吸 收 間 1 I 不 平 衡 引 起 J 而 導 至 骨 質 流 失 0 此 種 骨 質 排 空 導 致 某 1 I Μ 體 i 特 別 是 經 後 婦 女 9 接 受 卵 巢 切 除 婦 女 > 正 在 接 1 受 或 曾 經 接 受 長 的 時 間 皮 質 類 固 醇 治 療 者 9 性 腺 發 育 不 叙 I 良 者 9 及 庫 興 氏 症 候 群 者 〇 對 於 骨 質 替 代 有 特 別 需 求 之 1 1 患 者 也 可 使 用 本 發 明 之 化 合 物 9 包 括 骨 析 骨 結 構 缺 陷 1 I 9 以 及 接 受 骨 相 關 手 術 及 / 或 植 入 腾 複 物 〇 除 前 述 問 題 1 I 之 外 » 該 等 化 合 物 可 用 於 治 療 骨 疏 鬆 病 > 巴 待 氏 病 9 1 1 骨 軟 化 9 骨 質 耗 損 9 子 宮 内 膜 癌 多 發 性 脅 钱 瘤 及 其 他 1 | 形 式 對 骨 組 繊 具 有 有 害 影 繼 的 癌 形 式 Ο 此 處 列 舉 的 疾 病 1 治 法 包 括 對 需 此 治 療 之 個 體 投 予 醫 藥 有 效 量 之 一 種 或 多 1 1 -2 1 - 1 1 1 1 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ29?公f ) A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明 ( ^) 種 本 發 明 化 合 物 或 其 藥 學 上 可 接 受 鹽 〇 本 明 也 包 含 醫 藥 組 成 物 » 包 括 一 種 或 多 種 本 發 明 化 合 物 及 / 或 其 翳 藥 上 可 接 受 鹽 連 同 種 或 多 種 醫 學 上 可 接 受 m 劑 9 賦 形 m 等 0 應 了 解 的 是 該 等 化 合 物 之 剤 量 、 服 法 用 1 將 隨 疾 病 及 接 受 治 療 的 個 體 ΕΠΧ 而 異 » 且 由 醫 師 判 斷 決 定 〇 較 佳 以 低 劑 量 投 予 一 種 或 多 種 本 文 所 述 化 合 物 〇 然 後 η 加 劑 量 至 獲 得 所 需 效 果 為 止 〇 該 等 化 物 之 有 效 投 予 可 以 約 0 . 1毫克/天 至約1 ,〇 0 0 毫 克 / 曰 之 劑 量 給 予 0 較 佳 5 投 予 將 於 約 1 0 毫 克 / 天 至 約 600毫克/天, 更佳為約5 0毫克到6 0 0 毫 克 / 天 於 單 一 劑 量 或 二 個 或 以 上 之 分 別 劑 量 〇 該 劑 量 可 & 直 接 使 用 活 性 化 合 物 至 接 受 者 血 流 中 之 任 何 方 式 投 予 包 括 Ρ 服 » 經 植 入 » 非 m «h-L. 腸 道 (包括, 肌肉, 腹膜内和 安下注射) 、 直 腸 ) 陰 道 > 及 經 皮 〇 為 所 掲 示 之 巨 的 9 7 解 的 是 經 皮 投 予 包 括 所 有 投 予 模 過 身 體 表 面 及 包 括 上 皮 和 黏 膜 組 織 之 身 體 路 徑 的 内 襯 0 該 投 予 可 使 用 本 發 明 Λ 合 物 > 或 其 藥 學 上 可 接 受 鹽 以 乳 液 乳 膏 » 泡 沫 9 編 囊 懸 浮 液 溶 液 及 栓 劑 (直腸或陰道)進 行 〇 含 本 發 明 活 性 化 合 物 之 Π 服 配 方 可 包 括 任 何 習 知 使 用 的 型 式 » 包 括 錠 劑 1 膠 囊 t 頰 的 型 式 9 糖 鍵 , 片 劑 及 P 服 液 體 〇 膠 囊 可 包 含 活 性 成 分 與 惰 性 載 體 / 或 稀 釋 劑 例 如 藥 學 上 可 接 受 澱 粉 (例如玉米、 馬鈴薯或 木薯澱粉), jh.+ 蔗 糖 > 人 工 甜 味 劑 9 粉 狀 -2 纖 2 - 維 素 * 例 如 結 晶 和 微 晶 m 維 ---------一裝-- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) '?τ 喊膠(莫克等 用得自EM 祈。在 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明( >丨) 素,麵粉,明膠,膠,等等。有效之錠劑#方可以習知 壓縮,濕式製粒或乾式製粒方法製造及利m藥學上接受 稀釋劑,黏合劑,潤滑劑,崩散劑,懸浮或安定劑,包 括但不限制於,硬脂酸鎂,硬脂酸,滑石,月桂基硫酸 納,徹晶纖維素,羧甲基繼維素鈣,聚乙烯毗咯啶 明海藻酸,阿拉伯醪,三仙檸樣S丨納,複合矽 酸鹽,碳酸鈣,甘胺酸,糊精,蔴糖,花楸醇,磷酸二 鈣,硫酸鈣,乳糖,高嶺土,甘露醇,氯化納,滑石, 乾澱粉,糖粉。於此口服配方可利用標準延運或時間釋 放配方以改變活性化合物之趿收。栓劑配方可從傳統物 質,包括可可脂,有或没有添加腦以改變栓劑熔點,及 甘油。亦可使用水溶性栓劑基,例如各種^子量之聚乙 二醇。(Please read the precautions on the back before filling this page), 1T Μ Β7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (1) 1 1 Due to the selectivity of these compounds, it can be used for treatment Or prevent breastfeeding 1 1 milk due to estrogen deficiency (in some groups such as bone or heart blood vessels) or 1 1 related disease states or syndromes. It can also be used in η treatment from the uterus please 1 membrane difference Or endometriotic hyperplasia »Heteroplastic effect or pre-reading 1 1 1 | Method of growth 〇Back 1 I 1 1 The compound of the present invention acts like estrogen to lower cholesterol by rain 1 | Ability and prevention of bone loss. 0% of these compounds can be used to treat many of the issues caused by 1 I and 1 estrogen effects and excess or deficiency of estrogen. Osteoporosis, pineal disease, prostate hypertrophy »Infertility» Breast cancer 9 Endometrial cancer * Heart palpitations Page 1 I Vascular diseases 9 Contraceptives of Alzheimer's disease and melanoma. In addition, these chemical compounds can be used for menopause Later women or other women must be supplemented with estrogen M hormone 1 I hormone deficiency as hormone replacement therapy 0 1 1 The compounds of the present invention can also be used in the treatment and prevention of bone loss9 Bone 1 Mass loss may be caused by individual new bone group iron 1 I imbalance between generated and old tissue absorption causes J to lead to bone loss 0 This type of bone emptying leads to 1 1 Μ body i, especially postmenopausal women 9 women undergoing ovariectomy > receiving 1 or once Patients receiving long-term corticosteroid treatment 9 Gonadal dysplasia I Good 9 and Cushing syndrome 0 Special needs for bone replacement 1 1 People can also use the compound 9 of the present invention, including osteoporotic structure defect 1 I 9 and undergoing bone related surgery and / or implantation of Tengfu. In addition to the aforementioned question 1 I »These compounds can be used to treat osteoporosis > Bardt's disease 9 1 1 Osteomalacia 9 Bone loss 9 Endometrial cancer Multiple money tumours and other 1 | Forms of cancer that have a harmful effect on the bone marrow Ο Diseases listed here 1 The treated individual administers one or more pharmaceutically effective amounts of 1 1 -2 1-1 1 1 1 This paper size is applicable to the Chinese National Standard (CNS) Λ4 specification (210 × 29? Male f) A7 B7 Staff consumption of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the cooperative V. Description of the invention (^) A compound of the present invention or a pharmaceutically acceptable salt thereof. The present invention also includes a pharmaceutical composition »including one or more compounds of the present invention and / or its peony Accepted salt together with one or more medically acceptable m agents 9 forms m etc. 0 It should be understood that the amount of these compounds and how they are used 1 will vary depending on the disease and the individual being treated »and determined by the physician 〇 Preferably, one or more of the compounds described herein are administered in a low dose, and then eta is dosed until the desired effect is obtained. The effective administration of the compound can be from about 0.1 mg / day to about 1,000 mg. A dose of 0 is preferred, and 5 is administered at a dose of about 10 mg / day to about 600 mg / day, more preferably about 50 mg to 600 mg / day in a single dose or two or more respectively. Dosage: This dose can be administered by any means including direct application of the active compound to the recipient's bloodstream including P administration »Implantation» non-m «hL. Intestinal tract (including, intramuscular, intraperitoneal and subcutaneous injection), Rectum) vagina > Transdermal is the huge 9 7 shown. The solution is transdermal administration, which includes all the linings of the body surface and the lining of the body path including epithelial and mucosal tissues. 0. This administration can use the present invention. Compounds or their pharmaceutically acceptable salts are carried out with emulsion creams »Foam 9 capsulating suspension solutions and suppositories (rectal or vaginal). Formulations containing active compounds of the invention may include any conventionally used form» Including lozenge 1 capsule t cheek type 9 sugar bond, tablet and liquid P capsules may contain active ingredients and inert carriers / or diluents such as pharmaceutically acceptable starch (such as corn, potato or tapioca starch), jh. + Sucrose > artificial sweetener 9 powder-2 fiber 2-vitamin * such as crystalline and microcrystalline m-dimensional --------- one pack-(Please read the precautions on the back before filling in this (Page) This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) '? Τ shout gum (Merck, etc., available from EM pray. Printed in the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Description (> 丨) Vegetarian, flour, gelatin, gum, etc. Effective tablets can be produced by conventional compression, wet granulation or dry granulation methods and can be used in pharmaceuticals to accept diluents, binders, lubricants, disintegrating agents, suspensions or stabilizers, including but not limited to, Magnesium stearate, stearic acid, talc, sodium lauryl sulfate, crystalline cellulose, calcium carboxymethyldividin calcium, polyvinylpyrrolidamine alginic acid, arabic tincture, Sanxian lemon-like sodium Silicate, calcium carbonate, glycine, dextrin, mannose, anthocyanin, dicalcium phosphate, calcium sulfate, lactose, kaolin, mannitol, sodium chloride, talc, dry starch, powdered sugar. Oral formulations can be modified here using standard extended or time release formulations to alter the yield of the active compound. Suppositories can be formulated from traditional substances, including cocoa butter, with or without the addition of brain to alter the suppository melting point, and glycerin. Water-soluble suppository bases such as polyethylene glycol in various amounts can also be used.

Aldrich Sure Seal™溶_,無水没有進步純化, 可做為本文所述反應中及可從Aldrich化學公司。所有 反應進行於氮大氣壓下。使用230-400目矽 级60,Aldrich化學公司)芫成色層分析。倒 Science之矽凝膠60F254板完成薄層色層分 Brucher AM-400或 Bruker DPX-300儀器於 DJS0中獲得 1 HNMR光譜及化學位移報告為ppbu熔點测定於Thoeas-Hoover儀器且未經校正。IR光譜記錄於Perkin-Elner 繞射光柵或Perkin-El*er784光譜。質譜記丨ϋ於kratos MS 50或Finnigan 8230質譜儀。元素分析係利用Perkin -E 1 b e r 2 4 0 0元素分析器獲得。除非説明否j^lj ,化合物 -2 3 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------ί 裝-- (請先閲讀背面之注意事項再填寫本頁) -1Τ 五、發明説明(^) A7 B7 合物之命名 之CHN於已知化學式之理論值的〇·4%内。化 藉由Beilstein Autonom™程式逹成。 α -漳酬合成 Hi α -溴酮之合成方梗藉由將起始苯基酮溶ψ於乙醚(0·05 -0 . 1 0 Μ )及於室溫,逐滴加入1 . 1當量之溴完 成。反應可 以T L C檢測起始物質之消耗監测。以碳酸氫^水溶液接箸 1 0 %亞硫酸鈉水溶液洗滌結束反應。以鹽水 及經硫酸鎂乾燥。反應混合物之濃縮典型産 及純度之溴酮。溴酮以其本身(沒有純化或珠性)而使用 於下一步驟。 3 -甲某Ν丨盹 洗滌乙醚層 生良好産率 ----------ίΊ-- (請先閲讀背面之注意事項再填寫本頁) 流程圖8X~^》-NHa.C丨 CAS# [51145-58-5]Aldrich Sure Seal ™ is soluble, anhydrous without purification and can be used in the reactions described herein and from Aldrich Chemical Company. All reactions were performed under nitrogen atmosphere. 230-400 mesh silicon grade 60 (Aldrich Chemical Co.), chromophore analysis. The silica gel 60F254 plate of Science was used to complete the thin layer color separation. Brucher AM-400 or Bruker DPX-300 instrument was used to obtain the 1 HNMR spectrum and chemical shift report in DJS0. The melting point was determined on the Thoeas-Hoover instrument without correction. IR spectra were recorded in Perkin-Elner diffraction gratings or Perkin-El * er784 spectra. Mass spectra were recorded on a Kratos MS 50 or Finnigan 8230 mass spectrometer. Elemental analysis was obtained using a Perkin-E 1 be r 2 4 0 0 elemental analyzer. Unless stated otherwise, compound-2 3-This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) --------- ί Packing-(Please read the precautions on the back first Fill out this page again) -1Τ 5. Description of the invention (^) The named CHN of the A7 B7 compound is within 0.4% of the theoretical value of the known chemical formula. Transformation is accomplished with the Beilstein Autonom ™ program. Synthetic formula of α-zhangyin to synthesize Hi α-bromo ketone By dissolving the starting phenyl ketone in diethyl ether (0.05-0.10 M) and adding 1.1 equivalents dropwise at room temperature. Bromine is complete. The reaction can be monitored by T L C detection of starting material consumption. The reaction was completed by washing with a hydrogen carbonate aqueous solution followed by a 10% aqueous sodium sulfite solution. Brine and dried over magnesium sulfate. Concentration of the reaction mixture typically yields bromone in purity. Bromone was used as such (no purification or beading) in the next step. 3-A certain Ν 丨 盹 washed ether layer good yield ---------- ίΊ-- (Please read the precautions on the back before filling this page) Flow chart 8X ~ ^》-NHa.C丨 CAS # [51145-58-5]

1 -E t a N,DMF 訂1 -E t a N, DMF order

Br 2 -額外之 苯胺Br 2-additional aniline

實施例编號卜20 經濟部中央標準局員工消費合作社印製Example No. 20 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

表1Table 1

No. 1 Η Η No. la F ΟΒα No. 2 Η 4’-ΟΒη 本紙張尺度適用中國國家標準(CNS ) A4規格(_2f〇4X_297公釐 A7 B7 五、發明説明(η) 經濟部中央標準局員工消費合作社印装 表1 (鑕 實施例编號 No. 3 OBn Η No. 4 OBn 4’-OMe No. 5 OMe 4,-OMe No. 6 OBn 4’-OEt No. 7 OBn 4,-OBn No. 8 OBn 4,-F No. 9 OBn 3’-OMe,4,-OBn No. 10 OBn 3,,4,-0CH20- No. 11 OBn 4,-0-iPr No. 12 OBn 4,-0-Cp No. 13 OBn 4’-CF3 No. 14 OBn 4’-CH3 No. 15 OBn 4’-Cl No. 16 OBn 2’-OMe,4’-OMe No. 17 OBn 3’-OBn No. 18 OBn 4’-OBn,3’-F No. 19 OBn 3,-OMe No. 20 OBn 4,-OCF3 11 實敝.丄 5 - 苄氣基- 2-U-苄氩基-苯基卜 3 -甲基-1 iL- IB』 將4-苄氣基苯胺鹽酸鹽CAS编號〔51145-5 8 ~ 9 0 . 23奠耳),4 '-苄氧基-2-溴 苯苯基苯丙· ic 6 6 4 1 4 - 1 9 - 5〕 ( 2 1 克,0 · Q 6 6 莫耳)及 5 0 毫升 D MF 瓶 中《於回流加熱反應3 0分鐘, 然後冷卻至 室 配 於250毫升EtGAc和100毫升1N fi C 1 (水溶液 )O (水溶液)及鹽水洗滌EtO Ac及經 MgSO 4乾燥a 灌 53 (45克 以 NaHCO -25- ----------1^-- (請先聞讀背面之注意事項再填寫本頁)No. 1 Η Η No. la F 〇Βα No. 2 Η 4'-〇Βη This paper size applies to Chinese National Standards (CNS) A4 specifications (_2f〇4X_297 mm A7 B7 V. Description of invention (η) Central Bureau of Standards, Ministry of Economic Affairs Employee Consumer Cooperative Cooperative Form 1 (锧 Example No. 3 OBn Η No. 4 OBn 4'-OMe No. 5 OMe 4, -OMe No. 6 OBn 4'-OEt No. 7 OBn 4, -OBn No. 8 OBn 4, -F No. 9 OBn 3'-OMe, 4, -OBn No. 10 OBn 3 ,, 4, -0CH20- No. 11 OBn 4, 0-iPr No. 12 OBn 4,- 0-Cp No. 13 OBn 4'-CF3 No. 14 OBn 4'-CH3 No. 15 OBn 4'-Cl No. 16 OBn 2'-OMe, 4'-OMe No. 17 OBn 3'-OBn No. 18 OBn 4'-OBn, 3'-F No. 19 OBn 3, -OMe No. 20 OBn 4, -OCF3 11 敝. 5-benzylamino-2-U-benzylarginyl-phenylbenzene 3 -Methyl-1 iL- IB "CAS number [51145-5 8 ~ 9 0. 23 Moore), 4'-benzyloxy-2-bromophenylphenylbenzene C.ic 6 6 4 1 4-1 9-5] (2 1 g, 0 · Q 6 6 mol) and 50 ml D MF bottle "heat reaction at reflux for 30 minutes, Then cool to room with 250 ml of EtGAc and 100 ml of 1N fi C 1 (aqueous solution) O (aqueous solution) and brine to wash EtO Ac and dry it with MgSO 4 and pour 53 (45 g with NaHCO -25- ------ ---- 1 ^-(Please read the notes on the back before filling in this page)

,1T 本紙張尺度適用t國國家標準(CNS ) A4規格(210X297公釐) 經 濟 部 t 央 標 準 局 貝 工 消 費 合 作 社 印 袈 Α7 Β7 五、發明説明(μ) 及將殘留溶解於c H 2 C 1 2中且加入己烷以汶 澱出2 5克之 粗固體。將固體溶解於CH2C12及於矽凝i 上蒸發,且 使用C Hfl 2 /己烷(1 2 5 )層析以産生9 . 2克沒 棕色固體 (33%): Mp = 150-152°C; ^NMR (DMSO) 10.88 (s, 1 H), 7.56 (d, 2 H, J = 8.8 Hz), 7.48 (d, 4 H, J = 7.9 Hz), 7.42· 7.29 (m, 6H), 7.21 (d, 1 H, J = 7.0 Hz), 7.13 (d, 2 H, J = 8.8 Hz), 7.08 (d, 1 H, J =2.2 Hz), 6.94 (dd, 1 H, J = 8.8, 2.4 Hz), 5.16 (s, 2 H), 5.11 (s, 2 H), 2.33 (s, 3 H); IR (KBr) 3470, 2880,2820,1620 cm'1; MS el m/z 419. 亦為說明奮施例编號7之方法2 ί頴示於流稈圖8 ) 所使用之試劑與方法1相同,除於此方 去中使用額 外之三乙胺之外。溴酮编號〔6 6 4 1 4 - 1 9 - 5〕 (50 · 0克, 0.16莫耳)於200毫升DMF中以苯胺鹽酸鹽CA 3編號〔 51145-58-5] (44克,0.2 2莫耳)及反應以氤 冲冼10分鐘 。加入三乙胺(54.6毫升)及反應於12(^加; a 2小時。 TLC分析(EtOAc/己烷)顯示起始物質形成較 極性點而消 失。使反應混合物冷卻及加入額外之48克$ 胺鹽酸鹽。 反應於1 5 0 °C加熱2小時。加入額外之5克; 隹胺及反應 於1 5 (TC加熱額外之3 0分鐘。使反應混合® ; 爹卻至室溫 ,然後注入至約1 . 5升之水和以2升之Z酸< 1酯萃取。 如果需要的話固體以額外之乙酸乙酯溶解° 以1升之1 N NaO Η水溶液,1升水,鹽水洗滌,然後經硫 酸鎂乾燥及 過濾。濃縮有機層以産生粗固體,該固 50毫升甲醇 一起攪拌及過濾。然後此固體與乙酸乙_ 一 起攪拌及過 濾。固體與甲醇和乙醚交替攪拌直到為白 及具有相似 於方法1所述编號7之熔點的熔點。反磨S -9 β - ----- 生36克産物。 本紙張尺度適用+國國家標準(CNS > Α4規格(210X297公釐) 請 先 閲 背 Λ 之 注 意 事 項 再 填 寫 本 頁 訂 經濟部中央揉準局貝工消费合作社印製 A7 B7 五、發明説明(<) Ml眩物理數墟 下列3 -甲基吲呤(编號1 -编號2 0〉係根據流 程圖2使用 方法之步驟,利用適當之經取代溴酮(如上f ί述製備)和 苯胺(商業上可獲得,A 1 d r i c h )做為起始劑 合成。 審旃例编號1 2 -荣某-3 -申甚-1 Η - B5 Mp = 90 -94°C; !h NMR (DMSO) 11.13 (s, 1 H), 7.68 - 7.64 (n ί, 2 H), 7.54 - 7.46 (m, 3 H), 7.37 - 7.32 (m, 2 H), 7.12 - 7.06 (m, 1 H), 7.03 - 6.97 (m, 1 Η), 2.40 (s, 3 H); MS el m/z 207 (M+). 奮旃例缠號la 5-氩- 2- (4-苄氤甚-荣某 甲基-1 Η - 哑1 Mp= 1 4 3 - 1 4 6 °C 富旃例編號2 2-(4 -苄氬甚-荣甚甲甚-1 H-llil ίϊ Mp = 118 - 120°C; 1h NMR (DMSO) 11.03 (s, 1 H), 7.57 (dd, 2 H, J = 2.0 Hz, 6.6 Hz), 7.48 - 7.46 (m, 3 H), 7.44 - 7.28 ( m, 4 Η), 7.18 - 7.11 (m, 2 H), 7.08 - 7.03 (m, 1 H), 7.0 - 6.95 (m, 1 H), 5.16 (s 2 Η), 2.36 (s, 3 H); MS el m/z 313 (M+). 奮施例编號3 5 -苄氳某-2 -茱某-3 -甲某-1 H - m m Mp = 141-144°C; Ή NMR(DMSO) 10.98 (s, 1 H), 7.65-7.61 (m 2 Η), 7.51-7.44 (m, 4 H), 7.42-7.28 (m, 4 H), 7.23 (d, 1 H, J = 8.8Hz), 7.10 (d, 1 Η, J = 2.5Hz), 6.80 (d, 1 H , J = 6.0Hz), 5.10 (s, 2 H), 2.36 (s, 3 H); MS el m/ ε 313 (Μ+). 奮施例编號4 5-节氣某- 2- (4 -甲氬某-笨基) -3 -甲某 -1 Η - B4I ¢4 Mp =158°C; Ή NMR 10.85 (brs, 1 H), 7.56 (d, 2 H, J = 8.8 Hz ),7.48 (d, 2 Η, J = 8.3 Hz), 7.45 - 7.36 (m, 2 H), 7.34 -7.28 (m, 1 H), 7.21 (d, 1 H ,J = 8.6 Hz), 7.09 - 7.04 (m, 3 H), 6.79 (dd, 1 H, J = 8.8 Hz), 5.11 (s, 2 H), 3.80 (s 3 Η), 2.33 (s, 3 H); IR (KBr) 3400, 2900,1610 αη'1; MS el m/z 343 (M+); C23H21NO2 +〇·25Η2 0之 CHN計算值 〇 -27- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐), 1T This paper size is applicable to the national standard (CNS) A4 specification (210X297 mm) Ministry of Economic Affairs t Central Standards Bureau Shellfish Consumer Cooperative Seal A7 B7 V. Description of the invention (μ) and dissolving the residue in c H 2 C Add 12 and add hexane to precipitate 25 g of crude solid. The solid was dissolved in CH2C12 and evaporated on silica gel i, and chromatographed using C Hfl 2 / hexane (125) to give 9.2 g of a brown solid (33%): Mp = 150-152 ° C; ^ NMR (DMSO) 10.88 (s, 1 H), 7.56 (d, 2 H, J = 8.8 Hz), 7.48 (d, 4 H, J = 7.9 Hz), 7.42 · 29 (m, 6H), 7.21 ( d, 1 H, J = 7.0 Hz), 7.13 (d, 2 H, J = 8.8 Hz), 7.08 (d, 1 H, J = 2.2 Hz), 6.94 (dd, 1 H, J = 8.8, 2.4 Hz ), 5.16 (s, 2 H), 5.11 (s, 2 H), 2.33 (s, 3 H); IR (KBr) 3470, 2880, 2820, 1620 cm'1; MS el m / z 419. Also for Method 2 of Fen Example No. 7 is shown in Figure 8) The reagent used is the same as Method 1, except that additional triethylamine is used here. Bromone number [6 6 4 1 4-1 9-5] (50 · 0 g, 0.16 mol) in 200 ml DMF with aniline hydrochloride CA 3 [51145-58-5] (44 g, 0.2 2 mol) and the reaction was rinsed for 10 minutes. Triethylamine (54.6 mL) was added and the reaction was allowed to proceed at 12 h (a plus 2 h. TLC analysis (EtOAc / hexane) showed that the starting material formed a more polar point and disappeared. The reaction mixture was cooled and an additional 48 g was added. Amine hydrochloride. The reaction was heated at 150 ° C for 2 hours. An additional 5 g was added; the amidine and the reaction were heated at 15 (TC for an additional 30 minutes. Mix the reaction ®; Dat to room temperature, then Fill with about 1.5 liters of water and extract with 2 liters of Z acid < 1 ester. If necessary solids are dissolved with additional ethyl acetate ° Washed with 1 liter of 1 N NaO Η aqueous solution, 1 liter of water, brine, It was then dried over magnesium sulfate and filtered. The organic layer was concentrated to produce a crude solid, which was stirred and filtered with 50 ml of methanol. The solid was then stirred and filtered with ethyl acetate. The solid was alternately stirred with methanol and ether until it was white and The melting point is similar to the melting point of No. 7 described in Method 1. Back grinding S -9 β------ produces 36 grams of products. This paper size applies + national national standards (CNS > A4 size (210X297 mm) Please read the notes of back Λ before filling Write this page to print A7 B7 printed by the Shellfish Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs. 5. Description of the invention (<) Ml dazzling physical numbers following 3 -methylindrine (No. 1-No. 2 0) are based on Scheme 2 uses the steps of the method, using appropriate substituted bromoketones (prepared as described above) and aniline (commercially available, A 1 drich) as the initiator synthesis. Case No. 1 2-Rong -3 -Shenxi-1 Η-B5 Mp = 90 -94 ° C;! H NMR (DMSO) 11.13 (s, 1 H), 7.68-7.64 (n ί, 2 H), 7.54-7.46 (m, 3 H), 7.37-7.32 (m, 2 H), 7.12-7.06 (m, 1 H), 7.03-6.97 (m, 1 Η), 2.40 (s, 3 H); MS el m / z 207 (M + ). Fentative case number la 5-argon 2- 2- (4-benzylpyrene-Rongmou methyl-1 Η-dumb 1 Mp = 1 4 3-1 4 6 ° C Rich case number 2 2- ( 4 -benzyl argon- Rongshijia -1 H-llil ίϊ Mp = 118-120 ° C; 1h NMR (DMSO) 11.03 (s, 1 H), 7.57 (dd, 2 H, J = 2.0 Hz, 6.6 Hz), 7.48-7.46 (m, 3 H), 7.44-7.28 (m, 4 Η), 7.18-7.11 (m, 2 H), 7.08-7.03 (m, 1 H), 7.0-6.95 (m, 1 H), 5.16 (s 2 Η), 2.36 (s, 3 H); MS el m / z 313 (M +). Fen example number 3 5-benzamidine -2-jumou -3-a certain-1 H-mm Mp = 141-144 ° C; Ή NMR (DMSO) 10.98 (s, 1 H), 7.65-7.61 (m 2 Η), 7.51-7.44 (m, 4 H), 7.42-7.28 (m, 4 H), 7.23 (d, 1 H, J = 8.8Hz), 7.10 (d, 1 Η, J = 2.5Hz), 6.80 (d, 1 H, J = 6.0Hz), 5.10 (s, 2 H), 2.36 (s, 3 H); MS el m / ε 313 (Μ +). Example number 4 5-solar term-2- (4 -methylargon-benzyl) -3 -methyl-1-4-B4I ¢ 4 Mp = 158 ° C; Ή NMR 10.85 (brs, 1 H), 7.56 (d , 2 H, J = 8.8 Hz), 7.48 (d, 2 Η, J = 8.3 Hz), 7.45-7.36 (m, 2 H), 7.34 -7.28 (m, 1 H), 7.21 (d, 1 H, J = 8.6 Hz), 7.09-7.04 (m, 3 H), 6.79 (dd, 1 H, J = 8.8 Hz), 5.11 (s, 2 H), 3.80 (s 3 Η), 2.33 (s, 3 H ); IR (KBr) 3400, 2900, 1610 αη'1; MS el m / z 343 (M +); C23H21NO2 + 〇 · 25Η2 0 CHN calculation value 〇-27- (Please read the precautions on the back before filling in this (Page) This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm)

V 訂 A7 B7 五、發明説明(a ) -2- (4-用氤某-¾某 實施例编號5 &_二£_£ -1 Η - _引廣朵 H , J » 2.2 Hz). 3 Η), 2.33 (s , 3 H); •Ί -申甚 Μρ = 139 - 142°C; lH NMR (DMSO) 10.85 (s , 1 H), 7.57 (d , ^ H , J = 8.8 Hz), 7.19 (d , 1 H , J = 8.6 Hz), 7.04 (d, 2 H, J = 6.8 Hz), 6.95 (d , 6.71 (dd , 1H , J = 8.5 Hz, J = 2.4 Hz), 3.80 (s , 3 H), 3.76 (s , MS el m/z 267 (M+); C H w N 0 2 之 C Η N 計算值 實施例编號6 5二荒..氫盖」二i-tZ^氮羞二复盖 8.6 Hz, J = 2.4 U (t, 3 H, J = 7.0V order A7 B7 V. Description of the invention (a) -2- (4- Use 氤 a-¾ an embodiment number 5 & _ 二 £ _ £ -1 Η-_Introduction H, J »2.2 Hz) 3 Η), 2.33 (s, 3 H); • Ί-Shen Μρ = 139-142 ° C; lH NMR (DMSO) 10.85 (s, 1 H), 7.57 (d, ^ H, J = 8.8 Hz ), 7.19 (d, 1 H, J = 8.6 Hz), 7.04 (d, 2 H, J = 6.8 Hz), 6.95 (d, 6.71 (dd, 1H, J = 8.5 Hz, J = 2.4 Hz), 3.80 (s, 3 H), 3.76 (s, MS el m / z 267 (M +); C Η N calculated for CH w N 0 2 Example No. 6 5 Shame II covers 8.6 Hz, J = 2.4 U (t, 3 H, J = 7.0

Mp = 143-145°0^ NMR (DMSO) 10.86 (s , 1H), 7.54 (d , 2 it, J = 8.5 Hz), 7.46 (d, 2 H , J = 7.3 Hz), 7.41-7.37 (m , 2 H), 7.32-7.30 (m, 1 H), 7.20 (d, 1 H, J = 8.6 Hz), 7.05 (d , 1 H), 7.03 (d, 2 H, J = 8.8 Hz), 6.79 (dd , 1 H, J Hz), 5.10 (s, 2 H), 4.07 (q , 2 H, J = 6.8 Hz), 2.32 (s , 3 H), l.i Hz); MS el m/z 357 (M+). 實施例编號8 5^二¥—级^二2二LL级二苯蓋」:_3二l蓋二二吲双Mp = 143-145 ° 0 ^ NMR (DMSO) 10.86 (s, 1H), 7.54 (d, 2 it, J = 8.5 Hz), 7.46 (d, 2 H, J = 7.3 Hz), 7.41-7.37 (m , 2 H), 7.32-7.30 (m, 1 H), 7.20 (d, 1 H, J = 8.6 Hz), 7.05 (d, 1 H), 7.03 (d, 2 H, J = 8.8 Hz), 6.79 (dd, 1 H, J Hz), 5.10 (s, 2 H), 4.07 (q, 2 H, J = 6.8 Hz), 2.32 (s, 3 H), li Hz); MS el m / z 357 ( M +). Example No. 8 5 ^ 二 ¥ —grade ^ 2 2 LL grade diphenyl cover ": _3 2 l cover

Mp = 132°C; NMR (DMSO) 11.0 (s, 1 H), 7.68-7.64 (m, 2 H), 7.49-7.47 (m, 2 H), 7.41-7.31 (m, 5 H), 7.23 (d, 1 H, J = 8.8 Hz), 7.10 (d, 1 H, J = 2.4 Hz), 6.82 (dd, 1 H, J = 8.8, 2.4 Hz), 5.11 (s, 2 H), 2.34 (s, 3 H); MS m/z 331; c 22 H 18 F N 0 之 C Η N 計算值。 實施例軀號 (請先閱讀背面之注意事項再填寫本頁) r节氛某-2-(4 -苄氤某-3-印i I某-茱基) -3 -申某一1 Η -1¾Mp = 132 ° C; NMR (DMSO) 11.0 (s, 1 H), 7.68-7.64 (m, 2 H), 7.49-7.47 (m, 2 H), 7.41-7.31 (m, 5 H), 7.23 ( d, 1 H, J = 8.8 Hz), 7.10 (d, 1 H, J = 2.4 Hz), 6.82 (dd, 1 H, J = 8.8, 2.4 Hz), 5.11 (s, 2 H), 2.34 (s , 3 H); MS m / z 331; C Η N calculated for c 22 H 18 FN 0. Example body number (please read the precautions on the back before filling this page) r Festival A certain -2- (4 -benzyl a certain -3- India i a certain-Juki) -3 -Shen a certain 1 Η- 1¾

Mp = 155 -158°C; Ή NMR (DMSO) 10.88 (s , 1H), 7.50 - ^.45 (m , 4 H), 7.41 7.35 (m ,6H), 7.22 - 7.20 (m , 2 H), 7.14 (s , 2 H), 7.08 (d , 1H , J = 2.2Hz). 6.78 (dd, 1H, J = 8.5 Hz, J = 2.4Hz), 5,13 (s , 2H), 5.11(s , 2H), 3.8^ (s, 3H), 2.35 (s,3H); MS el m/z 449 (M+). 經濟部中央標準局貝工消費合作社印製 實施例編號ID 2 -苯并f 1 . 3 Ί二指闲-5 -某-^氛基-3 甲某-1 Η - Μ丨Pg ,J = 7.0 Hz), 7.40 H, J = 8.8 Hz, J 357 (M+);Mp = 155 -158 ° C; Ή NMR (DMSO) 10.88 (s, 1H), 7.50-^ .45 (m, 4 H), 7.41 7.35 (m, 6H), 7.22-7.20 (m, 2 H), 7.14 (s, 2 H), 7.08 (d, 1H, J = 2.2Hz). 6.78 (dd, 1H, J = 8.5 Hz, J = 2.4Hz), 5,13 (s, 2H), 5.11 (s, 2H), 3.8 ^ (s, 3H), 2.35 (s, 3H); MS el m / z 449 (M +). Example number ID 2-benzof 1 is printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. 3 Ί two fingers leisure -5-a-^ aryl-3 a certain -1 Η-Μ 丨 Pg, J = 7.0 Hz), 7.40 H, J = 8.8 Hz, J 357 (M +);

Mp = 142-145°C; Ή NMR (DMSO) 10.86 (s , 1H), 7.48 (d , 2 H -7.30 (m , 3 H), 7.20 (m , 2 H), 7.10 - 7.05 (m, 3 H ), 6.78 (dd, =2.4 Hz), 6.06 (s, 2 H), 5.10 (s, 2 H), 2.31 (s , 3 H); MS el m/z C 23 Η 19 N 0 3 之 C Η N 計算值 e 一 28- 本紙張尺度適用中國國家標準(CNS ) ( 210X297公釐) 五、發明説明(β 資施例组铽1 某)-1 Η - til 1¾ A7 B7 m 基U4-興 :基)-3-φ Μρ = 136 - 138°C; lH NMR (DMSO) 10.86 (s, 1 H), 7.55 - 7.51 7.47 (d, 2 H, J = 7.3 Hz), 7.40 - 7.34 (mt 2 H), 7.39 - 7.28 (m (d, 1 H, J = 8.7 Hz), 7.06 (d, 1 H, J » 2.2 Hz), 7.02 (d, 2 H, J (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 5.10 (s, 2 H), 4.68 - 4.62 (m, .1 φ 1.28 (d, 6 H, J = 6.0 Hz); MS el m/z 371 (M+). (m, 2 H), 7.50 -1 H), 7.20 8.8 Hz), 6.77 ,2.32 (s, 3 H), :一苯 .基..丄 實施例编號1 2 5-苄氛基-2-(4-環戍氤 -1 Η -141 η Μρ = 161 - 167°C; !Η NMR (DMSO) 10.85 (s, 1 H), 7.53 (d. 2 k J = 8.8 Hz), 7.47 (d, 2 H, J = 8.4 Hz), 7.40 - 7.36 (m, 2 H), 7.33 - 7.28 (m, 1 H), 7.20 (d, 1 H, J = 8.6 Hz), 7.07 (d, 1 H, J = 2.4 Hz), 7.01 (d, 2 H, J = 8.8 Hz), 6.78 (dd, 1 H, J = 8.6 Hz, 2.2 Hz), 5.10 (s, 2 H), 4.88 - 4.84 (m, 1 H), 2.32 (s, 3 H), 1.99 - 1.88 (m, 2 H), 1.78 - 1.69 (m, 4 H), 1.64 - 1.52 (m, 2 H); 2920,1600 cm·1; MS el m/z 397 (M+); C2?Hz?N〇2 +0.25H 實施例編號13 5二i氳..基二2_-__L4二三氬里基二笨HMJi IR (KBr) 3400, 2 0之CHN計算值 盖」-二1二用.—. 經濟部中央標準扃員工消費合作社印製 Ή NMR (DMSO) 11.0 (br s, l H), 7.87 - 7.82 (m, 4 H), 7.48 (c, 7.44 - 7.35 (m, 2 H), 7.34 - 7.26 (m, 2 H), 7.15 (d, 1 H, J = 2.2 (dd, 1 H, J = 8.6 Hz, 2.4 Hz), 5.12 (s, 2 H), 2.41 (s, 3 H); C23HisF3 NO 之 CHN計算值 〇 —l基 ,2 H, J = 8.8 Hz), Hz), 6.87 實施例编號Η 5-苄氮某-2-U-ff 甚 -1 Η - 1¾ Μρ = 144 - 146°C; iH NMR (DMSO) 10.91 (s, 1 H), 7.56 - 7.20 (m, 10 H), 7.08 (d, 1 H, J = 2.4 Hz), 6.80 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 5.11 (s, (s, 3 H), 2.34 (s, 3 H); MS el m/z 327(M+). 實施例辑號1 5 5-苄氛某-2-(4-氛-茱某)-3- Μρ = 134-136°C; Ή NMR (DMSO) 11.04 (s , 1H), 7.65 (d , 2H, -29. 本紙張尺度逋用中國國家標準(CNS ) A4規格(210X297公釐) L-丄-1盖 2 Η), 2.34Mp = 142-145 ° C; Ή NMR (DMSO) 10.86 (s, 1H), 7.48 (d, 2 H -7.30 (m, 3 H), 7.20 (m, 2 H), 7.10-7.05 (m, 3 H), 6.78 (dd, = 2.4 Hz), 6.06 (s, 2 H), 5.10 (s, 2 H), 2.31 (s, 3 H); MS el m / z C 23 Η 19 N 0 3C计算 N Calculated value e 28- This paper size applies to Chinese National Standard (CNS) (210X297 mm) V. Description of the invention (β Assets Example Group 铽 1 -1) 某-til 1¾ A7 B7 m U4-xing : Radical) -3-φ Μρ = 136-138 ° C; lH NMR (DMSO) 10.86 (s, 1 H), 7.55-7.51 7.47 (d, 2 H, J = 7.3 Hz), 7.40-7.34 (mt 2 H), 7.39-7.28 (m (d, 1 H, J = 8.7 Hz), 7.06 (d, 1 H, J »2.2 Hz), 7.02 (d, 2 H, J (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 5.10 (s, 2 H), 4.68-4.62 (m, .1 φ 1.28 (d, 6 H, J = 6.0 Hz); MS el m / z 371 (M +). (M, 2 H), 7.50 -1 H), 7.20 8.8 Hz), 6.77, 2.32 (s, 3 H),: monophenyl.yl: 丄 Example No. 1 2 5-benzyl-2- (4-ring戍 氤 -1 Η -141 η Μρ = 161-167 ° C;! Η NMR (DMSO) 10.85 (s, 1 H), 7.53 (d. 2 k J = 8.8 Hz), 7.47 (d, 2 H, J = 8.4 Hz), 7.40-7.36 (m, 2 H), 7.33-7.28 (m, 1 H), 7.20 (d, 1 H, J = 8.6 Hz), 7.07 (d, 1 H, J = 2.4 Hz), 7.01 (d, 2 H, J = 8.8 Hz), 6.78 (dd, 1 H, J = 8.6 Hz, 2.2 Hz) , 5.10 (s, 2 H), 4.88-4.84 (m, 1 H), 2.32 (s, 3 H), 1.99-1.88 (m, 2 H), 1.78-1.69 (m, 4 H), 1.64-1.52 (m, 2 H); 2920,1600 cm · 1; MS el m / z 397 (M +); C2? Hz? N2 + 0.25H Example No. 13 5 2 i 氲 .. Tri-Arginyl Diben HMJi IR (KBr) 3400, 2 0 CHN calculated value cover "-22 1 2-.-Central Standard of the Ministry of Economic Affairs 扃 Printed by Employee Consumer Cooperative Ή NMR (DMSO) 11.0 (br s, l H), 7.87-7.82 (m, 4 H), 7.48 (c, 7.44-7.35 (m, 2 H), 7.34-7.26 (m, 2 H), 7.15 (d, 1 H, J = 2.2 (dd, 1 H, J = 8.6 Hz, 2.4 Hz), 5.12 (s, 2 H), 2.41 (s, 3 H); Calculated CHN value of C23HisF3 NO 0-1 base, 2 H, J = 8.8 Hz), Hz) , 6.87 Example number Η 5-benzylazine-2-U-ff or even -1 Η-1¾ Μρ = 144-146 ° C; iH NMR (DMSO) 10.91 (s, 1 H), 7.56-7.20 (m , 10 H), 7.08 (d, 1 H, J = 2.4 Hz), 6.80 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 5.11 (s, (s, 3 H), 2.34 (s, 3 H); MS el m / z 327 (M +). Example No. 1 5 5-Benzyl-2- (4- -朱某) -3- Μρ = 134-136 ° C; Ή NMR (DMSO) 11.04 (s, 1H), 7.65 (d, 2H, -29. This paper uses Chinese National Standard (CNS) A4 specifications ( 210X297 mm) L- 丄 -1 cover 2 Η), 2.34

甲某-1 H - HI U J = 8.3Hz), 7.53 (請先閲讀背面之注意事項再填寫本頁)A certain -1 H-HI U J = 8.3Hz), 7.53 (Please read the precautions on the back before filling this page)

經 濟 部 中 央 標 準 % 員 工 消 費 合 作 社 Α7 Β7 五、發明説明(w、 (d, 2 H , J » 8.5Hz), 7.47 (d , 2 Η , J » 6.8 Hz), 7.41 - 7.37 (m ,2H>, 7.31 · 7.28 (m f 1H), 7.25 (d , 1H , J » 8.5 Hz), 7.11 (d , 1 H , J * 2.4Hz), 6.82 (dd , 1H , J =8.8 Hz , J = 2.4 Hz), 5.11 (s , 2H), 2.35 (s , 3H); I R (KBr) 3380, 1210 c··1 , Hs e I */z 3 4 7 ( M + ) ; C 22 H w C 1 N 0 2 之 CHN計算值 實施例编號16 5 -节氩某-2-( 2.4 -二某 -荣某)-:?- 甲某-1 Η - Η丨盹 Oil; NMR (DMSO) 10.58 (s, 1 H), 7.50 - 7.18 (m, 7 H), 7.0 m 1 H, J = 2.4 Hz), 6.76 (dd, 1 H, J = 2.3 Hz, 8.6 Hz), 6.69 - 6.62 (m, 2 H), 5 .11 (s,2 H), 3.82 (s, 3 H), 3.78 (s, 3 H), 2.12 (s, 3 H). 實施例编號17 Hi.蓋二1-13二i JL基二笨_基 丄::3 t用.基_ -1 Η - ΜΙ ΙΪ Mp = 83-86°C 奮施例组號18 5 -苄氩某- 2- U-窄氩某-.H :-芏某)- 甲某-1 Η - Ml獅4 Mp = 135 - 137°C; AH NMR (DMSO) 10.94 (s, 1 H), 7.50 - 7.3 1 (m, 13 Η), 7.22 (d, 1 Ht J = 8.6 Hz), 7.10 (d, 1 H, J = 2.2 Hz), 6.81 (dd, 1 H, J = 5.6 Hz, 2.2 Hz), 5,23 (s, 2 H), 5.11 (s, 2 H), 2.34 (s, 3 H); MS el m/Z 437 (M+); C 29 H 24 F N 0 2 之 C Η N 計算值 實施例编號1 9 5二i氮基-2- (3-甲氣基-苯..3 i ) - 3-甲基 zAiLilMJL·. Mp = 107 - 109°C; 'H NMR (DMSO) 11.00 (s, 1 H), 7.51 -1/ 8 (m, 2 H), 7.43 - 7.20 (m, 7 H), 7.13 - 7.12 (d, 1 H, J = 2.1 Hz), 6.93 - 6.90 (dd, 1 H, J = 2.3 Hz, J = 5.7 Hz), 6.86 - 6.82 (dd, 1 H, J = 2.3 Hz,J = 6.3 Hz), 5.12 (s, 2 H), 3.83 (s, 3 H), 2.38 (s, 3 H); IR (KBr) 3400, 2900 1600 cmMS el / z 3 4 3 ( K 〇 ; C 23 Η 21 N 0 2 之 C Η N 計算俏 實施例S3號20 5*~¥氛某-3-申某-2-(4 -- if 1申氤甚-¾ 甚 1 - 1 Η - Mp = 127 - 128°C; *H NMR (DMSO) 11.07 (s, 1 H), 7.77 - 7.7 —30— 本紙張尺度適用中國國家標準(CNS > A4規格(210X 297公釐) 請 先 聞 背 面 之 注 訂Central Standards of the Ministry of Economic Affairs% Employee Consumer Cooperative Association A7 B7 V. Description of Invention (w, (d, 2 H, J »8.5Hz), 7.47 (d, 2 Η, J» 6.8 Hz), 7.41-7.37 (m, 2H > , 7.31 · 7.28 (mf 1H), 7.25 (d, 1H, J »8.5 Hz), 7.11 (d, 1 H, J * 2.4Hz), 6.82 (dd, 1H, J = 8.8 Hz, J = 2.4 Hz) , 5.11 (s, 2H), 2.35 (s, 3H); IR (KBr) 3380, 1210 c · 1, Hs e I * / z 3 4 7 (M +); C 22 H w C 1 N 0 2 Example of calculated values of CHN 16 5 -Section Argon-2- (2.4 -Second-Rongmou)-:?-Jiamou-1 Η-Η 丨 盹 Oil; NMR (DMSO) 10.58 (s, 1 H), 7.50-7.18 (m, 7 H), 7.0 m 1 H, J = 2.4 Hz), 6.76 (dd, 1 H, J = 2.3 Hz, 8.6 Hz), 6.69-6.62 (m, 2 H), 5 .11 (s, 2 H), 3.82 (s, 3 H), 3.78 (s, 3 H), 2.12 (s, 3 H). Example No. 17 Hi. Cap II 1-13 II JL base Dibenzyl radical :: 3 t. Radical_ -1 Η-ΜΙ Ι Ϊ Mp = 83-86 ° C Fen Example Group No. 18 5-benzyl argon-2- U-narrow argon -.H:-芏 某)-Jiamou-1 Η-Ml Lion 4 Mp = 135-137 ° C; AH NMR (DMSO) 10.94 (s, 1 H), 7.50-7.3 1 (m, 13 Η), 7.22 (d, 1 Ht J = 8.6 Hz), 7.10 (d, 1 H, J = 2.2 Hz), 6.81 (dd, 1 H, J = 5.6 Hz, 2.2 Hz), 5,23 (s, 2 H), 5.11 (s, 2 H), 2.34 (s, 3 H); MS el m / Z 437 (M +); C H N calculated for C 29 H 24 FN 0 2 Example No. 1 9 5 dii-nitro-2- (3 -Methylamino-benzene: 3 i)-3-methyl zAiLilMJL .. Mp = 107-109 ° C; 'H NMR (DMSO) 11.00 (s, 1 H), 7.51 -1 / 8 (m, 2 H), 7.43-7.20 (m, 7 H), 7.13-7.12 (d, 1 H, J = 2.1 Hz), 6.93-6.90 (dd, 1 H, J = 2.3 Hz, J = 5.7 Hz), 6.86- 6.82 (dd, 1 H, J = 2.3 Hz, J = 6.3 Hz), 5.12 (s, 2 H), 3.83 (s, 3 H), 2.38 (s, 3 H); IR (KBr) 3400, 2900 1600 cmMS el / z 3 4 3 (K 〇; C 23 Η 21 N 0 2 C Η N Calculation Example S3 No. 20 5 * ~ ¥ mood some-3-shen some-2- (4-if 1氤 Very-¾ Even 1-1 Η-Mp = 127-128 ° C; * H NMR (DMSO) 11.07 (s, 1 H), 7.77-7.7 —30— This paper size applies the Chinese National Standard (CNS > A4 Specifications (210X 297mm) Please read the note on the back first

I L.I L.

頁 經濟部中央標準局員工消費合作社印製Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閲讀背面之注意事項再填寫本頁) A7 五、發明説明(和 表 2 經濟部中央標準局員工消費合作社印製 實施例编號 X Q 編號2 1 Η fl 编號22 OBn H 编號23 OBn 4 ' - 0 M e 编號24 UPie 4 f -OMe 编號25 OBn 4 ' -OEt 编號26 OBn 4 ' -OBn 编號27 OBn 4 ' - F 編號28 OBn 3 ' -OMe , 4 ' -OBn 编號29 OBn 4 " - 0 - i P r 编號30 OBn 3' ,4 ' -0CH 2 〇- 编號31 OBn 4,-OCp 编號32 OBn 4,-CF 3 编號33 OBn 4 1 - C 1 编號34 OBn 2 T -OHe , 4 ' -OMe (請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page) A7 V. Description of invention (and Table 2 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Example No. XQ No. 2 1 Η fl No. 22 OBn H No. 23 OBn 4 '-0 Me number 24 UPie 4 f -OMe number 25 OBn 4' -OEt number 26 OBn 4 '-OBn number 27 OBn 4'--F number 28 OBn 3 '-OMe, 4'- OBn number 29 OBn 4 "-0-i P r number 30 OBn 3 ', 4' -0CH 2 〇- number 31 OBn 4, -OCp number 32 OBn 4, -CF 3 number 33 OBn 4 1-C 1 No. 34 OBn 2 T -OHe, 4 '-OMe (Please read the notes on the back before filling this page)

L -,Λ . *1Τ 處-方·..法1. -B3I »朵(吲呤 升)之溶液 理β攪拌反 4-75-3] 醚一起研磨 0Mp = 129-131°C; h 五、發明説明(Λι ) @ Hq ff倫例迫號2 6之3 -甲基卩$乙酸乙 _{4-「5 -苄氬甚- 2- (4 -苄氤某-荣某)-3二I _1_甚申甚1 -茱氤基)-乙酴酯 5-苄氣基- 2-(4-苄氧基-苯基)-3-甲基-Π 實施例編號7 ) ( 3 2克,7 7毫莫耳)於D M F ( 0 · 1 5 冷卻至0-C且以氫化納(2.2克,89毫莫耳)處 應20分鐘,然後加入氛化苄基CAS N〇〔804S (29克,127毫莫耳)及反應於室溫攪拌18小時。將反應 混合物注入至水中及以乙酸乙酯萃取。以鹽水洗滌乙酸 乙酯及經硫酸鎂乾燥,濃縮乙酸乙酯且與4醚一起研磨 ,以獲得21克之白色固體。濃縮濾液及與乙 以産生額外7克之白色固體,總産率為28克 NMR (DMSO) 7.47 (d, 4 H, J = 7.2 Hz), 7.39 (q, 4 H, J = 7.9 Hz), Ί36-132 (m, 1 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.19 (d, 1 H, J = 9.0 Hz), 7.13-7.09 (m, 4 H), 6.80 (dd, 1 H, J = 8.8, 2.4 Hz), 6.73 (s, 4 H), 5.16 (s, 2 H), 5.1 i (s, 2 H), 5.11 (s, 2 H), 4.66 (s, 2 H), 4.11 (q, 2 H, J = 7.2 Hz), 2.15 (s, 3 H), 1.16 (t, 3 H, J = 7.2 Hz); MS el m/z 612. (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印裝 pm g酷之物珲數據.- 根據流程圖9使用方法3以選自(编號1至 為起始物質之適當經取代之3 -甲基吲呤製備 基化産物。 實施例編號 2 1 ( 4 - Μ - 苤氳基)-乙酸乙酯 3 3 编號16)作 下列吲呤烷 1 -某申甚Ί 本紙張尺度逋用中國國家標準(CNS ) A4規格(210X 297公釐) 五、發明説明( A7 B7L-, Λ. * 1Τ place-Fang · .. Method 1. -B3I »Dor (indrine liter) solution β β stirring anti 4-75-3] ether together grinding 0Mp = 129-131 ° C; h five Description of the invention (Λι) @ Hq FF 伦 例 force No. 2 6 of 3 -methyl hydrazine $ acetic acid ethyl _ {4- "5-benzyl argon even-2-(4-benzyl umbrium-Rongmou)-3 2 I _1_Shishen 1-Erythryl) -acetamidate 5-benzyloxy-2- (4-benzyloxy-phenyl) -3-methyl-Π Example No. 7) (3 2 g , 7 7 mol) was cooled to 0-C in DMF (0 · 1 5 and should be treated with sodium hydride (2.2 g, 89 mol) for 20 minutes, and then the benzyl CAS NO (804S (29 G, 127 mmol) and the reaction was stirred at room temperature for 18 hours. The reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate was washed with brine and dried over magnesium sulfate, the ethyl acetate was concentrated and together with 4 ether Triturated to obtain 21 g of a white solid. The filtrate was concentrated and combined with B to yield an additional 7 g of white solid with a total yield of 28 g NMR (DMSO) 7.47 (d, 4 H, J = 7.2 Hz), 7.39 (q, 4 H, J = 7.9 Hz), Ί36-132 (m, 1 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.19 (d, 1 H, J = 9.0 Hz), 7.13-7.09 (m, 4 H), 6.80 (dd, 1 H, J = 8.8, 2.4 Hz), 6.73 (s, 4 H), 5.16 (s, 2 H), 5.1 i (s, 2 H), 5.11 (s, 2 H) , 4.66 (s, 2 H), 4.11 (q, 2 H, J = 7.2 Hz), 2.15 (s, 3 H), 1.16 (t, 3 H, J = 7.2 Hz); MS el m / z 612. (Please read the precautions on the back before filling out this page.) The data of pm g is printed on the shellfish consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs.-Use method 3 according to flowchart 9 to select from (numbers 1 to starting Properly substituted 3-methylindine of the starting material was used to prepare the acylated product. Example No. 2 1 (4-M-fluorenyl) -ethyl acetate 3 3 No. 16) as the following indinoline 1-a Shen XiΊ The paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297 mm) 5. Description of the invention (A7 B7

Oil; lH NMR (DMSO) 7.57 - 7.30 (m, 7 H), 7.13 - 7.02 (m, 2 H), 5.22 (s, 2 H), 4.65 (s, 2 H), 4.09 (q, 2 H, J = 7.2 Hz), 2.20 (t, 3 H, J = 7.0 Hz); MS el m/z 399 (M+). $), 6.77 - 6.70 (m, 4 (s, 3 H), 1.15 甚田甚1芏氤甚)^酴7.酷 Oil; ΐ NMR(DMSO) 7.50 - 7.40 (m, 10 Η), 7.22 (d, 1 Η , J (d , 1H ,J = 2.5Hz), 6.83 (d, 1 H, J = 2.5 Hz), 6.72 (s , 4 H ), 5 (s, 2 H), 4.65 (s, 2 H), 4.10 (q, 2 H, J = 7.2 Hz), 2.16 (s, 3 H), 7.0Hz); MS el m/z 505 (M+). $.4Hz), 7.14 .18 (s, 2 H),5.11 1.14 (t,3H, J = 實施例编號2 3 ί 4 - f 5 -窄氬某-2 - ( 4 -甲氫$ -荣某) -3 - φ某-Ν丨盹-1 -某申某1 -茱氫某1 - 7.酸 Μρ = 90 - 96°C; Ή NMR (DMSO) 7.47 (d, 2 H, J = 6.8 Hz), 7j 7.33 - 7.27 (m, 3 H), 7.19 (d, 1 H, J = 8.8 Hz), 7.12 (d, 1 H, J (d, 2 H, J = 8.8 Hz), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.74 (s (s, 2 H), 5.11 (s, 2 H), 4.65 (s, 2 H), 4.11 (q, 2 H, J = 7.0 Hz), (s, 3 H), 1.16 (t, 3 H, J = 7.0 Hz); IR (KBr) 2990, 2900, 1760, m/z 536 (M+H+).Oil; lH NMR (DMSO) 7.57-7.30 (m, 7 H), 7.13-7.02 (m, 2 H), 5.22 (s, 2 H), 4.65 (s, 2 H), 4.09 (q, 2 H, J = 7.2 Hz), 2.20 (t, 3 H, J = 7.0 Hz); MS el m / z 399 (M +). $), 6.77-6.70 (m, 4 (s, 3 H), 1.15芏 氤)) 7. Cool Oil; ΐ NMR (DMSO) 7.50-7.40 (m, 10 Η), 7.22 (d, 1 Η, J (d, 1H, J = 2.5Hz), 6.83 (d, 1 H, J = 2.5 Hz), 6.72 (s, 4 H), 5 (s, 2 H), 4.65 (s, 2 H), 4.10 (q, 2 H, J = 7.2 Hz), 2.16 (s, 3 H), 7.0Hz); MS el m / z 505 (M +). $ .4Hz), 7.14 .18 (s, 2 H), 5.11 1.14 (t, 3H, J = Example No. 2 3 ί 4- f 5 -narrow argon -2-(4 -methyl hydrogen $ -rongmou) -3-φ om -N 丨 盹 -1-um a -1-ruthium -1-7. acid Μρ = 90-96 ° C; Ή NMR (DMSO) 7.47 (d, 2 H, J = 6.8 Hz), 7j 7.33-7.27 (m, 3 H), 7.19 (d, 1 H, J = 8.8 Hz), 7.12 (d, 1 H , J (d, 2 H, J = 8.8 Hz), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.74 (s (s, 2 H), 5.11 (s, 2 H), 4.65 ( s, 2 H), 4.11 (q, 2 H, J = 7.0 Hz), (s, 3 H), 1.16 (t, 3 H, J = 7.0 Hz); IR (KBr) 2990, 2900, 1760, m / z 536 (M + H +).

i - 7.37 (m, 2 H), 2.4 Hz), 7.03 t 4 H), 5.16 3.79 (s, 3 H), 2.15 10cm-l;MSFAB ^^1- ^^^1 11 In nn 1 I ^^1 In HI I— ^ t. 、-» (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 34- 本紙張度適用中國國家標準(CNS ) A4規格(210X297公釐) 五、發明説明(分) A7 B7 實掩例編號2 4丄_4[ 5 -甲氤基-2 - (4 甲JK主:苯基)-3 里基.二吲1蓋簋_基」„_-乙1乙酸 Mp = 109-113°C; Ή NMR (DMSO) 7.27 (d, 2 H, J = 8.8Hz), 7.17 (d , 1H , J* 8.8 Hz), 7.03 (d , 2 H J = 8.6 Hz), 6.99 (d , 1 , J = 2.5 Hz), 6.78 - 6.70 (m , 5 H), 5.15 (s , 2H), 4.65 (s , 2 Η), 4.Π (q , 2 H, J = 7.0 Hz), 3.78 (s , 3 H), 3.76 (s, 3 H), 2.15 (s, 3 H), 1.15 (t, 3 H , J = 7.1 Hz) (M+). MS el m/z 459 資掩例SB號2 5丄JLr_ _ L i: i氣基二.2 :.丄4 :.乙_氯_ 申某-Ml丨g - 1 -某申某1 -采氩某}-乙胁Ζ ΒΠ .基二一苯一蓋丄二-3—i-7.37 (m, 2 H), 2.4 Hz), 7.03 t 4 H), 5.16 3.79 (s, 3 H), 2.15 10cm-l; MSFAB ^^ 1- ^^^ 1 11 In nn 1 I ^^ 1 In HI I— ^ t. 、-»(Please read the notes on the back before filling this page) Printed by the Central Standards Bureau of the Ministry of Economic Affairs, Shelley Consumer Cooperatives 34- This paper is compatible with Chinese National Standard (CNS) A4 specifications ( 210X297 mm) 5. Description of the invention (minutes) A7 B7 Covered case number 2 4 丄 _4 [5 -methylamino-2-(4 methylJK main: phenyl) -3 riyl. Diindyl1 cover _Group '' __acetic acid Mp = 109-113 ° C; Ή NMR (DMSO) 7.27 (d, 2 H, J = 8.8Hz), 7.17 (d, 1H, J * 8.8 Hz), 7.03 (d , 2 HJ = 8.6 Hz), 6.99 (d, 1, J = 2.5 Hz), 6.78-6.70 (m, 5 H), 5.15 (s, 2H), 4.65 (s, 2 Η), 4.Π (q , 2 H, J = 7.0 Hz), 3.78 (s, 3 H), 3.76 (s, 3 H), 2.15 (s, 3 H), 1.15 (t, 3 H, J = 7.1 Hz) (M +). MS el m / z 459 data cover example SB No. 2 5 丄 JLr_ _ L i: i gas group II. 2:. 丄 4:. 乙 _Cl__ Shenmou-Ml 丨 g-1 -Mr. Shenm 1-Mining Argon} -ethoxyzyl β β.

Mp = 113-115°C; Ή NMR (DMSO) 7.45 (d , 2 H, J =7.3 Hz), 7.40 - 7.25 (m , 5 H), 7.17 (d, 1 H , J =8.8 Hz), 7.11 (d , 1 H , J =2.2 Hz), 7.01 (d , 2 H , J = 6.8 Hz), 6.78 (d<* , 1 H , J = 8.8Hz, J = 2.4 Hz), (,.73 (s , 4 H), 5.15 (s, 2 H), 5.10 (s , 2 H), 4.65 (s , 2 H), 4.15 - 4.01 (m , 4 H), 2.14 (s , 3H), 1.33 (t, 3 H, J = 5.7 Hz), 1.16 (t, 3 H, J= 7.1 Hz); MS el m/z 549 (V1+).Mp = 113-115 ° C; Ή NMR (DMSO) 7.45 (d, 2 H, J = 7.3 Hz), 7.40-7.25 (m, 5 H), 7.17 (d, 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.01 (d, 2 H, J = 6.8 Hz), 6.78 (d < *, 1 H, J = 8.8Hz, J = 2.4 Hz), (, .73 ( s, 4 H), 5.15 (s, 2 H), 5.10 (s, 2 H), 4.65 (s, 2 H), 4.15-4.01 (m, 4 H), 2.14 (s, 3H), 1.33 (t , 3 H, J = 5.7 Hz), 1.16 (t, 3 H, J = 7.1 Hz); MS el m / z 549 (V1 +).

實施例编號2 7 ( 4- ί 5-苄氣基-2- (4-M -咄- 1 -某申某1 -荣氤某)7.酴... I —基」二3二SL盖 1h NMR (DMSO) 7.50 - 7.15 (m, 16 H), 5.20 (s, 2 H), 5.12 (s, 2 H), 4.62 (s, 2 H), 4.13 (q, 2 H, J = 7.1 Hz), 2.18 (s, 3 H), 1.20 (t, 3 H, J = 7.1 Hz). 寊铯例M號2 B .丄丄-.〔5二茉i基-2 - ( 3 -甩氣 -3 -甲拣-Ml 8¾ -卜基咀基].::蓋置基丄乙.脸 (裝------ίτ (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製Example No. 2 7 (4- ί 5-Benzylamino-2- (4-M-咄-1 -some Shenmou 1 -Rong 氤 mou) 7. 酴 ... I — 基 "二三 二 SL Cover 1h NMR (DMSO) 7.50-7.15 (m, 16 H), 5.20 (s, 2 H), 5.12 (s, 2 H), 4.62 (s, 2 H), 4.13 (q, 2 H, J = 7.1 Hz), 2.18 (s, 3 H), 1.20 (t, 3 H, J = 7.1 Hz). Rubidium cesium example M No. 2 B. 丄 丄-. (5 dimolyl-2-(3-gas -3-甲 择 -Ml 8¾ -Bu Jizui]. :: Fat base Ji B.Face (fitting ------ ίτ (please read the precautions on the back before filling this page) Central standard of the Ministry of Economic Affairs Printed by Bureau Consumers Cooperative

Foam; Ή NMR (DMSO) 7.50 - 7.30 (m , 10 H), 7.22 (d, 2H, j = 9.1 Hz), 7.13 (d, 2 H, J = 8.6 Hz), 6.85 - 6.70 (m, 6 H), 5.17 (s, 2H), 5.13 (s, 2h)f 5.11 (s, 2 H), 4.66 (s , 2 H), 4.14 (m , 2H), 3.61 (s, 3 H), 2.17 (s, 3 H), 1.16 (t, 3 H, J = 7.0 Hz). .35· 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 裝 Α7 Β7 五、發明説明(科) 實施例《號29丄Α:丄5二ifiL基.-丄-_(4.二興1 -1-_里_基-HLliL二m盖丄:玉」&_基」二乙酸 乙酯 CHI; lH NMR (DMSO) 7.46 (d, 2H, J 7.7 Hz), 7.42 - 7.28 (ι η, 3 Η), 7.25 (d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 (d, 1 H, J =2.4 Hz), 6.99 (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 ( 5, 4 Η), 5.15 (s, 2 H), 5.10 (s, 2 H), 4.70 - 4.60 (m, 3 H), 4.10 (q, 2 H, J = ^.0 Hz), 2.15 (s, 3 H), 1.27 (d, 6 H, J = 5.9 Hz), 1.16 (t, 3 H, J = 7.1 Hz); M! el m/z 563 (M+). 審*|s 俐迫《 .Ή) i 4 - Γ 5 - ¥ 氦甚-2 - ( 3 . 4 -甲 11 14氤基-芏 氩某)-3 -甲基-丨ί - 1 -基甲基]-苯氤基L Oil; Ή NMR (DMSO) 7.45 (d, 2 H, J = 7.0 Hz), 7.37 (m , 2 H ),7.32 (m , 1 Η), 7.19 (d , 1H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.00 (d , 1 H, J = 7.9 Hz), 6.90 (d , 1 H, 5.0 Hz), 6.82 - 6.75 (m , 6H), 6.07 (s , 2H), 5.16 (s ,2 Η), 5.10 (s, 2H), 4.65 (s ,2 H), 4.10 (m , 2 H), 2.15 (s , 3 H), 1.15 (t, J Η , J = 7.0 Hz); MS el m/z 549 (M+). 奮掄例迫號31 (4-Γ5 -申氩某- 2- U-琨戍 氣某-苯基」_ -3 -甲某-Ml ίϊ - 1 -某甲某1 -茱氳某1 - 7.酚 乙里 Mp = 96-98°C; Ή NMR (DMSO) 7.47 (d, 1 H, J = 7.2 Hz), 7.4 0 - 7.36 (m, 2 Η), 7.33 - 7.30 (m, 1 H), 7.26 (m, 2 H), 7.18 (d, l H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.4 Hz), 6.98 (d, 2 H, J = 8.8 Hz), 6.79 (dd, 1 H, =8.8 Hz, 2.4 Hz), 6.74 (s, 5 H), 5.15 (s, 2 H), 5.11 (s, 2 H), 4.86 - 4.80 (m, 1 H) ,4.66 (s, 2H), 4.13 (q, 2 H, J = 7.2 Hz), 2.15 (s, 3 H), 1.98 - 1.85 (m, 2 H), 1.79 - 1.65 (m, 4 H), 1.62 -1.55 (m, 2 H), 1.16 (t, 3 H, J = 7.0 Hz); IR (KBr) 2950, 2910 2890, 1760, 1610 c R , M s el n/z 583 (H + ) ; CHN 計算價 C:77 .;)3 H : 6 . 6 7 N:2.38 實澜值:C:76.76 H:6.63 N:2.27 奮施例组號32丨4-Γ5-笮氩某某 (4-= M W 基-笨基 > -丨4丨呤-〗-某申某Ί -荣氩某1 fii 1乙醋 Mp = 221°C; Ή NMR (DMSO) 7.83 (d, 2 H, J * 8.1 Hz), 7.60 (d, 2 H, J = 7.9 Hz), 7.48 (d, 2 H, J = 8.4 Hz), 7.40 -7.36 (m, 4 H), 7.18 (d, 1 H, J = :2.4 Hz), 6.86 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.72 (s, 4 H), 5.21 (s, 2 H), 5.12 (s, 2 H), 4.65 -36- 本紙張尺度適用中國國家標準(CNS } A4規格(21 OX297公釐) 請 先 閲 之 注 意 事 項 再 填 寫 本 頁 訂Foam; Ή NMR (DMSO) 7.50-7.30 (m, 10 H), 7.22 (d, 2H, j = 9.1 Hz), 7.13 (d, 2 H, J = 8.6 Hz), 6.85-6.70 (m, 6 H ), 5.17 (s, 2H), 5.13 (s, 2h) f 5.11 (s, 2 H), 4.66 (s, 2 H), 4.14 (m, 2H), 3.61 (s, 3 H), 2.17 (s , 3 H), 1.16 (t, 3 H, J = 7.0 Hz). .35 · This paper size is applicable to China National Standard (CNS) A4 (210X297 mm, printed by staff consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, Α7 Β7, five 2. Description of the Invention (Family) Example "No. 29 丄 Α: 丄 5 二 ifiL 基 .- 丄 -_ (4. 二 兴 1 -1-_ 里 _ 基 -HLliL 二 m 盖 丄: 玉" & _ 基"Diethyl acetate CHI; lH NMR (DMSO) 7.46 (d, 2H, J 7.7 Hz), 7.42-7.28 (ι η, 3 Η), 7.25 (d, 2 H, J = 8.7 Hz), 7.17 (d , 1 H, J = 8.7 Hz), 7.11 (d, 1 H, J = 2.4 Hz), 6.99 (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz ), 6.73 (5, 4 Η), 5.15 (s, 2 H), 5.10 (s, 2 H), 4.70-4.60 (m, 3 H), 4.10 (q, 2 H, J = ^ .0 Hz) , 2.15 (s, 3 H), 1.27 (d, 6 H, J = 5.9 Hz), 1.16 (t, 3 H, J = 7.1 Hz); M! El m / z 563 (M +). Review * | s Li Li ".Ή) i 4-Γ 5- Helium even -2-(3.4 -methyl 11 14 fluorenyl-fluorine argon) -3 -methyl- 丨-1 -ylmethyl] -phenylfluorenyl L Oil; Ή NMR (DMSO) 7.45 (d , 2 H, J = 7.0 Hz), 7.37 (m, 2 H), 7.32 (m, 1 Η), 7.19 (d, 1H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz) , 7.00 (d, 1 H, J = 7.9 Hz), 6.90 (d, 1 H, 5.0 Hz), 6.82-6.75 (m, 6H), 6.07 (s, 2H), 5.16 (s, 2 Η), 5.10 (s, 2H), 4.65 (s, 2 H), 4.10 (m, 2 H), 2.15 (s, 3 H), 1.15 (t, J Η, J = 7.0 Hz); MS el m / z 549 ( M +). Fenju Lie 31 (4-Γ5 -Shen Ar Mou 2- 2-U-Ga Mou-Phenyl "_ -3 -A Mou-Ml ίϊ-1 -A Mou 1 -Fructus Mou 1-7. Methylphenol phenol = 96-98 ° C; Ή NMR (DMSO) 7.47 (d, 1 H, J = 7.2 Hz), 7.4 0-7.36 (m, 2 Η), 7.33-7.30 (m, 1 H), 7.26 (m, 2 H), 7.18 (d, l H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.4 Hz), 6.98 (d, 2 H, J = 8.8 Hz) , 6.79 (dd, 1 H, = 8.8 Hz, 2.4 Hz), 6.74 (s, 5 H), 5.15 (s, 2 H), 5.11 (s, 2 H), 4.86-4.80 (m, 1 H), 4.66 (s, 2H), 4.13 (q, 2 H, J = 7.2 Hz), 2.15 (s, 3 H), 1.98-1.85 (m, 2 H), 1.79-1.65 (m, 4 H), 1.62- 1.55 (m, 2 H), 1.16 (t, 3 H, J = 7.0 Hz); IR (KBr) 2950, 2910 2890, 1760, 1610 c R, M s el n / z 583 (H +); CHN calculated price C: 77 .;) 3 H: 6. 6 7 N: 2.38 Real value: C: 76.76 H: 6.63 N: 2.27 Fen example group number 32 丨 4-Γ5- 笮 argon (4- = MW-based-benzyl) >-丨 4 丨 Pyrene-〗-ShenmingΊ -Rongxiong 1 fii 1 ethyl acetate Mp = 221 ° C; Ή NMR (DMSO) 7.83 (d, 2 H, J * 8.1 Hz), 7.60 (d , 2 H, J = 7.9 Hz), 7.48 (d, 2 H, J = 8.4 Hz), 7.40 -7.36 (m, 4 H), 7.18 (d, 1 H, J =: 2.4 Hz), 6.86 (dd , 1 H, J = 8.8 Hz, 2.4 Hz), 6.72 (s, 4 H), 5.21 (s, 2 H), 5.12 (s, 2 H), 4.65 -36- This paper size applies to the Chinese National Standard (CNS } A4 size (21 OX297 mm) Please read the precautions before filling in this page to order

五、發明説明(X A7 B7 7.0 Hz); IR (KBr) (s, 2 H), 4.11 (q, 2 H, J = 7.2 Hz), 2.20 (s, 3 H), 1.16 (t, 3 H, J = 2920,1730c··1 ;Hs el bi/z 573(M + ); + 0 2 5 H 2 0之計算值 實施例編 » 33 .丄 a二..[mi.-2二 u - m).-.3-中.16 HI - 1 -某甲某1 -芏氛某)酸_乙盟. Mp = 99-101°C; Ή NMR (DMSO) 7.52 (d, 2 H, J = 8.6Hz), 7,46 (d, 2 H , J = 6.8 Hz), 7.42 - 7.38 (m ,4 H), 7.36 (m , 1H), 7.25 (d ,1 H , J = 9.0Hz),7.14 (d , 1 H , J = 2.4Hz), 6.83 (dd , 1 H , J Hz), 6.72 (s, 4 H), 5.18 (s , 2 H), 5.11( s , 2 H), 4.65 (s , 2 H), 4 7.2 Hz), 2.16 (s , 3 H), 1.15 (t, 3H , J = 7.2 Hz); MS cl m/z 539 ( C 33 H ^ C 1 N 0 4 之 C Η N 計算值 實施例編號3 4丄生二丄5 r (2_ · 甲 里—羞二_姐1:丄二[£_1丄二:篆1盖丄._二乙酸乙酯 Oil; !h NMR (DMSO) 7.30 - 6.45 (m, 15 H), 4.95 (s, 2 H), 4.75 4.50 (s, 2 H), 3.97 (q, 2 H, J = 7.1 Hz), 3.65 (s, 3 H), 3.51 (s, 3 1.01 (t, 3 H, J = 7.1 Hz). 8·8Ηζ , J = 2.5 11 (q,2H, J = Λ+y, .氣..基)-.3-. -4.65 (m, 2 Η), Η), 1.87 (3 Η), (讀先閱讀背面之注意事項再填寫本頁)V. Description of the invention (X A7 B7 7.0 Hz); IR (KBr) (s, 2 H), 4.11 (q, 2 H, J = 7.2 Hz), 2.20 (s, 3 H), 1.16 (t, 3 H , J = 2920, 1730c ·· 1; Hs el bi / z 573 (M +); + 0 2 5 H 2 0 Calculated Example Compilation »33. 丄 a 二 .. [mi.-2 二 u- m) .-. 3-Medium.16 HI-1 -A certain a certain 1 -Ambient a certain) acid_Ethyl. Mp = 99-101 ° C; Ή NMR (DMSO) 7.52 (d, 2 H, J = 8.6Hz), 7,46 (d, 2 H, J = 6.8 Hz), 7.42-7.38 (m, 4 H), 7.36 (m, 1H), 7.25 (d, 1 H, J = 9.0Hz), 7.14 (d, 1 H, J = 2.4Hz), 6.83 (dd, 1 H, J Hz), 6.72 (s, 4 H), 5.18 (s, 2 H), 5.11 (s, 2 H), 4.65 (s , 2 H), 4 7.2 Hz), 2.16 (s, 3 H), 1.15 (t, 3H, J = 7.2 Hz); MS cl m / z 539 (C 33 H ^ C 1 N 0 4 of C Η N Calculated value Example No. 3 4 丄 生 二 丄 5 r (2_ · Jiali—Xi Er_Jie 1: 丄 二 [£ _1 丄 二: 篆 1 盖 丄 ._Diethyl acetate Oil;! H NMR (DMSO ) 7.30-6.45 (m, 15 H), 4.95 (s, 2 H), 4.75 4.50 (s, 2 H), 3.97 (q, 2 H, J = 7.1 Hz), 3.65 (s, 3 H), 3.51 (s, 3 1.01 (t, 3 H, J = 7.1 Hz). 8 · 8Ηζ, J = 2.5 11 (q, 2H, J = Λ + y, .gas..base)-. 3-. -4.65 ( m, 2 Η), Η), 1.87 (3 Η), (Read the notes on the back before filling in this page)

、1T 3 -甲某盹1¾荣乙鹾 流程圓10 經濟部中央標準局員工消費合作社印製、 1T 3-Jiamou 1¾ Rong Yi 鹾 Process Circle 10 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

〇 〇Η 〔實施例编號21.24·27_29·34 實施例编號35*46 •37. 本紙張尺度適用中國國家標隼(CNS ) Α4規格(210X297公釐) 五、發明説明(π ) A7 B7 說Bfl奮捕?锎溢號3 R :> 3 -甲甚时丨呤笨醵合丨成方法 之_im L fA- Γ 5 -苄氳某- 2- U-苄氩某-茏基)甚- NIP# -1 -某申某Ί -笨氣基I _二乙„i 得自前述步驟之编號26(5.5克,8.8毫莫ψ)於THF(50 毫升)之溶液冷卻至〇°C及逐滴加入LiAlH4 於T H F之溶液。於0 °C 3 D分鐘後,以水小心饨捽熄反應, 且分佈於810 4(;和1(111(:1之間。以>^304乾;||£1:(^(;,濃 縮,及以EtOAc/己烷(2 : 3)於矽凝膠上層析以産生 克之编號3 8之白色泡沫: foam: !H NMR (DMSO) 7.48-7.46 (m, 4 H), 7.42-7.27 (m, 8 H;, 7.20 (d, 1 H, J = 8.8 Hz), 7.12-7.10 (m, 3 H), 6.80 (dd, 1 H, J = 8.8, 2.4 Hz), 6.73 (s, 4 H), 5.15 (s, 2 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 4.80 (t, 1 J = 5.5 Hz), 3.86 (t, 2 H, J = 4.8 Hz), 3.63 (q, 2 H, J = 5.3 Hz), 2.15 (s, 3 H). 料丨盹荣乙醇夕物理數墟 稂據流程圖10使用方法4以選自編號21至 當經取代之吲昤乙酯製備下列化合物。 编號3 4之適 實施例编號3 5 2ji_丄丄二f 2 -苯華-3 -甲基-吲時-1 -羞—里.. 某1 -茱Μ某)醇 ----------it-- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝〇〇Η [Example No. 21.24 · 27_29 · 34 Example No. 35 * 46 • 37. This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 5. Description of the invention (π) A7 B7 Say Bfl Strike?锎 overflow number 3 R : > 3 -Methysine 丨 iminobenzidine synthesis _im L fA- Γ 5 -benzylamidine-2 -U-benzylargon -amyl) even-NIP #- 1-Some Shenmiao-Benzoyl I _ diethyl „i The solution of No. 26 (5.5 g, 8.8 mmol) from the previous step in THF (50 ml) was cooled to 0 ° C and added dropwise. LiAlH4 in THF solution. After 3 D minutes at 0 ° C, the reaction was carefully quenched with water and distributed between 810 4 (; and 1 (111 (: 1. Dry with> ^ 304; || £ 1: (^ (;, concentrated, and chromatographed on a silica gel with EtOAc / hexanes (2: 3) to produce grams of white foam numbered 38: foam:! H NMR (DMSO) 7.48-7.46 ( m, 4 H), 7.42-7.27 (m, 8 H ;, 7.20 (d, 1 H, J = 8.8 Hz), 7.12-7.10 (m, 3 H), 6.80 (dd, 1 H, J = 8.8, 2.4 Hz), 6.73 (s, 4 H), 5.15 (s, 2 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 4.80 (t, 1 J = 5.5 Hz), 3.86 (t , 2 H, J = 4.8 Hz), 3.63 (q, 2 H, J = 5.3 Hz), 2.15 (s, 3 H). Material 盹 Ethanol Ethanol Physical Data Market Use Method 4 to select according to Flowchart 10 The following compounds were prepared from No. 21 to when substituted indylethyl esters. Suitable examples of No. 3 4 No. 3 5 2ji_ 丄 丄 二 f 2 -phenanthrene-3 -methyl-indio-1 -shy—Li: 1-Ju M) alcohol ---------- it-- (please first (Read the notes on the back and fill out this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

Oil; 1h NMR (DMSO) 7.57 - 7.32 (m, 7 H), 7.13 - 7.02 (m, 5.21 (s, 2 H), 4.80 (s, 1 H), 3.86 - 3.83 (m, 2 H), 3.62 (s, 2 H), m/z 357 (M+). :ί Η), 6.74 (s, 4 Η), :».20 (s, 3 H); MS el 實施例编號3 δ 2- (4- Γ 5 -甲氣基-2- 基」 -39- 本紙張尺度適用中國國家標準(CNS > A4規格(210X 297公釐) :8.8 Hz ), 7.03 ,5H) , 5.14 (s, 2 (s, 3 H), 3.63 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(w)Oil; 1h NMR (DMSO) 7.57-7.32 (m, 7 H), 7.13-7.02 (m, 5.21 (s, 2 H), 4.80 (s, 1 H), 3.86-3.83 (m, 2 H), 3.62 (s, 2 H), m / z 357 (M +).: ί Η), 6.74 (s, 4 Η),: ».20 (s, 3 H); MS el Example No. 3 δ 2- ( 4- Γ 5 -methylamino-2-based "-39- This paper size applies to Chinese national standards (CNS > A4 size (210X 297 mm): 8.8 Hz), 7.03, 5H), 5.14 (s, 2 (s, 3 H), 3.63 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (w)

Oil; 'H NMR (DMSO) 7.27 (d, 2 H , J = 8.8Hz),7.17 (d, 1 H, J (d, 2 H J = 8.6 Hz), 6.99 (d , 1 H , J = 2.5 Hz), 6.78 - 6.70 (m H), 4.80 (brs, 1H), 3.85 (t, 2 H, J = 5.0 Hz), 3.78 (s , 3H), 3.76 (t, 2H , J = 5.0 Hz), 2.16 (s , 3H); MS el m/z 417 (M+). 實施例编號3 7 2- f4- ί 5 -苄氫某-2-(4 -7. iS某-茱甚) -3 -申某-Pi!丨盹-1 -某甲某Ί -荣氤甚1 - 7.醆Oil; 'H NMR (DMSO) 7.27 (d, 2 H, J = 8.8 Hz), 7.17 (d, 1 H, J (d, 2 HJ = 8.6 Hz), 6.99 (d, 1 H, J = 2.5 Hz ), 6.78-6.70 (m H), 4.80 (brs, 1H), 3.85 (t, 2 H, J = 5.0 Hz), 3.78 (s, 3H), 3.76 (t, 2H, J = 5.0 Hz), 2.16 (s, 3H); MS el m / z 417 (M +). Example No. 3 7 2- f4- ί 5 -Benzyl hydrogen -2- (4 -7. iS 某-朱 茱) -3 -Shen -Pi! 丨 盹 -1 -A Jia Mou -Rong Yu 1-7. 醆

Foam; Ή NMR (DMSO) 7.45 (d , 2 Η , J =7.3 Hz), 7.40 - 7.25 (m , 5 H), 7.17 (d , 1 H , J = 8.8 Hz), 7.11 (d , 1 H , J =2.2 Hz), 7.01 (d , 2 E , J = 6.8 Hz), 6.78 (dd , 1 H , J = 8.8Hz, J = 2.4 Hz), 6.73 (s , 4H), 5.15 (s, 2 H), 5.10 (s , 2H), 4.80 (brs, 1 H), 4.06 (q , 2 H, J = 6.8 Hz), 3.85 (t, 2 H , J = 5.0 Hj:), 3.63 (t, 2H , J 4.8 Hz), 2.14 (s , 3H), 1.33 (t, 3H, J = 6.9 Hz); MS el m/z 507 (M+). 4 0- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁)Foam; Ή NMR (DMSO) 7.45 (d, 2 Η, J = 7.3 Hz), 7.40-7.25 (m, 5 H), 7.17 (d, 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.01 (d, 2 E, J = 6.8 Hz), 6.78 (dd, 1 H, J = 8.8Hz, J = 2.4 Hz), 6.73 (s, 4H), 5.15 (s, 2 H ), 5.10 (s, 2H), 4.80 (brs, 1 H), 4.06 (q, 2 H, J = 6.8 Hz), 3.85 (t, 2 H, J = 5.0 Hj :), 3.63 (t, 2H, J 4.8 Hz), 2.14 (s, 3H), 1.33 (t, 3H, J = 6.9 Hz); MS el m / z 507 (M +). 4 0- This paper size applies to China National Standard (CNS) A4 specifications ( 210X297 mm) (Please read the notes on the back before filling this page)

五、發明説朗(β ) A7 B7 ® 施例缠號 39 2二 L4:. L5二iSLA*二2L二U二藶二鹿_盖_) - 3二麗 基-1-某申某1 某1 -,.酵 lH NMR (DMSO) 7.40 - 6.60 (m, 16 Η), 5.10 (s, 1 Η), 5.07 (s, 3.76 (t, 2 H, J = 4.9 Hz), 3.53 (t, 2 H, J * 5.0 Hz), 2.06 (s, 3 H). 窨施例编號40 2- ( 4- Γ 5 -苄氮某申二氩某Δ.Β :H). 5.02 (s. 2 H), 二ϋ ) - 3 - Φ某-盹- 1 -某g某Ί -采氤某1 Oil; Ή NMR (DMSO) 7.45 (d, 2 H ,J = 7.0 Hz), 7.37 (m , 2 7.19 (d, 1H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.00 (d, 1 H (d, 1 H ,5.0 Hz), 6.82 - 6.75 (m , 6H), 6.07 (s , 2 H), 5.16 (s , :» (s , 2 H), 3.86 (t, 2 H , J « 5.0 Hz), 3.63 (t, 2 H , J = 5.0 Hz),:. m/z507(M+). H), 7.32 (m, 1 H), ,J = 7.9 Hz), 6.90 H), 5.10 15 (s, 3 H); MS cl 實施例编號4 1 2二.奴二工上1.氣.—基.二2—-丄4:一11 基> -3 -甲某-|ij| 1¾ - 1 -某申甚Ί -荣氤基丄二乙V. Invention Talk (β) A7 B7 ® Example No. 39 2 2 L4 :. L5 2 iSLA * 2 2 L 2 U 2 2 2 2 deer _ cover _)-3 2 Li Kei-1-Some Shen 1 1 Some 1 -, .H NMR (DMSO) 7.40-6.60 (m, 16 Η), 5.10 (s, 1 Η), 5.07 (s, 3.76 (t, 2 H, J = 4.9 Hz), 3.53 (t, 2 H , J * 5.0 Hz), 2.06 (s, 3 H). 窨 Example No. 40 2- (4- Γ 5 -benzyl nitrogen, some argon, some Δ.B: H). 5.02 (s. 2 H) , Ϋ)-3-Φ-盹-1-gg-Ί-mining 氤 1 Oil; Ή NMR (DMSO) 7.45 (d, 2 H, J = 7.0 Hz), 7.37 (m, 2 7.19 ( d, 1H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.00 (d, 1 H (d, 1 H, 5.0 Hz), 6.82-6.75 (m, 6H), 6.07 ( s, 2 H), 5.16 (s,: »(s, 2 H), 3.86 (t, 2 H, J« 5.0 Hz), 3.63 (t, 2 H, J = 5.0 Hz),: m / z507 (M +). H), 7.32 (m, 1 H),, J = 7.9 Hz), 6.90 H), 5.10 15 (s, 3 H); MS cl Example No. 4 1 2 2.2. 1. qi.—base. 2: 2— 丄 4: one 11 bases> -3-Jiamou- | ij | 1¾-1-a certain Shen Qiyong-Rongji bases two second

Foam; lH NMR (DMSO) 7.46 (d, 2H, J = 7.7 Hz), 7.42 - 7.28 ( (d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 (d, 1 H, J (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 (s, (s, 2 H), 5.10 (s, 2 H), 4.80 (bs, 1 H), 4.70 - 4.60 (m, 1 H), 3.8: (t, 2 H, J = 4.8 Hz), 3.63 (t, 2 H, J = 5.1 Hz), 2.13 (s, 3 H), 1.3( (d, 6 a J = 5.9 Hz); MS el m/z 521 (M+). 醇 n, 3 H), 7.25 2.4 Hz), 6.99 4 H), 5.14 it (請先閱讀背面之注意事項再填寫本頁)Foam; lH NMR (DMSO) 7.46 (d, 2H, J = 7.7 Hz), 7.42-7.28 ((d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 ( d, 1 H, J (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 (s, (s, 2 H), 5.10 (s, 2 H), 4.80 (bs, 1 H), 4.70-4.60 (m, 1 H), 3.8: (t, 2 H, J = 4.8 Hz), 3.63 (t, 2 H, J = 5.1 Hz), 2.13 ( s, 3 H), 1.3 ((d, 6 a J = 5.9 Hz); MS el m / z 521 (M +). Alcohol n, 3 H), 7.25 2.4 Hz), 6.99 4 H), 5.14 it (Please (Read the notes on the back before filling out this page)

*1T 經濟部中央橾準局員工消費合作杜印製* 1T Printed by the Central Consumers' Association of the Ministry of Economy

實施例编號4 2 2二丄4 -丄5_:i親基-2 - ( 4 -燦 $_1_二._3二5__^二!^1_!5__1_1二基_见_.基—1———:龙...氣.基丨.....-乙 Mp = 129-13TC; Ή NMR (DMSO) 7.47 (d, 2 H, J = 7.2 Hz), 7.3 (t, 2 H, J = 7.2 Hz), 7.33 - 7.28 (m, 1 H), 7.25 (d, 2 H, J = 8.8 ψ (d, 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.4 Hz), 6.98 (d, 2 H, J (dd, 1 H, J = «.8 Hz, 2.4 Hz), 6.74 (s, 4H), 5.15 (s, 2 H), 5.11 (m, 1 H), 4.79 (t, 1 H, J = 5.7 Hz), 3.86 (t, 2 H, J = 4.8 Hz), 3.^ (q, 2 H, J = 5.1 Hz), 2.15 (s, 3 H), 1.96 - 1.87 (m, 2 H), 1.77 --1.53 (m, 2 H); IR (KBr) 3490 br, 2920, 1620 cm-1; MS el m/Z m 8 z), 7.18 8.8 Hz), 6.79 k 2 H), 4.84 - 4.80 3 1.65 (m, 4 H), 1.62 547 (M+). 41 t紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 五、發明説明(β) A7 B7 實施例編號43 2^丄_4^丄5二31_^基_二2_::—14.-三」1_且基二蓋 基_)二3二用_盖_-?此1[二1-基1基J.:苯级基}-乙 Foam; *H NMR (DMSO) 7.83 (d, 2 H, J = 8.1 Hz), 7.59 (d, 2 (d, 2 H, J = 8.3 Hz), 7.42 - 7.36 (m, 2 H), 7.35 - 7.29 (m, 2 H), (d, 1 H, J = 2.4 Hz), 6.87 (dd, 1 H, J = 8.1 Hz, 2.4 Hz), 6.77 -(s, 2 H), 5.12 (s, 2 H), 4.81 (br s, 1 H), 3.85 (t, 2 H, J = 5.1 Hz> (t, 2 H, J = 5.1 Hz), 2.19 (s, 3 H); MS cl m/z 531. J = 7.9 Hz), 7.47 7.18 5.68 (m, 4 H), 5.21 ,3.63 實施例编號4 4 2二_L4二 田甚-Η丨盹-1 -某申某1 5-节氤基-2 表二苯蓋丄 苯—氳-盖]-乙醇… OU; JH NMR (DMSO) 7.46 (d, 2 H, J = 7.2 Hz), 7.45 - 7.18 (rr, 8 H), 7.12 (d, 1 H, J = 2.4 Hz), 6.81 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 6.73 (s, 4 H), 5.15 (s, 2 H), 5.1(¾^. 2 H), 4.80 (bX 1 H), 3.85 (t, 2 H, J = 4.8 Hz), 3.63 (t, 2 H, J = 4.9 Hz), 2.34 (s, 3 H), 2.15 (s, 3 H); MS el m/z 477 (M+V 實施例编號4 5 L丄生二二蓋盖丄 基-_引咚-1 -基甲基]—二苯—1基丄—::乙—醇 Μρ= 110- 113°C; Ή NMR (DMSO) 7.52 (d , 2 H, J = 8.6Ηφ 6.8Hz), 7.38 (m ,4 H), 7.42 - 7.37 (m , 1 H), 7.25 (d, 1 H, J J = 2.4Hz), 6.83 (dd ,1H, J = 8.8Hz , J = 2.5 Hz), 6.76 - 6.70 ( H), 5.11 (s ,2H), 3.85 (t, 2H , J = 5.2Hz), 3.63 (t, 2H , J= 5.0 MS el m/z 497 (M+). ,7.46 (d, 2 H, J = Φ.ΟΗζ), 7.14 (d, 1 H, m, 4H), 5.17 (s , 2 Hz), 2.16 (s , 3 H); 丄.4 - Γ 5 -节氛.蓋..:+m. 4_' -1 -¾甲某Ί -采氣基I -Z1 (請先閱讀背面之注意事項再填寫本頁)Example No. 4 2 2 2 丄 4-丄 5_: i parent-2-(4 -Can $ _1_ 二 ._3 二 5 __ ^ 二! ^ 1_! 5__1_1 二 基 _ 见 _ 基基 -1—— -: Dragon ... Ga.Base 丨 .....- B Mp = 129-13TC; Ή NMR (DMSO) 7.47 (d, 2 H, J = 7.2 Hz), 7.3 (t, 2 H, J = 7.2 Hz), 7.33-7.28 (m, 1 H), 7.25 (d, 2 H, J = 8.8 ψ (d, 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.4 Hz), 6.98 (d, 2 H, J (dd, 1 H, J = «.8 Hz, 2.4 Hz), 6.74 (s, 4H), 5.15 (s, 2 H), 5.11 (m, 1 H), 4.79 ( t, 1 H, J = 5.7 Hz), 3.86 (t, 2 H, J = 4.8 Hz), 3. ^ (q, 2 H, J = 5.1 Hz), 2.15 (s, 3 H), 1.96-1.87 (m, 2 H), 1.77 --1.53 (m, 2 H); IR (KBr) 3490 br, 2920, 1620 cm-1; MS el m / Z m 8 z), 7.18 8.8 Hz), 6.79 k 2 H), 4.84-4.80 3 1.65 (m, 4 H), 1.62 547 (M +). 41 t paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 5. Description of the invention (β) A7 B7 Examples No. 43 2 ^ 丄 _4 ^ 丄 5 two 31_ ^ base_two 2_ :: -14.-three "1_ and base two cover__) two 3 two use _ cover _-? This 1 [二 1- 基1-base J .: Benzyl) -Ethyl Foam; * H NMR (DMSO) 7.83 (d, 2 H, J = 8.1 Hz), 7.59 (d, 2 (d, 2 H, J = 8.3 Hz), 7.42-7.36 (m, 2 H), 7.35-7.29 (m, 2 H), (d, 1 H, J = 2.4 Hz), 6.87 (dd, 1 H, J = 8.1 Hz, 2.4 Hz), 6.77- (s, 2 H), 5.12 (s, 2 H), 4.81 (br s, 1 H), 3.85 (t, 2 H, J = 5.1 Hz > (t, 2 H, J = 5.1 Hz), 2.19 ( s, 3 H); MS cl m / z 531. J = 7.9 Hz), 7.47 7.18 5.68 (m, 4 H), 5.21, 3.63 Example No. 4 4 2 2_L4 Ertian even-Η 丨 盹- 1 -Shenmou 1 5-Membenyl-2 Table Diphenylcaprobenzene-fluorene-cabin] -Ethanol ... OU; JH NMR (DMSO) 7.46 (d, 2 H, J = 7.2 Hz), 7.45-7.18 (rr, 8 H), 7.12 (d, 1 H, J = 2.4 Hz), 6.81 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 6.73 (s, 4 H), 5.15 (s, 2 H ), 5.1 (¾ ^. 2 H), 4.80 (bX 1 H), 3.85 (t, 2 H, J = 4.8 Hz), 3.63 (t, 2 H, J = 4.9 Hz), 2.34 (s, 3 H ), 2.15 (s, 3 H); MS el m / z 477 (M + V Example No. 4 5 L peroxodicapronyl- _ hydrazone-1 -ylmethyl] -diphenyl- 1-based 丄 — :: ethyl alcohol Mρ = 110- 113 ° C; Ή NMR (DMSO) 7.52 (d, 2 H, J = 8.6Ηφ 6.8Hz), 7.38 (m, 4 H), 7.42-7.37 (m , 1 H), 7.25 (d, 1 H, JJ = 2.4Hz), 6.83 (dd, 1H, J = 8.8Hz, J = 2.5 Hz), 6.76-6.70 (H), 5.11 (s, 2H), 3.85 (t, 2H, J = 5.2Hz), 3.63 (t, 2H, J = 5.0 MS el m / z 497 (M +)., 7.46 (d, 2 H, J = Φ.ΟΗζ), 7.14 (d, 1 H, m, 4H), 5.17 (s, 2 Hz), 2.16 (s, 3 H); 丄. 4-Γ 5-rhythm. Cover: + m. 4_ '-1-¾ -Gas base I -Z1 (Please read the precautions on the back before filling this page)

.V.V

,1T 經濟部中央標準局員工消費合作社印製, 1T Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

Oil; !h NMR (DMSO) 7.46 (d, 2 H, J = 7.5 Hz), 7.39 - 7.35 (m, 1H), 7.16 - 7.06 (m, 3 H), 6.82 - 6.72 (m, 5 H), 6.68 (d, 1 (dd, 1 H, J = 2.4 Hz, 8.3 Hz), 5.0 (s, 1 H), 4.88 (s, 2 H), 4.85 4.69 (d, 1 H, J = 6.3 Hz), 3.63 (t, 2 H, J = 6.9 Hz), 3.58 (s, 3 ψ 3.40 (t, 2 H, J = 6.9 Hz), 1.80 (s, 3 H). m基-笨 醇 (中,2 Η), 7.31 -7.28 H, J = 2.2 Hz), 6.61 ,1H, J = 6.3 Hz), ,3.46 (s, 3 H), 4 > — ‘紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標隼局員工消費合作社印製 A7 B7 _ ,_ 五、發明説明(μ ) 3 -甲基》引呤苯乙基溴化物之數據 流程圓11Oil;! H NMR (DMSO) 7.46 (d, 2 H, J = 7.5 Hz), 7.39-7.35 (m, 1H), 7.16-7.06 (m, 3 H), 6.82-6.72 (m, 5 H), 6.68 (d, 1 (dd, 1 H, J = 2.4 Hz, 8.3 Hz), 5.0 (s, 1 H), 4.88 (s, 2 H), 4.85 4.69 (d, 1 H, J = 6.3 Hz), 3.63 (t, 2 H, J = 6.9 Hz), 3.58 (s, 3 ψ 3.40 (t, 2 H, J = 6.9 Hz), 1.80 (s, 3 H) .m-benzyl alcohol (medium, 2 Η ), 7.31 -7.28 H, J = 2.2 Hz), 6.61, 1H, J = 6.3 Hz),, 3.46 (s, 3 H), 4 > — 'The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 (Mm) A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs _, _ V. Description of the Invention (μ) 3 -methyl "data

(請先閲讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) A7 B7 五、發明説明(# ) 表 4 (缠) 經濟部中央標準局員工消費合作社印製 實施例编號 X Q 编號51 OBn 4 ' - F 编號52 OBn 3' ,4 ' -OCH 2 0- 编號5 2 a OBn 3'-OMe,4'-OBn 编號53 OBn 4 f - 0 - i P r 編號54 OBn 4 r -OCp 编號55 OBn 4 ' -CF 3 编號56 OBn 4 ' -CH a 編號57 OBn 4 ' - C 1 說明曹旃例绾號5 0夕3 -甲甚荣乙某淖化物 成.方法5之奮驗步驟 5 -节氣基-2-(4-苄氩某-茏某)-1-「4-(2-淳|-7>.氬某) -44- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----------ίν-- (請先閲讀背面之注意事項再填寫本頁) 、1Τ 經 A7 B7 五、發明説明(〇) 节華 Ί - 3 -甲.基 將 CBr4 (2.9克,8·7毫莫耳)和 PPH3 (2. 3克,8 . 7毫 莫耳)加至實施例编號38(3.3克,5.8毫莫ΐ -)於T H F之溶 液中。反應於室溫攪拌3小時,然後濃縮 及使用E t 0 A c /己烷(1: 4)之梯度溶離於矽凝膠上層析’ 以産生1 3 . 2 克白色固髏:M p = U 1 - 1 3 4 °C ; 1 Η N M D Μ SO ) 7.64- 7 · 3 0 (in,1 〇 Η ),7 · 2 9 { d,2 Η,J = 8 . 8 Η ζ〉,7 . 2 0(d, 1 Η , J = 8.8 Hz),7.12-7.09(ni,3H),6.80(dd,lH,J = 8.8, 2.4 Hz ) ,6.77-6.73(βι,4Η), 5.16(s,2H), 5.13(s, 2 Η ) , 5.11 (s,2H), 4.2〇(t,2H,J=5.3 Hz), 3.73(t,2 Η , J = 5 . 5 Β ζ ) ,2.15(s,3H);MS FAB 631/633(M+H+ ,Br存 在)。 芜7,某漫.JL®之物理.數據.. 下列化合物根據流程圖11如方法中所述孩 :用適當選自 编號3 5 -编號4 5之經取代吲鸣製得。 两施例编號47 1- Γ 4-(2 -淖-乙Μ基)-苄基 )-2 -荣某-3- 田甚-1 Η - Β4Ι呤 Oil; 1h NMR (DMSO) 7.57 - 7.32 (m, 7 H), 7.13 - 7.02 (m, 2 Η), 6.74 (s, 4 Η), 5.21 (s, 2 H), 4.19 (t, 2 H, J = 5.2 Hz), 3.71 (t, 2 H, J = 5.5 Hz ),2.20 (s, 3 H); MS el m/z 419 (M+)· 審油;俐迫號48 甲氩某- 2- (4 -申氯基-茱寒 )-1- Γ 4- (2 -淖-氣某)-¥某Ί - 3 -甲某-1 Η - 丨鸣 Oil; Ή NMR (DMSO) 7.27 (d , 2 Η , J = 8.8Hz),7.17 (d, 1H, J =8.8 Hz), 7.03 (d , 2 H J = 8.6 Hz), 6.99 (d , 1 H , J = 2.5 Hz), 6.80 - 6.69 (m , 5 H) , 5.14 (s, 2H), 4.19 (t, 2H , J = 5.4 Hz), 3.78 (s , 3 H), 3.76 (s , 3 H), 3 72 (t,2H , J = 5.5 Hz), 2.16 (s , 3H); MS el m/z 479 (M+). -4 5- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請k, 閲 讀 背 面 之 注 意 事 項 再 填 寫 本 頁 訂This paper size applies to Chinese National Standard (CNS) A4 specifications (210 × 297 mm) A7 B7 V. Description of invention (#) Table 4 (Entangled) Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Example No. XQ No. 51 OBn 4 '-F No. 52 OBn 3', 4 '-OCH 2 0-No. 5 2 a OBn 3'-OMe, 4'-OBn No. 53 OBn 4 f-0-i P r No. 54 OBn 4 r -OCp No. 55 OBn 4 '-CF 3 No. 56 OBn 4' -CH a No. 57 OBn 4 '-C 1 Explain Cao Yulin No. 5 0 Xi 3-Jia Xirong Yi Formation. Method 5 Test step 5-solar terms 2- (4-benzyl argon -1-茏) -1- "4- (2-chun | -7 >. argon) -44- This paper size applies to Chinese national standards (CNS ) A4 specification (210X 297 mm) ---------- ίν-- (Please read the notes on the back before filling in this page), 1T via A7 B7 V. Description of invention (〇) -3-A. Add CBr4 (2.9 g, 8.7 mmol) and PPH3 (2.3 g, 8.7 mmol) to Example No. 38 (3.3 g, 5.8 mmol)- ) In THF solution. The reaction was stirred at room temperature for 3 hours, then concentrated and Et 0 A c / hexane was used. 1: 4) gradient chromatography on silica gel to produce 13.2 g white solid skull: M p = U 1-1 3 4 ° C; 1 Η NMD Μ SO) 7.64- 7 · 3 0 (in, 1 〇Η), 7 · 2 9 {d, 2 Η, J = 8.8 Η ζ>, 7. 2 0 (d, 1 Η, J = 8.8 Hz), 7.12-7.09 (ni, 3H ), 6.80 (dd, 1H, J = 8.8, 2.4 Hz), 6.77-6.73 (βι, 4Η), 5.16 (s, 2H), 5.13 (s, 2 Η), 5.11 (s, 2H), 4.2〇 ( t, 2H, J = 5.3 Hz), 3.73 (t, 2 Η, J = 5.5 Β ζ), 2.15 (s, 3H); MS FAB 631/633 (M + H +, Br exists). Wu 7, Physical, data, and chemical properties of a certain JL®. The following compounds are described in the method according to Scheme 11: Prepared with substituted indole appropriately selected from No. 3 5-No. 45. Two example numbers 47 1- Γ 4- (2 -fluorene-ethylmethyl) -benzyl) -2-Rongmou-3- Tianshi-1 Η-Β4ΙTermine Oil; 1h NMR (DMSO) 7.57-7.32 (m, 7 H), 7.13-7.02 (m, 2 Η), 6.74 (s, 4 Η), 5.21 (s, 2 H), 4.19 (t, 2 H, J = 5.2 Hz), 3.71 (t, 2 H, J = 5.5 Hz), 2.20 (s, 3 H); MS el m / z 419 (M +) · oil review; Li Li 48 Methyl Argon-2- (4 -Shenyl chloride-Zhuhan) -1- Γ 4- (2-淖-气 某)-¥ some Ί-3-甲某 -1 Η-丨 ming Oil; Ή NMR (DMSO) 7.27 (d, 2 Η, J = 8.8Hz), 7.17 (d, 1H, J = 8.8 Hz), 7.03 (d, 2 HJ = 8.6 Hz), 6.99 (d, 1 H, J = 2.5 Hz), 6.80-6.69 (m, 5 H), 5.14 (s, 2H ), 4.19 (t, 2H, J = 5.4 Hz), 3.78 (s, 3 H), 3.76 (s, 3 H), 3 72 (t, 2H, J = 5.5 Hz), 2.16 (s, 3H); MS el m / z 479 (M +). -4 5- This paper size is applicable to China National Standard (CNS) A4 (210X 297mm) Please k, read the notes on the back and fill in this page to order

中 央 標 準 局 員 工 消 費 合 作 社 印 製 經 濟 部 中 標 準 局 貝 合 作 社 印 製 A7 B7 五、發明説明(#) 啻掄锎组號49 5-苄氩甚-?-(4-7.舊,甚-¾甚 )-1- 「4- (2 -淖氩甚)-苄某Ί -2 -荣甚 ΒίΙ Ρ5 Mp = 118-120°C; lH NMR (DMSO) 7.45 (d , 2 H, J =7.3 Hz), 7.41 - 7.26 (m,5 H),7.17 (d,1 H,J = 8.8 Hz), 7.11 (d,1 H,J =2.2 Hz ),7.01 (d , 2 H , J = 6.8 Hz), 6.78 (dd , 1 H , J = 8.8Hz, J = 2.4 Hz), 6 78 - 6.74 (m , 4 Η), 5.15 (s, 2 H), 5.10 (s , 2 H), 4.22 - 4.18 (m, 2 H), 4.04 (q , 2 H ,J = 6.8 Hz), 3.72 (t, 2 H , J = 5.5 Hz), 2.14 (s , 3 H), 1.33 (t, 3 H , J = 7.0Hz); N [S el m/z 569 (M+). 奮施例編號51 5 -苄氣基-1- f4-(2 -淳-7,氳 某)-苄甚1 -2 - U -氩-采某)-:?-甲某-1 Η -础P4 Mp = 114-116°C; !h NMR (DMSO) 7.47 (m, 2 H), 7.45 - 7.20 ;m, 8 Η), 7.14 (d, 1 H, J = 2.4 Hz), 6.83 (dd, 1 H, J = 2.7 Hz, 9.0 Hz), 6.80 - 6.70 (m, 4 H), 5.16 (s, 2 H), 5.11 (s, 2H), 4.19 (t, 2 H, J = 5.27 Hz), 3.72 (t, 2 H, J = 6.4 Hz), 2.15 (s,3H); Ms el ai/z 543(M + );C3iHz?BrFN0: t之CHN計算值e 實施例编號52 2-苯并[1.31二焯某-5-某· 5 -窄氬某 1- Γ 4-(2 -'?阜-7.氣某-苄某 Ί -·*?-田某- ΙΗ-ΒϋΙ n Mp = 133-136°C; *H NMR (DMSO) 7.45 (d, 2 H, J = 7.0 Hz),: .41-7.38 (m , 2 H), 7.35-7.30 (m , 1 H), 7.19 (d ,1 H, J = 8.8 Hz), 7.11 (d, 1 H, J : =2.2 Hz), 7.00 (d, 1 H, J = 7.9 Hz), 6.90 (d , 1 H, 1.4 Hz), 6.82 - 6.78 (m, 2H), 6.77 (s, 4 H), 6.07 (s, 2 H), 5.16 (s, 2 H), 5.10 (s, 2 H), 4.20 (t, 2 H, J = 5.5 Hz), 3.73 (t, 2H, J =5.2Hz), 2.15 (s , 3H); MS el m/z 569 (M+). 實施例编號52a 5 -苄氫某-1-「4-(2-漳-Ζ’Ί 【某1 -笮 某1 -2-(3-田氲某-4 -苄氮某-荣甚田某 -1 Η - B4I (4 Foam; lH NMR (DMSO) 7.47 - 7.42 (m, 4 H), 7.40 - 7.30 (m, 6 Η), 7.20 (d, 1 Η, J =8.8 Hz), 7.12-7.10 (m, 2 H), 6.86 - 6.84 (m, 2 H), 6.81 (dd, 1 Η, J = 8.8 Hz, 2.4 Hz), 6.78 (s, 4 H), 5.17 (s, 2 H), 5.11 (s, 2 H), 5.10 (s, 2 H), U0 (t,2 H, J = 5.0 Hz), 3.72 (t, 2 H, J = 5.4 Hz), 3.63 (s, 3 H), 2.17 (s, 3 H );MS FAB m/z 662 (M+H+). -46- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閱 讀 背 Φ 之 注 寫 頁Printed by the Consumer Standards Cooperative of the Central Bureau of Standards Printed by the Bureau of Standards of the Ministry of Economic Affairs Printed by A7 B7 V. Description of the Invention (#) 号 Group No. 49 5-Benzyl Argon-?-(4-7. Old, even-¾ Even) -1- 「4- (2-淖 argon) -benzyl Ί -2 -Rongshi Β5 Mp = 118-120 ° C; lH NMR (DMSO) 7.45 (d, 2 H, J = 7.3 Hz ), 7.41-7.26 (m, 5 H), 7.17 (d, 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.01 (d, 2 H, J = 6.8 Hz) , 6.78 (dd, 1 H, J = 8.8Hz, J = 2.4 Hz), 6 78-6.74 (m, 4 Η), 5.15 (s, 2 H), 5.10 (s, 2 H), 4.22-4.18 ( m, 2 H), 4.04 (q, 2 H, J = 6.8 Hz), 3.72 (t, 2 H, J = 5.5 Hz), 2.14 (s, 3 H), 1.33 (t, 3 H, J = 7.0 Hz); N [S el m / z 569 (M +). Fen Example No. 51 5 -benzylamino-1-f4- (2 -chun-7, 氲) -benzyl 1 -2 -U -argon -Caimou)-:?-Amou-1 Η -Basic P4 Mp = 114-116 ° C;! H NMR (DMSO) 7.47 (m, 2 H), 7.45-7.20; m, 8 Η), 7.14 ( d, 1 H, J = 2.4 Hz), 6.83 (dd, 1 H, J = 2.7 Hz, 9.0 Hz), 6.80-6.70 (m, 4 H), 5.16 (s, 2 H), 5.11 (s, 2H ), 4.19 (t, 2 H, J = 5.27 Hz) , 3.72 (t, 2 H, J = 6.4 Hz), 2.15 (s, 3H); Ms el ai / z 543 (M +); C3iHz? BrFN0: calculated value of CHN for t e Example No. 52 2-benzene And [1.31 二 焯 某 -5- 某 · 5 -narrow argon 1- Γ 4- (2-'? Fu-7. Qisome-benzyl Ί-· *?-田某-ΙΗ-ΒϋΙ n Mp = 133-136 ° C; * H NMR (DMSO) 7.45 (d, 2 H, J = 7.0 Hz) ,: .41-7.38 (m, 2 H), 7.35-7.30 (m, 1 H), 7.19 (d , 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J: = 2.2 Hz), 7.00 (d, 1 H, J = 7.9 Hz), 6.90 (d, 1 H, 1.4 Hz), 6.82- 6.78 (m, 2H), 6.77 (s, 4 H), 6.07 (s, 2 H), 5.16 (s, 2 H), 5.10 (s, 2 H), 4.20 (t, 2 H, J = 5.5 Hz ), 3.73 (t, 2H, J = 5.2Hz), 2.15 (s, 3H); MS el m / z 569 (M +). Example No. 52a 5 -Benzylhydrogen-1-"4- (2- Zhang-Z'Ί 【some 1-笮 some 1 -2- (3- Tian 氲 some-4-benzazepine some- Rongshitian some -1 Η-B4I (4 Foam; lH NMR (DMSO) 7.47-7.42 (m , 4 H), 7.40-7.30 (m, 6 Η), 7.20 (d, 1 Η, J = 8.8 Hz), 7.12-7.10 (m, 2 H), 6.86-6.84 (m, 2 H), 6.81 ( dd, 1 Η, J = 8.8 Hz, 2.4 Hz), 6.78 (s, 4 H), 5.17 (s, 2 H), 5.11 (s, 2 H), 5.10 (s, 2 H), U0 (t, 2 H, J = 5.0 Hz), 3 .72 (t, 2 H, J = 5.4 Hz), 3.63 (s, 3 H), 2.17 (s, 3 H); MS FAB m / z 662 (M + H +). -46- This paper size applies to China National Standard (CNS) A4 specification (210X 297mm) Please read the note page on the back Φ first

I 五、發明説明(#) A7 B7 實施例编號δ 3 5-苄氣基小[4-(2-溴.7. ZJ& 某)-苄某ΊI. V. Description of the invention (#) A7 B7 Example number δ 3 5-Benzylamino group is small [4- (2-bromo. 7. ZJ & some) -benzyl

-2-(4 -里丙氫某-茱某3-申某-1Η -»4丨Ρ癸 Mp = 125 - 128°C; lH NMR (DMSO) 7.46 (d, 2H, J = 7.7 Hz), 7.25 (d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 (d, 1 (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 (s, 2 H), 5.10 (s, 2 H), 4.70 - 4.60 (m, 1 H), 4.19 (t, 2 H, J = 5 (t, 2 H, J = 4.4 Hz), 2.13 (s, 3 H), 1.30 (d, 6 H, J = 5.9 Hz); MS 7.42 - 7.28 (m, 3 H), 】i, J = 2.4 Hz), 6.99 (s,4H), 5.14 3 Hz), 3.72 el mjz 583 (M+). 實施例編號54 5 -苄氩甚-1 -「4 - f 2 -溥-7.氫 -2-(4-瑗戍氫某-茱某)-3-甲某-1>]-11引盹 Mp = 110 - 112°C; 7.47 (d, 2 H, J = 7.0 Hz), 7.38 (t, 2 H, J = 7.0 (m, 1 H), 7.25 (d, 2 H, J = 8.8 Hz), 7.18 (d, 1 H, J = 8.8 Hz), 7 (d, 1 H, J = 2.4 Hz), 6.98 (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J 6.78 - 6.74 (m, 4 H), 5.16 (s, 2 H), 5.11 (s, 2 H), 4.86 - 4.83 (A (t, 2 H, J = 5.3 Hz), 3.73 (t, 2 H, J = 5.5 Hz), 2.15 (s, 3 H), 2.0(i 1.79 - 1.65 (m, 4 H), 1.63 - 1.56 (m, 2 H); IR (KBr) 2950, 2910, /z 6 0 9 , 6 1 1 (M + ) ; Br 存在)〇-2- (4 -Lipromium-Jumou 3-Shenmou-1Η-»4 丨 Pdecane Mp = 125-128 ° C; lH NMR (DMSO) 7.46 (d, 2H, J = 7.7 Hz), 7.25 (d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 (d, 1 (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 (s, 2 H), 5.10 (s, 2 H), 4.70-4.60 (m, 1 H), 4.19 (t, 2 H, J = 5 (t, 2 H , J = 4.4 Hz), 2.13 (s, 3 H), 1.30 (d, 6 H, J = 5.9 Hz); MS 7.42-7.28 (m, 3 H),】 i, J = 2.4 Hz), 6.99 ( s, 4H), 5.14 3 Hz), 3.72 el mjz 583 (M +). Example No. 54 5-benzylargon and even 1-"4-f 2-溥 -7. hydrogen-2- (4-fluorene hydrogen Mum-Jumou) -3-A-mau-1 >]-11 Quote Mp = 110-112 ° C; 7.47 (d, 2 H, J = 7.0 Hz), 7.38 (t, 2 H, J = 7.0 ( m, 1 H), 7.25 (d, 2 H, J = 8.8 Hz), 7.18 (d, 1 H, J = 8.8 Hz), 7 (d, 1 H, J = 2.4 Hz), 6.98 (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J 6.78-6.74 (m, 4 H), 5.16 (s, 2 H), 5.11 (s, 2 H), 4.86-4.83 (A (t, 2 H, J = 5.3 Hz), 3.73 (t, 2 H, J = 5.5 Hz), 2.15 (s, 3 H), 2.0 (i 1.79-1.65 (m, 4 H), 1.63-1.56 (m, 2 H); IR (KBr) 2950, 2910, / z 6 0 9, 6 1 1 (M +); Br exists).

Hz), 7.35 - 7.28 11 =8.6 Hz, 2.4 Hz), ,1 H),4.20 -1.87 (m, 2 H), 1610 cm-1; MS el ------------ (請先聞讀背面之注意事項再填寫本頁)Hz), 7.35-7.28 11 = 8.6 Hz, 2.4 Hz),, 1 H), 4.20 -1.87 (m, 2 H), 1610 cm-1; MS el ------------ ( (Please read the notes on the back before filling out this page)

、1T 實施例编號5 5 5 -苄氣某-1 - Γ 4 - ( 2 -淳-Z.氩 -3 -甲某-2 - ( 4 -三氬申某-荣某)-1 Η - Nl Mp = 106 -109°C; 'H NMR (DMSO) 7.83 (d, 2 H, J = 8.1 Hz), 7.60 經濟部中央標準局員工消费合作社印製 iz), 7.39 9.0 Hz, 2.6 Hz), =5.3 Hz), 3.72 (d, 2 H, J = 7.9 Hz),7.35 - 7.29 (m, 2 H), 7.48 (d, 2 H, J = 8.6 (t, 2 H, J = 7.0 Hz), 7.18 (d, 1 H, J = 2.2 Hz), 6.87 (dd, 1 H, J 6.77 - 6.71 (m, 4 H), 5.22 (s, 2 H), 5.12 (s, 2 H), 4.20 (t, 2 H, J (t, 2 H, J = 5.3 Hz), 2.20 (s, 3 H); IR (KBr) 2910, 2850, 1620 cn^-1; MS el m/z 595, 593 (M+) 實施例編號56 苄氩某-1 -「4 - (2-?草-Z氣 3 -甲基- 2- U-申某-¾ 某11¾ -47- 苄甚1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 45 - 7.18 (m, 8 Η), 3 (s, 4 Η), 5.15 4.4 Hz), 2.34 E )-苄某Ί A7 ___B7_ 五、發明説明(仙)、 1T Example No. 5 5 5 -Benzyl gas -1-Γ 4-(2 -Chun-Z. Argon-3 -Memo-2-(4 -Triargon Shenmou -Rongmou) -1 Η- Nl Mp = 106 -109 ° C; 'H NMR (DMSO) 7.83 (d, 2 H, J = 8.1 Hz), 7.60 printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 7.39 9.0 Hz, 2.6 Hz), = 5.3 Hz), 3.72 (d, 2 H, J = 7.9 Hz), 7.35-7.29 (m, 2 H), 7.48 (d, 2 H, J = 8.6 (t, 2 H, J = 7.0 Hz), 7.18 (d, 1 H, J = 2.2 Hz), 6.87 (dd, 1 H, J 6.77-6.71 (m, 4 H), 5.22 (s, 2 H), 5.12 (s, 2 H), 4.20 (t , 2 H, J (t, 2 H, J = 5.3 Hz), 2.20 (s, 3 H); IR (KBr) 2910, 2850, 1620 cn ^ -1; MS el m / z 595, 593 (M +) Example No. 56 Benzyl Argon-1-"4-(2-? Grass-Z gas 3-methyl-2-U-Shenmou-¾ a certain 11¾ -47- Benzene 1) This paper size applies Chinese national standards ( CNS) A4 specification (210X297 mm) 45-7.18 (m, 8 Η), 3 (s, 4 Η), 5.15 4.4 Hz), 2.34 E) -benzyl Ί A7 ___B7_ 5. Description of the invention (sen)

Mp = 82 - 95°C; 1h NMR (DMSO) 7.46 (d, 2 H, J = 7.2 Hz), 7 7.12 (d, 1 H, J = 2.4 Hz), 6.81 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), (s, 2 H), 5.10 (s, 2 H), 4.19 (t, 2 H, J = 5.3 Hz), 3.72 (t, 2 H, J (s, 3 H), 2.15 (s, 3 H); MS el m/z 539 (M+). 實施例编號5 7 5-节氯某-1-「4-(2-漳-Z氩 3 -甲某-2 - U -氣-茱某)-1 Η - NlMp = 82-95 ° C; 1h NMR (DMSO) 7.46 (d, 2 H, J = 7.2 Hz), 7 7.12 (d, 1 H, J = 2.4 Hz), 6.81 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), (s, 2 H), 5.10 (s, 2 H), 4.19 (t, 2 H, J = 5.3 Hz), 3.72 (t, 2 H, J (s, 3 H), 2.15 (s, 3 H); MS el m / z 539 (M +). Example No. 5 7 5-Methyl Chlorine-1- "4- (2-Zhang-Z Argon 3-甲某 -2-U- Qi-Zhumou) -1 Η-Nl

Hz), 7.38 f = 2.4Hz), 6.83 5.11 (s,2H), 4.19 el m/z 559 (M+). (請先閲讀背面之注意事項再填寫本頁) ,4· 訂 經濟部中央標準局員工消费合作社印製 本紙張尺度適用中國國家標準(CNS > A1 2 3 4規格(210X 297公釐) 1 H NMR (DMSO) 7.52 (d ,2H, J = 8.6Hz),7.46 (d , 2H, J = 6.$ 2 (m ,4 H),7.36 (m , 1H),7.25 (d ,1H , J = 9.0Hz),7.14 (d , 1H , 3 (dd , 1H , J = 8.8Hz , J = 2.5 Hz), 6.72 (m ,4H), 5.17 (s , 2H), 4 (t, 2H , J = 5.5 Hz), 3.72 (t, 2H , J = 5.5 Hz), 2.16 (s , 3H); M5Hz), 7.38 f = 2.4Hz), 6.83 5.11 (s, 2H), 4.19 el m / z 559 (M +). (Please read the notes on the back before filling this page), 4. Order the Central Bureau of Standards of the Ministry of Economic Affairs The paper size printed by the employee consumer cooperative is applicable to Chinese national standards (CNS > A1 2 3 4 specifications (210X 297 mm) 1 H NMR (DMSO) 7.52 (d, 2H, J = 8.6Hz), 7.46 (d, 2H , J = 6. $ 2 (m, 4 H), 7.36 (m, 1H), 7.25 (d, 1H, J = 9.0Hz), 7.14 (d, 1H, 3 (dd, 1H, J = 8.8Hz, J = 2.5 Hz), 6.72 (m, 4H), 5.17 (s, 2H), 4 (t, 2H, J = 5.5 Hz), 3.72 (t, 2H, J = 5.5 Hz), 2.16 (s, 3H) ; M5

7 B7 B

五、發明説明卜7 ) 某毕3 -甲基吲昤苯乙基氣化物使用作為中間 流程圖12 CI 體之數據V. Description of the invention Bu 7) The use of a certain 3-methylindinophenethyl gaseous gas as an intermediate flow chart 12 CI data

NaH, DMF Ο 實施例编號17·1β,2〇NaH, DMF 〇 Example No. 17.1β, 2〇

Cl CAS# [99847-Θ7-7]Cl CAS # [99847-Θ7-7]

Cl 實施例编號58-60 (請先閱讀背面之注意事項再填寫本頁)Cl Example No. 58-60 (Please read the notes on the back before filling this page)

I >I >

表 'τ Γ 經濟部中央標準局員工消費合作社印製 實施例编號. κ No. 58 OBn 3,-C IBn No. 59 OBn 3,-F ,4,-OBn No. 60 OBn 4’-( )CF, •49- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(砧) 說— tmi迫號μ ;;> 3 -田甚蚓盹荣某氣化 物会成 Α.法之Hn 5^3£崖1-_2-〇节氩甚-采甚)-1-「4-(2-氣 -?*. m 基)- 甲某-1 Η - ί 引 14 將0.85克氫化納(60%於礦物油中)加至5- 节氣基-3 - 甲基-2- (3-苄氧基-苯基)-1Η-吲呤(吲U朵實S 5例17)於80 毫升乾燥DMF之溶液中。混合物權拌30分鐘( 直到没有泡 泡出現)之後,加入4 . 8克1 -氯甲基-4 - ( 2 -氣 -乙氧基-篆 CAS编號〔 9 9 8 4 7-87-7〕。反應混合物允許方 ξ室溫反應過 夜。將200毫升之乙酸乙酯加至反應混合物f 3 ,然後以水 (3 X 1 G 0毫升)洗滌。收集有機溶液,以飽和 食鹽水洗滌 ,除去經硫酸鎂乾燥,過濾及於旋轉蒸發器 中蒸發至乾。 産物於乙酸乙酯中再结晶。 Μρ = 125 - 127°C; »H NMR (DMSO) 7.48 - 7.46 (d, 2 H, J = 5.8 Hz), 7.40 - 7.35 (m, 7 H), 7.33 - 7.28 (m, 2 H), 7.23 - 7.21 (d, 1 H, J = 8.8 Hz), 7.13-7.12 (d, 1 H, J = 2.2 Hz), 7.07 - 7.04 (m, 1 H), 6.94 - 6.92 (d, 2 H, J = 6.1 Hz), 6.83 - 6.80 (dd, 1 H, J = 2.5 Hz, J = 6.3 Hz), 6.78 - 6.72 (m, 4 H), 5.] 4(s, 2H), 5.11 (s, 2 H), 5.04 (s, 2 H), 4.13 - 4.10 (t, 2 H, J = 5.1 Hz), 3.86 - 3 84 (t, 2 H, J = 5.1 Hz), 2.14 (s, 3 H); IR 3420, 2900 cm1; MS el ti/z 587 (M+); C38H34C1N03 之計算值 CHN0 叫丨US茱某氣化物之物理數據 下列化合物根據流程圖1 2如方法5 a中所述 使用適當經 取代吲呤编號1 8和编號2 ϋ製造。 «神}例销辦_S 9 fi-苄氤甚- 2- (4-苄氫基-3-鼠 -韦華)1 _ "- Γ卜r氣-7.值‘某)-苄基]-3 -甲基-1 ILdl [LI -50- 本紙張尺度適用中國圃家標率(CNS ) A4規格(210X297公釐) 請 先 閲 背 之 注 意 事 項 再 五、發明説明(ο ) Α7 Β7Table 'τ Γ Example number printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economy. Κ No. 58 OBn 3, -C IBn No. 59 OBn 3, -F, 4, -OBn No. 60 OBn 4'-( ) CF, • 49- This paper size is in accordance with Chinese National Standard (CNS) A4 (21 OX 297 mm) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (Anvil) ; ≫ 3-Tian Qi earthworm 盹 Rong a certain gaseous material will form A. Hn 5 ^ 3 £ 1-_2-〇 knot argon even-mining) -1- "4- (2- 气-? *. m-based)-Form-1-Η-ί 14 Add 0.85 g of sodium hydride (60% in mineral oil) to 5-solenyl-3 -methyl-2- (3-benzyloxy- Phenyl) -1Η-indine (Indodol S 5 case 17) in 80 ml of dry DMF solution. After mixing the mixture for 30 minutes (until no bubbles appear), add 4.8 g of 1-chloroform 4- (2-Gas-ethoxy-fluorene) CAS number [9 9 8 4 7-87-7]. The reaction mixture was allowed to react overnight at room temperature. 200 ml of ethyl acetate was added to the reaction mixture. f 3, then washed with water (3 X 1 G 0 ml). The organic solution was washed with saturated brine, dried over magnesium sulfate, filtered and evaporated to dryness on a rotary evaporator. The product was recrystallized from ethyl acetate. Μρ = 125-127 ° C; »H NMR (DMSO) 7.48 -7.46 (d, 2 H, J = 5.8 Hz), 7.40-7.35 (m, 7 H), 7.33-7.28 (m, 2 H), 7.23-7.21 (d, 1 H, J = 8.8 Hz), 7.13 -7.12 (d, 1 H, J = 2.2 Hz), 7.07-7.04 (m, 1 H), 6.94-6.92 (d, 2 H, J = 6.1 Hz), 6.83-6.80 (dd, 1 H, J = 2.5 Hz, J = 6.3 Hz), 6.78-6.72 (m, 4 H), 5.] 4 (s, 2H), 5.11 (s, 2 H), 5.04 (s, 2 H), 4.13-4.10 (t , 2 H, J = 5.1 Hz), 3.86-3 84 (t, 2 H, J = 5.1 Hz), 2.14 (s, 3 H); IR 3420, 2900 cm1; MS el ti / z 587 (M +); The calculated value of C38H34C1N03 CHN0 is called the physical data of the gaseous substance of the US. The following compounds were prepared according to Scheme 12 using the appropriate substituted indines numbered 18 and 2 as described in Method 5a. «God} Sales Office _S 9 fi-benzyl hydrazone-2- (4-benzylhydroxy-3-rat-weihua) 1 _ "-Γρr gas-7. Value 'some)-benzyl ] -3 -Methyl-1 ILdl [LI -50- This paper size is applicable to Chinese garden house standard (CNS) A4 specification (210X297mm) Please read the precautions before back 5. The invention description (ο) Α7 Β7

Mp = 88-91°C; !h NMR (DMSO) 7.49-7.43 (m, 4H), 7.43-7.21! (m, 2H), 7.13-7.09 (m, 2H), 6.88-6.72 (m, 5H), 5.21 (s, 2H), (s, 2H), 4.13 (t, 2H, J = 5.2 Hz), 3.87 (t, 2H, J =5.2 Hz), 2.16Mp = 88-91 ° C;! H NMR (DMSO) 7.49-7.43 (m, 4H), 7.43-7.21! (M, 2H), 7.13-7.09 (m, 2H), 6.88-6.72 (m, 5H) , 5.21 (s, 2H), (s, 2H), 4.13 (t, 2H, J = 5.2 Hz), 3.87 (t, 2H, J = 5.2 Hz), 2.16

(m, 7H), 7.26-7.21 |.18 (s, 2H), 5.11 (s, 3H); MS el m/Z 6 0 5 ( M + ) ; C 38 H 33 C 1 F N 0 3 之 C Η N 計算值 0 實施例編號δ I) Η -爷M某-1 -「4 -「2 -(氣-才M某)-苄 某1 - 3 -甲甚-2 - ( 4 -三氩甲氬某-荣某)-1 Η ff朵(m, 7H), 7.26-7.21 | .18 (s, 2H), 5.11 (s, 3H); MS el m / Z 6 0 5 (M +); C 38 H 33 C 1 FN 0 3C Η N Calculated value 0 Example number δ I) Η-MM -1-"4-" 2-(Qi-Cai M)-benzyl 1-3-methyl even-2-(4-triargon methyl argon (Rongmou) -1 Η ff 朵

Mp = 108 - 110°C; Ή NMR (DMSO) 7.49 - 7.48 (m, 6 H), 7.40 - 7.25 (m, 4 H), 7.17 - 7.16 (d, 1 H, J = 2.9 Hz), 6.88 - 6.84 (m, 1 H), 6.77 - 6 72 (m, 4 H), 5.20 (s, 2 H), 5.14 - 5.13 (d, 2 H, J = 2.3 Hz), 4.16 - 4.11 (m, 2 H) 3.89 - 3.84 (m, 2 H), 2.19 - 2.17 (m, 3 H); IR 3400, 2900,1600 cm1; MS 4 m/z 566 (M+): C 32 H C 1 F 3 N 0 3 + 0 . 2 5 H 2 0 之 C Η N 計算值。' 胺7.氬某HI目朵 流程圖1 3 Z (胺) THF當 X= Br -^ 或Z (胺) DMF,K1當 C 1Mp = 108-110 ° C; Ή NMR (DMSO) 7.49-7.48 (m, 6 H), 7.40-7.25 (m, 4 H), 7.17-7.16 (d, 1 H, J = 2.9 Hz), 6.88- 6.84 (m, 1 H), 6.77-6 72 (m, 4 H), 5.20 (s, 2 H), 5.14-5.13 (d, 2 H, J = 2.3 Hz), 4.16-4.11 (m, 2 H ) 3.89-3.84 (m, 2 H), 2.19-2.17 (m, 3 H); IR 3400, 2900, 1600 cm1; MS 4 m / z 566 (M +): C 32 HC 1 F 3 N 0 3 + 0 . Calculated value of C Η N for 2 5 H 2 0. 'Amine 7. A certain argon of argon flow chart 1 3 Z (amine) THF when X = Br-^ or Z (amine) DMF, K1 when C 1

ό C' (請先閱讀背面之注意事項再填寫本頁) 、1Τό C '(Please read the notes on the back before filling this page), 1Τ

X Ζ 實#例编號6卜84 經濟部中央標準局員工消費合作社印製 實施例编號47-60 5 1- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐〉 A7 B7 五、發明説明(β ) 經濟部中央標準局員工消費合作社印製 X· 實施例编號 6 Q z No. 61 OBn 4*-0Et 0 No. 62 OBn H o No. 63 OBn 4’-0Bn 0 No. 64 OBn 4’-0Bn 0 No. 65 OBn 4’-0Bn (請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印家 A7 B7 五、發明説明(β) 表6 (績) 實施例編號. Q No. 66 OBn 4’-OBn fV\ No. 66a OBn 4,-OBn k No. 67 OBn 4,-OBn σ No. 68 OBn 4’-OBn a No. 69 OBn 4,-OBn O No. 70 OBn 4,-OBn No. 71 OBn 4,-OBn No. 71a OBn 4,-OBn No. 72 OBn 4,-F 0 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS > A4規格(210 X 297公釐) 經濟部中央標準局員工消費合作社印製 五、發明説明(P ) 表 6 (續) 實施例编號 K No. 72a OBn 4,-F 0 No. 72b OBn 4,-Cl 0 No. 73 OBn 3’,4,-0CH2O 0 No. 74 OBn 4,-0-iPr 0 No. 75 OBn 4,-CH3 0 No. 76 OBn 3’-OBn 0 No. 77 OBn 3’-OBn 0 No. 78 OBn 4,-OBn,3,-F 0 No. 79 OBn 4,-OBn,3,-F r 0 (請先閲讀背面之注意事項再填寫本頁) -¾ 、va 丁 本紙張尺度適用中國國家標準(CNS } A4規格(210 X 297公釐)X C 例 #Example No. 6144 84 Example printed by the Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs, No. 47-60 5 1- This paper size applies to China National Standard (CNS) Α4 size (210 × 297 mm> A7 B7 5 Description of the invention (β) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. Example No. 6 Q z No. 61 OBn 4 * -0Et 0 No. 62 OBn H o No. 63 OBn 4'-0Bn 0 No 64 OBn 4'-0Bn 0 No. 65 OBn 4'-0Bn (Please read the notes on the back before filling out this page) The size of the paper is applicable to China National Standard (CNS) A4 (210X297 mm) Central Ministry of Economic Affairs Standards Bureau Consumers' Consumer Cooperative A7 B7 V. Description of Invention (β) Table 6 (Performance) Example No. Q No. 66 OBn 4'-OBn fV \ No. 66a OBn 4, -OBn k No. 67 OBn 4 -OBn σ No. 68 OBn 4'-OBn a No. 69 OBn 4, -OBn O No. 70 OBn 4, -OBn No. 71 OBn 4, -OBn No. 71a OBn 4, -OBn No. 72 OBn 4, -F 0 (Please read the notes on the back before filling out this page) This paper size applies to Chinese national standards (CNS > A4 size (210 X 297 mm)) Ministry of Economic Affairs Printed by the Central Standards Bureau's Consumer Cooperatives V. Description of Invention (P) Table 6 (Continued) Example No. K No. 72a OBn 4, -F 0 No. 72b OBn 4, -Cl 0 No. 73 OBn 3 ', 4, -0CH2O 0 No. 74 OBn 4, -0-iPr 0 No. 75 OBn 4, -CH3 0 No. 76 OBn 3'-OBn 0 No. 77 OBn 3'-OBn 0 No. 78 OBn 4,- OBn, 3, -F 0 No. 79 OBn 4, -OBn, 3, -F r 0 (Please read the precautions on the back before filling out this page) -¾, va The size of this paper is applicable to Chinese national standards (CNS) A4 size (210 X 297 mm)

7 7 A B 五、發明説明(β) 表 M續) 實施例编號t K a 1Z.... No. 80 OBn 3,-OMe 0 No. 81 OBn 4,-OCF3 0 No. 82 OBn 4,-OBn hn-〇 No. 83 OBn 4’-OBn No. 84 OBn 3,-OMe 0 銳明奮掄锎編號(Π夕通:> 取代的公是方法6 :> 奮驗步酿 (請先閲讀背面之注意事項再填寫本頁) R-窄氬某- 2- U-窄藿;某-苄某1 -申某-1-1 4- (2-六 、ye Γ 經濟部中央揉準局貝工消費合作社印製 BH;腚-1 -某-乙Μ某)-节某} - 1 Η -时丨眩 實施例编號50(3.2克,5.0毫莫耳)於1'1^(50毫升)之 溶液以六氳吡啶(5毫升,5 0毫奠耳)處理及加熱至回 流。5小時之後,濃縮反應混物及溶解於E t 0 A c ,以飽 和NaHC03洗滌,經MgS04乾燥及使用EtOH./己烷至 EtOAc之梯度溶離管柱層析於矽凝驂。産物(Ϊ.7克)為 白色固體具有Mp= 93-9 5°C ; 'H NMR (DMSO) 7.48-7.46 (m, 4 H), 7.42-7.38 (m, 4 H), 7.38-7.32 (m, 2 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.19 (d, 1 H, J = 9.0 Hz), 7.12-7.10 (m, 3 H), 6.80 (dd, 1 H, J =8.8, 2.4 Hz), 6.73 (s, 4 H), 5.15 (s, 2 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 3.93 (t, 2 H, J = 5.7 Hz), 2.60-2.50 (m, 2 H), 2.41-2.30 (m, 4 H), 2.15 3 H), 1.47-1.42 (m, 4 H), 1.36-1.32 (m, 2 H); MS FAB 637 (M+iT). -55- 本紙張尺度適用_國國家標準(0灿>八4規格(210父297公釐) 經 濟 部 中 央 樣 準 局 員 合 作 社 印 褽 A7 B7 五、發明説明(r4 ) 銳昍產物绾號76之氣化物取代合成的方法R9 夕廣擇性步駿„ 實施例编號ϊδ 5-苄氩基- 2-(3二y氩某-¾某 )士田某 -1- Γ4-ίί>-六氩毗啶-1-甚-?*,氬某甚Ί -1 Η - Β引 將1 .]毫升(H · 0 1 1 2莫耳)六氫吡啶,及0 . 9 3克(0 · 0 5 6 莫耳)之碘化鉀加至1.1克(0.00953莫耳)5-1 氣基-2 - ( 3 - 苄氧基-苯基)-3-甲基-1-〔 4-(2-氯-乙氧基 )-苄基] -3 -甲基-1 Η - (實施例編號5 8 )於1 0毫升D M F之溶液中 。反應混合物加熱至〜4 0 - 5 0 °C經4小時。涓 合物冷卻 至室溫之後,加入150毫升乙酸乙酯,及以冰 (3 X 1 0 0毫 升)洗滌混合物。收集有機溶液,以飽和食齒 水洗滌, 除去,經硫酸鎂乾燥,過濾及蒸發以在産物 沌化後産生 1 . 0克産物。 Mp = 125 - 126°C; !H NMR (DMSO) 7.48 - 7.45 (d, 2 H, J = 7 2 Hz), 7.41 - 7.35 (m, 7 H), 7.33 - 7.28 (m, 2 H), 7.23 - 7.21 (d, 1 H, J = 9.0 Hz),' .13-7.12 (d, 1 H, J = 2.4 Hz), 7.06 - 7.03 (m, 1 H), 6.95 - 6.91 (m, 2 H),( .83 - 6.80 (dd, 1 H, J = 2.4 Hz, J = 6.3 Hz), 6.75 - 6.70 (m, 4 H), 5.13 (s, 2 H),5.11 (s,2 Η), 5.02 (s, 2 H), 3.93 - 3.90 (t, 2 H, J = 6.0 Hz), 2.56 - 2.53 (t, 2 H, J = 5.9 Hz), 2.49 -2.48 (m, 4 H), 2.14 (s, 3 H), 1.46 - 1.40 (m, 4 H), 1.35 - 1.31 :tn, 2 H); IR (KBr) 3400,2900cm·1 ;Ms el m/z 636(M + );C43H44 li 2 〇 3 + 0 . 2 5 H 2 0之C Η N計算值。 胺取代夕化会物的物理勒墟 下列化物藉由流程圖1 3使用方法6製備。 P耗實施例编 號76-编號84使用方法6a製備以外β 奮旃例缠號61 苄氩某-2-(4 -7,氫基-苯基 )Ί 田 -56- 本紙張尺度適用中圃固家橾準(CNS〉Α4規格(210X297公釐) 請 先 閲 讀 背 Λ 之 注 意 事 項 再7 7 AB V. Description of the Invention (β) Table M continued) Example No. t K a 1Z .... No. 80 OBn 3, -OMe 0 No. 81 OBn 4, -OCF3 0 No. 82 OBn 4, -OBn hn-〇No. 83 OBn 4'-OBn No. 84 OBn 3, -OMe 0 sharp Ming Fen number (Π Xitong: > replaced by the public method 6: > Endurance step brewing (please Read the precautions on the back before filling in this page) R-Narrow arg-2-U-Narrow cymbal; A-benzyl-1-Shenm-1-1 4- (2-VI, ye Γ Central Ministry of Economic Affairs BH printed by the local shellfish consumer cooperative; 腚 -1 -some-bm) -festival}-1 Η-hrs. Example No. 50 (3.2 g, 5.0 mmol) at 1'1 ^ ( 50 ml) solution was treated with hexapyridine (5 ml, 50 mmol) and heated to reflux. After 5 hours, the reaction mixture was concentrated and dissolved in E t 0 A c, washed with saturated NaHC03, and dried over MgS04. And column chromatography on silica gel using a gradient dissolution column with EtOH./hexane to EtOAc. The product (Ϊ.7 g) was a white solid with Mp = 93-9 5 ° C; 'H NMR (DMSO) 7.48-7.46 (m, 4 H), 7.42-7.38 (m, 4 H), 7.38-7.32 (m, 2 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.19 (d, 1 H, J = 9.0 Hz ), 7.12-7.10 (m, 3 H), 6.80 (dd, 1 H, J = 8.8, 2.4 Hz), 6.73 (s, 4 H), 5.15 (s, 2 H), 5.13 (s, 2 H) , 5.11 (s, 2 H), 3.93 (t, 2 H, J = 5.7 Hz), 2.60-2.50 (m, 2 H), 2.41-2.30 (m, 4 H), 2.15 3 H), 1.47-1.42 (m, 4 H), 1.36-1.32 (m, 2 H); MS FAB 637 (M + iT). -55- This paper size is applicable to _ national national standard (0can > 8 4 specifications (210 father 297 male) (Centi) A7 B7, a cooperative of the Central Bureau of Prospecting and Coordinating of the Ministry of Economic Affairs, V. Description of the invention (r4) Method for synthesis of gaseous product No. 76 of Razor Product R9 Xi Xuan Optional Step Jun „Example No. δ δ 5-Benzyl Argon Radical-2- (3 diy arg--¾) Shitian -1- Γ4-ί > -hexaargyrimidine-1-even-? *, Argon is even Ί -1 Η-Β primer will be 1. ] Ml (H · 0 1 12 Moore) of hexahydropyridine, and 0.93 g (0.056 Moore) of potassium iodide was added to 1.1 g (0.00953 Moore) 5-1 gas-based -2- (3-benzyloxy-phenyl) -3-methyl-1- [4- (2-chloro-ethoxy) -benzyl] -3-methyl-1 Η-(Example No. 5 8) In 10 ml of DMF solution. The reaction mixture was heated to ~ 40-50 ° C over 4 hours. After the trickle was cooled to room temperature, 150 ml of ethyl acetate was added, and the mixture was washed with ice (3 × 100 mL). The organic solution was collected, washed with saturated edentulous water, removed, dried over magnesium sulfate, filtered and evaporated to produce 1.0 g of product after the product was chaotic. Mp = 125-126 ° C;! H NMR (DMSO) 7.48-7.45 (d, 2 H, J = 7 2 Hz), 7.41-7.35 (m, 7 H), 7.33-7.28 (m, 2 H), 7.23-7.21 (d, 1 H, J = 9.0 Hz), '.13-7.12 (d, 1 H, J = 2.4 Hz), 7.06-7.03 (m, 1 H), 6.95-6.91 (m, 2 H ), (.83-6.80 (dd, 1 H, J = 2.4 Hz, J = 6.3 Hz), 6.75-6.70 (m, 4 H), 5.13 (s, 2 H), 5.11 (s, 2 Η), 5.02 (s, 2 H), 3.93-3.90 (t, 2 H, J = 6.0 Hz), 2.56-2.53 (t, 2 H, J = 5.9 Hz), 2.49 -2.48 (m, 4 H), 2.14 ( s, 3 H), 1.46-1.40 (m, 4 H), 1.35-1.31: tn, 2 H); IR (KBr) 3400, 2900cm · 1; Ms el m / z 636 (M +); C43H44 li 2 Calculated value of C Η N for 0 3 + 0.2 5 H 2 0. The following compounds were prepared using amines in place of the following compounds: P Consumption Example No. 76-No. 84 Use method 6a for preparation other than β Fenxi Example No. 61 Benzyl argon -2- (4-7, hydrogen-phenyl) Ί Tian-56- This paper is applicable to the standard Pugu Family Standard (CNS> Α4 Specification (210X297mm) Please read the precautions of back Λ before

L 訂 經 濟 A7 B7 五、發明説明(<) 甚-1-「4-0-六Μ卅腚-1-某-乙氳某苄莊 1 - 1 Η - Bil Μρ = 188 - 191°C; *H NMR (DMSO) 7.45 (d , 2 H, J =7.3 Hz) H), 7.17 (d , 1 H , J = 8.8 Hz), 7.11 (d , 1 H , J =2.2 Hz), 7.01 Hz), 6.78 (dd , 1 H , J = 8.8Hz, J = 2.4 Hz), 6.73 (s , 4H), 5.1; 2H), 4.05 (q, 2H, J = 6.8 Hz), 3.93 (t, 2H , J = 6.0 Hz), 2.55 (t 2.41 - 2.35 (m , 4 H), 2.14 (s , 3 H), 1.46 - 1.40 (m , 4H), 1.38 el m/z 574 (M+). 審渝例編醏fi2 氣某-2-笨某-卜甲基-1 ,7.40 - 7.25 (m , 5 (d , 2 Η , J = 6.8 5(s, 2H), 5.10 (s, ,2H, J = 5.7 Hz), -1.30 (m, 5 H); MS -「4- 吖庚因-1-基-乙氧基)-苄基〕-1H-吲》朵 Oil; Ή NMR (DMSO) 7.50-7.43 (m , 4 H), 7.42-7.37 (m , 5 H H), 7.22 (d , 1 H, J = 8.8 Hz), 7.14 (d , 1 H , J = 2.4 Hz), 6.81 Hz), 6.72 (s , 4 H), 5.18 (s, 2 H), 5.11 (s , 2 H), 3.90 (t, 2 H , 2.75 (m , 2 H), 2.68-2.59 (m , 4 H), 2.16 (s , 3 H), 1.58-1.43 (n 544 (M+). 宥掄例皡號fi4 5-节氬某- 2- (4 -苄氬基-苯基 ),7.33-7.30(m , 1 (d , 1 H , J = 6.6 J = 6.1 Hz), 2.81-i, 8 H); MS el m/z )-申某 -1 - ί 4 - Ο -吖廉闵-1 -某-7,氬基)-苄基]- 1 H - »ίίΙ Μρ = 106 - 107°C; 'H NMR (DMSO) 7.47 (d, 4 H, J = 8.3 Hz), 7.36 - 7.30 (m, 2 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.19 (d, 1 H, J 7.10 (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz), 6.73 (s, 4 H), 5.15 ( (s, 2 H), 5.11 (s, 2 H), 3.90 (t, 2 H, J = 5.9 Hz), 2.76 (t, 2 H, J 2.56 (m, 4 H), 2.15 (s, 3 H), 1.58 - 1.44 (m, 8 H); MS FAB mA 審渝俐溢號ft ϋ S-节氬甚- 2- (4-苄氫基-乙S 7.41 - 7.36 (m, 4 H), =8.8 Hz), 7.14 -},2H), 5.13 =5.9 Hz), 2.64 -651 (M+H+). :某3 -甲 甚-爷甚1 1 - r 4 - ί 2 -里芮胺某-:ι -基-乙氣 )-苄甚1 -1 Η -㈣U朵 Μρ = 148 - 150°C; *H NMR (DMSO) 7.47 (d, 4 H, J = 8.3 Hz) (m, 4 H), 7.36 - 7.32 (m, 2 H), 7.28 (d, 2 H, J = 8.8 Hz), 7.19 7.13 - 7.08 (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.76 -(s, 2 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 3.75 (t, 2 H, J = 7.0 Hz), (t, 2 H, J = 7.0 Hz), 2.15 (s, 3 H), 0.93 (d, 12 H, J = 6.4 Hz); M (M+H+). -^7- 7.41 - 7.36 (i, 1 H, J = 9.0 Hz), 5.68 (m, 4 H), 5.14 ::.95 (m, 2 H), 2.67 !> FAB m/z 653 本紙張尺度適用中菌國家標準(CNS ) A4規格(210X297公釐} 請 先 閱 讀 背 Φ 之 注 意 事 項 再 訂 央 標 準 局 員 X. 消 費 合 作 社 印 製 五、發明説明(a ) A7 B7 實施例编號β 6 5 -苄氣基-2 - ( 4 -苄氧基_.二苯_._基 -1-「4-0 -丁甚-田胺某-1-某乙氯基)-苄基 Μρ = 101 - 104°C; lH NMR ( DMSO) 7.45 (d, 4 H J = 7.5 Hz) H ), 7.19 (d , 1 H J = 8.8 Hz), 7.12-7.08 (in , 3 H), 6.80 (dd , 1 1 h - fli?i mOrder L economy A7 B7 V. Description of the invention (<) Even -1- "4-0- 六 Μ 卅 腚 -1- 某-乙 氲 某 Benzezhuang 1-1 Η-Bil Μρ = 188-191 ° C; * H NMR (DMSO) 7.45 (d, 2 H, J = 7.3 Hz) H), 7.17 (d, 1 H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.01 Hz) , 6.78 (dd, 1 H, J = 8.8Hz, J = 2.4 Hz), 6.73 (s, 4H), 5.1; 2H), 4.05 (q, 2H, J = 6.8 Hz), 3.93 (t, 2H, J = 6.0 Hz), 2.55 (t 2.41-2.35 (m, 4 H), 2.14 (s, 3 H), 1.46-1.40 (m, 4H), 1.38 el m / z 574 (M +). fi2 Qimou-2-benmou-bumethyl-1, 7.40-7.25 (m, 5 (d, 2 Η, J = 6.8 5 (s, 2H), 5.10 (s,, 2H, J = 5.7 Hz),- 1.30 (m, 5 H); MS-"4-azepine-1-yl-ethoxy) -benzyl] -1H-ind" Oil; Ή NMR (DMSO) 7.50-7.43 (m, 4 H ), 7.42-7.37 (m, 5 HH), 7.22 (d, 1 H, J = 8.8 Hz), 7.14 (d, 1 H, J = 2.4 Hz), 6.81 Hz), 6.72 (s, 4 H), 5.18 (s, 2 H), 5.11 (s, 2 H), 3.90 (t, 2 H, 2.75 (m, 2 H), 2.68-2.59 (m, 4 H), 2.16 (s, 3 H), 1.58 -1.43 (n 544 (M +). Example No. fi4 5-section argon 2--2- (4-benzylargonyl-phenyl), 7.33-7.30 (m, 1 (d, 1 H, J = 6.6 J = 6.1 Hz), 2.81-i, 8 H); MS el m / z) -Shenmou-1-ί 4-Ο -Aclanmin-1 -mother-7 , Argon) -benzyl]-1 H-»ίΙ Μρ = 106-107 ° C; 'H NMR (DMSO) 7.47 (d, 4 H, J = 8.3 Hz), 7.36-7.30 (m, 2 H) , 7.29 (d, 2 H, J = 8.8 Hz), 7.19 (d, 1 H, J 7.10 (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz), 6.73 (s, 4 H) , 5.15 ((s, 2 H), 5.11 (s, 2 H), 3.90 (t, 2 H, J = 5.9 Hz), 2.76 (t, 2 H, J 2.56 (m, 4 H), 2.15 (s , 3 H), 1.58-1.44 (m, 8 H); MS FAB mA 渝 溢 溢 ft ϋ S-Sulfur argon and even 2- (4-benzylhydrogen-ethyl S 7.41-7.36 (m, 4 H ), = 8.8 Hz), 7.14-}, 2H), 5.13 = 5.9 Hz), 2.64 -651 (M + H +).: Some 3 -methyl-yexyl 1 1-r 4-ί 2-rilimide Some-: ι-yl-ethane) -benzyl 1 -1 Η-㈣U Μρ = 148-150 ° C; * H NMR (DMSO) 7.47 (d, 4 H, J = 8.3 Hz) (m, 4 H), 7.36-7.32 (m, 2 H), 7.28 (d, 2 H, J = 8.8 Hz), 7.19 7.13-7.08 (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.76-(s, 2 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 3.75 (t, 2 H, J = 7.0 Hz), (t, 2 H, J = 7.0 Hz), 2.15 (s, 3 H), 0.93 (d, 12 H, J = 6.4 Hz); M (M + H +).-^ 7- 7.41-7.36 (i, 1 H, J = 9.0 Hz), 5.68 (m, 4 H), 5.14: .95 (m, 2 H), 2.67! ≫ FAB m / z 653 This paper size is applicable to the National Standard for Chinese Bacteria (CNS) A4 (210X297 mm) Please read the precautions on the back Φ before ordering by the Central Bureau of Standards X. Printed by the Consumer Cooperative V. Invention Description ( a) A7 B7 Example No. β 6 5 -benzyloxy-2-(4-benzyloxy_.diphenyl _._ yl-1- "4-0 -butanyl-Tamine Ethyl chloride) -benzyl Mρ = 101-104 ° C; lH NMR (DMSO) 7.45 (d, 4 HJ = 7.5 Hz) H), 7.19 (d, 1 HJ = 8.8 Hz), 7.12-7.08 (in, 3 H), 6.80 (dd, 1 1 h-fli? Im

,7.40 - 7.25 (m, i H , J = 6.5 Hz, J 2.4 Hz), 6.72 (s, 4 H), 5.14 (s , 2 H), 5.13 (s, 2 H), 5.10 (s , 2 H), 3.91 (t, 2 H , J = 5.9 Hz), 2.64-2.59 (m , 2H), 2.35-2.29 (m, 2 H), 2.17 (s, 3 H), 2.14 (s ,3 H), 1.40-1.31 (m , 2 H), 1.25-1.19 (m , 2 H), 0.83 (t, 3 H, 7.? Hz); MS el m/z 638 (M+). ! 實施例编號66a 5·-苄氧基氯基-苤 -1-(4 -二田胺某-7.氛某)-苄某]-1 H..-时1 一喺, 7.40-7.25 (m, i H, J = 6.5 Hz, J 2.4 Hz), 6.72 (s, 4 H), 5.14 (s, 2 H), 5.13 (s, 2 H), 5.10 (s, 2 H ), 3.91 (t, 2 H, J = 5.9 Hz), 2.64-2.59 (m, 2H), 2.35-2.29 (m, 2 H), 2.17 (s, 3 H), 2.14 (s, 3 H), 1.40-1.31 (m, 2 H), 1.25-1.19 (m, 2 H), 0.83 (t, 3 H, 7.? Hz); MS el m / z 638 (M +). Example No. 66a 5 · -Benzyloxychloro-fluorene-1- (4-diamineamine-7. Amo) -benzyl] -1 H ..- hour 1

Mp= 1 2 3 - 1 2 4 °C -1 - f 4 - f 2 - (2 -申甚-六Μ卅啶-1 -某)7·氫甚[)-苄基1_ -1Η - 8¾Mp = 1 2 3-1 2 4 ° C -1-f 4-f 2-(2 -Shenshi-Hexamidine-1-some) 7. Hydrogen []-benzyl 1_ -1Η-8¾

Mp= 12 1°C 實施例编號6 8 I苄氬基-2- (_4-竿氧.基.-苯基 申某 1- (4- rm -闲某-六 Μ Bit, 啶-l-某-ΪΒ- b?i m Mp= 9 0°G 實施例编號6 9 5-苄氣基- 2- (4 -苄氣基-茉基 -3-甲某 I. ―― I I I I I —L^---I n n ^ (讀先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消费合作社印裝 1 ~ f 4 - Γ 2-(4 -甲某-六蕾.fftf.麻-1-某‘氣:某) -1 Η - Ρ^ί ί$ Μρ = 98°C; Ή NMR (DMSO) 7.46 (d, 4 H, J = 7.2 Hz), 7.42 - 7.h 7.31 (m, 2 H), 7.28 (d, 2 H, J = 8.6 Hz), 7.19 (d, 1 H, J = 9.0 Hz[) (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.73 (s, 4 H), 5.15 6 (m, 4 H), 7.36 ,7.12 - 7.10 s,2H), 5.13 58- 本紙張尺度適用中國國家標準(CNS > A4規格(21 OX 297公釐) 經 濟 部 t 央 樣 準 % 貝 合 作 社 印 装 Α7 Β7 五、發明説明(〇) (s, 2 Η), 5.11 (s, 2 Η), 3.93 (t, 2 H, J = 5.9 Hz), 2.85 - 2.78 (m, 2 H), 2.62 - 2.56 (m, 2 H), 2.15 (s, 3 H), 1.97 - 1.87 (m, 2 H), 1.55 - 1.47 (m, 2 i), 1.30- 1.20 (m, 1 H), 1.15 - 1.02 (m, 2 H), 0.85 (d, 3 H, J = 6.6 Hz); MS es:: m/z 651 (M+l)+. 審掄例®號7(1 β-笮氩某- 2- U-苄氩某-¾某 )-3 -甲基 -1 ί 4 -「2 - ( ΠΒ ) - 2 . β -二申某-六氤蚍啶-1 -甚)-Z S某) -竿甚)-1 H - 841 Β5 Μρ = 106 - 107°C; Ή NMR (DMSO) 7.46 (d, 4 H, J = 8.1 Hz), 7.42 - 7.36 (m, 4 Η), 7.37 - 7.31 (m, 2 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.18 (d, 1 H, J =8.8 Hz), 7.14 - 7.09 (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.72 (s, 4 H: ,5.14 (s, 2 Η), 5.13 (s, 2 H), 5.11 (s, 2 H), 3.84 (t, 2 H, J = 7.0 Hz), 2.84 (t, 2 H, J =6.6 Hz), 2.44 - 2.37 (m, 2 H), 2.15 (s, 3 H), 1.60 - 1.43 (m, 3 H), 1.32 -1.18( m, 1 Η), 1.16 - 1.06 (m, 2 H), L01 (d, 6 H, J = 6.2 Hz). 奮旃例編號71 5-芾氳某-2-(4 -苄氬某-荣某 )-申某 -(4-「2-(1.:?.3-三甲某-6-吖-譬瑗「2 2 · 1 Ί 辛-β- 某)-7.氩某)-芾某 1 - 1 Η - B4I »4 Μρ = 107 °C ; MS ESI m/z 7 0 5 (M + + 1) + 實施例S號71a (IS.4R)-5-苄氩基-2-(4-窄 氬某-茉某) -3-甲基-ί4-Γ2-(2-吖-等撢 Γ2.2.11 南· 2 -某)氛 基)-苄基)-1 Η - S引Β朵 用以取代溴化物之(1 S d S ) - 2 -吖-環環〔: ,2,1〕庚烷 僳根據 Syn.Comm,26(3) ,577-584(1996)所概 述步驟製備。 Μρ = 95 - 100°C; !h NMR (DMSO) 7.32 - 6.55 (m, 21 H), 5.1C )-4.90(m,6H), 3.69 (t, 2 H, J = 5.9 Hz), 2.65 - 2.5 (m, 3 H), 2.10 (s, 2 H), 2.0 (s, 3 Η), 1.50 - 1.0 (m, 7 H). -59- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 請 先 閲 讀 背 之 注 項 再 填 寫 本 頁 訂 經 濟 部 t 央 標 準 局 Μ s. 消 費 合 作 社 Α7 Β7 五、發明説明(η) 奮施例編號72 5 -苄氣基- 2- (4 -氟-¾某)-3- 甲某-1 - Γ 4-(2 -吖康因-1-某-7.氩基 竿某} ίΐ Oil; Ή NMR (DMSO) 7.50 - 7.43 (m, 2 H), 7.42 - 7.33 (m, 4 K H), 7.13 (d, 1 H, J = 2.4 Hz), 6.83 (dd, 1 H, J = 2.4 Hz, 6.7 Hz) 5.14 (s, 2 H), 5.11 (s, 2 H), 3.89 (t, 2 H, J = 5.9 Hz), 3.20 (m, ^ (t, 2 H, J = 6.0 Hz), 2.15 (s, 3 H), 1.60 - 1.40 (m, 8 H); MS el rr 窗掄例编號72a 5 -苄氤某- 2- (4 -氬-¾某 ),7.32 - 7.20 (m, 4 ,6.71 (s, 4 Η), Η), 2.74 (ζ 562 (Μ+). -申甚-1- Γ 4-(2 -六 SHH;啶-1-某)-7.氬某苄甚)-1 Η-ΡίΙ 1¾ Oil; !h NMR (DMSO) 7.32 - 6.53 (m, 16 H), 5.00 (s, 2 H), 4.9 H, J = 5.8 Hz), 3.22 - 3.14 (m, 4 H), 2.40 (t, 2 H, J = 5.8 Hz),: I. 17 (m, 6 H). 審餱例編號72b 5-芾氩某- 2- (4 -氡-茏某)-3 6 (s, 2 Η), 3.77 (t, 2 .0 (s, 3 Η), 1.29 - -甲某-1 - 「4 - ( 2 -六氤毗啶-1 -某)-7.氤某)-苄某1 - 1 卜Ρ4Ι枠 Oil; ^ NMR (DMSO) 7.52 (d, 2 H, J = 8.6 Hz), 7.46 (d, 2 H, J 7.37 (m, 4 H), 7.35 - 7.29 (m, 1 H), 7.25 (d, 1 H, J = 9.0 Hz), 7 Hz), 6.83 (dd, 1 H, J = 8.8 Hz, 2.5 Hz), 6.72 - 6.65 (m, 4 H), 5. 2 H), 3.90 (t, 2 H, J = 5.9 Hz), 2.55 (t, 2 H, J = 6.0 Hz), 2.41 -(s, 3 H), 1.44 - 1.39 (m, 4 H), 1.38 - 1.29 (m, 2 H); MS el m/z 5( 審掄俐ilS號7 3 5 -节氤甚-2 · Γ 2 . S -伸甲二氩 =6.8 Hz), 7.41 -14 (d, 1 H, J = 2.4 16(s, 2H), 5.11 (s, L26 (m, 4H), 2.16 Λ (M+). K - ¾ 甚 Ί -3 -甲甚-1 - Γ 4 - ( 2 -六氬W,腚-1 -甚 -7.氳某 !-苄某) -1 η - nil m Foam; !H NMR (DMSO) 7.45 (d, 2 H ,J = 7.0 Hz), 7.41-7.37 (m, (m, 1 H), 7.19 (d, 1H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7.( Hz), 6.90 (d, 1 H, 1.4 Hz), 6.82 - 6.78 (m , 2H), 6.74 (s, 4 H), t (s , 2 H), 5.10 (s , 2 H), 3.93 (t, 2H, i = 6.0 Hz), 2.56 (t, 2 H , 2.35 (m , 4H), 2.15 (s , 3H), 1.48-1.41 (m, 4H), 1.38-1.28 (m , 21 (M+). -6 0 - 2 Η), 7.33-7.29 :0 (d, 1 H, J = 7.9 • 07(s,2H), 5.16 Γ = 6.0Hz), 2.41--[); MS el m/z 574 本紙張尺度適用中國國家橾準(CNS > A4規格(210X297公釐) 頁 請 先 聞 讀 背 Φ 之 注 意 事 項 再 訂 五、發明説明(巧) A7 B7 實施例编號Ή 5-苄氫基- 2-(4-異丙氩某-荣 某一Ί - Γ 4 - f ;> -六氣 P技辟一1 -某一氣某)一节 IE 1 - 1 Η - P^lMp = 12 1 ° C Example No. 6 8 I Benzylarginyl 2- (_4-poleoxy.yl.-phenylshen 1-(4- rm-free-6 M Bit, pyridine-1- Some -ΪΒ- b? Im Mp = 9 0 ° G Example No. 6 9 5-benzylamino- 2- (4-benzylamino-mosyl-3-methyl I. —— IIIII —L ^- --I nn ^ (Read the precautions on the back before filling out this page) Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1 ~ f 4-Γ 2- (4-甲某-六 蕾 .fftf. 麻- 1-some 'gas: some) -1 Η-Ρ ^ ί Μρ = 98 ° C; Ή NMR (DMSO) 7.46 (d, 4 H, J = 7.2 Hz), 7.42-7.h 7.31 (m, 2 H), 7.28 (d, 2 H, J = 8.6 Hz), 7.19 (d, 1 H, J = 9.0 Hz () (m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.73 (s, 4 H), 5.15 6 (m, 4 H), 7.36, 7.12-7.10 s, 2H), 5.13 58- This paper size applies to the Chinese national standard (CNS > A4 size (21 OX 297 (Mm) Ministry of Economic Affairs t Central sample standard% Cooperative printed A7 Β7 V. Description of the invention (〇) (s, 2 Η), 5.11 (s, 2 Η), 3.93 (t, 2 H, J = 5.9 Hz) , 2.85-2.78 (m, 2 H), 2.62-2.56 (m, 2 H), 2.15 (s, 3 H), 1.97-1.87 (m, 2 H), 1.55-1.47 (m, 2 i), 1.30- 1.20 (m, 1 H), 1.15-1.02 (m, 2 H), 0.85 (d, 3 H, J = 6.6 Hz); MS es: m / z 651 (M + l) + Examination Case® No. 7 (1 β- 笮 argon-2-U-Benzyl Ar--¾)-3-Methyl-1 ί 4-"2-(ΠΒ)-2. Β-Ershen -Hexamidine-1 -even) -ZS)-pole even) -1 H-841 Β5 Μρ = 106-107 ° C; Ή NMR (DMSO) 7.46 (d, 4 H, J = 8.1 Hz), 7.42-7.36 (m, 4 Η), 7.37-7.31 (m, 2 H), 7.29 (d, 2 H, J = 8.8 Hz), 7.18 (d, 1 H, J = 8.8 Hz), 7.14-7.09 ( m, 3 H), 6.80 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 6.72 (s, 4 H:, 5.14 (s, 2 Η), 5.13 (s, 2 H), 5.11 (s, 2 H), 3.84 (t, 2 H, J = 7.0 Hz), 2.84 (t, 2 H, J = 6.6 Hz), 2.44-2.37 (m, 2 H), 2.15 (s, 3 H), 1.60- 1.43 (m, 3 H), 1.32 -1.18 (m, 1 Η), 1.16-1.06 (m, 2 H), L01 (d, 6 H, J = 6.2 Hz). Fentative case number 71 5- 芾 氲-2-(4-benzyl argon-Rongmou)-Shenmou-(4- "2- (1.:?. 3-Trimethyl-6-acridine-such as" 2 2 · 1 Ί Xin-β -A) -7. Arga)-芾 a 1-1 Η-B4I »4 Μρ = 107 ° C; MS ESI m / z 7 0 5 (M + + 1) + Example S No. 71a (IS.4R ) -5-benzyl Phenyl-2- (4-narrow argon-mozine) -3-methyl-ί4-Γ2- (2-acyl-equivalent Γ 2.2.11 nam · 2 -an aryl group) -benzyl) -1 Η -S-B is used to replace (1 S d S) of bromide-2 -Acridine-ring [:, 2,1] Heptane 僳 According to Syn.Comm, 26 (3), 577-584 (1996) Prepared as outlined. Μρ = 95-100 ° C;! H NMR (DMSO) 7.32-6.55 (m, 21 H), 5.1C)-4.90 (m, 6H), 3.69 (t, 2 H, J = 5.9 Hz), 2.65- 2.5 (m, 3 H), 2.10 (s, 2 H), 2.0 (s, 3 Η), 1.50-1.0 (m, 7 H). -59- This paper size applies to China National Standard (CNS) A4 specifications ( 210X297 mm) Please read the note below and fill in this page to order the Ministry of Economic Affairs, the Central Standards Bureau, M s. Consumer Cooperatives A7, B7 V. Description of the Invention (η) Fen Example No. 72 5 -Benzyl group-2- ( 4 -Fluoro-¾some) -3-methyl-1-Γ 4- (2 -acconine-1-some-7. Argon-based rod}} ΐ Oil; Ή NMR (DMSO) 7.50-7.43 (m, 2 H), 7.42-7.33 (m, 4 KH), 7.13 (d, 1 H, J = 2.4 Hz), 6.83 (dd, 1 H, J = 2.4 Hz, 6.7 Hz) 5.14 (s, 2 H), 5.11 (s, 2 H), 3.89 (t, 2 H, J = 5.9 Hz), 3.20 (m, ^ (t, 2 H, J = 6.0 Hz), 2.15 (s, 3 H), 1.60-1.40 ( m, 8 H); MS el rr window case number 72a 5-benzamidine-2-(4-argon-¾), 7.32-7.20 (m, 4, 6.71 (s, 4 Η), Η) , 2.74 (ζ 562 (Μ +). -Shenshi-1- Γ 4- (2 -Hexa SHH; pyridine-1-some) -7. Argon benzyl) -1 Η-ΡίΙ 1¾ Oil;! H NMR (DMSO) 7.3 2-6.53 (m, 16 H), 5.00 (s, 2 H), 4.9 H, J = 5.8 Hz), 3.22-3.14 (m, 4 H), 2.40 (t, 2 H, J = 5.8 Hz), : I. 17 (m, 6 H). Examination case number 72b 5- 某 argon-2- (4-氡-茏)-3 6 (s, 2 Η), 3.77 (t, 2 .0 ( s, 3 Η), 1.29--A certain -1-"4-(2 -Hexapyridine-1 -A)-7..A)-benzyl 1-1 PB4Ι 枠 Oil; ^ NMR (DMSO ) 7.52 (d, 2 H, J = 8.6 Hz), 7.46 (d, 2 H, J 7.37 (m, 4 H), 7.35-7.29 (m, 1 H), 7.25 (d, 1 H, J = 9.0 Hz), 7 Hz), 6.83 (dd, 1 H, J = 8.8 Hz, 2.5 Hz), 6.72-6.65 (m, 4 H), 5. 2 H), 3.90 (t, 2 H, J = 5.9 Hz ), 2.55 (t, 2 H, J = 6.0 Hz), 2.41-(s, 3 H), 1.44-1.39 (m, 4 H), 1.38-1.29 (m, 2 H); MS el m / z 5 (Shen LiliS No. 7 3 5-Section 2-Γ 2. S-Dimethyl argon = 6.8 Hz), 7.41 -14 (d, 1 H, J = 2.4 16 (s, 2H), 5.11 (s, L26 (m, 4H), 2.16 Λ (M +). K-¾ Ί Ί -3-甲 甚 -1-Γ 4-(2 -hexaargon W, 腚 -1--7-7. 氲-Benzene) -1 η-nil m Foam;! H NMR (DMSO) 7.45 (d, 2 H, J = 7.0 Hz), 7.41-7.37 (m, (m, 1 H), 7.19 (d, 1H, J = 8.8 Hz), 7.11 (d, 1 H, J = 2.2 Hz), 7 . (Hz), 6.90 (d, 1 H, 1.4 Hz), 6.82-6.78 (m, 2H), 6.74 (s, 4 H), t (s, 2 H), 5.10 (s, 2 H), 3.93 (t, 2H, i = 6.0 Hz), 2.56 (t, 2 H, 2.35 (m, 4H), 2.15 (s, 3H), 1.48-1.41 (m, 4H), 1.38-1.28 (m, 21 (M + ). -6 0-2 Η), 7.33-7.29: 0 (d, 1 H, J = 7.9 • 07 (s, 2H), 5.16 Γ = 6.0Hz), 2.41-(); MS el m / z 574 This paper size applies to China National Standards (CNS > A4 size (210X297mm). Please read the notes of the back Φ before ordering. 5. Description of the invention (Clever) A7 B7 Example number Ή 5-Benzylhydrogen -2- (4-isopropylargonium-Rongjiu Ί-Γ 4-f) >-Six-qi P-Tech 1-1-Qi-qi) IE 1-1 Η-P ^ l

Foam; 1h NMR (DMSO) 7.46 (d, 2H, J = 7.7 Hz), 7.42 - 7.28 ( (d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 (d, 1 H, J = (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 (s (s, 2 H), 5.10 (s, 2 H), 4.70 - 4.60 (m, 1 H), 3.92 (t, 2 H, J = 5.7 (t, 2 H, 5.7 Hz), 2.40 - 2.30 (bs, 4 H), 2.15 (s, 3 H), 1.50 - 1.40 ( 1.30 (m, 2 H), 1.28 (d, 6 H, J = 6.2 Hz); MS el m/z 588 (M+). m, 3 Η), 7.25 2.4 Hz), 6.99 4 Η), 5.14 Hz), 2.55 m, 4 Η), 1.40 實施例编號7 5 窄氬某 4-申某-荣某1 Γ4-(2 -六氤卅啶-1-某 氩某)-窄某1 -1 3 -甲某-1 Η - P^[ 11¾Foam; 1h NMR (DMSO) 7.46 (d, 2H, J = 7.7 Hz), 7.42-7.28 ((d, 2 H, J = 8.7 Hz), 7.17 (d, 1 H, J = 8.7 Hz), 7.11 ( d, 1 H, J = (d, 2 H, J = 8.6 Hz), 6.79 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.73 (s (s, 2 H), 5.10 (s, 2 H), 4.70-4.60 (m, 1 H), 3.92 (t, 2 H, J = 5.7 (t, 2 H, 5.7 Hz), 2.40-2.30 (bs, 4 H), 2.15 (s, 3 H) , 1.50-1.40 (1.30 (m, 2 H), 1.28 (d, 6 H, J = 6.2 Hz); MS el m / z 588 (M +). M, 3 Η), 7.25 2.4 Hz), 6.99 4 Η ), 5.14 Hz), 2.55 m, 4 Η), 1.40 Example No. 7 5 Narrow Argon 4-Shenmou-Rongmou 1 Γ4- (2 -Hexamin-1--1-Ar-Hom) -Narrow 1 -1 3-甲某 -1 Η-P ^ [11¾

Oil; ιΗ NMR (DMSO) 7.46 (d, 2 H, J = 7.2 Hz), 7.45 - 7.18 (m, 8 H), 7.12 (d, 1 H, J = 2.4 Hz), 6.81 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 6.73 (si 4 H), 5.15 (s, 2 H), 5.10 (s, 2 H), 3.92 (t, 2 H, J = 5.9 Hz), 2.55 (t, 2 H, J 2.30 (m, 7 H), 2.10 (s, 3 H), 1.50 - 1.40 (m, 4 H), 1.48 - 1.35 H 2 H); MS el m/z 544 (M+). 5.9 Hz), 2.45 - 實施例編號7 7 4-(2 -吖庠W-l -某-Z. 某)-窄某〕 5-爷氫某-2-门-苄g某-荣某)-3 -申甚 經濟部中央橾準局貝工消費合作社印聚Oil; ιΗ NMR (DMSO) 7.46 (d, 2 H, J = 7.2 Hz), 7.45-7.18 (m, 8 H), 7.12 (d, 1 H, J = 2.4 Hz), 6.81 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 6.73 (si 4 H), 5.15 (s, 2 H), 5.10 (s, 2 H), 3.92 (t, 2 H, J = 5.9 Hz), 2.55 (t, 2 H, J 2.30 (m, 7 H), 2.10 (s, 3 H), 1.50-1.40 (m, 4 H), 1.48-1.35 H 2 H); MS el m / z 544 (M +). 5.9 Hz) , 2.45-Example No. 7 7 4- (2 -Acridine Wl -some-Z. Some) -narrow some] 5-ye hydrogen some-2-door-benzyl g some-rong some) -3 -Shenzhen Economic Printed Prints of Shellfish Consumer Cooperatives, Central Procurement Bureau

Mp = 103 - 105°C; lH NMR (DMSO) 7.47 - 7.45 (d, 2 H, J = 8.1 (m, 7 H), 7.32 - 7.29 (t, 2 H, 7.0 Hz), 7.23 - 7.21 (d, 1 H, J = 8.? (d, 1 H, J = 2.1 Hz), 7.06 - 7.03 (m, 1 H), 6.95 - 6.91 (m, 2 H), (m, 1 H), 6.75 - 6.73 (m, 4 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 5.02 ( 3.87 (t, 2 H, J = 6.0 Hz), 2.76 - 2.73 (t, 2 H, J = 6.0 Hz), 2.49 -(s, 3 H), 1.51 (s, 8 H); IR 3400, 2900 cm1; MS el m/z 650 (M+);Mp = 103-105 ° C; lH NMR (DMSO) 7.47-7.45 (d, 2 H, J = 8.1 (m, 7 H), 7.32-7.29 (t, 2 H, 7.0 Hz), 7.23-7.21 (d , 1 H, J = 8.? (D, 1 H, J = 2.1 Hz), 7.06-7.03 (m, 1 H), 6.95-6.91 (m, 2 H), (m, 1 H), 6.75- 6.73 (m, 4 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 5.02 (3.87 (t, 2 H, J = 6.0 Hz), 2.76-2.73 (t, 2 H, J = 6.0 Hz), 2.49-(s, 3 H), 1.51 (s, 8 H); IR 3400, 2900 cm1; MS el m / z 650 (M +);

Hz), 7.41 - 7.35 Hz), 7.13-7.12 ¢.83-6.80 s, 2 Η), 3.90 -148 (m, 4 Η), 2.13 c 44 H 4e N 2 〇 3之c Η N計算值 -6 1 本紙張尺度逋用中國囷家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注項再填寫本頁)Hz), 7.41-7.35 Hz), 7.13-7.12 ¢ .83-6.80 s, 2 Η), 3.90 -148 (m, 4 Η), 2.13 c 44 H 4e N 2 〇3 of c Η N calculated value -6 1 This paper is in Chinese Standard (CNS) Α4 size (210X 297mm) (Please read the note on the back before filling this page)

through

央 梂 準 局 員 合 作 杜 A7 B7 五、發明説明(w) Mp = 125-128°C; lR NMR (DMSO) 7.50 - 7.45 (m, 4 H), 7.43 --7.20 (m, 2 H), 7.14 - 7.09 (m, 2 H), 6.82 (dd, 1 H, J = 2.4 Hz, H), 5.21 ( s, 2 H), 5.16 (s, 2 H), 5.11 (s, 2 H), 3.94 (t, 2 H, J =-(m, 2 H), 2.41 - 2.36 (m, 4 H), 2.15 (s, 3 H), 1.45 - 1.40 (m, 4 K H ) ; MS el m/Z 6 5 4 ( M + ) ; C 43 H 43 F N 2 0 3 之 C 奮施例缠號79 5-苄氩某-2-(4-苄氩基-3-氤 7.28 (m, 7 Η), 7.26 8.8 Hz), 6.72 (s, 4 .8 Hz), 2.62 - 2.56 ),1.40 - 1.31 (m, 2 ΐ N計算值 -茱某)-S- 珥甚-1-「4-(2 -吖唐闵-1-甚-7.氩某)-芾某 )-1 H - P4I Hi Mp = 122-124°C; !h NMR (DMSO) 7.50 - 7.28 (m, 10 H), 7.26 7.15 - 7.10 (m, 2 H), 6.88 - 6.76 (m, 2 H), 6.70 (s, 4 H), 5.22 (s 5.11 (s, 2H), 3.92 - 3.86 (m, 2H), 2.82 - 2.65 (m, 2H), 2_65 - 2.」 3H), 1.60-1.4(111, 8H);MS el tn/Z 668(M + ) C 44 H 4S F N 2 0 3 之 C Η N 計算值 奮施例編號&0 5-苄氯某- 2- ( 3-申氫某-荣某 •7.20(m,2H), 2H), 5.16 (s, 2H), »5 (m, 4H), 2.15 (s, 5 -1 - Γ 4- (2- 六氤毗啶-1-某-ZM某苄甚Ί -:? -甲某-1H -N丨 11¾ Mp 86 - 87°C; !H NMR (DMSO) 7.50 - 7.49 (m, 2 H), 7.46 - 7.3 7.21 (d, 1 H, J = 8.8 Hz), 7.15 - 7.14 (d, 1 H, J = 2.3 Hz), 7.00 -6.88 - 6.81 (m, 2 H), 6.75 (s, 4 H), 5.18 (s, 2 H), 5.12 (s, 2 H), (t, 2 H, J = 5.9 Hz), 3.71 (s, 3 H), 2.59 - 2.55 (t, 2 H, J = 5.8 Hz 2.18 (s, 3 H), 1.49 - 1.42 (m, 4 H), 1.37 - 1.34 (m, 2 H); MS el rr c 3? H 40 N 2 0 3 + fl · 2 5 H 2 0 之 C Η N 計算值。 奮施例編號81 fi-苄氬甚-3-甲甚-1- Γ4-(2- L (m, 4 H), 7.24 - 6.93 (m, 2 H), 1.96 - 3.92 ),2.37 (s, 4 H), !z 561 (M+); 夂氳啶 -卜基-乙氫某)-苄某1 - 2 - ( 4 -三氩申気某-笼 某)-1 H - 吲1— Mp = 107 - 108°C; *H NMR (DMSO) 7.52 - 7.45 (m, 6 H), 7.41 -7.17 - 7.16 (d, 1 H, J = 2.3 Hz), 6.87 - 6.84 (dd, 1 H, J = 2.3 Hz -6.68 (m, 4 H), 5.18 (s, 2 H), 5.13 (s, 2 H), 3.95 - 3.91 (t, 2 H, 2.54 (t, 2 H, J = 5.9 Hz), 2.38 - 2.34 (m, 4 H), 2.17 - 2.15 (s, 3 (m, 4 H), 1.35 - 1.34 (d, 2 H, J = 4.9 Hz); IR 3400, 2900,1600 cr -62- 7.26 (m, 4 H), ,J = 6.4Hz), 6.75 =5.9 Hz), 2.58 -El), 1.49 - 1.42 if1; MS el m/z 615 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閲 tt 背 面 之 注 意 事 項 再Cooperation with Central Bureau Associate Members Du A7 B7 V. Description of Invention (w) Mp = 125-128 ° C; lR NMR (DMSO) 7.50-7.45 (m, 4 H), 7.43 --7.20 (m, 2 H), 7.14 -7.09 (m, 2 H), 6.82 (dd, 1 H, J = 2.4 Hz, H), 5.21 (s, 2 H), 5.16 (s, 2 H), 5.11 (s, 2 H), 3.94 ( t, 2 H, J =-(m, 2 H), 2.41-2.36 (m, 4 H), 2.15 (s, 3 H), 1.45-1.40 (m, 4 KH); MS el m / Z 6 5 4 (M +); C 43 H 43 FN 2 0 3 C Fen Example No. 79 5-benzylargon-2- (4-benzylargon-3- 氤 7.28 (m, 7 Η), 7.26 8.8 Hz), 6.72 (s, 4 .8 Hz), 2.62-2.56), 1.40-1.31 (m, 2 ΐ N Calculated Value-Jumou) -S- 珥 Ge-1- 「4- (2 -azetanmin -1-even-7. Argon) -rium) -1 H-P4I Hi Mp = 122-124 ° C;! H NMR (DMSO) 7.50-7.28 (m, 10 H), 7.26 7.15-7.10 (m , 2 H), 6.88-6.76 (m, 2 H), 6.70 (s, 4 H), 5.22 (s 5.11 (s, 2H), 3.92-3.86 (m, 2H), 2.82-2.65 (m, 2H) , 2_65-2. '' 3H), 1.60-1.4 (111, 8H); MS el tn / Z 668 (M +) C 44 H 4S FN 2 0 3 C Η N calculated value Example number & 0 5 -Benzyl chloride-2- (3-shenhydrogen-Rongmou7.20 (m, 2H), 2H), 5.16 (s, 2H), »5 (m, 4H), 2 .15 (s, 5 -1-Γ 4- (2-hexamidinepyrimidine-1-some-ZM some benzyl)-:? -a certain-1H -N 丨 11¾ Mp 86-87 ° C;! H NMR (DMSO) 7.50-7.49 (m, 2 H), 7.46-7.3 7.21 (d, 1 H, J = 8.8 Hz), 7.15-7.14 (d, 1 H, J = 2.3 Hz), 7.00 -6.88-6.81 (m, 2 H), 6.75 (s, 4 H), 5.18 (s, 2 H), 5.12 (s, 2 H), (t, 2 H, J = 5.9 Hz), 3.71 (s, 3 H) , 2.59-2.55 (t, 2 H, J = 5.8 Hz 2.18 (s, 3 H), 1.49-1.42 (m, 4 H), 1.37-1.34 (m, 2 H); MS el rr c 3? H 40 Calculated C Η N for N 2 0 3 + fl · 2 5 H 2 0. Fen example number 81 fi-benzyl argon-3-methyl even-1- Γ4- (2- L (m, 4 H), 7.24-6.93 (m, 2 H), 1.96-3.92), 2.37 (s, 4 H),! Z 561 (M +); pyridine-b-yl-ethylhydrogen) -benzyl 1-2-(4 -triargonium-methylene)-1 H-ind1— Mp = 107-108 ° C; * H NMR (DMSO) 7.52-7.45 (m, 6 H), 7.41 -7.17-7.16 (d, 1 H, J = 2.3 Hz), 6.87-6.84 (dd, 1 H, J = 2.3 Hz -6.68 (m, 4 H), 5.18 (s, 2 H), 5.13 (s, 2 H), 3.95-3.91 (t, 2 H, 2.54 (t, 2 H, J = 5.9 Hz), 2.38 -2.34 (m, 4 H), 2.17-2.15 (s, 3 (m, 4 H), 1.35-1.34 (d, 2 H, J = 4.9 Hz); IR 3400, 2900,1600 cr -62- 7.26 ( m, 4 H),, J = 6.4 Hz), 6.75 = 5.9 Hz), 2.58 -El), 1.49-1.42 if1; MS el m / z 615 This paper size applies to China National Standard (CNS) A4 specification (210X 297 Mm) Please read the notes on the back of tt before

訂 經 ▲ 部 中 央 標 準 局 員 X. 消 費 合 作 社 印 製 ....... - r . ' 1 Α7 Li:::·... Β7 五、發明説明(…) (M + ); CgrHrFs N2 03 2CHN 計算值。 啻掄例4Θ號82 节氩某- 2- U-苄 S甚-关甚) -3-田甚-仰115-1-甚甲甚1 -荣氤甚1 -7.某) -瑄P.甚1胺 Mp = 87-90°C; !h NMR (DMSO) 7.46(dd, 4H, J= 6.9Hz, 0.6Hz) ,7.42-7.27 (m, 9H), 7.19 (d, 1H, J= 9Hz), 7.14-7.08 (m, 3H), 6.80 (dd, 1H, J= 6.4Hz, 2.4Hz), 6.75- 6.70 (m, 4H), 5.15(s, 2H), 5.13 (s, 2H), 5.13(s, 2H), 3.89 (t, 2H, J= 5.6), 2.84 (m, 2H), 2.48 (m, 1H), 2.14 (s, 3H), 1.80 ( m, 2H), 1.65 (r α, 2H), 1.61 (m, 1H), 0.96-1.19 (m, 5H); MS el nVZ 650 (M+); C44H4eN2 〇4 之 CHN 計算值。 窗掄例迫號8 3 芊氫甚- 2- (4 -苄氫基-苯基 H -田甚 -甲某六氣吡畊-1-某)-7.氫某Ί -苄* 1 - 1 H - 吲呤 Mp = 88-91°C; lK NMR (DMSO) 7.47 (m, 4H), 7.26-7.42 (m, 8 Ά), 7.19 (d, 1H, J= 8.8), 7.10-1.12 (m, 3H), 6.80 (q, 1H, J= 6,3Hz, 2.4H j), 6.73 (m, 4H), 5.15 (s, 2H), 5.13 (s, 2H), 5.11 (s, 2H), 3.94 (t, 2H, J= 5.9Hz), >.59 (t, 2H), 2.42 (m, 4H), 2.29 (m, 4H), 2.15 (s, 3H), 2.12 (s, 3H); MS el m/Z 652 (M+); C 43 H 45 N 3 0 3 之 C Η N 計算值 / 窗to例迫睐84 1- Γ4-ί 2-吖庠庆1-1-甚)-Z奪 :甚)-苄甚Ί -5 -苄氩甚-2 -门-三甲氩某-荣甚-甲甚-1 H-Pil 11¾ Mp = 103 - 105°C; *H NMR (DMSO) 7.47 - 7.45 (d, 2 H, J = 8.1 Hz), 7.41 - 7.35 (m, 7 H), 7.32 - 7.29 (t, 2 H, 7.0 Hz), 7.23 - 7.21 (d, 1 H, J = 8 J Hz), 7.13 -7.12 (d, 1 H, J = 2.1 Hz), 7.06 - 7.03 (m, 1 H), 6.95 - 6.91 (m, 2 H),( .83 - 6.80 (m, 1 H), 6.75 - 6.73 (m, 4 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 5.02 (s, 2 I I), 3.90 - 3.87 (t, 2 H, J = 6.0 Hz), 2.76 - 2.73 (t, 2 H, J = 6.0 Hz), 2.49 - 2.48 (m, 4 H), 2.13 (s, 3H), 1.51 (s, 8 H); IR 3400, 2900 cm·1; MS el m/z 650 (M+); / -63- 本紙張尺度逋用中國國家標準(CNS ) A4規格(2!0X 297公釐) 請 I 先I 閱 | 讀| 背 之 注 意 事 項 再 fBooklet ▲ Printed by the Central Bureau of Standards X. Printed by the Consumer Cooperative .......-r. '1 Α7 Li ::: ... Β7 V. Description of the invention (…) (M +); CgrHrFs N2 03 2CHN calculated value.啻 抡 例 4Θ No. 82 knots argon-2- U-benzyl sulphate-guan shi) -3-Tian shi-yang 115-1-shijia shi 1-Rong xi shi 1 -7.)-瑄 P. Even 1 amine Mp = 87-90 ° C;! H NMR (DMSO) 7.46 (dd, 4H, J = 6.9Hz, 0.6Hz), 7.42-7.27 (m, 9H), 7.19 (d, 1H, J = 9Hz ), 7.14-7.08 (m, 3H), 6.80 (dd, 1H, J = 6.4Hz, 2.4Hz), 6.75- 6.70 (m, 4H), 5.15 (s, 2H), 5.13 (s, 2H), 5.13 (s, 2H), 3.89 (t, 2H, J = 5.6), 2.84 (m, 2H), 2.48 (m, 1H), 2.14 (s, 3H), 1.80 (m, 2H), 1.65 (r α, 2H), 1.61 (m, 1H), 0.96-1.19 (m, 5H); MS el nVZ 650 (M +); C44H4eN2 CHN calculated value. Window case No. 8 3 芊 甚 甚-2- (4 -benzylhydrogen-phenyl H-Tian shi-a certain hexakisperidine -1-)-7. hydrogen Ί 苄-benzyl * 1-1 H-indine Mp = 88-91 ° C; lK NMR (DMSO) 7.47 (m, 4H), 7.26-7.42 (m, 8 Ά), 7.19 (d, 1H, J = 8.8), 7.10-1.12 (m , 3H), 6.80 (q, 1H, J = 6,3Hz, 2.4H j), 6.73 (m, 4H), 5.15 (s, 2H), 5.13 (s, 2H), 5.11 (s, 2H), 3.94 (t, 2H, J = 5.9Hz), > .59 (t, 2H), 2.42 (m, 4H), 2.29 (m, 4H), 2.15 (s, 3H), 2.12 (s, 3H); MS el m / Z 652 (M +); C 43 H 45 N 3 0 3 The calculated value of C Η N / window is very popular 84 1- Γ4-ί 2-acene Qing 1-1- even) -Z wins: Even) -benzyl hydrazone -5 -benzyl argon-2 -gate-trimethyl argon- Rongji-methyl -1 H-Pil 11¾ Mp = 103-105 ° C; * H NMR (DMSO) 7.47-7.45 ( d, 2 H, J = 8.1 Hz), 7.41-7.35 (m, 7 H), 7.32-7.29 (t, 2 H, 7.0 Hz), 7.23-7.21 (d, 1 H, J = 8 J Hz), 7.13 -7.12 (d, 1 H, J = 2.1 Hz), 7.06-7.03 (m, 1 H), 6.95-6.91 (m, 2 H), (.83-6.80 (m, 1 H), 6.75-6.73 (m, 4 H), 5.13 (s, 2 H), 5.11 (s, 2 H), 5.02 (s, 2 II), 3.90-3.87 (t, 2 H, J = 6.0 Hz), 2.76-2.73 ( t, 2 H , J = 6.0 Hz), 2.49-2.48 (m, 4 H), 2.13 (s, 3H), 1.51 (s, 8 H); IR 3400, 2900 cm · 1; MS el m / z 650 (M +); / -63- This paper size uses Chinese National Standard (CNS) A4 specifications (2! 0X 297mm) Please read it first | Read | Notes for back then f

I 裝 II 訂 A7 B7 > 五、發明説明“ C 44 H 4e N 2 0 3 之 C Η N 計算值。 得自本文之表11(ER受體數據表,下文)之I Pack II Order A7 B7 > V. Description of the invention "Calculated values of C Η N for C 44 H 4e N 2 0 3. Available from Table 11 (ER Receptor Data Sheet, below)

Z 表 實施例编她 7i 0 ζ No. 85 Η Η ο No. 86 Η 4,-ΟΗ ο (請先閲讀背面之注意事項再填寫本頁)Form Z Example 7i 0 ζ No. 85 Η Η ο No. 86 Η 4, -ΟΗ ο (Please read the precautions on the back before filling this page)

L ,11 經濟部中央標準局員工消費合作社印製 -64- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 五、發明説明(w ) 經濟部中央標準局員工消費合作社印製 A7 B7 實施例蝙號丨 X 表7 (績 α ) No. 87 OH Η o No. 88 OMe 4,-ΟΗ o No. 89 OH 4,-OMc o No. 90 OMe 4,-OMe o No. 91 OMe 4,OMe o No. 92 OH 4,-OEt o No. 93 OH 4*-OEt G No. 94 F 4,-OH o No. 95 OH H ( ) No. 96 OH 4,-OH c No. 97 OH 4,-OH 厂 V. > No. 98 OH 4,-OH c ) (請先閲讀背面之注意事項再填寫本頁) I- I -1 —^1L, 11 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs-64- This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) V. Description of the invention (w) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 Example No. 丨 X Table 7 (Performance α) No. 87 OH Η o No. 88 OMe 4, -OΗ o No. 89 OH 4, -OMc o No. 90 OMe 4, -OMe o No. 91 OMe 4, OMe o No. 92 OH 4, -OEt o No. 93 OH 4 * -OEt G No. 94 F 4, -OH o No. 95 OH H () No. 96 OH 4, and -OH c No. 97 OH 4, -OH Factory V. > No. 98 OH 4, -OH c) (Please read the notes on the back before filling this page) I- I -1 — ^ 1

、1T 65 -1^1 ----« I-..... 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇><297公釐) 五、發明説明(糾) A7 B7 表7 (績、 1T 65 -1 ^ 1 ---- «I -..... This paper size applies Chinese National Standard (CNS) A4 specification (21〇 > < 297 mm) 5. Description of the invention (correction) A7 B7 Table 7 (Performance

Vummmyi X ΙΟ zVummmyi X ΙΟ z

No. 99No. 99

OHOH

4,-OH N·4, -OH N ·

No. 100No. 100

OHOH

4,-OH4, -OH

No. 101No. 101

OHOH

4,-OH4, -OH

NvNv

No. 102No. 102

OHOH

4,-OH4, -OH

NvNv

No. 103No. 103

OHOH

4,-OH4, -OH

KK

No. 104No. 104

OHOH

4,-OH — I I n I n In I 1^. ^ n n n n n n T 、v5 (請先閱讀背面之注意事項再填寫本頁) N.4, -OH — I I n I n In I 1 ^. ^ N n n n n n T, v5 (Please read the precautions on the back before filling this page) N.

No. 105No. 105

OH 4,·ΟΗOH 4, · ΟΗ

NvNv

No. 106No. 106

OHOH

4,-OH4, -OH

No. 107No. 107

OHOH

4,-OH :〇 經濟部中央標準局員工消費合作社印製4, -OH: 〇 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

No. 108No. 108

OHOH

4,-OH 私紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標隼局員工消費合作社印製 A7 _ B7 五、發明説明(w) 表7 <續) 實施例蹁號 m ▼冒課 No. 109 OH 4,-OH No. 110 OH 4,-OH 〇 No. Ill OH 4,-OH No. 112 OH 4,·ΟΗ No. 113 OH 4,-OH 〇-° Ν®* 114 OH 4’-OH No. 115 OH 4*-OH No. 116 OH 4,-F o No. 117 OH 4,-F 〇 No. 118 OH 3,-OMe,4,-OH o No. 119 OH 3,,4,-0CH20- o 67 .!.. Ii HH - i - - -- - - - -I II 界 n^i (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 表7 (績) 實掩例编號 X No. 120 OH 4’-0*iPr C ) No. 121 OH 4’-OiPr V No. 122 'OH 4,-0-Cp No. 123 OH 4,-CF3 C No. 124 OH 4,-CH3 No. 125 OH 4,-Cl ) No. 126 OH 2\4\-Dimethoxy E) No. 127 OH 3,-OH c p No. 128 OH 3,-〇H ( p No. 129 OH 4,-OH,3’-F ( ·: p> No. 130 OH 4,-OH,3’-F ( t) No. 131 OH 3,-OMe c :) No. 132 OH 4,-OCF3 ( i) 經 濟 部 t ▲ 標 準 局 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明U7 ) 說明窨旅例组號9 7 ;>句,含苄某_盹鸣夕Μ仆 * m 2 - u -铧甚-荣甚)-:?-田某-1 -「4 - 2 -六氳毗Ιί ? - 1 -革 _ Κ 籮基)-苄甚1 - 1 Η - Ν丨Β4 - 5 - _ 以编號6 3 ( 2 . 2克,3 . 4毫莫耳)於T H F / E tu Η ..之溶液處 理10% Pd/C (1.1克)之懸浮液。加入環己: 二烯(6,0毫升,, 6 3毫莫耳)及攪拌反應48小時。經養路斯(Ce 1 i t e )過濾催 化劑,及濃縮反應混合物並使用M e 0 H / C Η 2 C1 2 (1 : 19 至1: 10)之梯度溶離,層析於矽凝膠上以産 生〇 . 8克呈 白色固體之産物。Μρ= 10 9-113 °C; CHN計算值 CagHazh 0 3 +0 . 5H 2 0 ; 1 H NHRi .64 ( s , 1 Η), 8.67 (s, 1 Η), 7.14 (d, 2 Η, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.( i Hz), 6.84 (d, 2 Η, J = 8.8 Hz), 6.79 (d, 1 H, J = 2.2 Hz), 6.74 (s, 4 H), 6.56 (dc !, 1 H, J = 8.8, 2.4 Hz), 5.09 (s, 2 H), 3.95-3.93 (m, 2 H), 2.60-2.51 (m, 2 H), 2 .39-2.38 (m, 4 Η), 2.09 (s, 3 H), 1.46-1.45 (m, 4 H), 1.35-1.34 (m, 2 H); IR (KB r) 3350 (br), 2920, 1620,1510 cm-1; MS (El) m/z 456. 或者,化合物可溶解於T H F/ E tun溶液中 (或其他適 當溶液)及以H 2和1 0 % P d / C使用b a 1 1 un或P a r r氫化器 氫化,在許多實施例中,該等化合物製成酸 加成鹽,一 HC1鹽之製備步驟如下所示(方法8)。 方法8 得自上述氫化步驟之1 Q克實施例編號9 7自 由鹼於大試 管中溶解於20毫升MeOH中。此以緩慢加入2. 5毫升1 . ON H C 1 ,然後加入4 · 0毫升去離子水處理。部分 打開試管於 大氣壓中以緩慢蒸發溶劑。約10分鐘之後, 晶開始出 現及4小時後過濾溶液及以水洗滌固體結晶 >産物以4 . 2 克白色結晶Η且具184-185 °C之熔點存在β月 if産生之回 -- 6 9 本紙張尺度適用中國國家標準(CNS ) Μ規格(2「0义297公釐) 請 先 閱 % 背 $1 之 注 意 事 項 再 填 寫 本 頁 訂 合 作 社 印 製 A7 B7 五、發明説明(w) 液額外收獲〇 · 3 0克之白色固體具熔點1 7 7 - 1 3 〇 °c ,計算 C29H32N2 〇3 +HC1 + 1H2 〇之 CHN計算值。 或者,化合物可轉變成四级銨鹽。合成實 施例编號107 之實例步驟如下所示(方法9)。 方法9 實施例编號1 〇 7 2 - (4-羥基-荣某申某-1 -r 4- (2- 六氣嫌症-:1 -基-乙氱基)-节某1 - 1 Η -盹B# - f -醇申W 化物„ 將0.8克之實施例编號97溶解於18毫升THf 中及以2毫 升碘甲烷處理》溶液加熱至回流1小時。使 反應冷卻至 室溫且過濾固體以産生0.72克之結晶固體。 M p : 2 1 4 - 2 1 7 "C ,計算 C29H32N2〇3+CH:3l + 0.5H2〇2CNH0 實施例编號1 〇 6 2 - U -羥基-笨某)-3 -田甚-1 -「 4- .二 基二 1-基-乙氯基)-苄某 Ί -1H-Pi?l 8¾ -R -醇申》 與编號106相同製備,除使用编號1〇〇 作為 起始物質之外:Μρ = 245 - 250% 1h NMR (DMSO) 9.66 (s, 1 Η), 8.69 (s, 1 Η), 7.16 (d, 2 Η, J = 8.4 Hz), 7.05 (d ,1 H, J = 8.8 Hz), 6.84 (d, 1 H, J = 8.6 Hz), 6.81 - 6.75 (m, 6H), 6.56 (dd, 1 H, J =2.4 Hz, 8.7 Hz), 5.12 (s, 2 H), 4.34 (m, 2 H), 3.70 (t, 2 H, J = 4.6 Hz), 3.11 (s, 'Η), 2.09 (s, 3 H); IR (KBr) 3 2 5 0 , 1 5 0 0, 1 2 5 0 ; M S el m/z 416(M Ο ;計算 C26 Has N 2 〇 3 +1.09 CH 3 I + 0 . 8H 2 〇之 CHN〇 最後之去保ϋ化合物少物理教墟 下列化合物為自由鹼,HC1鹽或乙酸鹽β ΐ ί們可根據 方法7中概述步驟使用適當苄基醚先質製備 >其中得自 表1之化合物不包含自由酚官能性,則其不 嚅要去苄基 化且不使用方法7。該等化合物(编號8 5 ,编 號9{)-編號 9 1 )仍如下出現。 本紙張尺度適用中國國家標準(CNS ) Α4規格(2i〇UX297公釐) 請 先 閲 面 之 注 意 事 項 再 填 寫 本 頁4, -OH private paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) Printed by A7 _ B7, Employee Consumer Cooperative of the Central Standardization Bureau of the Ministry of Economic Affairs 5. Description of the invention (w) Table 7 < Continued) Examples蹁 号 m ▼ No. 109 OH 4, —OH No. 110 OH 4, —OH 〇No. Ill OH 4, —OH No. 112 OH 4, · 〇Η No. 113 OH 4, —OH 〇- ° Ν® * 114 OH 4'-OH No. 115 OH 4 * -OH No. 116 OH 4, -F o No. 117 OH 4, -F 〇No. 118 OH 3, -OMe, 4, -OH o No . 119 OH 3, 4, -0CH20- o 67.! .. Ii HH-i-------I II nn ^ i (Please read the notes on the back before filling this page) This paper Standards are applicable to China National Standard (CNS) A4 specifications (210X 297 mm) Table 7 (Results) Case No. X No. 120 OH 4'-0 * iPr C) No. 121 OH 4'-OiPr V No. 122 'OH 4, -0-Cp No. 123 OH 4, —CF3 C No. 124 OH 4, —CH3 No. 125 OH 4, —Cl) No. 126 OH 2 \ 4 \ -Dimethoxy E) No. 127 OH 3, -OH cp No. 128 OH 3, -〇H (p No. 129 OH 4, -OH, 3'-F (·: p > No. 130 OH 4, -OH, 3'-F (t ) No. 131 OH 3, -OMe c :) No. 132 OH 4, -OCF3 (i) Ministry of Economic Affairs t ▲ Printed by the Consumer Bureau of Standards Bureau A7 B7 V. Description of the invention U7) Description of travel group number 9 7 ;> Sentence, containing benzyl _ 盹 明 夕 ΜΜ * m 2-u-铧 铧-甚))-:?-田某 -1-"4-2-六 氲 比 Ιί?-1-革 _ Κ 箩)-benzyl 1-1 Η-Ν 丨 Β4-5-_ treated with a solution of the number 6 3 (2.2 g, 3.4 mmol) in THF / E tu Η .. 10% Suspension of Pd / C (1.1 g). Cyclohexane: diene (6.0 ml, 63 mmol) was added and the reaction was stirred for 48 hours. The catalyst was filtered through Ce 1 ite, and the reaction mixture was concentrated and dissociated using a gradient of Me 0 H / C Η 2 C1 2 (1: 19 to 1: 10), and chromatographed on a silica gel to produce. . 8 g of product as a white solid. Μρ = 10 9-113 ° C; calculated CHN CagHazh 0 3 +0. 5H 2 0; 1 H NHRi .64 (s, 1 Η), 8.67 (s, 1 Η), 7.14 (d, 2 Η, J = 8.6 Hz), 7.05 (d, 1 H, J = 8. (i Hz), 6.84 (d, 2 Η, J = 8.8 Hz), 6.79 (d, 1 H, J = 2.2 Hz), 6.74 (s , 4 H), 6.56 (dc!, 1 H, J = 8.8, 2.4 Hz), 5.09 (s, 2 H), 3.95-3.93 (m, 2 H), 2.60-2.51 (m, 2 H), 2 .39-2.38 (m, 4 Η), 2.09 (s, 3 H), 1.46-1.45 (m, 4 H), 1.35-1.34 (m, 2 H); IR (KB r) 3350 (br), 2920 , 1620, 1510 cm-1; MS (El) m / z 456. Alternatively, the compound can be dissolved in THF / E tun solution (or other appropriate solution) and use ba 1 with H 2 and 10% P d / C 1 un or Parr hydrogenator hydrogenation. In many embodiments, these compounds are made into acid addition salts. The preparation steps of a HC1 salt are shown below (Method 8). Method 8 1 Qg from the above hydrogenation step Example No. 9 7 The free base was dissolved in 20 ml of MeOH in a large test tube. This was slowly added with 2.5 ml of 1. ON HC 1 and then treated with 4.0 ml of deionized water. Partially opened the test tube at atmospheric pressure to Slowly evaporate the solvent. Approx. 10 After the clock, the crystals appeared and the solution was filtered and the solid crystals were washed with water after 4 hours. The product contained 4.2 g of white crystals and had a melting point of 184-185 ° C. There was a β-if produced back-6 9 copies Paper size applies Chinese National Standard (CNS) M specifications (2 "0 meaning 297 mm) Please read the precautions of% 1 before filling in this page and order the cooperative to print A7 B7. 5. The invention description (w) The liquid is additionally harvested. 30 grams of white solid with a melting point of 177-1300 ° C, calculate the calculated CHN of C29H32N2 〇3 + HC1 + 1H2 〇. Alternatively, the compound can be converted into a quaternary ammonium salt. Synthetic Example No. 107 Example steps are shown below (Method 9). Method 9 Example No. 1 〇7 2-(4-Hydroxy-Rong Mou Shen Mou-1 -r 4- (2-Hexa-Symptom-: 1-yl-Ethyl) -Jie Mou 1-1 Η -盹 B #-f-申 物 申 物。 0.8 g of Example No. 97 was dissolved in 18 ml of THf and treated with 2 ml of methyl iodide. The solution was heated to reflux for 1 hour. The reaction was cooled to room temperature and the solid was filtered to 0.72 g of a crystalline solid was produced. M p: 2 1 4-2 1 7 " C, calculated C29H32N2O3 + CH: 3l + 0.5H2〇2CNH0 Example No. 1 〇6 2-U -hydroxy-benzium)- 3 -Tianji-1-"4-.Diyldi1-yl-ethylchloro) -benzyl -1H-Pi? L 8¾-R-alcohol," same preparation as No. 106, except using the number 100% as starting material: Μρ = 245-250% 1h NMR (DMSO) 9.66 (s, 1 Η), 8.69 (s, 1 Η), 7.16 (d, 2 Η, J = 8.4 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.84 (d, 1 H, J = 8.6 Hz), 6.81-6.75 (m, 6H), 6.56 (dd, 1 H, J = 2.4 Hz, 8.7 Hz) , 5.12 (s, 2 H), 4.34 (m, 2 H), 3.70 (t, 2 H, J = 4.6 Hz), 3.11 (s, 'Η), 2.09 (s, 3 H); IR (KBr) 3 2 5 0, 1 5 0 0, 1 2 5 0; MS el m / z 416 (M Ο; Calculate C26 Has N 2 〇3 +1.09 CH 3 I + 0.8H 2 〇CHN 〇 The last deprotection compounds less physical education market The following compounds are free base, HC1 salt or acetate β ΐ We can follow the method 7 The steps outlined in the above are prepared using the appropriate benzyl ether precursor> where the compound obtained from Table 1 does not contain free phenol functionality, it does not require debenzylation and does not use Method 7. These compounds (No. 8 5 , No. 9 {)-No. 9 1) still appear as follows. This paper size applies to Chinese National Standard (CNS) Α4 specification (2i0UX297 mm) Please read the precautions before filling in this page

訂 經 濟 部 中 央 標 準 局 員 工 經 濟 部 中 央 標 準 員 合 作 社 印 製 五、發明説明Mf) 齊施例编號85 4- {3 -甲基-1- [4-(2 -六養 卅腚-1 -甚 -7 ^ ^ « 1 - 1 Η - 0^1 > ί Η Γ η Μρ = 134 - 137°C; *Η NMR (DMSO) 10.33 (s, 1Η), 7.56 - 7.; Η, J = 8.1 Hz), 7.14 - 7.0 (m, 2 H), 6.80 (s, 4 H), 5.24 (s, 2 ll 5.0 Hz), 3.50 - 3.40 (m, 4 H), 3.0 -2.95 (m, 2 H), 2.10 (s, 3 E H), 1.40 - 1.35 (m, 1 H); IR 3400, 2900,1510,1250 cm'1; MS [M + H]+ ; C29 H32 N2 0 + 1.0HC1 + 1.0H2 〇 之 旃例编號以-甲甚六匍 8 (m, 6 Η), 7.32 (d, 1 ),4.28 (t, 2 H, J = ),1.80 - 1.60 (m, 5 +) FAB m/z 425 ;HN計算值。 卅D? - 1 -甚 -严,氣蒂)一雙甚 Ί - 1 Η - ¢4 - 2 - * 1 -0¾ (HC LL Μρ = 192 - 194°C; 1H NMR (DMSO), 10.28 (s, 1 H), 9.75 (s, (m, 1H), 7.27 (dd, 1 H, J = 7.0 Hz, 0.7 Hz), 7.18 (d, 2 H, J = (m, 2 H), 6.86 (d, 2 H, J = 8.6 Hz), 6.80 (s, 4 H), 5.20 (s, 2 ¥ (t, 2 H, J = 4.9 Hz), 3.50 - 3.35 (m, 4 H), 3.0 - 2.85 (m, 2 H), 1.60 (m, 5 H), 1.40 - 1.30 (m, 1 H); IR 3400, 3100, 2600, 150( _., ....... m/z 4 4 0 ( M + ) ; C29H32N2 〇2 +1 HC1 之 CHN; 宵聊例稱號87 2-田甚-2-¾某-1-Γ 4-(2-: 1 Η), 7.51 - 7.49 7.6 Hz), 7.09 - 7.02 X 4.28 2.20 (s, 3 H), 1.80 -1, 1225 cm-1; MS el 汁算值。 ^ M Btt, fl? -1 - 甚-Z 蕾.甚)-苄甚 1 - 1 Η - nil - 5 -醇_ UULLL Μρ = 228-230°C; ιΗ NMR 10.1 (brs , 1 Η), 8.76 (s, 1 Η), 7.55 (m , 5 H ),7.10 (d, 1 Η, J = 8.8 Hz), 6.85 - 6.80 (m , 5 H), 6. Hz), 5.15 (s, 2 H), 4.25 (t, 2 H, J = 4.8 Hz), 3.47-3.35 (m , 4 (m, 2 H), 2.12 (s , 3 H), 1.75-1.65 (m, 5 H), 1.31-1.28 (m , 1 (H + ) ; C29 fl32 N 2 〇 2 +1 HCL+ . 33H 2 CHN IR(KBr)3200,2500,1450,1200c»-1 〇 窨施例缠號88 4- f5-甲氫某-3-甲某-1+ { -7.45 >1 (d , 1 H , J = 8.8 H), 2.96-2.87 H); MS el m/z 440 計算值; 4 _ Γ 2 -(六 氩毗啶-1 -某)-7.篋某)节某1 - 1 Η -时盹-2 - 某 ί -a» Mpt = 87-90°C; *H NMR (DMSO) 9.67 (s, 1 H), 7.16 (d, 2 H, (1 H buried), 6.98 (d, 1 H, J = 2.4 Hz), 6.85 (d, 2 H, J= 8.6 H (dd, 1 H, J = 8.8, 2.4 Hz), 5.13 (s, 2 H), 3.94 (t, 2 H, J = 5.7 2.63-2.50 (m, 2 H), 2.43-2.31 (m, 4 H), 2.15 (s, 3 H), 1.49-1.- 71 1 = 8.6 Hz), 7.16 6.73 (s, 4 Η), 6.69 tlz), 3.76 (s, 3 H), 40 (m, 4 H),1.39- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 請 先 閱 讀 背 Λ 之 注 頁Ordered by the Central Standards Bureau of the Ministry of Economic Affairs. Printed by the Central Standards Cooperative of the Ministry of Economic Affairs. 5. Description of Invention Mf) Qi Example No. 85 4- {3 -methyl-1- [4- (2-六 养 卅 腚 -1- -7 ^ ^ «1-1 Η-0 ^ 1 > ί Η Γ η Μρ = 134-137 ° C; * Η NMR (DMSO) 10.33 (s, 1Η), 7.56-7 .; Η, J = 8.1 Hz), 7.14-7.0 (m, 2 H), 6.80 (s, 4 H), 5.24 (s, 2 ll 5.0 Hz), 3.50-3.40 (m, 4 H), 3.0 -2.95 (m, 2 H ), 2.10 (s, 3 EH), 1.40-1.35 (m, 1 H); IR 3400, 2900,1510,1250 cm'1; MS [M + H] +; C29 H32 N2 0 + 1.0HC1 + 1.0H2 〇The example numbers are-Jiaxiu Liu 8 (m, 6 Η), 7.32 (d, 1), 4.28 (t, 2 H, J =), 1.80-1.60 (m, 5 +) FAB m / z 425; HN calculated value.卅 D?-1 -Very-strict, airy) a pair of very Ί-1 Η-¢ 4-2-* 1 -0¾ (HC LL Μρ = 192-194 ° C; 1H NMR (DMSO), 10.28 (s , 1 H), 9.75 (s, (m, 1H), 7.27 (dd, 1 H, J = 7.0 Hz, 0.7 Hz), 7.18 (d, 2 H, J = (m, 2 H), 6.86 (d , 2 H, J = 8.6 Hz), 6.80 (s, 4 H), 5.20 (s, 2 ¥ (t, 2 H, J = 4.9 Hz), 3.50-3.35 (m, 4 H), 3.0-2.85 ( m, 2 H), 1.60 (m, 5 H), 1.40-1.30 (m, 1 H); IR 3400, 3100, 2600, 150 (_., ....... m / z 4 4 0 ( M +); C29H32N2 〇2 +1 CHN of HC1; Example of a small chat 87 2- 田田 -2-¾ 某 -1-Γ 4- (2-: 1 Η), 7.51-7.49 7.6 Hz), 7.09- 7.02 X 4.28 2.20 (s, 3 H), 1.80 -1, 1225 cm-1; MS el juice calculated. ^ M Btt, fl? -1-Even-Z Lei. Even)-benzyl 1-1 Η- nil-5 -alcohol_ UULLL Μρ = 228-230 ° C; ιΗ NMR 10.1 (brs, 1 Η), 8.76 (s, 1 Η), 7.55 (m, 5 H), 7.10 (d, 1 Η, J = 8.8 Hz), 6.85-6.80 (m, 5 H), 6. Hz), 5.15 (s, 2 H), 4.25 (t, 2 H, J = 4.8 Hz), 3.47-3.35 (m, 4 (m, 2 H), 2.12 (s, 3 H), 1.75-1.65 (m, 5 H), 1.31-1.28 (m, 1 (H +); C29 fl32 N 2 〇2 +1 HCL +. 33H 2 CHN IR (KBr ) 32 00,2500,1450,1200c »-1 〇 Example Example No. 88 4- f5-methylhydrogen-3-methyl-1 -1+ {-7.45 > 1 (d, 1 H, J = 8.8 H), 2.96-2.87 H); MS el m / z 440 Calculated value; 4 _ Γ 2-(hexaargyrimidine-1 -some) -7. 箧 some) section 1-1 Η-时 盹 -2-certain ί -a »Mpt = 87-90 ° C; * H NMR (DMSO) 9.67 (s, 1 H), 7.16 (d, 2 H, (1 H buried), 6.98 (d, 1 H, J = 2.4 Hz) , 6.85 (d, 2 H, J = 8.6 H (dd, 1 H, J = 8.8, 2.4 Hz), 5.13 (s, 2 H), 3.94 (t, 2 H, J = 5.7 2.63-2.50 (m, 2 H), 2.43-2.31 (m, 4 H), 2.15 (s, 3 H), 1.49-1.- 71 1 = 8.6 Hz), 7.16 6.73 (s, 4 Η), 6.69 tlz), 3.76 (s , 3 H), 40 (m, 4 H), 1.39- This paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) Please read the back page first

I 五、發明説明(10) 1.25 (m, 2 H); IR (KBr) 3400 (br), 2920^.1610,1520 cm'1; MS cl m/z 470I. Description of the invention (10) 1.25 (m, 2 H); IR (KBr) 3400 (br), 2920 ^ .1610, 1520 cm'1; MS cl m / z 470

Can H 30 Π 34 〇3 +0.1H2 〇之co計算值。 實施例编號& 9 (4 -甲氤基-苯基-)-3 -甲基―Can H 30 Π 34 〇3 + 0.1H2 〇co calculated value. Example No. & 9 (4-methylamino-phenyl-)-3 -methyl-

Mp = 188-189°C; !H NMR (DMSO) 8.70 (s, 1 H), 7.27 (d, 2 H, J = 8.6 Hz), 7.06 (d, 1 H, J =: 8.6 Hz), 7 Hz), 6.81 (d, 1 H, J= 2.2 Hz), 6.73 (s. ^ H), 6.58 (dd, 1 H, J (s, 2 H), 3.93 (t, 2 H, J = 5.9 Hz), 3.79 (s, 3 H), 2.56 (t, 2 H 2.32 (m, 4 H), 2.10 (s, 3 H), 1.47-1.41 (m, 4 H), 1.34-1.31 (r|i 470; C30H34N2 〇3 +O.IH2 〇 之 CHN 計算值 〇 實施例编號9 ϋ 甲氣某-2-(4-甲氬基-宏基 f 4- Γ 02 (d, 2 H, J = 8.8 8.8, 2.4 Hz), 5.10 J = 5.9 Hz), 2.41-,2 H); MS el nVz )-申某-1 - ---------|裝-- (請先閱讀背面之注意事項再填寫本頁)Mp = 188-189 ° C;! H NMR (DMSO) 8.70 (s, 1 H), 7.27 (d, 2 H, J = 8.6 Hz), 7.06 (d, 1 H, J =: 8.6 Hz), 7 Hz), 6.81 (d, 1 H, J = 2.2 Hz), 6.73 (s. ^ H), 6.58 (dd, 1 H, J (s, 2 H), 3.93 (t, 2 H, J = 5.9 Hz ), 3.79 (s, 3 H), 2.56 (t, 2 H 2.32 (m, 4 H), 2.10 (s, 3 H), 1.47-1.41 (m, 4 H), 1.34-1.31 (r | i 470 Calculated CHN of C30H34N2 〇3 + O.IH2 〇 Example No. 9 甲 A methyl-2- (4-methylarginyl-macro f 4- Γ 02 (d, 2 H, J = 8.8 8.8, 2.4 Hz), 5.10 J = 5.9 Hz), 2.41-, 2 H); MS el nVz) -Shenmou-1---------- | install-(Please read the precautions on the back before (Fill in this page)

4-(2-六 Μ Βΐί 眭-1 -某-M 某)-苄基 1 -U4- (2-hexa Μ Βΐί 眭 -1 -some-M some) -benzyl 1 -U

Mp * 188-191°C; JH NMR (DMSO) 10.35 (brs , 1 H), 7.27 (d 7.17 (d . 1H , J= 8.8 Hz), 7.03 (d , 2 H J = 8.6 Hz), 6.99 (d , 6.82 - 6.78 (m , 4 H), 6.71 (dd , 1 H , J = 8.8 Hz , J = 2.5 Hz), f 4.22 (m , 2H), 3.79 (s , 3H), 3.76 (s , 3H), 3.43 - 3.36 (m ,4 H) H), 2.16 (s, 3 H), 1.80 - 1.59 (m ,5 H), 1.41 - 1.26 (m , 1H); IR (KBr) 2920 ,2 H , J = 8.8Hz), 1 H , J = 2.5 Hz), 17 (s, 2 H), 4.31 -2.97 - 2.83 (m , 2 ,1450 , 1 2 5 0 c·'1 , MS e I m/z 484(M+);C3i Hge N2 〇 : C 〇計算值 實施例编號Θ 1 Ί - Γ 4 - ( 2 -吖甫闵-1 -某-乙氤 1 flCL 之 某)-笮某1 訂 經濟部中央標準局員工消費合作社印製 -5-甲氣基- 2- (4 -甲氣基-苯基)-3 -甲基-1H Mp = 161*163eC; Ή NMR (DMSO) 10.65 (brs, 1H), 7.27 (d, 2 H , J = 8.8Hz), 7.17 (d, 1H , J = 8.8 Hz), 7.03 (d, 2 H J = i (d , 1 H , J = 2.5 Hz), 6.82 - 6.77 (m, 4 H) ,6.71 (dd, 1 H, J 5.17 (s, 2 H), 4.27 (m, 2H), 3.79 (s, 3H)t 3.76 (s, 3H ), 3.44 - 3 (m , 2H), 2.16 (s , 3H), 1.82 - 1.77 (m, 4 H), 1.63 1.48 (m, 4 (H+) ; 〇32 H38 N 2 〇 3 +1 HC]之 CHN 計算值 e -7 2- mm (ηc 1) 8.8 .6 Hz) , 6.99 Hz, J = 2.5 Hz), .30 (m, 4 H), 3.17 H); MS el m/z 499 本紙張尺度適用中國國家標隼(CNS〉A4規格(210X297公釐) A7 B7 五、發明説明(? /) 實施例编號92 2-(4-乙氳基-笨某)-3-甲某-六氣咐畔-卜甚-7‘氫基)-苄某1 1 Η -砘盹-5 1 - Γ 4 ~「2. 篮Mp * 188-191 ° C; JH NMR (DMSO) 10.35 (brs, 1 H), 7.27 (d 7.17 (d. 1H, J = 8.8 Hz), 7.03 (d, 2 HJ = 8.6 Hz), 6.99 (d , 6.82-6.78 (m, 4 H), 6.71 (dd, 1 H, J = 8.8 Hz, J = 2.5 Hz), f 4.22 (m, 2H), 3.79 (s, 3H), 3.76 (s, 3H) , 3.43-3.36 (m, 4 H) H), 2.16 (s, 3 H), 1.80-1.59 (m, 5 H), 1.41-1.26 (m, 1H); IR (KBr) 2920, 2 H, J = 8.8Hz), 1 H, J = 2.5 Hz), 17 (s, 2 H), 4.31 -2.97-2.83 (m, 2, 1450, 1 2 5 0 c · '1, MS e I m / z 484 (M +); C3i Hge N2 〇: C 〇 Calculated Value Example No. Θ 1 Ί-Γ 4-(2 -Acvmin-1 -One -B-1 氤 CLCL-)-1 Printed by the Bureau of Consumers of the Bureau of Standards --5-methyl-2- (4-methyl-4-phenyl) -3-methyl-1H Mp = 161 * 163eC; Ή NMR (DMSO) 10.65 (brs, 1H) , 7.27 (d, 2 H, J = 8.8 Hz), 7.17 (d, 1H, J = 8.8 Hz), 7.03 (d, 2 HJ = i (d, 1 H, J = 2.5 Hz), 6.82-6.77 ( m, 4 H), 6.71 (dd, 1 H, J 5.17 (s, 2 H), 4.27 (m, 2H), 3.79 (s, 3H) t 3.76 (s, 3H), 3.44-3 (m, 2H ), 2.16 (s, 3H), 1.82-1.77 (m, 4 H), 1.63 1.48 (m, 4 (H + ); 〇32 H38 N 2 〇3 +1 HC] calculated CHN e-7 2- mm (ηc 1) 8.8.6 Hz), 6.99 Hz, J = 2.5 Hz), .30 (m, 4 H) , 3.17 H); MS el m / z 499 This paper size is applicable to Chinese national standard (CNS> A4 specification (210X297 mm) A7 B7 V. Description of invention (? /) Example No. 92 2- (4-Ethyl-benzyl) -3-A-m-Liuqi-Pan-Bu--7'hydrogen) -Benzyl 1 1 Η -Η-5 1 -Γ 4 ~ 「2. Basket

Mp = 173-175°C; Ή NMR (DMSO) 8.69 (s, 1 H), 7.25 (d, 2 ^, J = 8.8Hz), 7.04 (d, 1H, J = 8.8 Hz), 6.99 (dd, 2 H, J = 6.8 Hz , J = 2.0 Hz), 6.80 (d, 1 H , J = 2.2 Hz), 6.73 (s ,4H), 6.59 (dd , 1 H , J = 8.5 Ϊ 5.09 (s , 2H), 4.05 (q , 2 H, J = 7.03 Hz), 3.93 (t, 2 H , J = 6.0 (m , 2H), 2.41 - 2.36 (m ,4 H), 2.09 (s , 3H), 1.45 - 1.41 (m , 4tt; (a,5H);MS el b/z 484(H + ); Cai H36 N2 〇3 I-.25H2 之CHN計算值 2.2), 班z), 2.62 - 2.56 ),1.38 - 1.30Mp = 173-175 ° C; Ή NMR (DMSO) 8.69 (s, 1 H), 7.25 (d, 2 ^, J = 8.8Hz), 7.04 (d, 1H, J = 8.8 Hz), 6.99 (dd, 2 H, J = 6.8 Hz, J = 2.0 Hz), 6.80 (d, 1 H, J = 2.2 Hz), 6.73 (s, 4H), 6.59 (dd, 1 H, J = 8.5 Ϊ 5.09 (s, 2H ), 4.05 (q, 2 H, J = 7.03 Hz), 3.93 (t, 2 H, J = 6.0 (m, 2H), 2.41-2.36 (m, 4 H), 2.09 (s, 3H), 1.45- 1.41 (m, 4tt; (a, 5H); MS el b / z 484 (H +); Cai H36 N2 〇3 I-.25H2 CHN calculated value 2.2), Ban z), 2.62-2.56), 1.38- 1.30

實施例编號93 1- [ 4-(2-吖庚因-1-基)-乙氬 -2 - U - 7*.氬基-笮某)-3 -申甚-1 Η - 盹-R -醇 Mp = 133-135°C; Ή NMR (DMSO) 8.69 (s , 1 H), 7.25 (d , 2 H (d , 1H, J = 8.8 Hz), 6.99 (dd , 2 Η , I = 6.8 Hz , J = 2.0 Hz), 6.80 (d , 1 H , J = 2.2Hz), 6.73 (s ,4H), 6.59 (dd , 1 H , J = 8.5 ψ: 5.09 (s , 2H), 4.05 (q , 2H, J = 7.03 Hz), 3.90 (t, 2H , J = 6.1 =6.0 Hz), 2.62 - 2.58 (m , 4 H)t 2.09 (s , 3 H),1.58 - 1.44 (m , (t, 3H, J = 7.0 Hz); IR (KBr) 2930,1470,1250 CM'1; MS cl m/i 甚)-节某1 J = 8.8Hz), 7.04 z, J = 2.2 Hz), ),2.75 (t, 2H , J 8 H),1.33 498 (M+); C32Hg8N2 之 CHN計算值 實施例编號9 4 4 - f 5 -氬-3-甲基Γ 4 ~(2~ 六氬批腚Example No. 93 1- [4- (2-Azaheptin-1-yl) -ethylargon-2 -U-7 * .argon-pyridine) -3 -Shenxi-1 Η-盹 -R -Alcohol Mp = 133-135 ° C; Ή NMR (DMSO) 8.69 (s, 1 H), 7.25 (d, 2 H (d, 1H, J = 8.8 Hz), 6.99 (dd, 2 Η, I = 6.8 Hz, J = 2.0 Hz), 6.80 (d, 1 H, J = 2.2Hz), 6.73 (s, 4H), 6.59 (dd, 1 H, J = 8.5 ψ: 5.09 (s, 2H), 4.05 (q , 2H, J = 7.03 Hz), 3.90 (t, 2H, J = 6.1 = 6.0 Hz), 2.62-2.58 (m, 4 H) t 2.09 (s, 3 H), 1.58-1.44 (m, (t, 3H, J = 7.0 Hz); IR (KBr) 2930, 1470, 1250 CM'1; MS cl m / i even)-section 1 J = 8.8Hz), 7.04 z, J = 2.2 Hz),), 2.75 (t, 2H, J 8 H), 1.33 498 (M +); calculated CHN of C32Hg8N2 Example No. 9 4 4-f 5 -argon-3-methyl Γ 4 ~ (2 ~ hexaargon)

Mp = 223-225°C; Ή NMR (DMSO) 10.30 (br s , 1H), 7.27 - 7.23 7.17 (d , 2 H , J = 8.6 Hz), 6.88 - 6.79 (m , 7H), 5.20 (s , 2H), 4. (t, 2H , J = 5.0 Hz), 3.42 - 3.35 (m, 4 H), 3.00 - 2.85 (m , 2 H), 1.78 - 1.70 (m, 4 H), 1.67 - 1.59 (m , 1 H), 1.40 - 1.26 (m , 1 H) (M+). (m,2H), 28 2.14 (s , 3 Η), MS el m/z 458 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 寅施例编號9 5 1-「4-(2-8丫审因-1-基)-乙氧某)-±^基~1 甚-9 -芏甚11¾ -5 -醇- (HC1)Mp = 223-225 ° C; Ή NMR (DMSO) 10.30 (br s, 1H), 7.27-7.23 7.17 (d, 2 H, J = 8.6 Hz), 6.88-6.79 (m, 7H), 5.20 (s, 2H), 4. (t, 2H, J = 5.0 Hz), 3.42-3.35 (m, 4 H), 3.00-2.85 (m, 2 H), 1.78-1.70 (m, 4 H), 1.67-1.59 ( m, 1 H), 1.40-1.26 (m, 1 H) (M +). (m, 2H), 28 2.14 (s, 3 Η), MS el m / z 458 (Please read the notes on the back before filling (This page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 9-芏 11¾-5-alcohol-(HC1)

Mp = 203-204°C ; Ή NMR (DMSO) 10.50 (brs , 1 H), 8.80 (s , 1 (m, 5 H); 7.10 (d , 1 H, J = 8.8Hz), 6.83 - 6.77 (m, 5 H), 6.60 (d Hz), 5.15 (s , 2H ), 4.26 (t, 2 H , J = 5.2 Hz), 3.45 - 3.35 (m , 4 H), 7.50 - 7.38 ,1 H , J = 6.6 H), 3.21-3.10 (m 73 本紙張尺度適用中國國家樣準(CNS ) A4規格(210X297公釐) A7 _ B7 五、發明説明 2 H), 2.12 (s, 3H), 1.85-1.75 (m , 4 H), 1.70 - 1.51 (m , 4 H); P|lS el m/z 454 (M+); c 30 H 34 N 2 〇 2 + 1 H C l 之 C Η N 計算值。Mp = 203-204 ° C; Ή NMR (DMSO) 10.50 (brs, 1 H), 8.80 (s, 1 (m, 5 H); 7.10 (d, 1 H, J = 8.8Hz), 6.83-6.77 ( m, 5 H), 6.60 (d Hz), 5.15 (s, 2H), 4.26 (t, 2 H, J = 5.2 Hz), 3.45-3.35 (m, 4 H), 7.50-7.38, 1 H, J = 6.6 H), 3.21-3.10 (m 73 This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) A7 _ B7 V. Description of the invention 2 H), 2.12 (s, 3H), 1.85-1.75 (m, 4 H), 1.70-1.51 (m, 4 H); P | lS el m / z 454 (M +); c 30 H 34 N 2 〇 2 + C l N calculated value.

實施例编號9 δ ?-(4-锊某-荣某)-3,甲某-1卜「4-(2 - Hi -1 -基)一7,氣甚)一带甚]-1 Η - »41 8¾ - 5 - SI /IR (DMS0) 9.65 (s, 8.6 Hz), 6.84 (d, 2 2 Hz), 6.74 (s, 4 2.80-2.75 (m, 2 H), 0 cm*1; MS (El) 某V-苄某Ί (請先閲讀背面之注意事項再填寫本頁)Example No. 9 δ?-(4- 锊 某-荣 某) -3, Jiamou-1bu "4- (2-Hi -1 -based)-7, Qi even)] -1- »41 8¾-5-SI / IR (DMS0) 9.65 (s, 8.6 Hz), 6.84 (d, 2 2 Hz), 6.74 (s, 4 2.80-2.75 (m, 2 H), 0 cm * 1; MS (El) Some V-benzylamine (Please read the precautions on the back before filling this page)

Mp = 105-110oC; CHN calc’d for C28H30N2O3 + 0.4 H20; 4 NI 1 H), 8.67 (s, 1 H), 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J H, J = 2 H), 6.79 (d, 1 H, J = 2.4 Hz), 6.56 (dd, 1 H, J = 8.6, 2. H), 5.09 (s, 2 H), 3.95 (t, 2 H, J = 5.7 Hz), 3.39-3.23 (m, 4 H), 2.09 (s, 3 H), 1.67-1.64 (m, 4 H); IR (KBr) 3410 (br), 1620,151 m/z 442 實施例编號Θ 8 1- f4-(2-吖庠厌i-1-某-乙璧Mp = 105-110oC; CHN calc'd for C28H30N2O3 + 0.4 H20; 4 NI 1 H), 8.67 (s, 1 H), 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, JH, J = 2 H), 6.79 (d, 1 H, J = 2.4 Hz), 6.56 (dd, 1 H, J = 8.6, 2. H), 5.09 (s, 2 H), 3.95 (t, 2 H, J = 5.7 Hz), 3.39-3.23 (m, 4 H), 2.09 (s, 3 H), 1.67-1.64 (m, 4 H); IR (KBr) 3410 (br), 1620,151 m / z 442 Example No. Θ 8 1- f4- (2-Azine i-1-a-acetamidine

LCLLCL

Mp = 168 - 171°C; lH NMR (DMSO) 10.11 (br s, 1 H), 9.70 (s, 1 H), 8.71 (s, 1 H); 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.85 (d, 2 H, J = 8.8 Hz), 6.80 -6.77 (m, 5 H), 6.56 (dd, 1 H, J = 8.8 Hz, 2.2 Hz), 5.11 (s, 2 H), 4.26 (t, 2 H, J = 4.6 Hz), 3.48 - 3.30 (m, 4 H), 3.22 - 3.08 (m, 2 H), 2.09 (s, 3 H), 1.83 - 1.76 (m, 4 H), 1.67 - 1.48 (m, 4 H); IR (KBr) 3500 br, 3250 br, 2900, 1610; MS FAB m/z 471 (M + H + } ; C 3〇 H 34 N 2 〇 a + 2 . 5 H 2 0 + HGl^ CHN|t ^ M 實施例编號98乙酸鹽Mp = 168-171 ° C; lH NMR (DMSO) 10.11 (br s, 1 H), 9.70 (s, 1 H), 8.71 (s, 1 H); 7.15 (d, 2 H, J = 8.6 Hz) , 7.05 (d, 1 H, J = 8.8 Hz), 6.85 (d, 2 H, J = 8.8 Hz), 6.80 -6.77 (m, 5 H), 6.56 (dd, 1 H, J = 8.8 Hz, 2.2 Hz), 5.11 (s, 2 H), 4.26 (t, 2 H, J = 4.6 Hz), 3.48-3.30 (m, 4 H), 3.22-3.08 (m, 2 H), 2.09 (s, 3 H ), 1.83-1.76 (m, 4 H), 1.67-1.48 (m, 4 H); IR (KBr) 3500 br, 3250 br, 2900, 1610; MS FAB m / z 471 (M + H +); C 3〇H 34 N 2 〇a + 2. 5 H 2 0 + HGl ^ CHNt ^ M Example No. 98 Acetate

由编號38自由齡從南酮和乙酸沈濺製得 Mp= 1 7 4 - 1 7 8°C 實施例编號9 θ 1- ί 4- (2-吖辛-1-基-乙氯基| 經濟部中央標準局員工消費合作社印製Mp = 1 7 4-1 7 8 ° C was prepared from sedone and acetic acid by number 38 free age. Printed by Staff Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs

-2-(4-掷某一¾ 某)一3-ff 某一1H-H4I -5-酵 Mp = 98 - 102°C; lH NMR (DMSO) 9.63 (s, 1 H), 8.68 (s, 1 H), H), 7.05 (d, 1 H, J = 8.5 Hz), 6.83 (dd, 2 H, J = 2.0 Hz, 6.6 Hz)L 7.15-7.13 (m, 2 6.79 (d, 1 H, J = 2.2 Hz), 6.73 (s, 4 H), 6.55 (dd, 1 H, J = 2.2 Hz, 8.6 Hz), 5.08 (s, 2 H), 3.89 (t, 2 H, J = 5.7 Hz), 2.74 (t, 2 H, J = 5.4 Hz), 2.55 (bs, 4 H), 2.08 (s, 3 H), 1.55 (s, 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX297公釐) 經 濟 部 中 央 標 準 局 員 工 消 費 合 社 印 製 A7 B7 ~ * 一 * … .· .·— ........ 一 五、發明説明) H), 1.46 (s, 8 H); IR 3400, 2900,1250 cm'1; MS el mjz 484 (Μ c 31 Η 36 N 2 ο 3 + . 30Η 2 0 之 CHN 計算值。 富施例溢號100 2-U -镩某-茱基)-3 -甲某- +); 1- Γ 4-(2-- 甲甚-1-某-7*.氩某、-苄甚Ί -1Η-»4ΙΙΙ$-ϋ -醇 416 (M+); 1 - r 4-ί?-二 Μρ = 95 - 105°C; IR (KBr) 3400 br, 2900,1610 cm1; MS el m/2 Cze Has N 2 〇 3 +0 . 5H 2 〇 之 CHN 計算值。 窨旃例編號1 (Π 2 - U -掷某-荣基)-3 -甲基- 乙某-1 -甚-7. «某}-爷某 1 - 1 Η - ΒίΙ 115 - 5 -海 侃R (DMSO) 9.64 J = 8.8 Hz), 6.84 (d, ,1 H, J = 8.8, 2.4 >8-2.40 (m, 4 Η), )50,1610,1510 :氲某)-苄 Μρ = 100· 107oC; CHN calc’d for Ca Η32 Ν2〇3 + 0.25 Η20; ιΗ (s, 1 Η), 8.67 (s, 1 Η), 7.14 (d, 2 Η, J = 8.6 Hz), 7.05 (d, 1 H, 2 H, J = 8.6 Hz), 6.79 (d, 1 H, 2.2 Hz), 6.74 (s, 4 H), 6.56 (dd Hz), 5.09 (s, 2 H), 3.95-3.85 (m, 2 H), 2.80-2.60 (m, 2 H), 2. 2.09 (s, 3 H), 0.93 (t, 6 H, J = 7.0 Hz); IR (KBr) 3410 (br), 2 cm'1; MS FAB 445 (M+H+). 奮施例编號102 1-「4- i2-(二異丙胺某-Z 某Ί -2-(镩某-¾某某- IH-仰呤- 5- S Ϊ Μρ = 83 - 86°C;lH NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 H), 8.6), 7.04 (d, 1 H, J = 8.6 Hz), 6.83 (d, 2 H, J = 8.6 Hz), 6.78 6.72 (m, 4 H), 6.55 (dd, 1 H, J = 2.4 Hz, 8.2 Hz), 5.08 (s, 2 H] 6.0 Hz), 2.80 - 2.63 (m, 2 H), 2.59 - 2.45 (m, 4 H), 2.10 (s, 3 H), 0.79 (t, 6 H, J = 7.3 Hz); IR 3400,2900, 1250; MS FAB ml CaoHaet^ 03 +.20H2 0 之 CHN 計算值。 啻掄俐號1iU 二丁某胺某-7 7.14(d,2H, J = ;d, 1 H, J = 2.2 Hz), ,3.88 (t, 2 H, J = i), 1.41 - 1.30 (m, 4 :473 [M+H+]; 氣基).-苄— 甚1-2-(4-掷某-笼甚)-:?-甲某-111-叫丨114-5 -m Foam; 'H NMR (DMSO) 9.63 (s, 1H), 8.66 (s , 1 H), 7.15 (d , 2 H, J = 8.6 Hz), 7.05 (d , 1 H , J = 8.8 Hz), 6.83 (d 6.79 (d, 1 H, J = 4.2 Hz), 6.78 - 6.71 (m, 4 H), 6.55 75 2 H, J = 8.6 Hz), 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閲 讀 背 面 之 注 意 事 項 再 填 寫 本 頁 五、發明説明(夕孕) A7 B7 (dd , 1 H , J = 8.6 Hz J = 2.4 Hz), 5.10 (s, 2 H), 3.88 (t, 2 H, J 2.62 (m , 2H), 2.42-2.34 (m, 4 H), 2.08 (s , 3 H), 1.38 - 1.19 H, J = 7.2 Hz); IR (KBr) 3400,1450 cm -1; MS el m/z 501 (Mi) 5.5 Hz), 2.68-m , 8H), 0.82 (t, 6 實施例编號1 (Η 1- Γ4-「2-(二里丙胺某-7‘.氳某)-苄 某Ί -2-(4 -镩甚-芏甚>-3-申某-醇H),-2- (4-throw a certain ¾ a certain) a 3-ff a certain 1H-H4I -5- enzyme Mp = 98-102 ° C; lH NMR (DMSO) 9.63 (s, 1 H), 8.68 (s, 1 H), H), 7.05 (d, 1 H, J = 8.5 Hz), 6.83 (dd, 2 H, J = 2.0 Hz, 6.6 Hz) L 7.15-7.13 (m, 2 6.79 (d, 1 H, J = 2.2 Hz), 6.73 (s, 4 H), 6.55 (dd, 1 H, J = 2.2 Hz, 8.6 Hz), 5.08 (s, 2 H), 3.89 (t, 2 H, J = 5.7 Hz) , 2.74 (t, 2 H, J = 5.4 Hz), 2.55 (bs, 4 H), 2.08 (s, 3 H), 1.55 (s, this paper size applies Chinese National Standard (CNS) A4 specification (2 丨 OX297 (Mm) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 ~ * 1 *…........ .5. Description of the invention) H), 1.46 (s, 8 H) ; IR 3400, 2900, 1250 cm'1; MS el mjz 484 (Μ c 31 Η 36 N 2 ο 3 +. 30Η 2 0 CHN calculation value. Rich example number 100 2-U-镩 某-朱 基) -3 -methyl- +-); 1- Γ 4- (2--methyl--1--1--7 *. Argon, -benzyl -1 Η-»4 ΙΙΙ $-ϋ -ol 416 (M +) ; 1-r 4-ί? -Two Μρ = 95-105 ° C; IR (KBr) 3400 br, 2900, 1610 cm1; MS el m / 2 Cze Has N 2 〇3 +0. 5H 2 〇CHN calculation Value: Example number 1 (Π 2-U -Throw-Rongji) -3 -Methyl-Bie-1 -Even-7. «Some} -Man 1-1 Η-ΒίΙ 115-5 -Haikan R (DMSO) 9.64 J = 8.8 Hz), 6.84 (d,, 1 H, J = 8.8, 2.4 > 8-2.40 (m, 4 Η),) 50,1610,1510: 氲)-Benzene Mρ = 100 · 107oC; CHN calc'd for Ca Η32 Ν2〇3 + 0.25 Η20; ιΗ (s, 1 Η), 8.67 (s, 1 Η), 7.14 (d, 2 Η, J = 8.6 Hz), 7.05 (d, 1 H, 2 H, J = 8.6 Hz), 6.79 (d, 1 H, 2.2 Hz), 6.74 (s, 4 H), 6.56 (dd Hz), 5.09 (s, 2 H), 3.95-3.85 (m, 2 H) , 2.80-2.60 (m, 2 H), 2.2.09 (s, 3 H), 0.93 (t, 6 H, J = 7.0 Hz); IR (KBr) 3410 (br), 2 cm'1; MS FAB 445 (M + H +). Fen Example No. 102 1- "4-i2- (diisopropylamine-Z-something Ί-2- (镩 some-¾something-IH-sinine-5-S Ϊ Μρ = 83-86 ° C; lH NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 H), 8.6), 7.04 (d, 1 H, J = 8.6 Hz), 6.83 (d, 2 H , J = 8.6 Hz), 6.78 6.72 (m, 4 H), 6.55 (dd, 1 H, J = 2.4 Hz, 8.2 Hz), 5.08 (s, 2 H) 6.0 Hz), 2.80-2.63 (m, 2 H), 2.59-2.45 (m, 4 H), 2.10 (s, 3 H), 0.79 (t, 6 H, J = 7.3 Hz); IR 3400, 2900, 1250; MS FAB ml CaoHaet ^ 03 +.20 Calculated CHN of H2 0. Lili No. 1iU Dibutylamine-7-7.14 (d, 2H, J =; d, 1 H, J = 2.2 Hz),, 3.88 (t, 2 H, J = i), 1.41-1.30 (m , 4: 473 [M + H +]; air group) .- benzyl— even 1-2- (4-throw a certain-cage even)-:?-Jiamou-111-called 丨 114-5 -m Foam; ' H NMR (DMSO) 9.63 (s, 1H), 8.66 (s, 1 H), 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.83 (d 6.79 (d, 1 H, J = 4.2 Hz), 6.78-6.71 (m, 4 H), 6.55 75 2 H, J = 8.6 Hz), this paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm ) Please read the notes on the back before filling this page. V. Invention Description (Evening pregnancy) A7 B7 (dd, 1 H, J = 8.6 Hz J = 2.4 Hz), 5.10 (s, 2 H), 3.88 (t, 2 H, J 2.62 (m, 2H), 2.42-2.34 (m, 4 H), 2.08 (s, 3 H), 1.38-1.19 H, J = 7.2 Hz); IR (KBr) 3400, 1450 cm -1 ; MS el m / z 501 (Mi) 5.5 Hz), 2.68-m, 8H), 0.82 (t, 6 Example No. 1 (Η 1- Γ4- “2- (dipropylamine -7 ′. 氲(A) -benzyl alum -2- (4 -a avalanche-a very valence> -3-shen a-alcohol H),

Mp = 96 - 102°C; *H NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 8.6 Hz), 7.04 (d, 1 H, J = 8.6 Hz), 6.83 (d, 2 H, J = 8.6 Hz), 6[7i Hz), 6.77 - 6.69 (m, 4 H), 6.56 (dd, 1 H, J = 8.6 Hz, 2.2 Hz), 2 H, J = 7.0 Hz), 3.01 - 2.92 (m, 2 H), 2.67 (t, 2 H, J = 7.0 Hd), 7.14(d, 2H, J = 19 (d, 1 H, J = 2.4 :5.08 (s, 2 H), 3.75 (t, ),2.09 (s, 3 H), 0.93 (d, 12 H, 6.6 Hz); IR (KBr) 3400 br, 2940, 1620 cm-1; MS FAfi m/z 473 (M+H+); C 30 H 36 N 2 0 3 + 0 . 5 H 2 〇 之 c Η N 計算值 e 實施例编號1 〇 5 1- f 4-「2-( 丁某-申某-胺j基)_乙氣基.] -爷某1 -?-U-郑甚-荣某)-3-甲基Η - 5-醇 ,7.14 ,J = 8.8 Hz ), 6.78 e, J = 2.4 Hz), 5.08 29(m , 2 H), 2.20 H), 0.83 (t, 3 H , (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製Mp = 96-102 ° C; * H NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 8.6 Hz), 7.04 (d, 1 H, J = 8.6 Hz), 6.83 (d, 2 H , J = 8.6 Hz), 6 (7i Hz), 6.77-6.69 (m, 4 H), 6.56 (dd, 1 H, J = 8.6 Hz, 2.2 Hz), 2 H, J = 7.0 Hz), 3.01- 2.92 (m, 2 H), 2.67 (t, 2 H, J = 7.0 Hd), 7.14 (d, 2H, J = 19 (d, 1 H, J = 2.4: 5.08 (s, 2 H), 3.75 ( t,), 2.09 (s, 3 H), 0.93 (d, 12 H, 6.6 Hz); IR (KBr) 3400 br, 2940, 1620 cm-1; MS FAfi m / z 473 (M + H +); C 30 H 36 N 2 0 3 + 0.5 H 2 〇c Η N Calculated value e Example No. 1 〇5 1- f 4- "2- (Dingmou-Shenmou-amine j-based) _ethane Group.)-Yemou 1-?-U-Zheng Qi-Rongmou) 3-methylpyrene-5-ol, 7.14, J = 8.8 Hz), 6.78 e, J = 2.4 Hz), 5.08 29 (m , 2 H), 2.20 H), 0.83 (t, 3 H, (Please read the notes on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

Mp = 102-107°C; ^ NMR (DMSO) 9.60 (s , 1H), 8.67 ( s, 1H: (d , 2 H , J = 8.4 Hz), 7.04 (d , 1 H, J = 8.6 Hz), 6.82 (d , 21: (d , 1 H , J= 2.3 Hz ), 6.73 (s , 4 H), 6.55 (dd , 1 H , J = 8.8 H (s , 2 H), 3.92 (t, 2H , J =6.0 Hz), 2.64-2.59 (m , 2 H), 2.38-2. (br s, 3 H), 2.08 (s, 3 H), 1.40-1.31 (m , 2 H), 1.25-1.19 (m , 2 7.2 Hz); IR (KBr) 3420,1460,1230 cm'1; MS el m/z 638 (M+) 實施例编號1 08 ?-(4 -镩某-苯基甲基二1 田甚-六氩丨Η:啶-1 -某)-乙氣甚1 -苄基1 — 1H -吲呜-5 -醇- Mp = 121 - 123°C; NMR (DMSO) 9.65 (s, 1 H), 8.68 (s, 1 φ, 7.14 (d, 2 H, J = 8.6 Hz), 7.04 (d, 1 H, J = 8.8 Hz), 6.84 (d, 2 H, J (d, 1 H, J = 2.0 Hz), 6.74 (s, 4 H), 6.56 (dd, 1 R J = 8.8 Hz, (s, 2 H), 3.97 - 3.86 (m, 2 H), 2.95 - 2.73 (m, 2 H), 2.62 - 2.53 2.14 (m, 2 H), 2.09 (s, 3 H), 1.61 - 1.30 (m, 4 H), 1.28 - 1.09 \m, 2 H), 0.98 (d, 3 H J = 5.1 Hz); IR (KBr) 3400, 2920, 2850,1610 cm1; C3〇H34N2 03 + .25H2 0 之 CHN 計算值。 i 4 - Γ 2-(2- =8.6 Hz), 6.79 .4 Hz), 5.09 (m, 1 H), 2.36 - 76 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經 濟 部 中 央 標 準 為 員 合 作 社 印 製 A7 B7 五、發明説明Hi") 密谕钿4θί*1Π9 2-(4 -鄉某-¾基)-3 -申基-1- f 4 - Γ 2-(3- 田甚·六氲批砬-1-甚)-乙氛基Ί -节基]__二UL· 叫1 ¢5 -5-磨 Mp = 121 - 123°C; *H NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 H), 7.14 (dd, 2 H, J = 8.3 Hz, 1.4 Hz), 7.04 (dd, 1 H, J = 8.6 Hz, 1.2 Hz), 6.84 (dd, 2 H, J = 8.6 Hz, 1.7 Hz), 6.79 (s, 1 H), 6.79 (s, 4 H), 6.56 (d, 1 H, J = 8.6 Hz), 5.08 (s, 2 H), 3.94 (t, 2 H, J = 5.0 Hz), 2.86 -2.71 (m, 2 Η), 2.63 - 2.50 (m, 2 H), 2.48 (s, 3 H), 1.92 - 1.79 (m, 2 H), 1.63 > 1. 35 (m, 5 Η), 0.79 (d, 3 H, J = 5.2 Hz); IR (KBr) 3400, 2910, 1625 cm'1; .- C3〇H34N2 〇3 +0.25H2 〇 之 CHN 計算值。 奮淪例举蹄1 1 η 2 - U -掷某-茏甚)3-申基-1 - f 4- Γ 9.-U- 田甚-六MlttnS-l-某)-ZM基1 -苄某1 -1H- HI - 5 -醒(H C Π Mp = 154 - 162°C; *H NMR (DMSO) 10.00 (brs, 1 H), 9.71 (s, 11 i), 8.71 (s, 1 Η), 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.6 Hz), 6.85 (d, 2 H, J = 8.6 Hz), 6.83 -6.77 (m, 4 H), 6.57 (dd, 1 H, J = 8.6 Hz, 2.2 Hz), 5.11 (s, 2 H), 4.27 (t, 2 H, J * 4.8 Hz), 3.51 - 3.35 (m, 4 H), 3.01 - 2.87 (m, 2 H), 2.1 )9 (s, 3 H), 1.74 (d, 2 H, J = 13.4 Hz), 1.61 - 1.37 (m, 4 H), 0.88 (d, 3 H, J = 6.4 K z); IR (KBr) 3410, 2910, 1620 cm·1; MS el m/z 470 (M+H+); c 30 H 34 N 2 0 3 + H C 1 + 2 H 2 0 之 C Η N 計算值。 奮旃例缢號111 1-{4-「2-(3.3-二甲基-六食 ΐ卅腚-1 - 某)-氣某Ί -节某} -2-(4 -郵甚-茏甚)U 3 某-1 Η - U\ 11¾ -fi-fis (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.84 (d, 2 H, J = 8 6 Hz), 6.79 (d, 1 H, J = 2.4 Hz), 6.74 (s, 4 H), 6.56 (dd, 1 H, J = 8.8, 2.4 Hz) 5.09 (s, 2 H), 3.93 (t, 2 H, J =. 5.7 Hz), 2.60-2.50 (m, 2 H), 2.37-2.25 (m, 2 H), 2.09 (s, 3 H), 2.10-1.99 (m, 2 H), 1.46 (t, 2 H, J = 5.9 Hz), 1.13 (t, 2 H, J = 6.4 Hz), 0.86 (s,6H); MS elm/z484. «神!俐迫镰11;! 1- i4-「2-((腯)-2.6-二甲 Ϊ :六氣Bft 腚-1-甚)-,氦甚'|-爷甚1-2-(镡某-荣甚>- 甲甚 -1 Η - B4I 11¾ - f5 - SI Mp = 114 - 121°C; *H NMR (DMSO) 9.62 (s, 1 H), 8.64 (s, 1 H), 1 Ml (d, 2 H, J = 8.6 Hz), 7.01 (d, 1 H, J = 8.6 Hz), 6.81 (d, 2 H, J = 8 8 Hz), 6.76 77 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 請 先 閲 讀 背 之 注Mp = 102-107 ° C; ^ NMR (DMSO) 9.60 (s, 1H), 8.67 (s, 1H: (d, 2 H, J = 8.4 Hz), 7.04 (d, 1 H, J = 8.6 Hz) , 6.82 (d, 21: (d, 1 H, J = 2.3 Hz), 6.73 (s, 4 H), 6.55 (dd, 1 H, J = 8.8 H (s, 2 H), 3.92 (t, 2H , J = 6.0 Hz), 2.64-2.59 (m, 2 H), 2.38-2. (Br s, 3 H), 2.08 (s, 3 H), 1.40-1.31 (m, 2 H), 1.25-1.19 (m, 2 7.2 Hz); IR (KBr) 3420, 1460, 1230 cm'1; MS el m / z 638 (M +) Example No. 1 08?-(4 -Homo-phenylmethyldi-1 Tian Qi-Hexargon 丨 Η: Pyridine-1-Some)-Ethyl Gas 1-Benzyl 1-1H-Indho-5-ol-Mp = 121-123 ° C; NMR (DMSO) 9.65 (s, 1 H), 8.68 (s, 1 φ, 7.14 (d, 2 H, J = 8.6 Hz), 7.04 (d, 1 H, J = 8.8 Hz), 6.84 (d, 2 H, J (d, 1 H, J = 2.0 Hz), 6.74 (s, 4 H), 6.56 (dd, 1 RJ = 8.8 Hz, (s, 2 H), 3.97-3.86 (m, 2 H), 2.95-2.73 (m, 2 H) , 2.62-2.53 2.14 (m, 2 H), 2.09 (s, 3 H), 1.61-1.30 (m, 4 H), 1.28-1.09 \ m, 2 H), 0.98 (d, 3 HJ = 5.1 Hz) ; IR (KBr) 3400, 2920, 2850, 1610 cm1; Calculated CHN of C3〇H34N2 03 + .25H2 0. i 4-Γ 2- (2- = 8.6 Hz), 6.79 .4 Hz), 5.09 (m , 1 H), 2.36-76 This paper size applies Chinese National Standard (CNS) A4 (210X297 mm). The central standard of the Ministry of Economic Affairs prints A7 B7 for member cooperatives. 5. Description of the invention Hi ") Secret 4θί * 1Π9 2- (4 -Some-¾-based) -3 -Shenji-1-f 4-Γ 2- (3- Tianshi · Liu 氲 Pian-1--1-)-Ethyl group-Ί 基] __ 二UL is called 1 ¢ 5 -5-mill Mp = 121-123 ° C; * H NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 H), 7.14 (dd, 2 H, J = 8.3 Hz, 1.4 Hz), 7.04 (dd, 1 H, J = 8.6 Hz, 1.2 Hz), 6.84 (dd, 2 H, J = 8.6 Hz, 1.7 Hz), 6.79 (s, 1 H), 6.79 (s, 4 H), 6.56 (d, 1 H, J = 8.6 Hz), 5.08 (s, 2 H), 3.94 (t, 2 H, J = 5.0 Hz), 2.86 -2.71 (m, 2 Η), 2.63- 2.50 (m, 2 H), 2.48 (s, 3 H), 1.92-1.79 (m, 2 H), 1.63 > 1. 35 (m, 5 Η), 0.79 (d, 3 H, J = 5.2 Hz ); IR (KBr) 3400, 2910, 1625 cm'1; .- Calculated CHN of C3〇H34N2 〇3 + 0.25H2 〇. An example is Fen 1 1 η 2-U-Throw a certain-茏) 3-Shenji-1-f 4- Γ 9.-U- Tian even-six MlttnS-1-a) -ZM group 1-benzyl 1 -1H- HI-5-wake up (HC Π Mp = 154-162 ° C; * H NMR (DMSO) 10.00 (brs, 1 H), 9.71 (s, 11 i), 8.71 (s, 1 Η) , 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.6 Hz), 6.85 (d, 2 H, J = 8.6 Hz), 6.83 -6.77 (m, 4 H), 6.57 (dd, 1 H, J = 8.6 Hz, 2.2 Hz), 5.11 (s, 2 H), 4.27 (t, 2 H, J * 4.8 Hz), 3.51-3.35 (m, 4 H), 3.01-2.87 (m, 2 H), 2.1) 9 (s, 3 H), 1.74 (d, 2 H, J = 13.4 Hz), 1.61-1.37 (m, 4 H), 0.88 (d, 3 H, J = 6.4 K z); IR (KBr) 3410, 2910, 1620 cm1; MS el m / z 470 (M + H +); c 30 H 34 N 2 0 3 + HC 1 + 2 H 2 0 C Η N value. Fen 旃 缢 111 111 1- {4- 「2- (3.3-dimethyl-hexasex ΐ 卅 腚 -1-某)-气 Ί-某} -2- (4- ) U 3 -1 Η-U \ 11¾ -fi-fis (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.84 (d, 2 H, J = 8 6 Hz), 6.79 (d, 1 H, J = 2.4 Hz), 6.74 (s, 4 H), 6.56 (dd, 1 H, J = 8.8, 2.4 Hz) 5.09 (s, 2 H), 3.93 (t , 2 H, J =. 5.7 Hz), 2.60-2.50 (m, 2 H), 2.37-2.25 (m, 2 H), 2.09 (s, 3 H), 2.10-1.99 (m, 2 H), 1.46 (t, 2 H, J = 5.9 Hz), 1.13 (t, 2 H, J = 6.4 Hz), 0.86 (s, 6H); MS elm / z484. «God! Li forced sickle 11 ;! 1- i4- "2-((腯) -2.6-dimethylformamidine: six-qi Bft 腚 -1-even)-, helium ' -B4I 11¾-f5-SI Mp = 114-121 ° C; * H NMR (DMSO) 9.62 (s, 1 H), 8.64 (s, 1 H), 1 Ml (d, 2 H, J = 8.6 Hz) , 7.01 (d, 1 H, J = 8.6 Hz), 6.81 (d, 2 H, J = 8 8 Hz), 6.76 77 This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) Please read first Back note

I iI i

A7 __B7五、發明説明㈧心) (d, 1 H, J = 2.2 Hz), 6.72 - 6.66 (m, 4 Η), 6.53 (dd, 1 H, J 8.6 ittz, 2.2 Hz), 5.06 (s, 2 H), 3;86 - 3.72 (m, 2 H), 2.86 - 2.76 (m, 2 H), 2.43 - 2.35 (4, 2 H), 2.06 8 H); IR (KBr) ΌΓ + (s, 3 H), 1.78 - 1.59 (m, 3 H), 1.29 - 1.17 (m, 1 H), 1.12 - 0.92 (m, 3400 br, 2920, 1630 cm-1; MS FAB m/z 485 (M+H+); CHN calcd 〇 . 1丙酮+ 〇 . 7 5 H 2 0之C Η N計算值 實施例编號1 1 θ 2- U-掷某-¾某)-Ί - f 4- Γ 2-甚-六氳卅啶-1-甚)-?>.氩甚1-苄甚)-3-甲基 -5-鹺 U-藓 -1 Η -A7 __B7 V. Description of the invention (D, 1 H, J = 2.2 Hz), 6.72-6.66 (m, 4 Η), 6.53 (dd, 1 H, J 8.6 ittz, 2.2 Hz), 5.06 (s, 2 H), 3; 86-3.72 (m, 2 H), 2.86-2.76 (m, 2 H), 2.43-2.35 (4, 2 H), 2.06 8 H); IR (KBr) ΌΓ + (s, 3 H), 1.78-1.59 (m, 3 H), 1.29-1.17 (m, 1 H), 1.12-0.92 (m, 3400 br, 2920, 1630 cm-1; MS FAB m / z 485 (M + H + ); CHN calcd 〇. 1 acetone + 〇. 7 5 H 2 0 C Η N calculated value Example No. 1 1 θ 2- U-throw some-¾some) -Ί-f 4- Γ 2-even- Hexamidine-1-even)-? ≫ .Argon-1-benzyl) -3-methyl-5-fluorene U-bromo-1 Η-

Mp = 80 - 90°C; 1H NMR (DMSO) 9.66 (s, 1 H), 8.68 (s, 1 H), 7.1i (d, 2 H, J = 7.6 Hz), 7.04 (d, 1 H, J = 8.8 Hz), 6.84 (dd, 2 H, J = 2.0 Hz, 6.6 Hz), 6.78 (d, 1 H, 2.2 Hz), 6.73 (s, 4 H), 6.55 (dd, 1 H, J = 2.2 Hz, 8.6 (s, 2 H), 4.50 (d, 1 H, J = 4.2 Hz), 3.92 (t, 2 H, J = 5.8 Hz), 3.40 (in, (m, 2 H), 2.60 (m, 2 H), 2.10 (s, 3 H), 2.15-2.05 (m, 1 H), 1.75-1.< 1.42 - 1.28 (m, 2 H); IR (iCBr) 3400,2900,1250 cm*l; MS el m/z 4* C23H32N2 〇4 + .IICH2 CI2 之 CHH 計算值 實施例编號114 (IS. 4R)-卜(4-「2r(2-吖-雙環I 审-2-某)-7.氣甚Ί -苄甚1 -2-U -镩某-荣甚Mp = 80-90 ° C; 1H NMR (DMSO) 9.66 (s, 1 H), 8.68 (s, 1 H), 7.1i (d, 2 H, J = 7.6 Hz), 7.04 (d, 1 H, J = 8.8 Hz), 6.84 (dd, 2 H, J = 2.0 Hz, 6.6 Hz), 6.78 (d, 1 H, 2.2 Hz), 6.73 (s, 4 H), 6.55 (dd, 1 H, J = 2.2 Hz, 8.6 (s, 2 H), 4.50 (d, 1 H, J = 4.2 Hz), 3.92 (t, 2 H, J = 5.8 Hz), 3.40 (in, (m, 2 H), 2.60 ( m, 2 H), 2.10 (s, 3 H), 2.15-2.05 (m, 1 H), 1.75-1. < 1.42-1.28 (m, 2 H); IR (iCBr) 3400, 2900, 1250 cm * l; MS el m / z 4 * C23H32N2 〇4 + .IICH2 CI2 Calculated CHH Example No. 114 (IS. 4R) -Bu (4- "2r (2-acyl-bicyclo I I-2- ) -7. Qi qi 苄 -benzyl 1 -2-U-镩--Rong shi

Hz), 5.09 ,2 Η), 2.72 ¢3 (m, 2 Η), "2(M+); 申某 -1 Η - 8¾ - S - SI Μρ = 125 - 130°C; iH NMR (DMSO) 9.65 (s, 1 Η), 8.67 (s, 1 Η), 1 8.6 Ηζ), 7.04 (d, 1 Η, J = 8.5 Ηζ), 6.83 (dd, 2 Η, J = 2,0 Ηζ, 6.6 Ηζ: J = 2.2 Ηζ), 6.73 (S, 4 Η), 6.55 (dd, 1 Η, J = 2.2 Ηζ, 8.6 Ηζ), 5.08 3.8 (m, 2 Η), 2.90 - 2.70 (3 Η), 2.30 - 2.20 (m, 2 Η), 2.10 (s, 3 Η), 1 Η), 1.60 - 1.30 (m, 4 Η), 1.25 - 1.15 (m, 2 H); IR (KBr) 3400, 29 .13(d,2H,J = ;),6.78 (d, 1 Η, (s, 2 Η), 3.95 -1.70 - 1.60 (m, 50, 1500; MS (+) 之C Η N計算值 4- Γ 2 n. n HI n - I n ^ -- - I n - - - T ^^ ^__________-a (請先閲讀背面.之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 F A Β μ / ζ 4 6 9 [ Μ + Η ] + ; C 3〇 Η 32 H 2 0 3 + · 3 4 Ε t 0 A 實施例编號1 1 5 2-U-镩某-荣某)-3 -甲基-l-M . 3 3 -三申某-fi -吖等頊「3 - 2 . 1 1辛-6 -某)^氳某1 -苄某1 1 Η -时1 8$ - 5 -醇 Mp = 98 - 100°C; lH NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 H), 7.^4 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.6 Hz), 6.84 (d, 2 H, J = 8. S (d, 1 H, J = 2.4 Hz), 6.75 - 6.69 (m, 4 H), 6.56 (dd, 1 H, J = 8.6 Hz. (s, 2 H), 3.83 (t, 2 H, J= 5.9 Hz), 3.12 - 3.07 (m, 1 H), 2.94 - 2.87 (: (d, 1 H, J = 9.2 Hz), 2.78 - 2.70 (m, 1 H), 2.17 (d, 1 H, J = 9.2 Hz), 1.55 - 1.42 (m, 2 H), 1.29 (q, 2 H, J = 13.6 Hz), 1.14 (s, 3 H), 1.1Hz), 5.09, 2 Η), 2.72 ¢ 3 (m, 2 Η), " 2 (M +); Shenmou -1 Η-8¾-S-SI Μρ = 125-130 ° C; iH NMR (DMSO) 9.65 (s, 1 Η), 8.67 (s, 1 Η), 1 8.6 Ηζ), 7.04 (d, 1 Η, J = 8.5 Ηζ), 6.83 (dd, 2 Η, J = 2,0 Ηζ, 6.6 Ηζ : J = 2.2 Ηζ), 6.73 (S, 4 Η), 6.55 (dd, 1 Η, J = 2.2 Ηζ, 8.6 Ηζ), 5.08 3.8 (m, 2 Η), 2.90-2.70 (3 Η), 2.30- 2.20 (m, 2 Η), 2.10 (s, 3 Η), 1 Η), 1.60-1.30 (m, 4 Η), 1.25-1.15 (m, 2 H); IR (KBr) 3400, 29 .13 ( d, 2H, J =;), 6.78 (d, 1 Η, (s, 2 Η), 3.95 -1.70-1.60 (m, 50, 1500; MS (+) calculated for C 计算 N 4- Γ 2 n n HI n-I n ^--I n---T ^^ ^ __________- a (Please read the notes on the back before filling in this page) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs FA Β μ / ζ 4 6 9 [Μ + Η] +; C 3〇Η 32 H 2 0 3 + · 3 4 Ε t 0 A Example No. 1 1 5 2-U- 镩 某-荣 某) -3-A Radical -lM. 3 3 -Sanshenmou -fi-acridine, etc. "3-2.. 1 1 oct-6-som ^^ some 1-benzine 1 1 1-hour 1 8 $-5 -ol Mp = 98-100 ° C; lH NMR (DMSO) 9.64 (s, 1 H), 8.67 (s, 1 H), 7. ^ 4 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.6 Hz), 6.84 (d, 2 H, J = 8. S (d , 1 H, J = 2.4 Hz), 6.75-6.69 (m, 4 H), 6.56 (dd, 1 H, J = 8.6 Hz. (S, 2 H), 3.83 (t, 2 H, J = 5.9 Hz ), 3.12-3.07 (m, 1 H), 2.94-2.87 (: (d, 1 H, J = 9.2 Hz), 2.78-2.70 (m, 1 H), 2.17 (d, 1 H, J = 9.2 Hz ), 1.55-1.42 (m, 2 H), 1.29 (q, 2 H, J = 13.6 Hz), 1.14 (s, 3 H), 1.1

Hz), 6.79 :,2.4 Hz), 5.08 ;m, 1 H), 2.85 2.09 (s, 3 H), • 1.02 (m, 2 H), 78 私紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經 Α7 Β7 五、發明説明(的) 0.96 (s, 3 Η), 0.82 (s, 3 H); IR (KBr) 3400 br, 2940, 2900,162 0 cm-1; MS ESI m/z 5 2 5 ( Μ + Η + ) ; C 34 Η40 Ν 2 〇 a +〇 - 5Η 2 0 之 CHNf -算值 宵_例迫號116 2-(4 -氩-苯基)-3 -甲某-卜 f 4 - ( 2 -六 氣吼rf - 1 -甚-7.氩甚)-苄甚Ί - 1 Η -叫丨8$ - 5 - 醇(η[ η Μρ = 201 - 203°C; !h NMR (DMSO) 10.22 (s, 1 H), 8.78 (s, 1 Η), 7.45 - 7.35 (m, 2 H), 7.34 - 7.25 (m, 2 H), 7.11 (d, 1 H, J = 8.6 Hz), 6.90 -6.70 (m, 5 Η), 6.61 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 5.15 (s, 2 H), 4.27 (t, 2 H, 4.8 i Ιζ), 3.50 - 3.34 (m, 4 H), 3.0 - 2.85 (m, 2 H), 2.10 (s, 3 H), 1.80 (m, 5 H), 1.4 )-1.25 (m, 1 H); MS e I ni/z 458(Μ+);〇29 Hai FN2 〇 2 + 1 H C 1 之C Η Ν計算值β 窜神例迫晡117 l-「4-(2 -吖庠因-卜基)-Z '氩甚)-节 甚 Ί -2-U-M -莶甚)-3-申某- IH-ϋίΙ US -5-8 Μρ = 181 - 184°C; ιΗ NMR (DMSO) 10.68 (s, 1 H), 8.80 (s, 1 Η), 7.50 - 7.36 (m, 2 H), 7.34 - 7.26 (m, 2 H), 7.12 (d, 1 H, J = 8.8 Hz), 6.86 - 6.73 (m, 5 Η), 6.63 (dd, 1H, J = 2.2 Hz, 8.5 Hz), 5.13 (s, 2H), 4.29 (t, 2 H, J = 5.2 Hz) ,3.50 - 3.30 (m, 4 H), 3.20 - 3.08 (m, 2 H), 2.11 (s, 3 H), 1.90 - 1.70 (m, 4 Η), 1 68 - 1.45 (m, 4 H); IR (KBr) 3500, 3100,2910,1450,1250 cm1; MS e/I m/z 472 (λ I+); C 30 H 33 F N 2 〇 2 + 1 H C 1 之 C Η N 計算值。 啻神例ifi號118 2-(3-甲氬某-4 -辉基-苯基 )-3 - W * - 1 - Γ4-「?-六氳吡啶-1-基-乙氬基)-苄基)- 1 H - ΡίΙ - 5 - 稻 f Η Γ 1 ) Μρ = 161-163°C; Ή NMR (DMSO) 10.12 (brs, 1H), 9.25 (s, 1 H), 8.71 (s , 1H), 7.05 (d, 1H , J = 8.5Hz), 6.85 - 6.79 (m, 8 H), 6.57 (dd , 1H , f = 8.5Hz , J = 2.2Hz), 5.13 (s , 2H), 4.27 (t, 2H , J = 5.0Hz), 3.64 (s , 3H), 1.44 - 3.37 (m , 4 H), 2.93 - 2.85 (ra , 2H), 2.11 (s , 3H), 1.80 - 1.60 (m , 5 H), 1.40 -1.25 (m, 1H); MS el in / z 486(M + );Cg〇 H34 N2 0 4 + 1 H C L + 1 H 2 0 ; IR (KBr) 3190, 1470, 1230c··1 之 CHN計算值。 奮施例绾號119 2-茱并二揹烷-U -3-甲甚-1- 「4-(2 -六氪卅庥-1-甚-7.氩某苄甚Ί ^ - nil Hi - 5 - fil ( Η Γ 1 ^ Mp = 122-125°C ; !H NMR (DMSO) 9.80 (brs, 1 H), 8.73 (s , l H),7.07 79 本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐〉 請 聞 Λ 之 注 意 事 項 再Hz), 6.79 :, 2.4 Hz), 5.08; m, 1 H), 2.85 2.09 (s, 3 H), • 1.02 (m, 2 H), 78 Private paper sizes are applicable to China National Standard (CNS) A4 specifications ( 210X297 mm) A7 B7 V. Description of the invention 0.96 (s, 3 Η), 0.82 (s, 3 H); IR (KBr) 3400 br, 2940, 2900, 162 0 cm-1; MS ESI m / z 5 2 5 (Μ + Η +); C 34 Η40 Ν 2 〇a + 〇-5 Η 2 0 CHNf-calculated value night_example forced number 116 2- (4-argon-phenyl) -3 -formaldehyde A-bu f 4-(2 -six gas roar rf-1 -even-7. Argon)-benzyl hydrazone-1 Η-called 丨 8 $-5-alcohol (η [η Μρ = 201-203 ° C ;! h NMR (DMSO) 10.22 (s, 1 H), 8.78 (s, 1 Η), 7.45-7.35 (m, 2 H), 7.34-7.25 (m, 2 H), 7.11 (d, 1 H, J = 8.6 Hz), 6.90 -6.70 (m, 5 Η), 6.61 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 5.15 (s, 2 H), 4.27 (t, 2 H, 4.8 i Ιζ ), 3.50-3.34 (m, 4 H), 3.0-2.85 (m, 2 H), 2.10 (s, 3 H), 1.80 (m, 5 H), 1.4) -1.25 (m, 1 H); MS e I ni / z 458 (Μ +); 〇29 Hai FN2 〇2 + 1 HC 1 C Η Calculated value β Channeling example pressure 晡 117 l- "4- (2 -acridine-bukey)- Z 'arg even)-knot very Ί UM Even) -3-Shenmou-IH-ϋίΙ US -5-8 Μρ = 181-184 ° C; ιΗ NMR (DMSO) 10.68 (s, 1 H), 8.80 (s, 1 Η), 7.50-7.36 (m , 2 H), 7.34-7.26 (m, 2 H), 7.12 (d, 1 H, J = 8.8 Hz), 6.86-6.73 (m, 5 Η), 6.63 (dd, 1H, J = 2.2 Hz, 8.5 Hz), 5.13 (s, 2H), 4.29 (t, 2 H, J = 5.2 Hz), 3.50-3.30 (m, 4 H), 3.20-3.08 (m, 2 H), 2.11 (s, 3 H) , 1.90-1.70 (m, 4 Η), 1 68-1.45 (m, 4 H); IR (KBr) 3500, 3100, 2910, 1450, 1250 cm1; MS e / I m / z 472 (λ I +); Calculated C Η N for C 30 H 33 FN 2 0 2 + 1 HC 1.啻 神 例 ifi No. 118 2- (3-methylargan-4 -huityl-phenyl) -3-W *-1-Γ4-"?-Hexapyridin-1-yl-ethylargyl) -benzyl Group)-1 H-ΡίΙ-5-ff Η Γ 1) Μρ = 161-163 ° C; Ή NMR (DMSO) 10.12 (brs, 1H), 9.25 (s, 1 H), 8.71 (s, 1H) , 7.05 (d, 1H, J = 8.5Hz), 6.85-6.79 (m, 8 H), 6.57 (dd, 1H, f = 8.5Hz, J = 2.2Hz), 5.13 (s, 2H), 4.27 (t , 2H, J = 5.0Hz), 3.64 (s, 3H), 1.44-3.37 (m, 4 H), 2.93-2.85 (ra, 2H), 2.11 (s, 3H), 1.80-1.60 (m, 5 H ), 1.40 -1.25 (m, 1H); MS el in / z 486 (M +); Cg〇H34 N2 0 4 + 1 HCL + 1 H 2 0; IR (KBr) 3190, 1470, 1230c ·· 1 Calculated value of CHN. Fenshi Example No. 119 2-Cyclopentadiene-U -3-methylphen-1--1- 4- (2-hexamethyl-1-phen-7. -nil Hi-5-fil (Η Γ 1 ^ Mp = 122-125 ° C;! H NMR (DMSO) 9.80 (brs, 1 H), 8.73 (s, l H), 7.07 79 This paper is applicable to China Standard (CNS > A4 specification (210X297 mm) Please read the precautions of Λ before

I 中 央 標 準 局 員 工 消 費 合 作 社 印 製 五、發明説明(_邳) (d , 1 H, J = 8.7 Hz), 7.02 (d , 1 H, J = 8.0 Hz), 6.89 (d , 1 H,. 6.75 (m , 6 H), 6.58 (dd , 1 H , J = 6.4 Hz, J = 2.2Hz), 6.06 (s 4.30 - 4.19 (m, 2 H), 3.51 - 3.30 (m , 4 H), 199-2.85 (m, 2 H) 1.81-1.59 (m, 5 H), 1.41-1.26 (m, 1 H); MS el m/z 484(M+); c 30 H 32 N 2 0 4 + fl C 1 + . 2 6 H 2 0 之 c Η N 計算值。 實施例编號1 2 0 2-(4-里丙氬甚-¾某 =1.7 Hz), 6.80 -,2H), 5.13 (s, 2H), ,2.10 (s , 3 H), (Η C..1). Mp = 120 - 125°C; !h NMR (DMSO) 10.18 (s, 1 H), 8.73 (s, 1 H), 7.25 (d, 2 H, J =8.6 Hz), 7.04 (d, 1 H, J = 8.8 Hz), 6.99 (d, 2 H, J = 8.8 Hz), H), 6.59 (dd, 1 H, J = 2.2 Hz, 8.6 Hz), 5.12 (s, 2 H), 4.67 - 4.6 2 H, J = 4.8 Hz), 3.50 - 3.35 (m, 4 H), 3.0 - 2.85 (m, 2 H), 2.1(i (s, 3 H), 1.80 -1.60 (m, 5 H), 1.40 - 1.25 (m, 7 H); IR (KBr) 3400, 3000,1500,1250; MS el m/z 498(M + ); C32H38N2 03 +1.0HC1+.70H2 0之 CO計算值 -甚-Z _某Ί -笮 0.82 - 6.80 (m, 5 1 (m, 1 Η), 4.27 (t, 實施例编號1 U 1 - Γ 4 - ( 2 - B丫审闵 基]-2-(4 -里丙氫某-¾¾ ) -3 -里基-1H-0 引 fe-5 -醇(HC1)I Printed by the Consumer Standards Cooperative of the Central Bureau of Standards 5. Invention Description (_ () (d, 1 H, J = 8.7 Hz), 7.02 (d, 1 H, J = 8.0 Hz), 6.89 (d, 1 H ,. 6.75 (m, 6 H), 6.58 (dd, 1 H, J = 6.4 Hz, J = 2.2Hz), 6.06 (s 4.30-4.19 (m, 2 H), 3.51-3.30 (m, 4 H), 199 -2.85 (m, 2 H) 1.81-1.59 (m, 5 H), 1.41-1.26 (m, 1 H); MS el m / z 484 (M +); c 30 H 32 N 2 0 4 + fl C 1 +. Calculated value of c Η N for 2 6 H 2 0. Example No. 1 2 0 2- (4-Lipropyl Argon or -¾ = 1.7 Hz), 6.80-, 2H), 5.13 (s, 2H) ,, 2.10 (s, 3 H), (Η C..1). Mp = 120-125 ° C;! H NMR (DMSO) 10.18 (s, 1 H), 8.73 (s, 1 H), 7.25 ( d, 2 H, J = 8.6 Hz), 7.04 (d, 1 H, J = 8.8 Hz), 6.99 (d, 2 H, J = 8.8 Hz), H), 6.59 (dd, 1 H, J = 2.2 Hz, 8.6 Hz), 5.12 (s, 2 H), 4.67-4.6 2 H, J = 4.8 Hz), 3.50-3.35 (m, 4 H), 3.0-2.85 (m, 2 H), 2.1 (i ( s, 3 H), 1.80 -1.60 (m, 5 H), 1.40-1.25 (m, 7 H); IR (KBr) 3400, 3000, 1500, 1250; MS el m / z 498 (M +); C32H38N2 03 + 1.0HC1 + .70H2 0 CO calculated value-even -Z _some Ί-笮 0.82-6.80 (m, 5 1 (m, 1 Η), 4.27 (t, Example No. 1 U 1-Γ 4-(2-B Yasmin Minji) -2- (4 -Lipropane--¾¾) -3 -Riyi-1H-0 Lead fe-5-alcohol (HC1 )

Mp = 120 - 125°C; lH NMR (DMSO) 10.36 (s, 1 H), 8.73 (s, 1 (m, 2 H), 7.05 (d, 1 H, J = 8.8 Hz), 7.01 - 6.98 (m, 2 H), 6.85 -(dd, 1 H, J = 2.2 Hz, 8.6 Hz), 5.12 (s, 2 H), 4.67 - 4.61 (m, 1 H) (t, 2 H, J = 4.8 Hz), 3.50 - 3.30 (m, 4 H), 3.20 - 3.10 (m, 2 H), 1.75 (m, 4 H), 1.65 - 1.50 (m, 4 H), 1.27 (d, 6 H, J = 6.1 Hz); 1250: MS el m/z 512 (M+);計算值 + 1.0 HC1 + . i), ,7.26 - 7.23 6.75 (m, 5 H), 6.57 4.27 2.10 (s, 3 H), 1.85 -It (KBr) 3400, 1500, 5 HO. 實施例编號122 2- (4-環戊氣甚-笨基)-3-甲 S -1- i 4 -mMp = 120-125 ° C; lH NMR (DMSO) 10.36 (s, 1 H), 8.73 (s, 1 (m, 2 H), 7.05 (d, 1 H, J = 8.8 Hz), 7.01-6.98 ( m, 2 H), 6.85-(dd, 1 H, J = 2.2 Hz, 8.6 Hz), 5.12 (s, 2 H), 4.67-4.61 (m, 1 H) (t, 2 H, J = 4.8 Hz ), 3.50-3.30 (m, 4 H), 3.20-3.10 (m, 2 H), 1.75 (m, 4 H), 1.65-1.50 (m, 4 H), 1.27 (d, 6 H, J = 6.1 Hz); 1250: MS el m / z 512 (M +); calculated + 1.0 HC1 + .i),, 7.26-7.23 6.75 (m, 5 H), 6.57 4.27 2.10 (s, 3 H), 1.85 -It (KBr) 3400, 1500, 5 HO. Example No. 122 2- (4-Cyclopentane-benzyl) -3-methyl S -1- i 4 -m

Mp = 121 - 135°C; >H NMR (DMSO) 9.80 (br s, 1 H), 8.72 (s, 1 H), 7.24 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 (d, 2 H, J = 8.8 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.98 (d, 2 H, J 6.78 (m, 5 H), 6.57 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 5.13 (s, 2 H) 8.8 Hz), 6.83 -4.86 - 4.82 (m, 1 H), 4.25 (t, 2 H, J = 4.8 Hz), 3.50 - 3.38 (m, 4 H), 2.92 (c, 2 H, J = 8.8 Hz), 2.11 (s, 3 H), 1.98 - 1.85 (m, 2 H), 1.81 - 1.56 (m, 11 H), 1.41 (KBr) 3400,2920,1620 cm-1; MS el m/z 524 (M+); C33H4〇N2 03 +0.5H2 0 之 CHN 計算值 e 80Mp = 121-135 ° C; > H NMR (DMSO) 9.80 (br s, 1 H), 8.72 (s, 1 H), 7.24 (Please read the notes on the back before filling this page) Central Standards of the Ministry of Economic Affairs Printed by the Bureau's Consumer Cooperative (d, 2 H, J = 8.8 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6.98 (d, 2 H, J 6.78 (m, 5 H), 6.57 (dd , 1 H, J = 8.8 Hz, 2.4 Hz), 5.13 (s, 2 H) 8.8 Hz), 6.83 -4.86-4.82 (m, 1 H), 4.25 (t, 2 H, J = 4.8 Hz), 3.50 -3.38 (m, 4 H), 2.92 (c, 2 H, J = 8.8 Hz), 2.11 (s, 3 H), 1.98-1.85 (m, 2 H), 1.81-1.56 (m, 11 H), 1.41 (KBr) 3400,2920,1620 cm-1; MS el m / z 524 (M +); C33H4〇N2 03 + 0.5H2 0 CHN calculated value e 80

1.29 (m, 1 H); IR 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 五、發明説明() A7 B7 -1 -某-氬 實施例编號1 2 3 3 -甲棊- :L-i4-(2二六氣 甚)-节某 Ί -2-(4-=.氬甲甚一¾ 某)一1Η-Ν1_-5-_1.29 (m, 1 H); IR This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) V. Description of the invention () A7 B7 -1-Some-argon Example No. 1 2 3 3-A棊-: L-i4- (2 twenty-six qi even) -jiemou Ί -2- (4-=. Argon methyl a ¾) a 1Η-N1_-5-_

Mp = 174°C; 'H NMR (DMSO) 8.8 (s, 1 H), 7.82 (d, 2 H, J = J = 7.9 Hz), 7.17 (d, 1 H, J = 8.6 Hz), 6.86 (d, 1 H, J = 2.4 l·^) H), 6.65 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 5.16 (s, 2 H), 3.93 (t -2.56 (m, 2 H), 2.42 - 2.32 (m, 4 H), 2.15 (s, 3 H), 1.48 - 1.4(^ 1.29 (m, 2 H); IR (KBr) 3410,2910,2850, 1620 cm-1; MS el i.l Hz), 7.59 (d, 2 H, ,6.75 - 6.68 (m, 4 ^ H, J = 5.7 Hz), 2.62 (m, 4 H), 1.39 - n/z 508 (M+); C g〇 H 3i F 3 N 2 〇 2 + . 2 5 H 2 0 之 CHN計算值。 實施例编號1 2 4 田某-1-ί~4-(2 -六氣吡 甚)-爷甚1 - ?-對-申荣基-1 Η - Ν丨眙-5 -醇 1 -某-乙氣Mp = 174 ° C; 'H NMR (DMSO) 8.8 (s, 1 H), 7.82 (d, 2 H, J = J = 7.9 Hz), 7.17 (d, 1 H, J = 8.6 Hz), 6.86 ( d, 1 H, J = 2.4 l · ^) H), 6.65 (dd, 1 H, J = 8.8 Hz, 2.4 Hz), 5.16 (s, 2 H), 3.93 (t -2.56 (m, 2 H) , 2.42-2.32 (m, 4 H), 2.15 (s, 3 H), 1.48-1.4 (^ 1.29 (m, 2 H); IR (KBr) 3410,2910,2850, 1620 cm-1; MS el il Hz), 7.59 (d, 2 H,, 6.75-6.68 (m, 4 ^ H, J = 5.7 Hz), 2.62 (m, 4 H), 1.39-n / z 508 (M +); C g〇H 3i Calculated CHN of F 3 N 2 〇2 +. 2 5 H 2 0. Example No. 1 2 4 Tianmou-1-ί ~ 4- (2 -Hexapyrazine) -Yeye 1-? -Yes -Shen Rongji-1 Η-Ν 丨 眙 -5-Alcohol 1-Some-B gas

Mp = 162 - 164°C; NMR (DMSO) 8.70 (s, 1 H), 7.28 - 7.2 H, J = 8,4 Hz), 6.81 (d, 1 H, J = 2.2 Hz), 6.73 (s, 4 H), 6.58 C 8.8 Hz), 5.11 (s, 2 H), 3.92 (t, 2 H, J = 5.9 Hz), 2.55 (t, 2 H, J 2.30 (m, 7 H), 2.10 (s, 3 H), 1.50 - 1.40 (m, 4 H), 1.48 -1.35 3400, 2900, 1200; MS el m/z 454 (M+); C a〇 H 34 H 2 實施例编號1 2 5 ?-(4-氣.-荣某)-3-甲基-Mp = 162-164 ° C; NMR (DMSO) 8.70 (s, 1 H), 7.28-7.2 H, J = 8,4 Hz), 6.81 (d, 1 H, J = 2.2 Hz), 6.73 (s, 4 H), 6.58 C 8.8 Hz), 5.11 (s, 2 H), 3.92 (t, 2 H, J = 5.9 Hz), 2.55 (t, 2 H, J 2.30 (m, 7 H), 2.10 (s , 3 H), 1.50-1.40 (m, 4 H), 1.48 -1.35 3400, 2900, 1200; MS el m / z 454 (M +); C a〇H 34 H 2 Example No. 1 2 5?- (4-Gas.-Rong) -3-methyl-

Mm, 4 H), 7.07 (d, 1 «μ, 1 H, J = 2.4 Hz, 5.9 Hz), 2.45 -(b, 2 H); IR (KBr) 2 i CHN計算值 Γ 4-(2~六氣 醇Mm, 4 H), 7.07 (d, 1 `` μ, 1 H, J = 2.4 Hz, 5.9 Hz), 2.45-(b, 2 H); IR (KBr) 2 i CHN calculated value Γ 4- (2 ~ Hexanol

Mp = 161-164°C; 'H NMR (DMSO) 10.12 (brs , 1H), 8.80 (s, (d , 2H , J = 8.3 Hz), 7.36 (d , 2H , J = 8.8 Hz), 7.12 (d , 1 H , 6.75 (m, 5 H), 6.63 (dd , 1H , J = 8.8 Hz , J = 2.4 Hz), 5.14 (s (m , 2H), 3.45-3.36 (m , 4 H), 2.97 - 2.84 (m , 2H), 2.11 (s , (m, 5H), 1.37 - 1.25 (m, 1H); MS el m/z 475 (M+); C29 H31 c 1 N 2 0 2 +HCL+ . 25H 2 〇之 CHN計算值 實施例编號126 2-(2.4 -二申氩某-荣某)-2 (請先閱讀背面之注意事項再填寫本頁) 訂 (ΗΓ1 ) Η), 7.53 J = 8.8Hz), 6.85-,2H), 4.29-4.22 3H), 1.83-1.61 經濟部中央標準局員工消費合作社印製 审甚 「4 - (2 -六氩UK;眭-1 -某-Z氩甚 > -窄某Ί- till -5-mMp = 161-164 ° C; 'H NMR (DMSO) 10.12 (brs, 1H), 8.80 (s, (d, 2H, J = 8.3 Hz), 7.36 (d, 2H, J = 8.8 Hz), 7.12 ( d, 1 H, 6.75 (m, 5 H), 6.63 (dd, 1H, J = 8.8 Hz, J = 2.4 Hz), 5.14 (s (m, 2H), 3.45-3.36 (m, 4 H), 2.97 -2.84 (m, 2H), 2.11 (s, (m, 5H), 1.37-1.25 (m, 1H); MS el m / z 475 (M +); C29 H31 c 1 N 2 0 2 + HCL +. 25H 2 Example of the calculated value of CHN of 〇 2-126 (2.4-Ershen Arm-Rongm) -2 (Please read the precautions on the back before filling this page) Order (Γ1) Η), 7.53 J = 8.8Hz ), 6.85-, 2H), 4.29-4.22 3H), 1.83-1.61 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs, "4-(2 -hexagon UK; 眭 -1-some -Z argon > -Narrow Ί-till -5-m

Mp = 85 - 92°C; iH NMR PMSO) 8.62 (s, 1 H), 7.10 (d, 1 H, T = 8.4 Hz), 7.01 (d, 1 H, J = 8.6 Hz), 6.80 - 6.70 (m, 5 H), 6.69 (d, 1 H, 2.2 Hzi, 6.59 (dd, 1 H, J = 2.4 Hz, 8.5 Hz), 6.52 (dd, 1 H, J = 2.4 Hz, 8.8 H;:), 5.02 81 本紙張尺度適用中國國家橾準(CNS ) A4規格(21〇X297公釐〉 A7 B7 五、發明説明(扑) (d, 1 H, J = 6.5 Hz), 4.83 (d, 1 Η, ; = 6.3 Hz), 4.0 - 3.90 (m, 2 ^), 3.80 (s, 3 H), 3.67 (s, 3 H), 2.65 - 2.50 (m, 2 H), 2.45 - 2.30 (m, 4 H), 2.0 (s, 3 H), 1.55 - 1.40 (m, 4 H), 1.39 - 1.30 (m, 2 H); IR (KBr) 3400, 2900, 1520, 1250 MS el m/z 500 (M + ) ; C 31 H 36 N 2 0 4 + . (} 5 G H 2 C i 2 之 C Η N 計 3 r值。 宮旆例溢號1 2 7 2 - ( 3 -辉基-苯基> -3 -甲甚-1 -Γ 4 - ( 2 - 六氣报腚-1 -甚-7*.氫某)-苄甚]-1 Η -盹US - ϋ -Μ Mp = 115 - 118°C; 'H NMR (DMSO) 9.57 (s, 1 H), 8.71 (s, 1 H) ,7.27 - 7.23 (t, 1 H, J = 8.1 Hz), 7.06 - 7.04 (d, 1 Η, J = 8.8 Hz), 6.81 - 6.74 (m, 8 Η), 6.59 - 6.56 (dd, 1 H, J = 2.3 Hz, J = 6.3 Hz), 5.12 (s, 2 H), 3.94 - 3.91 (t, 2 Η, J = 5.9 Hz), 2.57 - 2.54 (t, 2 H, J = 5.8 Hz), 2.36 (s, 4 H), 2.11 (s, 3 H) ,1.45 - 1.41 (m, 4 H), 1.34 - 1.33 (m, 2 H); IR (KBr) 3400,2900 cm'1; MS el η/ζ 456 (M+); c 29 H 32 N 2 0 3 + 1 . 0 H 2 0 之 C H N 計算值。 實施例編號1 2 8 1 -〔 4 - ( 2 - U丫庚因-1 -基-乙1 c基]-苄基〕 -2 - ( 3 -禪蓽-笨甚)Ί Φ某-1 Η -㈣找-5 - II Mp = 94 - 97°C; Ή NMR (DMSO) 9.58 (s, 1 H), 8.71 (s, 1 H), 7 .27 - 7.23 (t, 1 H, J = 7.9 Hz), 7.07 - 7.04 (d, 1 H, J = 8.7 Hz), 6.81 - 6.74 (m, 8 Η), 6.59 - 6.56 (dd, 1 H, J = 2.4 Hz, J = 6.3 Hz), 5.12 (s, 2 H), 3.9 (m, 2 I I), 2.80 (s, 2 Η), 2.65 (s, 4 H), 2.11 (s, 3 H), 1.54 - 1.50 (m, 8 H); IR 3400, 2900 ( :m’1; MS el m/z 470 (M + );C;1〇 N2 〇3 +〇*'。抒2 O + 酸乙? i之C Η N計算值。 «施M编號129 -锊基-笨基)-3 -弓 1 甚-1 - Γ 4- ί?-六氣ίΗ;症-1-基-乙氬某 >-节基] i - s-m Mp = 117-119°C; !h NMR (DMSO) 10.1 (s, 1H), 8.71 (s, 1H),' .10-6.95 (m,4 H), 6.80 (d, 1H, J = 2.2Hz), 6.74 (s, 4H), 6.59 (dd, 1H, J = 2.2 Hz, 8.5 Hz), 5.1 (s, 2H), 3.93 (t, 2H, J = 5.9 Hz), 2.56 (t, 2H, J = 5.8 Hz), 2.44 - 2. SO (m, 4H), 2.10 (s, 3 H), 1.45 -1.40 (m, 4H), 1.36 -1.32 (m, 2H); MS el m/Z 475 (M 卜); C 29 H 31 F N 2 0 ,之 C 0 計算值。 82 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公嫠) 請 閱 t6 意 事 項 再 i 五、發明説明(W ) A7 B7 實施例编號13 I】2-(3-M - 4-揮基-苯基)-3-H基-1 醇Mp = 85-92 ° C; iH NMR PMSO) 8.62 (s, 1 H), 7.10 (d, 1 H, T = 8.4 Hz), 7.01 (d, 1 H, J = 8.6 Hz), 6.80-6.70 ( m, 5 H), 6.69 (d, 1 H, 2.2 Hzi, 6.59 (dd, 1 H, J = 2.4 Hz, 8.5 Hz), 6.52 (dd, 1 H, J = 2.4 Hz, 8.8 H; :), 5.02 81 This paper size is applicable to China National Standard (CNS) A4 (21 × 297mm> A7 B7) 5. Description of the invention (Fl) (d, 1 H, J = 6.5 Hz), 4.83 (d, 1 Η, ; = 6.3 Hz), 4.0-3.90 (m, 2 ^), 3.80 (s, 3 H), 3.67 (s, 3 H), 2.65-2.50 (m, 2 H), 2.45-2.30 (m, 4 H ), 2.0 (s, 3 H), 1.55-1.40 (m, 4 H), 1.39-1.30 (m, 2 H); IR (KBr) 3400, 2900, 1520, 1250 MS el m / z 500 (M + ); C 31 H 36 N 2 0 4 +. (} 5 GH 2 C i 2 The C Η N is calculated as 3 r value. Miyazaki case overflow number 1 2 7 2-(3 -fluoryl-phenyl >- 3 -methyl even -1 -Γ 4-(2-six gas reports 腚 -1-even -7 *. Hydrogen a)-benzyl] -1 Η-盹 US-ϋ -Μ Mp = 115-118 ° C; 'H NMR (DMSO) 9.57 (s, 1 H), 8.71 (s, 1 H), 7.27-7.23 (t, 1 H, J = 8.1 Hz), 7.06-7.04 (d, 1 Η, J = 8.8 Hz ), 6.81-6.74 (m, 8 Η), 6.59-6.56 (dd, 1 H, J = 2.3 Hz, J = 6.3 Hz), 5.12 (s, 2 H), 3.94-3.91 (t, 2 Η, J = 5.9 Hz), 2.57-2.54 (t, 2 H, J = 5.8 Hz), 2.36 (s, 4 H) , 2.11 (s, 3 H), 1.45-1.41 (m, 4 H), 1.34-1.33 (m, 2 H); IR (KBr) 3400, 2900 cm'1; MS el η / ζ 456 (M +); c 29 H 32 N 2 0 3 + 1. 0 CHN calculated value. Example No. 1 2 8 1-[4-(2-U-yacene-1 -yl-ethyl 1 c-yl] -benzyl] -2-(3 -chan 荜-stupid) Φ 某 -1 Η -㈣Find -5-II Mp = 94-97 ° C; Ή NMR (DMSO) 9.58 (s, 1 H), 8.71 (s, 1 H), 7.27-7.23 (t, 1 H, J = 7.9 Hz), 7.07-7.04 (d, 1 H, J = 8.7 Hz), 6.81-6.74 (m, 8 Η), 6.59-6.56 (dd, 1 H, J = 2.4 Hz, J = 6.3 Hz), 5.12 ( s, 2 H), 3.9 (m, 2 II), 2.80 (s, 2 Η), 2.65 (s, 4 H), 2.11 (s, 3 H), 1.54-1.50 (m, 8 H); IR 3400 , 2900 (: m'1; MS el m / z 470 (M +); C; 1〇N2 〇3 + 〇 * '. Calculate the value of C Η N of 2 O + acid ethyl? I. No. 129-fluorenyl-benzyl) -3-bow 1 and even -1-Γ 4- hexa-qi 症 Η -1--1-yl-ethyl argon >-knot base] i-sm Mp = 117- 119 ° C;! H NMR (DMSO) 10.1 (s, 1H), 8.71 (s, 1H), '.10-6.95 (m, 4 H), 6.80 (d, 1H, J = 2.2Hz), 6.74 ( s, 4H), 6.59 (dd, 1H, J = 2.2 Hz, 8.5 Hz), 5.1 (s, 2H), 3.93 (t, 2H, J = 5.9 Hz), 2.56 (t, 2H, J = 5.8 Hz) , 2.44-2. SO (m, 4H), 2.10 (s, 3 H), 1.45 -1.40 (m, 4H), 1.36 -1.32 (m, 2H); MS el m / Z 475 (M Bu); C 29 H 31 FN 2 0, the calculated value of C 0. 82 This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 cm). Please read the t6 notice and i. 5. Description of the invention (W) A7 B7 Example No. 13 I 】 2- (3-M-4-Voltyl-phenyl) -3-Hyl-1 alcohol

Mp = 88 - 91°C; lH NMR (DMSO) 10.10 (s, 1H), 8.71 ( s, 1H). H), 6.80( d, 1 H, J = 2.2 Hz), 6.74 ( s, 4 H), 6.58 ( dd, 1 H, J 5.10 ( s, 2 H), 3.91( t, 2 H, J = 5.9 Hz), 2.76 (t, 2 H, J = 5.9), ^.62 - 2.60 (m, 4H), 2.10 (s, 3H), 1.70 -1.40 (m, 8 H); MS el m/Z 488 (M+); C30 FN2 〇3 之 CHN 計算值。 實施例编號l 2 - ( 3 -申氩某-¾基)-3-甲基_ 六氤PH;啶-1 -某-7.氲某)-苄某1 - 1 Η - Η丨昤 7.12-6.94 (m, 4 2.2 Hz, 8.5 Hz), 丄 4- ( 2 請 先 聞 讀 背 之 注Mp = 88-91 ° C; lH NMR (DMSO) 10.10 (s, 1H), 8.71 (s, 1H). H), 6.80 (d, 1 H, J = 2.2 Hz), 6.74 (s, 4 H) , 6.58 (dd, 1 H, J 5.10 (s, 2 H), 3.91 (t, 2 H, J = 5.9 Hz), 2.76 (t, 2 H, J = 5.9), ^ .62-2.60 (m, 4H), 2.10 (s, 3H), 1.70 -1.40 (m, 8 H); MS el m / Z 488 (M +); C30 FN2 CHN calculation value. Example No. l 2-(3- Argon-¾yl) -3-methyl_hexamidine PH; pyridine-1 -some-7.-7some) -benzyl 1-1 Η-Η 丨 昤 7.12-6.94 (m, 4 2.2 Hz, 8.5 Hz ), 丄 4- (2 Please read the back note first

Mp = 120 - 123°C; Ή NMR (DMSO) 8.76 (s, 1 H), 7.42 - 7.46 ( 1 H, J = 7.9 Hz), 7.12 - 7.09 (d, 1 H, J = 8.7 Hz), 6.99 - 6.92 (m, 2 H), 6.86 - 6.8 5 (m, 2 H), 6.76 (s, 4 H), 6.63 - 6.60 (dd, 1 H, J = 2.1 Hz, J = 6.5 Hz), 5.14 (s, 2 H) J = 5.9 Hz), 3.70 (s, 3 H), 2.59 - 2.55 (t, 2 H, J = 5.9 Hz), 2.37 H), 1.49 - 1.44 (m, 4 H), 1.35 - 1.34 (m, 2 H); IR 3400, 2950,16 之 CHN 計算值》 鸾铯例编號1 2 3 -申甚-ΐ - [ 4二 甚)-节甚Ί -之- (4-二氣甲氨基)-卞—基·__J._二1. H- 項 再 填 % 本 頁Mp = 120-123 ° C; Ή NMR (DMSO) 8.76 (s, 1 H), 7.42-7.46 (1 H, J = 7.9 Hz), 7.12-7.09 (d, 1 H, J = 8.7 Hz), 6.99 -6.92 (m, 2 H), 6.86-6.8 5 (m, 2 H), 6.76 (s, 4 H), 6.63-6.60 (dd, 1 H, J = 2.1 Hz, J = 6.5 Hz), 5.14 ( s, 2 H) J = 5.9 Hz), 3.70 (s, 3 H), 2.59-2.55 (t, 2 H, J = 5.9 Hz), 2.37 H), 1.49-1.44 (m, 4 H), 1.35- 1.34 (m, 2 H); Calculated CHN of IR 3400, 2950, 16》 Caseum case number 1 2 3 -Shen Shi-ΐ-[4 二 甚]-节节 Ί- 之-(4- 二 气Methylamino)-卞 —Base · __J._ 二 1. Fill in H-%% of this page

J ,3.96 - 3.92(t, 2 H, s, 4 H), 2.14 (s, 3 X) cm'1; MS el m/z#471 (^1 -1 -甚-氩 i3i n - 5-m 訂 經濟部中央標準局員工消費合作社印製J, 3.96-3.92 (t, 2 H, s, 4 H), 2.14 (s, 3 X) cm'1; MS el m / z # 471 (^ 1 -1 -even-argon i3i n-5-m Order printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

Mp = 122 - 125°C; Ή NMR (DMSO) 8.80 (s, 1 H), 7.51 - 7.45 (m, 4 H), 7.17 - 7.14 (d, 1 H, J = 8.7 Hz), 6.85 - 6.84 (d, 1 H, J = 2.0 Hz), 6.75 - 6.6i' (m, 4 H), 6.66 6.62 (m, 1 H), 5.14 (s, 2 H), 3.95 - 3.92 (t, 2 H, J = 5.8 Hz), 2.5!> - 2.55 (t, 2 H, J 5.6 Hz), 2.49 - 2.38 (m, 4 H), 2.13 (s, 3 H), 1.47 - 1.44 (m, 4 H), H, J = 4.8 Hz);.IR 3400,2900,1600 cm·1; MS el m/z 525 (M+); c 30 H 31 F ^ N 2 〇 3 + 0 . 2 5 H 2 〇 之 C Η N 計算值 t 以氛,乙基或氰基取代於吲昤之3 -位置的化 成步驟和物理數據。 1.36 - 1.34 (d, 2 合物之合 83 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) A7 B7 五、發明説明(家>)Mp = 122-125 ° C; Ή NMR (DMSO) 8.80 (s, 1 H), 7.51-7.45 (m, 4 H), 7.17-7.14 (d, 1 H, J = 8.7 Hz), 6.85-6.84 ( d, 1 H, J = 2.0 Hz), 6.75-6.6i '(m, 4 H), 6.66 6.62 (m, 1 H), 5.14 (s, 2 H), 3.95-3.92 (t, 2 H, J = 5.8 Hz), 2.5! ≫-2.55 (t, 2 H, J 5.6 Hz), 2.49-2.38 (m, 4 H), 2.13 (s, 3 H), 1.47-1.44 (m, 4 H), H, J = 4.8 Hz); IR 3400, 2900, 1600 cm1; MS el m / z 525 (M +); c 30 H 31 F ^ N 2 〇3 + 0.25 H 2 〇C 之The calculated value of N is the formation step and physical data of the 3-position of indene substituted with cyano, ethyl or cyano. 1.36-1.34 (d, 2 combination of 83) This paper size is applicable to China National Standard (CNS) A4 size (210X297 mm) A7 B7 V. Description of invention (home >)

0H 表8 «施例编號 Q z No. 133 a H o No. 134 a H o No. 135 a H 〇 No. 136 a ch3 o No. 137 Et H Ό No. 138 CN H o No. 139 CN H o 3 -氛類似物组號绾號会成 流程圖,1 4 3 -氣g4丨盹:> 会成 (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央橾準局員工消費合作社印裝 84 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 五、發明説明(&0H Table 8 «Example No. Q z No. 133 a H o No. 134 a H o No. 135 a H 〇No. 136 a ch3 o No. 137 Et H Ό No. 138 CN H o No. 139 CN H o 3-The group number of the simulant analogue will become a flow chart, 1 4 3-qi g4 丨 盹: > will be (please read the precautions on the back before filling this page) Order the staff of the Central Government Bureau Consumption cooperative printing 84 This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 5. Description of the invention (&

R>HorCHj A7 B7 OBn 0R > HorCHj A7 B7 OBn 0

EtOH· H+ /=( J^-nh CAS#(51145-5e-5] 實施例编號EtOH · H + / = (J ^ -nh CAS # (51145-5e-5) Example number

OBn 實施例編號141_Α·Η 實施例编號142_A«H 實施例编號143-A>CH3 實施例编號140腙之形成 4-苄氧基苯阱CAS编號〔 5 1 1 4 5 - 5 8 - 5〕 (50 毫莫耳)與4-苄氧基苯乙酮CAS编號〔 5 4 6 9 6 -克,280.0毫莫耳)混合於純乙醇(800毫升) 化量之乙酸(5滴)。將反應加熱至回流經2, 流期間,冷凝産物從熱溶液固化出來。反應 。藉由真空過濾收集所要産物,呈黃色固體 • 0克,2 3 3 . 05-8] (63 . 加入催 5小時。回 冷卻至室溫 (8.6克, 86%). Mp = 165-174°C; ^ NMR (DMSO) 8.91 (s, 1 Η), 7.68 (c, 2 H, J = 8.8 Hz), 7.48 - 7.32 (m, 10 H), 7.12 (d, 2 H, J = 9 Hz), 7.00 (d, 2 H, J = i;.8 Hz), 6.88 (d, 2 H, J = 9.0 Hz). 5.11 (s, 2 H), 5.01 (s, 2 H), 2.17 (s, 3 H); MS el in/z 422 (M+). (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標隼局員H消費合作社印製 實施例编號1 4 1從腙形成吲哚:L苄氣基] 芜某)-1 Η -叫丨盹 Ν-(4-苄氣基-苯基)-N’ -〔 1-(4-苄氣基-苯 -腙(编號140)(10.0克,23.7毫莫耳),211(:1 59.17毫莫耳),乙酸(70毫升)進料至燒瓶中 -85- -(4-节氩某 基)亞乙基〕 2 (8.06克, 反應燒瓶 本紙張尺度適用t國國家標準(CNS ) A4規格(210X297公釐) 經 Α7 Β7 五、發明説明(私) 加熱至1 0 5 °C不超過2 0分鐘。在加熱間,反Μ i以TLC顯示 起始物質來小心監測反應。反應程序可以産 物從溶液固 化出來顯示。然後反應可冷卻至室溫且觀察 到更多産物 降落《反應内容物注至包含乙醚(100毫升HI 3 Η 2 0 ( 2 0 0 毫升)之分離漏斗中,將其激列搖動。不溶5丨 1留物為所 要的産物留置於乙醚層,其以真空過濾收集 。産物以在 乙醚中研磨進一步純化以産生淡灰色固體 .4克,6 % ) 〇 Mp = 202 - 204°C; ^ NMR (DMSO) 11.24 (s, 1 H), 7.73 (d, 2 H, J = 8.8 Hz), 7.48 -7.41(m, 4 H), 7.45 - 7.27 (m, 6 H), 7.25 (d, 1 H, J = 8.6 Hz), M2-7.04 (m, 3 H), 6.77 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 6.65 (d, 1 H, J = 1.5 Hz), 5.14 (s, 2 H), 5.08 (s, 2 H); IR 3420, 3000,1625 cm*1; MS el m/z 405 (M+); C28 H23 NO 2 +0.40H2 0之 CHN計算值。 窗掄俐迫號]4 2 B4I 11¾ 氣化以産生5 -苄氣基 _-3-氛-2- (4 -苄氳某-蒹某)-1 Η - B4I盹 5-苄氧基-1-(苄氧基-苯基)-1-吲昤(编號 141) (8 · 0克 ,20·0毫莫耳),CH2 Cl2 (50毫升)進料至卷 i瓶中。冷卻 反應至0T及加入正-氣丁二醯亞胺(2·9克, 22毫奠耳)。 反應於〇°C擬拌2 0分鐘。然後反應以1 0 %亞® ί:酸鈉溶液 洗滌,經MgS〇4 ,及濃编。將MeOH加至所得 琮色固體中 及攪拌混合物15分鐘。過濾出固體以産生6. 3克淡棕色 固體(7 8 % )。 Mp = 157-160°C ; Ή NMR (DMSO) 11.5 (s , 1 H), 7.80 (d, 2 H J = 7.0Hz), 7.42 -7.28 (m , 11 H), 7.17 (d, 2 H , J = 8.7 Hz), 7.01 (d , 1 H , J =: 2Hz), 6.88 (dd, 1 H, J = 8.8 Hz, J = 2.4 Hz), 5.17 (s , 2H), 5.13 (s , 2H); M S el m/z 439 (M+), - 8 6 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X 297公釐) 請 先 閱 讀 背 之 注 意 事 項 再 填 % 本 頁 中 標 準 局 貝 工 消 費 合 作 社 印 製 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 裝 A7 B7 五、發明説明(h) 奮施例编號143 爷氩某-3-覩- 2- (2 -甲某- 4 -节氬甚- 采某)-1 Η - #4丨 11¾ 此吲_合成類似於先前吲呤编號1 4 2 : Μ p :: Ή NMR (DMSO) 11.34 (s , 1 Η), 7.48 - 7.44 (m , 4 Η), 7.42 -1 .24 (m, 8 Η), 7.02 (dd , 2 Η , J = 9.3 Hz , J = 2.4 Hz), 6.95 (dd, 1 Η , J = 8.4 Hz J = 2.6Hz), 6.88 (dd , 1 Η, J = 8.8Hz, J =2.4 Hz), 5.16 (s , 2 H), 5.14 (s , 2 H), 2 .23 (s ,3 H); MS el m/z 453 (M+). 實施例编號1 4 4 吲呤之烷基化作用以産生_ 4 - f 氳某-3 -氣-D 4 -苄氤甚-荣甚)-;?-氣-屻鸣- 1 -甚®甚1 -茱氳某)Z酴7,酯 類似於概述於方法3之3 -甲基吲呤乙酸乙 酯之合成概 要完成此步驟。 Mp = 90-94°C; !H NMR (DMSO) 7.45 (d , 4H, J= 7.8 Hz),7.41 7.26 (m, 9H), 7.14 (d , 2 H , J = 8.7 Hz), 7.04 (d , 1 Η , i = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6.80-6.74 (m, 4H), 5.24 (s , 2] ΐ), 5.15 (s , 2H), 5.14 (s , 2H), 4.66 (s , 2 H), 4.12 (q, 2H, J = 7.2 Hz), 1.16 (t, 3 Ei , J = 7.5 Hz); MS eIm/z631(M+). 實施例编號145编號144之還原以産生编號1 45 2- f 4- 「fi-苄氳某-2-(4 -节氫某-荣某)-3-氣-吲P5 -甚申某Ί 芏氩某)Z.醇 類似於槪述於方法4之3 -甲基吲哚之合成 概要完成此 反應。化合物不純化或定性,但以所得使用 下一步驟。 實施例编號146编號145之溴化以産生节氣a ;-2 - ( 4 -带 氩甚-茏甚)-1 - Γ 4 - ( 2 -滇-7,氩甚)-苄某]- Λ-m, - 1 Η - -87- 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) 請 先 閲 讀 背 面 之 注 意 事 項 再 填 寫 本 頁OBn Example No. 141_Α · Η Example No. 142_A «H Example No. 143-A > CH3 Example No. 140 腙 formed 4-benzyloxybenzene trap CAS number [5 1 1 4 5-5 8 -5] (50 mmol) mixed with 4-benzyloxyacetophenone CAS number [5 4 6 9 6 -g, 280.0 mmol) in pure ethanol (800 ml) ). The reaction was heated to reflux over 2 hours, during which time the condensate solidified from the hot solution. Response. The desired product was collected by vacuum filtration as a yellow solid • 0 g, 2 3 3. 05-8] (63. Add for 5 hours. Cool back to room temperature (8.6 g, 86%). Mp = 165-174 ° C; ^ NMR (DMSO) 8.91 (s, 1 Η), 7.68 (c, 2 H, J = 8.8 Hz), 7.48-7.32 (m, 10 H), 7.12 (d, 2 H, J = 9 Hz) , 7.00 (d, 2 H, J = i; .8 Hz), 6.88 (d, 2 H, J = 9.0 Hz). 5.11 (s, 2 H), 5.01 (s, 2 H), 2.17 (s, 3 H); MS el in / z 422 (M +). (Please read the notes on the back before filling out this page) Member of the Central Bureau of Standards of the Ministry of Economic Affairs, H Consumer Cooperative, printed Example No. 1 4 1 Indole is formed from tritium : L benzylamino] Wu -1) Η-called 丨 N- (4-benzylamino-phenyl) -N '-[1- (4-benzylamino-benzene-fluorene (number 140) (10.0 g, 23.7 mmol), 211 (1: 59.17 mmol), acetic acid (70 ml) was fed to the flask -85--(4-benzyl argon) ethylene) 2 (8.06 g The paper size of the reaction flask is applicable to the national standard (CNS) A4 specification (210X297 mm). A7 B7 V. Description of the invention (private) Heating to 105 ° C for no more than 20 minutes. In the heating room, reverse M i is displayed in TLC Monitor the reaction carefully. The reaction procedure can be shown by the product solidifying from the solution. Then the reaction can be cooled to room temperature and more products are observed to fall. The reaction content is injected to contain ether (100 ml HI 3 Η 2 0 (2 0 0 ml) in a separatory funnel, shake it in a row. The insoluble 5 丨 1 retentate is left in the ether layer, which is collected by vacuum filtration. The product is further purified by trituration in ether to give a light gray solid. 4 G, 6%) 〇Mp = 202-204 ° C; ^ NMR (DMSO) 11.24 (s, 1 H), 7.73 (d, 2 H, J = 8.8 Hz), 7.48 -7.41 (m, 4 H), 7.45-7.27 (m, 6 H), 7.25 (d, 1 H, J = 8.6 Hz), M2-7.04 (m, 3 H), 6.77 (dd, 1 H, J = 2.4 Hz, 8.6 Hz), 6.65 (d, 1 H, J = 1.5 Hz), 5.14 (s, 2 H), 5.08 (s, 2 H); IR 3420, 3000, 1625 cm * 1; MS el m / z 405 (M +); C28 H23 Calculated CHN for NO 2 + 0.40H2 0. Chuangli Lihao] 4 2 B4I 11¾ is gasified to produce 5-benzyloxy-3--3--2- (4 -benzyl 氲--蒹) -1 Η-B4I 盹 5-benzyloxy-1 -(Benzyloxy-phenyl) -1-indazole (No. 141) (8.0 g, 20.0 mmol), CH2Cl2 (50 ml) was fed into a volume i bottle. The reaction was cooled to 0T and n- succinimide (2.9 g, 22 mmol) was added. The reaction was stirred at 0 ° C for 20 minutes. The reaction was then washed with a 10% acetic acid solution: sodium sulfate, concentrated with MgS04, and concentrated. MeOH was added to the resulting ocher solid and the mixture was stirred for 15 minutes. The solid was filtered off to give 6.3 g of a light brown solid (78%). Mp = 157-160 ° C; Ή NMR (DMSO) 11.5 (s, 1 H), 7.80 (d, 2 HJ = 7.0Hz), 7.42 -7.28 (m, 11 H), 7.17 (d, 2 H, J = 8.7 Hz), 7.01 (d, 1 H, J =: 2Hz), 6.88 (dd, 1 H, J = 8.8 Hz, J = 2.4 Hz), 5.17 (s, 2H), 5.13 (s, 2H); MS el m / z 439 (M +),-8 6-This paper size is applicable to China National Standard (CNS) A4 (2I0X 297 mm) Please read the precautions on the back and fill in% Cooperatives printed by the Central Bureau of Standards of the Ministry of Economic Affairs. Consumers' Cooperatives printed A7 B7. 5. Description of the invention (h) Fen Example No. 143 Yea Ar 3--3- 覩-2- (2-Jiamou-4-Section Argon-采) -1 Η-# 4 丨 11¾ This indole synthesis is similar to the previous indine number 1 4 2: Μ p :: Ή NMR (DMSO) 11.34 (s, 1 Η), 7.48-7.44 (m, 4 Η), 7.42 -1.24 (m, 8 Η), 7.02 (dd, 2 Η, J = 9.3 Hz, J = 2.4 Hz), 6.95 (dd, 1 Η, J = 8.4 Hz J = 2.6Hz), 6.88 (dd, 1 Η, J = 8.8Hz, J = 2.4 Hz), 5.16 (s, 2 H), 5.14 (s, 2 H), 2.23 (s, 3 H); MS el m / z 453 (M +). Example No. 1 4 4 Ind The alkylation of methoxine to produce _ 4-f 氲 some -3 -qi -D 4 -benzyl hydrazine-Rongshi)-;? -Qi-屻 ming-1 -Vine® even 1 -Fructus Corni) Z VII. The ester is completed similarly to the synthesis summary of ethyl 3-methylindolinate outlined in Method 3. Mp = 90-94 ° C;! H NMR (DMSO) 7.45 (d, 4H, J = 7.8 Hz), 7.41 7.26 (m, 9H), 7.14 (d, 2 H, J = 8.7 Hz), 7.04 (d , 1 Η, i = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6.80-6.74 (m, 4H), 5.24 (s, 2) ΐ), 5.15 (s, 2H), 5.14 (s, 2H), 4.66 (s, 2 H), 4.12 (q, 2H, J = 7.2 Hz), 1.16 (t, 3 Ei, J = 7.5 Hz); MS eIm / z631 (M +) Example No. 145 and No. 144 were reduced to produce No. 1 45 2-f 4- "fi-benzyl-2- (4 -hydrogen-saving-Rong) -3-qi-InP5-even Shen Mou, Gao, Meng, Z.) Alcohol was similar to the 3-methylindole synthesis summary described in Method 4. This reaction was completed. The compound was not purified or characterized, but the next step was used as obtained. Bromination of No. 145 to produce solar terms a; -2-(4-with argon even-茏 even)-1-Γ 4-(2-Yunnan-7, argon)-benzyl]-Λ-m, -1 Η--87- This paper size applies to Chinese National Standard (CNS) A4 (210 × 297 mm) Please read the precautions on the back before filling this page

訂 經濟部中央標準局員工消費合作社印製 五、發明説明(料) 類似於概述於方法方法5之3 -甲基吲呤之 合成概要完 成此反應。Mp = 155-1580(^111^0^30)7.45 (d ,4 H, J= 7.8 Hz),7.41 - 7.25 (m , 9H), 7.14 (d , 2 H , J = 8.7 1 Hz), 7.04 (d , 1 H , J = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6/r 4 (s, 4H), 5.24 (s , 2 H), 5.15 (s , 2H), 5.14 (s , 2 H), 4.20 (t, 2 H, J= 5.3Hz), 3.74 (t, 2 H , J = 5.3 Hz); MS el m/z 651 (M+). 實施例编號1 4 7以六氩吡啶取代编號1 4 6以i &牛5-苄氣 甚- 2- (4-韦® 某-架某)Ί氣-1- Γ 4- f 2'Xi <覦卅啶-1 - 某-7,氬某)-窄甚Ί - 1 Η - 11別盹 類似於概述於方法6之3 -甲基吲呤之合成 概要完成此 反應,使用六氫毗啶取代溴。 Mp 96-98°C; 'H NMR (DMSO) 7.45 (d , 4 H, J= 7.8 Hz), 7.40 7.30 (m,9H), 7.14 (d, 2 H , J = 8.7 Hz), 7.04 (d , 1 H , J = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6.74 (s, 4 H), 5.24 (s , 2H), 5.15 (s , 2 H), 5.14 (s , 2 H),: .93 (t, 2 H, J = 6.0 Hz), 2.56 (t, 2 H , J= 6.0 Hz), 2.41-2.32 (m , 4 H), 1.48-1.39 ( u,4 H), 1.38-1.31 (m , 2 H). 審输例迫號148 爷氣某- 2- U-苄氬某-来3 ϊ ) -3- M -1- 「4-(2-吖庠闵-1-某-7,氳某)-苄某1-11^-11< i m 與上述相同完成反應,除該取代胺使用六 亞乙胺之外。 Mp = 94-97°C; *H NMR (DMSO) 7.45 (d , 4H, J= 7.8 Hz), 7.42 -7.30 (m , 9H), 7.14 (d , 2 H , J = 8.7 Hz), 7.04 (d , 1 H , J = 2.4 Hz ), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6.74 (s, 4 H), 5.24 (s , 2H), 5. 15 (s,2H), 5.14 (s , 2H), 3.93 (t, 2 H, J = 6.0 Hz), 2.75 (t, 2H, J = 6.0 Hz), 2.6 : -2.59 (m , 4 H), 1.58-1.44 (m , 8 H); MS el m/z 671 (M+). 奮旃例越[號149 5 -苄僮;甚- 2- (2 -甲某-4-苄i 某-荣某1 -:?-氣-1- Γ 4-0 -六氤卅啶-1-某-Z Μ某)-气 ί 某 Ί -1 Η- "88- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先聞讀背面之注意事項再填寫本頁) A7 五、發明说明(幻 ρ^ι η 製造此化合物之反應類似於該製造编號1 OU; 'Η NMR(DMSO) 7.50 - 7.29 (m , 11 Η), 7.17 (d , 1 H , J (d, 1 H, J = 2.4Hz), 7.02 (d , 1H, J = 2.4Hz), 6.93 - 6.85 (in, 2 4H), 5.14 (s , 2H), 5.13 (s , 2H), 5.07 (m , 2 H), 3.92 (t, 2 H , (t, 2H , J = 5.9Hz), 2.42 - 2.29 (m , 4 H), 1.94 (s , 3H), 1.44 --1.34 (m , 2H). 實施例编號133 3-氣- 2- (4-猙某-苯基)-1- 7者。 :8.4Hz), 7.05 Η), 6.75 - 6.65 (m J = 5.9Hz), 2.55 1.40 (m ,4 H), 1.38 Γ 4-(2- 毗咯啶-卜基-乙氣基)-苄基)-1H-吲哚-5 淳(HCL) 如實施例编號134所合成Order Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (material) Similar to the synthesis summary of 3-methylindrine outlined in Method 5 of Method 5 to complete this reaction. Mp = 155-1580 (^ 111 ^ 0 ^ 30) 7.45 (d, 4 H, J = 7.8 Hz), 7.41-7.25 (m, 9H), 7.14 (d, 2 H, J = 8.7 1 Hz), 7.04 (d, 1 H, J = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6 / r 4 (s, 4H), 5.24 (s, 2 H), 5.15 ( s, 2H), 5.14 (s, 2 H), 4.20 (t, 2 H, J = 5.3Hz), 3.74 (t, 2 H, J = 5.3 Hz); MS el m / z 651 (M +). Implementation Example No. 1 4 7 Replaced with No. 1 4 6 with Hexapyridine No. 1 4 6 with i & bovine 5-benzyl gas and even 2- (4-Wei® XX-XX) Krypton -1- Γ 4- f 2 ' Xi < pyridine-1--7, argon)-Narrow even Ί-1 Η-11 盹 盹 is similar to the synthesis summary of 3-methylindrine outlined in Method 6 to complete the reaction using hexahydro Pyrimidine replaces bromine. Mp 96-98 ° C; 'H NMR (DMSO) 7.45 (d, 4 H, J = 7.8 Hz), 7.40 7.30 (m, 9H), 7.14 (d, 2 H, J = 8.7 Hz), 7.04 (d , 1 H, J = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6.74 (s, 4 H), 5.24 (s, 2H), 5.15 (s, 2 H) , 5.14 (s, 2 H) ,: .93 (t, 2 H, J = 6.0 Hz), 2.56 (t, 2 H, J = 6.0 Hz), 2.41-2.32 (m, 4 H), 1.48-1.39 (u, 4 H), 1.38-1.31 (m, 2 H). Case No. 148 for trial and submission-Yee-2-U-Benzyl Ar--3 3) -3- M -1- "4- ( 2-Azinemin-1--1-7, 氲 -1) -benzyl 1-11 ^ -11 < im The reaction is completed in the same manner as above, except that the substituted amine uses hexaethyleneamine. Mp = 94-97 ° C; * H NMR (DMSO) 7.45 (d, 4H, J = 7.8 Hz), 7.42 -7.30 (m, 9H), 7.14 (d, 2 H, J = 8.7 Hz), 7.04 (d, 1 H, J = 2.4 Hz), 6.91 (dd, 1 H, J = 9.0Hz, J = 2.5 Hz), 6.74 (s, 4 H), 5.24 (s, 2H), 5. 15 (s, 2H), 5.14 (s , 2H), 3.93 (t, 2 H, J = 6.0 Hz), 2.75 (t, 2H, J = 6.0 Hz), 2.6: -2.59 (m, 4 H), 1.58-1.44 (m, 8 H); MS el m / z 671 (M +). Fen Yi Yue Yue [No. 149 5 -Benzyl Tong; even-2- (2-甲某 -4-Benzene i Some -Rong some 1-:?-气 -1- Γ4-0 -Hexamidine-1-a-Z Μa) -Gas a certain -1 Η- " 88- This paper size applies to China National Standard (CNS) Α4 size (210X 297 mm) (please First read the notes on the back and then fill out this page) A7 V. Description of the invention (phantom) The reaction to make this compound is similar to that of manufacture number 1 OU; 'OU NMR (DMSO) 7.50-7.29 (m, 11 Η), 7.17 (d, 1 H, J (d, 1 H, J = 2.4Hz), 7.02 (d, 1H, J = 2.4Hz), 6.93-6.85 (in, 2 4H), 5.14 (s, 2H ), 5.13 (s, 2H), 5.07 (m, 2 H), 3.92 (t, 2 H, (t, 2H, J = 5.9Hz), 2.42-2.29 (m, 4 H), 1.94 (s, 3H ), 1.44 --1.34 (m, 2H). Example No. 133 3-Gas 2- 2- (4-Ammonium-phenyl) -1--7. : 8.4Hz), 7.05 Η), 6.75-6.65 (m J = 5.9Hz), 2.55 1.40 (m, 4 H), 1.38 Γ 4- (2-pyrrolidinyl-ethyl-ethoxy) -benzyl ) -1H-indole-5 (HCL) was synthesized as in Example No. 134

Mp = 233-235°C; lH NMR (DMSO) 10.50 (s, 1 H), 9.88 (s, 1 H|, 9.01 (s, 1 H), 7.30 -7.20 (m, 3 H), 6.90 * 6.80 (m, 7 H), 6.68 (dd, 1 H, J = 2.4, Hz, 8.8 Hz), 5.20 (s, 2 H), 4.22 (t, 2 H, J = 4.8 Hz), 3.47 (t, 2 H, J = 4.8 Hz), 3.1(1 (bm, 4 H), 1.90 (s, 4 H); IR (KBr) 3400,1625, 1475, 825 cm'1; MS el m/z 462 (M+); C27H77C1N2 〇b +1 HC1+.75H2 0 之 CHN 計算 實施例编號1 3 4除去苄酯以産生3 -氛- 2- U- 筠甚-荣甚) 1 Η - ί 引 11¾ (請先閱讀背面之注意事項再填寫本頁) 裝. 訂 經濟部中央橾隼局貝工消費合作社印製 -h-m (ηc η 類似於概述於方法7之3 -甲基吲呤之步驟 基醚。此化合物然後如前述方法8所述轉變 Ηρ= 207- 209 °C ; 1 H NHR(DMS0)10.10 概要除去苄 成鹽酸鹽; ,7.22 (d, 1 H, J : (bs . 1 Η), 9.86 (s , 1H), 9.07 (s , 1 H), 7.26 (d, 2 H, J = 8.6 Hz), 8.8 Hz), 6.87 (d , 2 H , J = 8.6Hz), 6.81 - 6.78 (m , 5 H), 6.65 (cd , 1 H, J = 8.8 Hz, J = 2.2 Hz), 5.20 (s, 2 H), 4.27 (t, 2H, J = 5.0Hz), 3.44 - 3:M (m , 4 H), 3.00 -2.85 (m , 2 H), 1.81-1.60 (m , 5H), 1.41 - 1.26 (m ,1 H); IR (KB ·) 3350, 1470 89- 本紙張尺度適用中國國家標準(CNS ) A4说格(210> 297公ft ) 經 濟 部 中 標 準 局 員 工 消 f 合 作 社 A7 B7 五、發明説明(以) ,1250GM-1;MS el 丨/z 4·76(Μ + );(:28ΐΙ29(:1Μ; 0 3 + H C L + 1 . 5 Β 2 0之C Η Ν計算值。 啻協例编镰13 5 氣- 2- (4 -禅某-2-笨基)-: -r 4- (2- 吖库闵-1-某-氬某)-苄某1 -1H-H丨呤-ίΐ-ΐ % (hcη 如實施例编號134所述合成。 Mp = 196-198°C; Ή NMR (DMSO) 10.10 (bre, 1 H), 9.86 (s, 1 Η), 9.07 (s , 1 Η), 7.26 (d, 2 H, J = 8.8 Hz), 7.22 (d , 1 H, J = 9.0 Hz), 6.87 (d , 2 i,J = 8.6Ηζ), 6.84 - 6.78 (m , 5 H ), 6.65 (dd , 1 H, J = 8.8 Hz, J = 2.2 Hz), 5. 20 (s, 2 Η), 4.27 (t ,2H, J = 5.0Hz), 3.45-3.30 (m , 4 H), 3.21-3.10 (m , 2 H), 1.82 1.76 (m , 4 Η), 1.65 - 1.46 (m, 4 H); MS cl m/z 491 (M+); Cm H 31 C 1 N 2 0 3 + 1 HC1 + . 37H 2 〇 之 CHN 計算; IR (KBr) 3400,3200,1450,1125 啻掄例编號1 3 6 3-氛- 2- (4 -羥基-甲基-茱基 )-1 - Γ 4- (2 -六氮卅啶-1 -某-7,氳某)-窄某Ί - 1 Η - Nl 卜fi-鹺 如编號134所述合成,除此化合物轉變成留 i酸鹽之外》 Foam; lH NMR (DMSO) 9.64 (s , 1H), 9.01 (s , 1H), 7.25 (d, 1 a J = 8.8Hz), 7.03 (d , 1 H , J = 8.1 Hz), 6.79 (d , 1 H , J= 2.4 Hz), 6.78 - 6.65 (m , 7 H), 5.06 - 4.92 (m , 2 H), 3.94 (t, 2 H, J = 5.9 ίζ), 2.62 - 2.57 (m ,2 H), 2.42 - 2.32 (m , 4 H), 1.90 (s , 3 H), 1.48- 1.40 (m , 4 H ),1.40 - 1.32 (m, 2 H); MS el m/z 490 (M+); IR (KBr) 3430,2900,1450 cml; C 29 H 31 C 1 N 2 〇 3 +1 . OH 2 〇 之 CHN計算值 e 3-乙基时丨哚類似物编號137之合成 非常類似於前述産生3 -甲基_§丨昤之實施例 ,使用方法 a及2-8合成此化合物。僅有之差異為所使拜 之起始物以 4’ -(苄氣基)-苯丁 _CAS 编號〔 26945-7 1 -1〕 取代4夂( -90- 本紙張尺度適用申國國家標準(CNS ) A4規格(210 X 297公釐) 請 先 閱 讀 背 Λ 之 注 意 事 項 再 t 訂 A7 B7 經 濟 8.8 Hz), 7.14 8.8 Hz, 2.2 Hz), 五、發明説明(矜 苄氣基)-苯丙中間物之數據如下。 實施例編號1 δ D 5_ -一玺11_: 2 -—(苄i基-苯_ ) - 3 -乙基 -Ί μ - Ni ff朵Mp = 233-235 ° C; lH NMR (DMSO) 10.50 (s, 1 H), 9.88 (s, 1 H |, 9.01 (s, 1 H), 7.30 -7.20 (m, 3 H), 6.90 * 6.80 (m, 7 H), 6.68 (dd, 1 H, J = 2.4, Hz, 8.8 Hz), 5.20 (s, 2 H), 4.22 (t, 2 H, J = 4.8 Hz), 3.47 (t, 2 H, J = 4.8 Hz), 3.1 (1 (bm, 4 H), 1.90 (s, 4 H); IR (KBr) 3400, 1625, 1475, 825 cm'1; MS el m / z 462 (M +) ; C27H77C1N2 〇b +1 HC1 + .75H2 0 CHN calculation Example No. 1 3 4 Remove the benzyl ester to produce 3-ambient-2- U- 筠--Rong even) 1 Η-引 引 11¾ (Please read the back first Please note that you need to fill in this page again.) Packing. Ordered by the Central Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperative, printed -hm (ηc η is similar to the step-based ether of 3-methylindolin outlined in Method 7. This compound is then as The transformation described in the aforementioned method 8 ρ = 207- 209 ° C; 1 H NHR (DMS0) 10.10 to remove benzyl hydrochloride; 7.22 (d, 1 H, J: (bs. 1 Η), 9.86 (s, 1H), 9.07 (s, 1 H), 7.26 (d, 2 H, J = 8.6 Hz), 8.8 Hz), 6.87 (d, 2 H, J = 8.6Hz), 6.81-6.78 (m, 5 H) , 6.65 (cd, 1 H, J = 8.8 Hz, J = 2.2 Hz), 5.20 (s, 2 H), 4.27 (t, 2H, J = 5.0Hz), 3.44-3 M (m, 4 H), 3.00 -2.85 (m, 2 H), 1.81-1.60 (m, 5H), 1.41-1.26 (m, 1 H); IR (KB ·) 3350, 1470 89- This paper size Applicable to China National Standard (CNS) A4 (210 > 297 ft) Staff of the Bureau of Standards in the Ministry of Economic Affairs Cooperative A7 B7 V. Description of invention (in), 1250GM-1; MS el 丨 / z 4 · 76 (Μ +); (: 28 ΐ 29 (: 1 M; 0 3 + HCL + 1.5 C 2 计算 Calculated value of NB. Xie Xie lian bian 13 5 qi-2- (4 -Zhanmou-2-benzyl)-: -r 4- (2-Azcumin-1-some-argon) -benzyl-1 -1H-H呤 ----% (hcη was synthesized as described in Example No. 134. Mp = 196-198 ° C; Ή NMR (DMSO) 10.10 (bre, 1 H), 9.86 (s, 1 Η), 9.07 ( s, 1 Η), 7.26 (d, 2 H, J = 8.8 Hz), 7.22 (d, 1 H, J = 9.0 Hz), 6.87 (d, 2 i, J = 8.6Ηζ), 6.84-6.78 (m , 5 H), 6.65 (dd, 1 H, J = 8.8 Hz, J = 2.2 Hz), 5. 20 (s, 2 Η), 4.27 (t, 2H, J = 5.0Hz), 3.45-3.30 (m , 4 H), 3.21-3.10 (m, 2 H), 1.82 1.76 (m, 4 Η), 1.65-1.46 (m, 4 H); MS cl m / z 491 (M +); Cm H 31 C 1 N CHN calculation of 2 0 3 + 1 HC1 +. 37H 2 〇; IR (KBr) 3400, 3200, 1450, 1125 Example No. 1 3 6 3-Amosphere 2- 2- (4-hydroxy-methyl-jugyl) ) -1-Γ 4- (2 -hexaazapyridine-1 -some-7, 氲)-narrow Ί-1 Η-Nl fi- 鹾 was synthesized as described in No. 134, except that this compound was converted into Beyond the sulphate, Foam; lH NMR (DMSO) 9.64 (s, 1H), 9.01 (s, 1H), 7.25 (d, 1 a J = 8.8 Hz), 7.03 (d, 1 H, J = 8.1 Hz), 6.79 (d, 1 H, J = 2.4 Hz), 6.78-6.65 (m , 7 H), 5.06-4.92 (m, 2 H), 3.94 (t, 2 H, J = 5.9 ζ), 2.62-2.57 (m, 2 H), 2.42-2.32 (m, 4 H), 1.90 ( s, 3 H), 1.48- 1.40 (m, 4 H), 1.40-1.32 (m, 2 H); MS el m / z 490 (M +); IR (KBr) 3430, 2900, 1450 cml; C 29 H 31 C 1 N 2 〇3 +1. Calculated CHN value of OH 2 〇 e 3-ethyl The synthesis of indole analogue number 137 is very similar to the previous example which produces 3 -methyl_§ 丨 昤, using Methods a and 2-8 synthesize this compound. The only difference is that the starting material of worship is replaced by 4 '-(benzyloxy) -phenidine_CAS number [26945-7 1 -1] (-90- Standard (CNS) A4 specification (210 X 297 mm) Please read the precautions of Λ before ordering A7 B7 (8.8 Hz), 7.14 8.8 Hz, 2.2 Hz), V. Description of the invention (fluorenyl benzyl)- The data of styrene-acrylic intermediates are as follows. Example No. 1 δ D 5_ -One seal 11_: 2-((benzyl i-benzene-)-3-ethyl-Ί μ-Ni ff flower

Mp= 101-108°C ; MS el m/z 433(M+)〇 實施例编號1 δ 1 f 4 -fc -苄氩某-2 - ( 4 -辛氩某I -茱某)-3 7,某-丨盹-1 -某申某Ί -荣氣基)7酴7.酯.Mp = 101-108 ° C; MS el m / z 433 (M +). Example No. 1 δ 1 f 4 -fc-benzyl argon -2-(4 -octyl argon-I-Juzhu)-3 7 ,--盹 盹-1-申 Ί-荣 气) 7 申 7. Ester.

Mp= 72- 7 5 °C ; MS el m/z 6 2 5 (M + ) 〇 實施例编號1 5 2 2- f 4-(5-苄氩某- 2- U-节氳I甚-¾甚) 3_-7,甚-NI盹-1 -某申某1 -茏氬甚1 - 7,醇Mp = 72- 7 5 ° C; MS el m / z 6 2 5 (M +) 〇 Example No. 1 5 2 2- f 4- (5-benzyl argon -2-U-section 氲 I even- ¾) 3_-7, even-NI 盹 -1-a certain 1-a argon 1-7, alcohol

Mp= 105-113。。; MS el m/z 5 8 3 (M + ) 0 實施例编號1 β 3节氩基-2-(4-苄氩某-¾甚)|-1-「4-(2 色:7.氲甚)-苄某 1 - 3 - 基-1 Η - IKI 8$Mp = 105-113. . MS el m / z 5 8 3 (M +) 0 Example No. 1 β 3-section argonyl-2- (4-benzylargon-¾even) | -1- "4- (2 Color: 7.氲 Very)-benzyl 1-3-base-1 Η-IKI 8 $

Mp=140°C (分解);MS el n/z 647,645(H + Br 存在) 實施例編號1 5 4 5-苄氣基- 2-(4-苄氣基-茱4)-3_乙基Mp = 140 ° C (decomposed); MS el n / z 647,645 (H + Br is present) Example No. 1 5 4 5-Benzylamino- 2- (4-benzylamino-Ru 4) -3_ethyl

-1 Η - »41 US-1 Η-»41 US

Mp = 92 - 96°C; Ή NMR (DMSO) 7.47 (d, 4 H, J = 7.2 Hz), Tj 2 - 7.39 (m, 4 H), 7.36 - 7.30 (m, 2 H), 7.27 (d, 2 H, J = 8.6 Hz), 7.18 (d, 1 H, J : (d, 1 H, J = 2.4 Hz), 7.10 (d, 2 H, J = 8.8 Hz), 6.79 (dd, 1 H, J 6.73 (s, 4 H), 5.13 (s, 2 H), 5.11 (s, 4 H), 3.93 (t, 2 H, J = 5.9 riz), 2.62 - 2.53 (m, 4 H),2.40 _ 2.33 (m,4 H),1.49 · 1.42 (m,4 H), 1.37 - 1.30 (m,2 H),1.10 (t, 3 H, J = 7.2 Hz); MS el m/z 650 (M+H+). (請先閲讀背面之注意事項再填寫本頁) -5 央 標 準 局 員 工 消 費 合 作 社 印 實施例编號1 3 ΐ 2 -<4 -羥基-茉某)-3-乙基-1 瓴PH;啶-1 -某-乙氬某)-苄某1 - 1 Η - Ml鸣-5 9 1 4-(2- (HC 1) 本紙張尺度適用中國國家標隼(CNS ) A4规格(210X 297公釐) 經濟部中央標準局員工消費合作社印裝Mp = 92-96 ° C; Ή NMR (DMSO) 7.47 (d, 4 H, J = 7.2 Hz), Tj 2-7.39 (m, 4 H), 7.36-7.30 (m, 2 H), 7.27 (d , 2 H, J = 8.6 Hz), 7.18 (d, 1 H, J: (d, 1 H, J = 2.4 Hz), 7.10 (d, 2 H, J = 8.8 Hz), 6.79 (dd, 1 H , J 6.73 (s, 4 H), 5.13 (s, 2 H), 5.11 (s, 4 H), 3.93 (t, 2 H, J = 5.9 riz), 2.62-2.53 (m, 4 H), 2.40 _ 2.33 (m, 4 H), 1.49 · 1.42 (m, 4 H), 1.37-1.30 (m, 2 H), 1.10 (t, 3 H, J = 7.2 Hz); MS el m / z 650 (M + H +). (Please read the notes on the back before filling out this page) -5 Central Standard Bureau Staff Consumer Cooperative Co., Ltd. Example No. 1 3 ΐ 2-< 4 -Hydroxy-Mo) -3-ethyl- 1 瓴 PH; pyridine-1 -some-ethyl argon) -benzyl 1-1 Η -Mlming-5 9 1 4- (2- (HC 1) This paper size applies to China National Standard (CNS) A4 specifications (210X 297 mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閲讀背面之注意事項再填寫本頁) 訂 經 濟 部 中 央 標 準 員 工 消 費 合 作 社 印 製 Α7 Β7 五、發明説明(力) 齊施例编號15 5 节氬某-3-氣某- 2- (4 -苄I Ϊ某-荣甚) -1 Η - ¢41 ¢4 於燒瓶中5 -苄氧基- 2- (4 -苄氧基-苯基)-:. H-吲P朵编號 141〔5.9克,14.6毫莫耳)與(:112(:12(90毫 升)混合且 冷卻至Q°C (起始物質不完全溶解於CH2 Cl2 中)。猛烈 攪拌期間,經45分鐘逐滴加入氣磺醯基異氰 酸酯(2.26 克〗6.0毫莫耳)於(^2(:12(25毫升)之溶液< 反應於〇 °c 進行2小時,同時以T L C檢測不溶之N -氣磺画 §胺中間物 之形成。在此期間之後,於〇°C經4 5分鐘逐為 §加入E t 3 N (1.47 克,14.6 毫升〉於 CH2 CI2 (25 毫升)。 反暱在〇 °c 額外的1小時和在室溫2小時。當反應時間 繼纊時藉由 産物之不溶固體形成觀察反應的進展。除去 溶劑和藉由 與甲醇一起研磨純化固體殘餘物以生産(4.0 克,6 3 · 8 % )。 Mp = 238 - 242°C; iH NMR (DMSO) 12.31 (s, 1 H) ,7.88 (d, 2 H, J = 8.8 Hz), 7.48 (d, 4 H, ; = 7.25 Hz), 7.55 - 7.30 (m, 7 H), 7.23 (c ,2 H, J = 8.8 Hz), 7.14 (d, 1 H, J = 2.4 Hz), 6.97 (dd, 1 H, J = 2.2 Hz, 8.8 Hz), 5.: 0(s,2H), 5.17 (s, 2 H); MS el m/z 430 (M+). 實施例编號1 5 6漠化4 - ( 2_-氨乙氳基丄1基_ 於〇°C慢慢地加入亞硫酵溴(7.13克,34.3 1毫莫耳)到 4-(2-氯乙氣基)苄基酵CAS编號[ 1 1 1 7 28-87 -1〕( 6 · 4克 ,34.31毫莫耳)於二噁烷(100毫升)。5分g 自之後反應 在〇 °C進行β反應混合物以乙醚(2 0 0毫升)稀 _和以Η 2 〇 (1父30毫升),然後~3{!(:03(2乂25毫升),举 口鹽水(30毫 升)洗滌》有機萃取物經MgS04乾燥和濃縮。 粗産物品 -9 3 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 請 先 閲 讀 背 之 注 意 事 項 再 填 寫 本 頁(Please read the precautions on the back before filling this page) Printed by the Central Standard Employee Consumer Cooperative of the Ministry of Economic Affairs, printed Α7 Β7 V. Description of the invention (force) Qi Example No. 15 5 Section Argon-3--3- (4-benzyl I ΪMou-Rong even) -1 Η-¢ 41 ¢ 4 in the flask 5-benzyloxy-2- (4-benzyloxy-phenyl)-:. H-IndP number 141 (5.9 g, 14.6 mmol) and (: 112 (: 12 (90 ml)) and cooled to Q ° C (the starting material is not completely dissolved in CH2Cl2). During vigorous stirring, dropwise over 45 minutes Gasosulfoisocyanate (2.26 g〗 6.0 mmol) was added to a solution of (2: 12 (25 ml) < reaction at 0 ° C for 2 hours, while insoluble N-gasoline was detected by TLC § The formation of amine intermediates. After this period, add Et 3 N (1.47 g, 14.6 mL) to CH2 CI2 (25 mL) at 0 ° C over 4 5 minutes. Reverse reaction at 0 ° c additional 1 hour at room temperature and 2 hours at room temperature. As the reaction time continues, observe the progress of the reaction by the formation of insoluble solids of the product. Remove the solvent and by combining with methanol The purified solid residue was triturated to produce (4.0 g, 63 · 8%). Mp = 238-242 ° C; iH NMR (DMSO) 12.31 (s, 1 H), 7.88 (d, 2 H, J = 8.8 Hz ), 7.48 (d, 4 H,; = 7.25 Hz), 7.55-7.30 (m, 7 H), 7.23 (c, 2 H, J = 8.8 Hz), 7.14 (d, 1 H, J = 2.4 Hz) , 6.97 (dd, 1 H, J = 2.2 Hz, 8.8 Hz), 5 .: 0 (s, 2H), 5.17 (s, 2 H); MS el m / z 430 (M +). Example No. 1 5 6 Desertification 4-(2_-Aminoacetamidinium 1 group _ Slowly add thionyl bromide (7.13 g, 34.3 1 mmol) to 4- (2-chloroethanyl) at 0 ° C. Benzyl fermenter CAS number [1 1 1 7 28-87 -1] (6.4 g, 34.31 mmol) in dioxane (100 ml). 5 min g Since then the reaction was performed at 0 ° C for β reaction The mixture was diluted with diethyl ether (200 ml) and Η 2 0 (1 ml 30 ml), and then ~ 3 {! (: 03 (2 乂 25 ml), washed with saline (30 ml)> organic extracts Dry over MgS04 and concentrate. Crude product -9 3-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297mm) Please read the notes on the back of the page before filling out this page

訂 五、發明説明(V ) A7 B7 以矽凝膠色層分析(15% EtOAc/己烷)純化.4産生5.0克 |MR (DMSO) 8Hz) , 4.68 5.27Hz (58%)所需要之産物。Mp=64-66°C; tH 7.37(d,2 Η ,J= 8.8 Hz), 6.93(d,2H, J=8 (s,2H), 4.24( 1;,2H,J = 5.05Hz), 3.93(t,^H,J ;MS el i/z 248(M+)〇 實施例编號1 5 7韦氣某- 2- (4 -荣甲氳基-笨_)-l- LAr (2 -氣-Z氣某)-苄某Ί - 3 -值甚-1 H - »41 1 55 (2·86克 在反應燒瓶中,3-氣基吲呤起始物質编號 ,6.64毫莫耳)溶解於0«?(25毫升)及於(^纟|慢加入^11 (191.2毫克,8毫莫耳)^反應於0<€攪拌2{)分鐘。在分 開的燒細頸瓶中,包含溴化4-(2 -氣乙氣基)苄基编號156 (1_81克,7.28毫莫耳)於DMF(15毫升)於0°C 以注射器取出之上述製得之吲呤陰離子溶液 攪拌2 0分鐘和升高至室溫經1小時反應以 熄滅β反應混合物分佈於EtOAc(2X 100毫升 ,緩慢加入 。反m於〇°c 幾滴的Η 2 〇 )和 Η 2 0 ( 8 0 毫升)之間。有機萃取物以鹽水(80毫升)洗4,經MgSO 乾燥,和濃縮。粗産物與乙醚一起研磨純化 色固體的産物(2_80克,70.4% )。 以産生里白 (请先聞讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製Article V. Description of the invention (V) A7 B7 was purified by silica gel chromatography (15% EtOAc / hexane). 4 produced 5.0 g of MR (DMSO) 8 Hz), 4.68 5.27 Hz (58%) . Mp = 64-66 ° C; tH 7.37 (d, 2 Η, J = 8.8 Hz), 6.93 (d, 2H, J = 8 (s, 2H), 4.24 (1;, 2H, J = 5.05Hz), 3.93 (t, ^ H, J; MS el i / z 248 (M +) 〇 Example No. 1 5 7 Wei Qi-2-(4-Rongamidinyl-stupid)-l- LAr (2- Gas-Z gas)-benzyl hydrazone-3-value even -1 H-»41 1 55 (2.86 grams in the reaction flask, 3-aminoindine starting material number, 6.64 mmol) Dissolve in 0 «? (25 ml) and add in (^ 11 | slowly add ^ 11 (191.2 mg, 8 millimoles) ^ React in 0 < € and stir for 2 {) minutes. In a separate burning flask, containing 4- (2-Gasylethyl) benzyl No. 156 (1-81 g, 7.28 mmol) in DMF (15 ml) at 0 ° C Take out the indine anion solution prepared above by stirring 2 0 minutes and warmed to room temperature over 1 hour to quench the reaction. The β reaction mixture was distributed in EtOAc (2X 100 mL, added slowly. A few drops of Η 2 0) at 0 ° C and Η 2 0 (80 ml) The organic extract was washed with brine (80 ml), dried over MgSO, and concentrated. The crude product was triturated with ether to purify the product as a colored solid (2_80 g, 70.4%). To produce a pale white (please first Note Complete this page and then read it back) Order Ministry of Economic Affairs Bureau of Standards staff printed consumer cooperatives

Mp = 160-162°C; !h NMR (DMSO) 7.53 - 7.28 (m, 13 6.97 (dd, 1 H, J = 2.4 Hz, 9.0 Hz), 6.86 - 6.78 (m, 4 H), 5.37 (s, H),4.15 a 2 H, J = 4.8 Hz),3.87 (t,2 H,J = 5.3 Hz); MS el m/z 實施例編號158和159 類似於方法6之概要步驟使用前述编號15 物質完成以六氫吡啶和六亞甲基胺取代氣基 -9 4 - 本紙張尺度適用_國國家標準(匚灿)六4規格(210'乂297公釐) I), 7.23 (m, 3 H), 2 Η), 5.18 (s,4 598 (M+). ?作為起始 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 製 Α7 Β7 五、發明説明(w) 奮餱例編號158苄氫基- 2- (4-苄氫某-笨某 -3 -氣某 _1- f4_(2_六氣批旋-〗~某乙氨某)*节某1 -1 Η - »41 ΙίΦ Mp = 148 - 150 °C; ΪΗ NMR (DMSO) 7.54 - 7.30 (m, 13 H), 7 25 - 7.18 (m, 3 Η), 6.98 (dd, 1 H, J = 2.4 Hz, 9.0 Hz), 6.84 - 6.74 (m, 4 H), 5.35 ( ,2 Η), 5.17 (s, 4 H), 3.94 (t, 2 H, 5.9 Hz), 2.55 (t, 2 H, 5.7 Hz), 2.35 (bs, ^ Η), 1.50 - 1.40 (m, 4 H), 1.38 - 1.25 (m, 2 H); IR 3400, 2910, 2250, 1250 cm1; MS FAB 648 [M+H]+. 啻旃例SS號lh 氧基- 2- (4 -苄氣基-笨基) -3-氣基 -1-「4-ί2 -吖庠闵-1-某氩某节某Ί -1 Η-11¾ 11¾ !h NMR (DMSO) 8.60 (br s, 1 H), 7.60 - 7.28 (m, 12 H), 7.25 7.16 (m, 3 Η), 6.97 (dd, 1 H, J = 2.4 Hz, 9.0 Hz), 6.88 - 6.75 (m, 4 H), 5.35 (s 2 Η), 5.17 (s, 4 H), 3.92 (t, 2 H, J = 6.2 Hz), 3.08-3.00 (m, 2 H), 2.77 (t, 2 H, J =5.9 Hz), 2.63 (t, 4 H, J = 4.8 Hz), 1.78 - 1.68 (m, 2 H), 1.60 -1.40 (m, 4 H); N IS el m/z 661 (M+). 實施例编號1 3 8和1 3 9 如方法7所述使用1 , 4 -環乙二烯和1 D % P d /C藉由氫 轉移除去苄基醚。化合物如方法8中所述轉 變成其個別 之鹽酸鹽。 奮施例编號138 5-禪某- 2- U- W某-荣某 -Γ 4-(2~六 氣吡啶-:1 -某-乙Μ某)-节某1 - 1 Η - P切丨# -腈( hc η Mp = 173 - 175°C; lH NMR (DMSO) 10.40 (s, 1 H), 10.12 (s, 1 Η), 9.40 (s, 1 Η), 7.38 (m, 2 H), 7.30 (d, 1 H, J = 8.8 Hz), 7.02 - 6.90 (m, 3 H), 6. 88 (s, 4 Η), 6.75 (dd, 1 H, J = 2.4 Hz, 9Hz), 5.33 (s, 2 H), 4.30 (t, 2 Ht J = 4.8 H ;),3.51 - 3.38 (m, 4 H), 2.92 (m, 2 H), 1.85 - 1.73 (m, 4 H), 1.68 * 1.59 (m, 1 ίΐ), 1.26- 1.21 (m, 1 H); IR 3400, 2200,1250 cm-1; MS el m/z 467 (M+); c 29 H 29 N 3 0 3 +1 . 0HC1 + 1 . OH 2 〇 之 CHN計算值 實施例编號1 3 9 1 -「4 - ( 2 -吖廉因-1 -某)-7, S甚)-苄 -95- 本紙張尺度適用中國國家標隼(CNS〉A4規格(210X297公釐) 請 先 閱 讀 背 之 注 意 事 項 再 養 訂 五、發明説明(料 A7 B7Mp = 160-162 ° C;! H NMR (DMSO) 7.53-7.28 (m, 13 6.97 (dd, 1 H, J = 2.4 Hz, 9.0 Hz), 6.86-6.78 (m, 4 H), 5.37 (s , H), 4.15 a 2 H, J = 4.8 Hz), 3.87 (t, 2 H, J = 5.3 Hz); MS el m / z Example Nos. 158 and 159 Similar steps to method 6 using the preceding numbers 15 Substances are completed with hexahydropyridine and hexamethyleneamine to replace the gas group-9 4-This paper size is applicable _ national standard (匚 Can) six 4 specifications (210 '乂 297 mm) I), 7.23 (m, 3 H), 2 Η), 5.18 (s, 4 598 (M +).? Printed as the starting consumer employee cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. 2- (4-benzylhydrogen-stupid-3 -gas a certain_1-f4_ (2_six-gas batch cyclone-〗 ~ a certain ethyl ammonia a certain) * jiemou 1 -1 Η-»41 ΙίΦ Mp = 148- 150 ° C; ΪΗ NMR (DMSO) 7.54-7.30 (m, 13 H), 7 25-7.18 (m, 3 Η), 6.98 (dd, 1 H, J = 2.4 Hz, 9.0 Hz), 6.84-6.74 ( m, 4 H), 5.35 (, 2 Η), 5.17 (s, 4 H), 3.94 (t, 2 H, 5.9 Hz), 2.55 (t, 2 H, 5.7 Hz), 2.35 (bs, ^ Η) , 1.50-1.40 (m, 4 H), 1.38-1.25 (m, 2 H); IR 3400 , 2910, 2250, 1250 cm1; MS FAB 648 [M + H] +. Example SS No. lh Oxyoxy-2- (4-benzyloxy-benzyl) -3-oxy-1--1-4- ί 2-acridine min-1-a certain argon a certain 某 -1 Η-11¾ 11¾! h NMR (DMSO) 8.60 (br s, 1 H), 7.60-7.28 (m, 12 H), 7.25 7.16 (m, 3 Η), 6.97 (dd, 1 H, J = 2.4 Hz, 9.0 Hz), 6.88-6.75 (m, 4 H), 5.35 (s 2 Η), 5.17 (s, 4 H), 3.92 (t, 2 H, J = 6.2 Hz), 3.08-3.00 (m, 2 H), 2.77 (t, 2 H, J = 5.9 Hz), 2.63 (t, 4 H, J = 4.8 Hz), 1.78-1.68 (m, 2 H), 1.60 -1.40 (m, 4 H); N IS el m / z 661 (M +). Example No. 1 3 8 and 1 3 9 Use 1, 4-cycloethylenediene as described in method 7 And 1 D% P d / C to remove the benzyl ether by hydrogen transfer. The compound was converted to its individual hydrochloride as described in Method 8. Fen Example No. 138 5-Zhen Mou 2- 2- U- W Mou-Rong Mou-Γ 4- (2 ~ Hexapyridine-: 1- Mou-BM Mou)-Kou Mou 1-1 Η-P-cut丨 # -Nitrile (hc η Mp = 173-175 ° C; lH NMR (DMSO) 10.40 (s, 1 H), 10.12 (s, 1 Η), 9.40 (s, 1 Η), 7.38 (m, 2 H ), 7.30 (d, 1 H, J = 8.8 Hz), 7.02-6.90 (m, 3 H), 6. 88 (s, 4 Η), 6.75 (dd, 1 H, J = 2.4 Hz, 9Hz), 5.33 (s, 2 H), 4.30 (t, 2 Ht J = 4.8 H;), 3.51-3.38 (m, 4 H), 2.92 (m, 2 H), 1.85-1.73 (m, 4 H), 1.68 * 1.59 (m, 1 ίΐ), 1.26- 1.21 (m, 1 H); IR 3400, 2200, 1250 cm-1; MS el m / z 467 (M +); c 29 H 29 N 3 0 3 +1. 0HC1 + 1. OH 2 〇 calculated value of CHN Example No. 1 3 9 1-"4-(2-acryl -1-a) -7, S even)-benzyl-95- This paper size applies to China National standard (CNS> A4 specification (210X297mm) Please read the precautions on the back first and then revise the description of the invention (material A7 B7

Mp = 160 < 163°C; lH NMR (DMSO) 10.22 (s, 1 H), 10.08 (s, 7.40 - 7.37 (m, 2 H), 7.30 (d, 1 H, 8.8 Hz), 7.0 - 6.90 (m, 3 H) (dd, 1 H, J = 2.41 Hz, 9 Hz), 5.33 (s, 2 H), 4.27 (t, 2 H, J = 5.0 H), 9.35 (s, 1 H), 6.87 (s, 4 H), 6.74 Hz), 3.50 - 3.30 (m, 4 H), 3.20 (m, 2 H), 1.85 - 1.70 (m, 4 H), 1.65 - 1.50 (m, 4 H); IR 3300, 2200, 1 2 5 0 c hi -1 ; M S e I b/z 4 8 1 ( M + ) ; C 3〇 H 31 1 H 2 0之C Η N計算值e 3 1 HC1Mp = 160 < 163 ° C; lH NMR (DMSO) 10.22 (s, 1 H), 10.08 (s, 7.40-7.37 (m, 2 H), 7.30 (d, 1 H, 8.8 Hz), 7.0-6.90 (m, 3 H) (dd, 1 H, J = 2.41 Hz, 9 Hz), 5.33 (s, 2 H), 4.27 (t, 2 H, J = 5.0 H), 9.35 (s, 1 H), 6.87 (s, 4 H), 6.74 Hz), 3.50-3.30 (m, 4 H), 3.20 (m, 2 H), 1.85-1.70 (m, 4 H), 1.65-1.50 (m, 4 H); IR 3300, 2200, 1 2 5 0 c hi -1; MS e I b / z 4 8 1 (M +); C 3〇H 31 1 H 2 0 C Η N Calculated value e 3 1 HC1

RR

VR O (請先閱讀背面之注意事項再填寫本頁) 、?τ 經濟部中央標準局員工消費合作杜印製 表9 實施例编號 R z 編號1 60 Et 0 編號1 6 1 t - B u 0 编號1 6 2 t - B u 0 96- 本紙張尺度適用中國國家標準(CNS ) A4規格〈210X 297公釐) 經 濟 部 t 央 準 員 工 消 費 合 杜 印 製 A7 B7 五、發明説明(作) 啻旆例溢號162 2-(4 -挥某-¾某)-3 -甲某-] —f 4-(2 -六 氤卅啶-1 -某-Z Μ甚)-苄某Ί - 1 Η -11¾盹-5 - f 51夕二-梓 戊酸酯 使用實施例编號97自由驗做為此合成之赳 始材料。於 20毫升CH2C12的编號97(1.0克,2.5毫莫] 耳)以二異丙 基乙胺(0.7克,6.3毫莫耳)和〇&amp;1311;卜0&gt;(八1 3處理。反應 冷卻到0 °C和以持戊醯基氨化物(0 . 7毫升, 5 . 6毫莫耳) 處理和允許至室溫並攪拌過夜。反應藉由以 CH a C1 2 稀 釋結束以水和鹽水洗牆。在經MgSO 4乾燥之 後濃縮溶液 且層析於矽凝膠(MeOH/CH2Cl2 , 1: 19). 以産生呈橘 色的泡沫的所需要物質(1.08克)。此物質料 然後溶解在 1 5毫升乙酸乙酯中和以2 . 5毫升1M HC 1/ Et 2 〇溶液處理 。加入己烷直到溶液轉變成霧狀。産物以H&lt; 1鹽沈澱出來 。此物質從乙酸乙酯/己烷再結晶以産生0 42克之純编 號 162: M p = 182-185°C ; C 33 Η 48 Ν 2 〇 s +HC + 0.25Η 2 〇之 C Η Ν計算值。 奮施例編號160 1-[ 4-(2-吖庚因-1-某-乙&gt; ii某)-苄 某 1 -2-U-辉某-茱某)-:? -申某 -醇;&gt; 二芮 酸酯(H C 1 ) 類似於實施例162製備化合物,除使用實) 另5例编號98當 做起始物質及所使用之醯化劑為氣化丙醯基 之外:Μ p = 宵施例編號161 1-ί4-(2 -吖庠W-1-某 _:某)-节 某1 -2-(4-锊某-¾某)-3 -甲某- IH-料丨盹-Π- -轅夕恃二戊 __0JJ_ 本紙張尺度適用中國國家標準(CNS ) A4規格(2Γ〇_Χ 297公釐) 請 先 閱 讀 背 意 事 項 再 奢 裝 訂 經濟部中央標準局員工消費合作社印袋 A7 B7五、發明説明(朴)酸酯(H U ) 類似於實施例编號162製備化合物,除使f 號98作為起始物質之外:Mp= 143-1S51°C ; C + H C 1 + Ο . 7 5 Η 2 0 之 C fl N 計算值。鬣—1篮1_號丄6泣-皇览VR O (please read the precautions on the back before filling this page),? Τ Printed by the Consumer Consumption Cooperation of the Central Standards Bureau of the Ministry of Economic Affairs 9 Example No. R z No. 1 60 Et 0 No. 1 6 1 t-B u 0 Number 1 6 2 t-B u 0 96- This paper size is applicable to Chinese National Standard (CNS) A4 specifications <210X 297 mm) Ministry of Economic Affairs t Central Prospective Staff Consumption and Printing A7 B7 V. Description of Invention (for ) Example overflow number 162 2- (4 -Waumou-¾some) -3 -Amou-] —f 4- (2 -Hexamidine-1 -Wa-Z Μ even) -Benzyl 1 Η -11¾ 盹 -5-f 51 Xi-Zyvalerate was freely tested as the starting material for this synthesis using Example No. 97. In 20 ml of CH2C12, number 97 (1.0 g, 2.5 mmol) was treated with diisopropylethylamine (0.7 g, 6.3 mmol) and O &1311; Bu &gt; (Au 13). Reaction Cooled to 0 ° C and treated with pentamyl amide (0.7 mL, 5.6 mmol) and allowed to room temperature and stirred overnight. The reaction was ended by dilution with CH a C1 2 with water and brine Wash the walls. After drying over MgSO 4, the solution was concentrated and chromatographed on a silica gel (MeOH / CH2Cl2, 1: 19). This gave the desired substance (1.08 g) as an orange foam. This material was then dissolved in 15 ml of ethyl acetate was neutralized and treated with 2.5 ml of a 1M HC 1 / Et 2 0 solution. Hexane was added until the solution turned into a mist. The product precipitated out as H &lt; 1 salt. This material was from ethyl acetate / hexane The alkane is recrystallized to yield 0 42 g of pure number 162: M p = 182-185 ° C; C 33 Η 48 Ν 2 〇s + HC + 0.25 Η 2 〇C Η Calculated value. Fen example number 160 1 -[4- (2-Azine-1-1-some-B &gt; ii) -benzyl-1-2-U-Hui-Jiu)-:? -Shenmou-ol; &gt; Direic acid Esters (HC 1) Preparation compounds, except for the actual use) Another 5 cases of No. 98 as starting materials and the fluorinating agent used is gasified propionyl group: Μ p = ^ Example No. 161 1-ί4- (2-acridine W-1-some_: some) -jiemou 1 -2- (4- 锊 some-¾some) -3-Jiamou-IH-material 丨 盹 -Π--辕 夕 辕 二 pent __0JJ_ This paper size Applicable to China National Standard (CNS) A4 specification (2Γ〇_Χ 297 mm) Please read the intent first and then bookbinding the printed bag A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs ) A compound was prepared similarly to Example No. 162, except that f No. 98 was used as the starting material: Mp = 143-1S51 ° C; C + HC 1 + 0. 7 5 Η 2 0 C fl N calculated value. Hyena—1 basket 1_ No. 6 weeping-Huang Lan

-98 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 實施例编 40 Η 50 0 2 Ο Β (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製-98 This paper size applies the Chinese National Standard (CNS) Α4 specification (210 × 297 mm) Example 40 Η 50 0 2 〇 Β (Please read the precautions on the back before filling this page) Order the consumption by the Central Standards Bureau of the Ministry of Economic Affairs Printed by a cooperative

—8= '—^1 -----I «^! !—I Hi. 1^1. - .1 n ......- 1^1 I - I ; : I— 1^1(請先閱讀背面之注意事項再填寫本頁) 經 濟 部 中 央 標 準 局 員 工 消 合 作 社 印 製 A7 B7 五、發明説明(衫) mm丄趾 2-U -镩某-茱某)-3-申某-1- ί4-六;i ΐ m腚-1 -甚) -丙氤甚)-窄某1 - 1 Η -叫1盹-5 -醇 根據流程圖1 6和下列提供步驟製備化合ί 3 : 方法1 1 奮施例編號1 6 3 a 4 - ( 3 -氣丙氩^ E )-爷某醇 4 -羥基苄基醇CAS编號〔 623-05-2〕(103 S , 80 . 5毫莫 耳)於乙醇(7 0毫升)之溶液以1,3 -溴氣丙烷 (1 6 . 0克,10 0 毫莫耳)處理和氫氣化鉀(5.ϋ克,8 9毫莫耳 )回流2小時 。冷卻溶液及過濾,然後濃縮濾液。濃縮答 1以乙醚處理 及以水,鹽水洗滌和經硫酸鎂乾燥。該物1 ί使用乙酸乙 酯/己烷(3: 7.)層析於矽凝膠上以産生呈g 丨色固體之産 物:Mp = 65°C; WNMR (DMSO) 7.21 (d, 2 H,J =8.8 Hz), 6.88 (d, 2 H, J = 8.8 Hz), 5.03 (t, 1 H, J = 5.7 Hz), 4.40 (d, 2H, J = 5.5 Hz), 4.05 (t, 2 H, J = 6.1 Hz), 3.77 (t, 2 H, J = 6.4 Hz); MS el m/z 200. 奮施例編號163b溴化4-(3 -氛丙氬基)-苄J : 4-(3-氛丙氣基)-苄基醇编號162(10.6克 ,52 . 8毫莫 耳)於二枵烷(〇 · 1 2 5升)之溶液冷卻至0°C並 以逐滴加入 亞硫酷溴(12.0克,58.0毫莫耳)處理β 10夕 鐘之後反應 完成〇以乙継稀釋二枵烷及以水,鹽水洗補 和經M g S 0 4 乾燥》該物質經濃縮以産生15克油狀物: •HNMRiDMSO) 7.36 (d, 2 H, J = 8.8 Hz), 6.92 (d, 2 H, J =8.6 Hz), 4.68 (s, 2 H), 4.08 (t, 2 H, J = 5.9 Hz), 3.77 (t, 2 H, J = 6.4 Hz); MS (FA lB) 266 (M+H+). -100- 本紙張尺度適用_國國家標準(CNS ) A4規格(210X297公釐) 請 kj 閱 讀 背 意 事 項 再 填 寫 本 頁 訂 經 濟 部 t 標 準 局 Μ 工 消 合 作 社 印 製 Α7 Β7 五、發明説明(π) 方—u_ 實施例溢號164 5-苄Μ某- 9- U-节氩某-采: Γ 4- ί 3-氣一1-基甲甚Ί 氛甚一3-申某一1H-I^ll^ 由5-苄氧基-2-(4-苄氣基-苯基)-3 -甲基 1Η-_引Β朵编 號7(6.5克,15.5毫莫耳)於0!^(60毫升)所; 巨成之溶液 冷卻至0 °C且以加入氫化納(〇 . 6 8克,1 7 . 0毫 莫耳)處理 並攪拌20分鐘。然後緩慢加入氯化4-(3 -氯i §氧基)-苄基 编號163於DMF(60毫升}之溶液。使反應至室 溫且攪拌2 小時。將反應注入至水中及以乙酸乙酯萃取 。以水,鹽 水洗滌乙酸乙酯及經硫酸鎂乾燥及濃縮。以 甲醇處理濃 縮及所要産物以白色固體沈澱,具有13 0-U 2 °C之熔點。 方法1 4 實施例缢號165 5 -苄氛甚- -苄氬基-荣3 E ) - 1 - Γ 4- (3_六氣哦游-1-甚-而氛甚)-韦某1 -&lt;3 -甲甚 -1 Η - Ρ;ίΙ 由5 -苄氧基- 2- (4 -苄氧基-苯基)1-〔 4-(3 -氣-丙氣基) -苄基]-3 -甲基-1 Η - 丨昤编號1 6 4 ( 3克,5 · 1毫奠耳), 碘化鉀(2 · 5克,1 5 _ 3毫莫耳)和六氫咄啶(3 . 〇毫升,30 . 6 毫莫耳)之於D M F ( 6 0毫升)1 0 0 °C加熱1 8小時。 將反應注 入至水中及以乙酸乙酯萃取。有機層以水, 鹽水洗滌及 經硫酸鎂乾燥。將溶液濃縮至一油狀物及藉 由加入沈澱 出産物。獲得呈白色固體之産物。Μρ=104·] L06°C; *H NMR (DMSO) 7.47 (d, 4 H, J = 7.5 Hz), 7.38 (q, 4 H, J = 7.9 H 〇, 7.36-7.30 (m, 1 H), 7.28 (d, 2 H, J = 8.3 Hz), 7.19 (d, 1 H, J = 8.8 Hz), M2-7.10 (m, 4H), 6.80 (dd, 1 H, J = 8.8, 2.0 Hz), 6.72 (s, 4 H), 5.14 (s, 2 H), 5.1: (s,2H), 5.11 (s, 2 H), 3.86 (t, 2 H, J = 6.4 Hz), 2.35-2.20 (m, 6 H), 2.14 (s,: Η), 1.78-1.75 (m, 2 H), 1.47-1.42 (m,4 H), 1.40-1.31 (m, 2 H); MS el m/z 650 -1 0 1 - 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX297公釐) /-*~v 請 先 閱 讀 背之 注 意 事 項 再 填 寫 本 頁 訂 五、發明説明( A7 B7 實施例编號1 6 e 2-(4-羥基-苯基)-3-甲某-j- ( 4- Γ 3- (六氩PH;啶-1 -甚)-丙氳甚Ί -笮某1 - 1 Η -师n 5-苄氣基- 2-(4-苄氧基-苯基)-1-〔 4-(3-基)-丙氣基)-苄基]-3-甲基-1H-吲昤编號] 於四氫呋喃(25毫升)和乙醇(25毫升)之溶液 之10%支撐於磺上之耙。加入己二烯(10毫3 室溫攪拌1 8小時。經賽里持(c e 1 i t e )過濾催 反應混合物和層析矽凝膠使用二氣甲烷/甲g 離呈白色泡沫之産物(0.8克)c Mp= 125-130°C; *1 U二 l 六氫吡啶-l-65(2.35¾ ) 加至2 . 3克 L )及反應於 化劑且濃縮 U 4 ·’ 1 )以溶 70 8· W 11 (s' 68( 9· (請先閱讀背面之注意事項再填寫本頁) (s, 1 H), 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6. J5--8 = '— ^ 1 ----- I «^!! —I Hi. 1 ^ 1.-.1 n ......- 1 ^ 1 I-I;: I— 1 ^ 1 ( Please read the notes on the back before filling in this page) A7 B7 printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of invention (shirt) mm 丄 Toe 2-U-镩 某-朱某) -3-Shenmou- 1- ί4- 六; i ΐ m 腚 -1-even)-propyl 氤 even)-narrow certain 1-1 Η-called 1 盹 -5-alcohol according to the flow chart 16 and the following steps to prepare the compound ί 3: Method 1 1 Fen Example No. 1 6 3 a 4-(3-Gapropargon ^ E) -Yemolol 4-Hydroxybenzyl alcohol CAS No. [623-05-2] (103 S, 80.5 mmol) Ear) in ethanol (70 ml), treated with 1,3-bromopropane (16.0 g, 100 mmol) and refluxed with potassium hydride (5.1 g, 89 mmol) 2 hours. The solution was cooled and filtered, and the filtrate was concentrated. Concentrated solution 1 was treated with ether and washed with water, brine and dried over magnesium sulfate. This product 1 was chromatographed on a silica gel using ethyl acetate / hexane (3: 7) to produce a g-colored solid product: Mp = 65 ° C; WNMR (DMSO) 7.21 (d, 2 H , J = 8.8 Hz), 6.88 (d, 2 H, J = 8.8 Hz), 5.03 (t, 1 H, J = 5.7 Hz), 4.40 (d, 2H, J = 5.5 Hz), 4.05 (t, 2 H, J = 6.1 Hz), 3.77 (t, 2 H, J = 6.4 Hz); MS el m / z 200. Fen Example No. 163b Bromide 4- (3 -trifluoropropylargonyl) -benzyl J: 4 A solution of-(3-aminopropanyl) -benzyl alcohol number 162 (10.6 g, 52.8 mmol) in dioxane (0.125 liters) was cooled to 0 ° C and dropped dropwise. Add thionyl bromide (12.0 g, 58.0 millimoles) to treat β 10 minutes. The reaction is complete. Dioxane is diluted with acetam and washed with water, brine and dried over M g S 0 4. The material is concentrated. To produce 15 grams of oil: HNMRiDMSO) 7.36 (d, 2 H, J = 8.8 Hz), 6.92 (d, 2 H, J = 8.6 Hz), 4.68 (s, 2 H), 4.08 (t, 2 H, J = 5.9 Hz), 3.77 (t, 2 H, J = 6.4 Hz); MS (FA lB) 266 (M + H +). -100- This paper size is applicable to the national standard (CNS) A4 specifications ( 210X297 mm) Please kj read the memorandum again Fill out this page and print it from the Ministry of Economic Affairs t Standard Bureau Μ Industrial Consumer Cooperatives A7 Β7 V. Description of the invention (π) Fang — u_ Example Ex. 164 -ί 3-Gas 1-ylmethyl stilbene Aromatics even 3-shen 1H-I ^ ll ^ By 5-benzyloxy-2- (4-benzylamino-phenyl) -3 -methyl 1Η-_ 引 Β 朵 # 7 (6.5g, 15.5mmol) in 0! ^ (60mL); Jucheng solution was cooled to 0 ° C and sodium hydride (0.68g, 1 7.0 mmol) and stir for 20 minutes. A solution of 4- (3-chloroi §oxy) -benzyl number 163 in DMF (60 ml) was then slowly added. The reaction was allowed to come to room temperature and stirred for 2 hours. The reaction was poured into water and ethyl acetate. Ester extraction. Wash ethyl acetate with water, brine and dry and concentrate over magnesium sulfate. Concentrate with methanol and precipitate the desired product as a white solid with a melting point of 13 0-U 2 ° C. Method 1 4 Example No. 165 5 -benzyl benzoate--benzyl arginyl-Rong 3 E)-1-Γ 4- (3_ 六 气 哦 游 -1-even -and even qi)-Wei Mou 1-&lt; 3 -methyl even -1 Η-Ρ; ί 1 by 5 -benzyloxy-2- (4-benzyloxy-phenyl) 1- [4- (3 -Ga-propanyl) -benzyl] -3 -methyl-1 Η -丨 昤 No. 1 6 4 (3 g, 5.1 mmol), potassium iodide (2.5 g, 15 _ 3 mmol) and hexahydropyridine (3.0 ml, 30.6 mmol) Mol) was heated in DMF (60 ml) at 100 ° C for 18 hours. The reaction was poured into water and extracted with ethyl acetate. The organic layer was washed with water, brine and dried over magnesium sulfate. The solution was concentrated to an oil and the product was precipitated by addition. The product was obtained as a white solid. Μρ = 104 ·] L06 ° C; * H NMR (DMSO) 7.47 (d, 4 H, J = 7.5 Hz), 7.38 (q, 4 H, J = 7.9 H 〇, 7.36-7.30 (m, 1 H) , 7.28 (d, 2 H, J = 8.3 Hz), 7.19 (d, 1 H, J = 8.8 Hz), M2-7.10 (m, 4H), 6.80 (dd, 1 H, J = 8.8, 2.0 Hz) , 6.72 (s, 4 H), 5.14 (s, 2 H), 5.1: (s, 2H), 5.11 (s, 2 H), 3.86 (t, 2 H, J = 6.4 Hz), 2.35-2.20 ( m, 6 H), 2.14 (s ,: Η), 1.78-1.75 (m, 2 H), 1.47-1.42 (m, 4 H), 1.40-1.31 (m, 2 H); MS el m / z 650 -1 0 1-This paper size is applicable to Chinese National Standard (CNS) A4 specification (21 OX297 mm) /-* ~ v Please read the precautions on the back before filling in this page. V. Description of the invention (A7 B7 embodiment edit No. 1 6 e 2- (4-hydroxy-phenyl) -3-methyl-j- (4- Γ 3- (hexahydrogen PH; pyridine-1-even) -propyl hydrazone -pyrene 1-1 Η-师 n 5-benzylamino- 2- (4-benzyloxy-phenyl) -1- [4- (3-yl) -propanyl) -benzyl] -3-methyl-1H- Indigo number] Rake supported on a sulfonate in 10% of a solution of tetrahydrofuran (25 ml) and ethanol (25 ml). Add hexadiene (10 mmol 3 and stir at room temperature for 18 hours. 1 ite) Filter the reaction mixture and chromatographic silica gel using digas methane / methyl g product (0.8 g) as a white foam. C Mp = 125-130 ° C; * 1 U dil hexahydropyridine-l-65 (2.35 ¾) Add to 2.3 g L) and react with chemical reagent and concentrate U 4 · '1) to dissolve 70 8 · W 11 (s' 68 (9 · (Please read the precautions on the back before filling this page) (s, 1 H), 7.15 (d, 2 H, J = 8.6 Hz), 7.05 (d, 1 H, J = 8.8 Hz), 6. J5

(d, 2 H, J = 8.6 Hz), 6.80 (d, 1 H, J = 2.4 Hz), 6.74 (d, 4 H, J 2.6 Hz), 6.57 (dd, 1 H, J = 8.6, 2.2 Hz), 5.09 (s, 2 H), 3.88 (t, 2 H, J = 6.4 Ηε), 3.60-3.15 (m, 2 H), 2.62-2.38 (m, 4 H), 2.09 (s, 3 H), 1.92-1.78 (m, 2 H) (m, 4 H), 1.42-1.30 (m, 2 H); IR (KBr) 3400 (br), 2900, 1620 m/z 470. 編號1 6 7和1 6 8之合成 1.55-1.43 1515 cm-1; MS el 訂 經濟部中央標準局貝工消費合作社印繁(d, 2 H, J = 8.6 Hz), 6.80 (d, 1 H, J = 2.4 Hz), 6.74 (d, 4 H, J 2.6 Hz), 6.57 (dd, 1 H, J = 8.6, 2.2 Hz ), 5.09 (s, 2 H), 3.88 (t, 2 H, J = 6.4 Ηε), 3.60-3.15 (m, 2 H), 2.62-2.38 (m, 4 H), 2.09 (s, 3 H) , 1.92-1.78 (m, 2 H) (m, 4 H), 1.42-1.30 (m, 2 H); IR (KBr) 3400 (br), 2900, 1620 m / z 470. Numbers 1 6 7 and 1 Synthesis of 6 8 1.55-1.43 1515 cm-1; MS el.

Z -10 2- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 經 濟 部 中 央 標 準 員 工 消 費 合 社 印 製 A7 B7 五、發明説明() 奮農unm L4-萍某-架華Γ3-甲氣某- 4- (2 -六氣 毗啶-1 -基 乙氩基)-苄甚1 - :?-申某-1 Η - 0¾丨盹-5 -醇 曹施例缢號1R9 (4-申_某-2-申氣某-¾氫; S )-乙酸乙酯 包含香草醛(20克,0.13莫耳),溴乙酸乙 酯(28. 4克, 0.17莫耳)和碩酸鉀(32.7克,0.24莫耳)和j 亏酮2 0 0毫升 之燒瓶加熱到回流3小時。反應允許至室溫 。除去丙謂 ,旦將殘餘物分佈在水和乙酸乙酯之間。乙 酸乙酯以鹽 水洗滌和經酸鎂乾燥。濃縮有機層,且固i 1與己烷一起 研磨産生28.4克的實施例編號169。 Mp = 56 - 59 °Q XH NMR (DMSO) 9.83 (s, 1 H), 7.50 (dd, 1 H, J = 2.0 Hz, 8.3 Hz), 7.42 (d, 1 H, J = 1.7 Hz), 7.07 (d, 1 H, J = 8.4 Hz), 4.91 ( !, 2 Η), 4.16 (q, 2 H, J = 7.2 Hz), 3.84 (s, 3 H), 1.20 (t, 3 H, J = 7.1 Hz); N IS el m/z 238 (M+); C H 14 0 s之C Η N計算值。 奮施例編號1 7 0 (4 -氣甲某-2 -申氩某-茏氩3 ί )-z. m r. m 實施例編號169(28.8克,0.119奠耳)於60 〇毫升的EtOH / Τ Ο ( 1 : 1 )的溶液於0 °C以硼氫化納(2 . 2 5多 5 , . 06莫 耳)處理和攪拌4 5分鐘。蒸發溶劑,且反應述 l合物以乙 酸乙酯稀釋和以1 H H C 1溶液洗滌。如此獲得 的呈油狀物 之産物(1 4 . 2克,0 . Q 5 9莫耳)溶解於1 4 0毫升 的THF中且 冷卻到0 °C。此溶液然後於n°c以逐滴加入亞 硫醯氮(7 . 38 克,Q.062莫耳)處理。在1小時之後將反應 注入4 0 0毫 升水内且以乙醚萃取。乙醚層以磺酸氫鈉溶 液洗滌和經 硫酸鎂乾燥。將此濃縮和使用乙酸乙酯/己 笼(1 : 9 )以 -1 0 4 - 本紙張尺度適用t國國家標準(CNS ) A4規格(210X297公釐) 請 先 閲 讀 背 面 i 事 項 再 填 馬 本 頁Z -10 2- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) Printed by the Consumer Standards of the Central Standard of the Ministry of Economic Affairs A7 B7 V. Description of the invention () Fennon unm L4-Pingmou-架 华 Γ3- 甲 气 某-4- (2 -Hexa-pyridine-1 -ylethylargonyl) -benzyl 1-:? -Shenmou-1 Η-0¾ 丨 盹 -5-Alcohol Shi Example No. 1R9 (4-Shen_some-2-Shenqisome-¾ hydrogen; S) -ethyl acetate contains vanillin (20 g, 0.13 mole), ethyl bromoacetate (28.4 g, 0.17 mole) A flask of 200 ml of potassium pegasus (32.7 g, 0.24 mol) and 200 ml of j-ketone was heated to reflux for 3 hours. The reaction was allowed to reach room temperature. Removal of the acetone, once the residue was distributed between water and ethyl acetate. Ethyl acetate was washed with brine and dried over magnesium acid. The organic layer was concentrated, and solid i 1 was triturated with hexane to give 28.4 g of Example No. 169. Mp = 56-59 ° Q XH NMR (DMSO) 9.83 (s, 1 H), 7.50 (dd, 1 H, J = 2.0 Hz, 8.3 Hz), 7.42 (d, 1 H, J = 1.7 Hz), 7.07 (d, 1 H, J = 8.4 Hz), 4.91 (!, 2 Η), 4.16 (q, 2 H, J = 7.2 Hz), 3.84 (s, 3 H), 1.20 (t, 3 H, J = 7.1 Hz); N IS el m / z 238 (M +); C Η N calculated for CH 14 0 s. Fen Example No. 1 7 0 (4-Qi Jia Mou-2-Shen Ar Mou-Xuan Ar 3)-z. M r. M Example No. 169 (28.8 g, 0.119 Moore) in 60 ml of EtOH The solution of ΤΟ (1: 1) was treated with sodium borohydride (2.25 more than 5,06mol) at 0 ° C and stirred for 4 5 minutes. The solvent was evaporated and the reaction mixture was diluted with ethyl acetate and washed with a 1 H H C 1 solution. The thus obtained oily product (14.2 g, 0. 59 mol) was dissolved in 140 ml of THF and cooled to 0 ° C. This solution was then treated at n ° C by dropwise addition of thionyl nitrogen (7.38 g, Q.062 moles). After 1 hour the reaction was poured into 400 ml of water and extracted with ether. The ether layer was washed with a sodium hydrogensulfonate solution and dried over magnesium sulfate. Concentrate this and use ethyl acetate / hexane cage (1: 9) to -1 0 4-This paper size is applicable to National Standards (CNS) A4 specifications (210X297 mm) Please read the i item on the back before filling in page

訂 經 濟 部 中 標 準 局 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(、m) 矽凝膠層析。獲得1 〇 . 5克呈白色固體的産物 〇 Μ p = 6 4- 66°C; ΪΗ NMR (DMSO) 7.06 (d, 1 H, J = 2.0 Hz), 6.91 (dd, 1 H, J = 2.0 Hz, 2.2 Hz), 6.83 (d, 1 H, J = 2.1 Hz), 4.75 (s, 2 Η), 4.70 (s, 2 H), 4.13 (q, 2 H, J = 7.2 Hz), 3,77 (s, 3 H), 1.19 (t, 3 H, J = 7.1 Hz); MS el IB / z 2 5 8 ( M + ) ; C 12 H 15 C 1 0 4 之 c Η N 計算值。 育淪例梢觫1 7 1 f 2 -田氳甚-4 - f 5 -窄氬某- 2 - (4 -苄氣 甚-¾某)-3-W甚某甲基]-苯氣基 1 Z酸乙酯 如方法3所逑使用實施例编號作為親售 1子劑完成 吲昤编號7之烷基化作用》 Mp = 120- 123°C; !h NMR (DMSO) 7.48 - 7.20 (m, 13 H), 7, 18 - 7.10 (m, 3 Η), 6.80 (dd, 1 H, J = 2,5 Hz, 8.8 Hz),6.64 (d,1 H,J = 8.4 Hz), 6· 52 (d, 1 H, J = 2.0 Hz), 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s ,4H),5.10 (s, 2 H), 4.61 (s, 2 H), 4.10 (q, 2 H, J = 7.0 Hz), 3.58 (s, 3 H), 2.15 (s,3 Η), 1.15 (t, 3 H, J = 7.0 Hz); MS el m/z 641 (M+). 拜施例绢號172 i 2-申氫某-4- f 5-苄氯J 氩某-荣某)-3 -申甚-时丨8¾ - :l -基甲基Ί -苯氲 某)-7,醇 如前逑方法4完成酯编號171之還原作用。 Mp = 86 - 90°C; lH NMR (DMSO) 7.48 - 7.20 (m, 13 H), 7,18 - 7.10 (m, 3 Η), 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), 6.52 (c I, 1 Η, J = 2.0 Hz), 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H), 5.10 (s, 2 H), 4.76 (t, 1 H, J = 5.5 Hz), 3.83 (t, 2 H, J = 5.1 Hz), 3.63 (q, 2 H, J =. .3 Hz), 3.56 (s, 3 H), 2.15 (s, 3 H); MS el m/z 599 (M+). «施例編號173 5-节氛某- 2- (4-辛氳基-苯夫 E )-1- Γ 3 - 甲氣某-4 - ( 2 -漳-Z.氲基)-苄基1 - 3二甲―基_^ \ - P4I Hi 類似方法5所述完成實施例编號172之醇3 1溴化物之 -1 05- 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) 請 先 閲 讀 背 面 之 3 i 訂 經濟部中央標準局員工消费合作社印製 B7五、發明説明(、時) 轉化。 Mp = 150 - 152°C; iH NMR (DMSO) 7.48 - 7.20 (m, 13 H), 7.] 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), ό|52 (d, 1 H, J = 2.0 Hz), 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H), 5.10 (s, 2 H), 4.15 (t, 2 H, J = 5.3 Hz), 3.70 (t, 2 H, J = 5.7 Hz), 3.^8 (s, 3 H), 2.15 (s, 3 H); MS el m/z 661 (M+). 實施例编號1 Ϊ -苄氳甚-2 - (4 -苄氳基-茉餐)-3 -甲基一 8 - 7.10 (m, 3 Η),Printed by the Ministry of Economic Affairs, Standard Bureau, Consumers' Cooperatives, A7 B7 V. Description of Invention (, m) Silica gel chromatography. Obtained 10.5 g of the product as a white solid. OM p = 6 4- 66 ° C; ΪΗ NMR (DMSO) 7.06 (d, 1 H, J = 2.0 Hz), 6.91 (dd, 1 H, J = 2.0 Hz, 2.2 Hz), 6.83 (d, 1 H, J = 2.1 Hz), 4.75 (s, 2 Η), 4.70 (s, 2 H), 4.13 (q, 2 H, J = 7.2 Hz), 3, 77 (s, 3 H), 1.19 (t, 3 H, J = 7.1 Hz); MS el IB / z 2 5 8 (M +); C 12 H 15 C 1 0 4 c Η N Calculated value. Examples of fertility: 觫 1 7 1 f 2-Tian 氲 even-4-f 5-Narrow argon-2-(4 -Benzyl gas--¾)-3W Benzyl group-benzene gas group 1 The ethyl ester of Z acid was used in Example 3 as the parent reagent to complete the alkylation of Indine No. 7 Mp = 120-123 ° C;! H NMR (DMSO) 7.48-7.20 ( m, 13 H), 7, 18-7.10 (m, 3 Η), 6.80 (dd, 1 H, J = 2,5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), 6 52 (d, 1 H, J = 2.0 Hz), 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4H), 5.10 (s, 2 H), 4.61 (s, 2 H), 4.10 (q, 2 H, J = 7.0 Hz), 3.58 (s, 3 H), 2.15 (s, 3 Η), 1.15 (t, 3 H, J = 7.0 Hz); MS el m / z 641 (M +). Bayer Example Silk No. 172 i 2-Shen hydrogen -4- f 5-Benzyl chloride J Argon-Rong) -3 -Shen Shi-shi 丨 8¾-: l-MethylmethylΊ- Benzamidine) -7, alcohol as described in the previous method 4 to complete the reduction of ester number 171. Mp = 86-90 ° C; lH NMR (DMSO) 7.48-7.20 (m, 13 H), 7,18-7.10 (m, 3 Η), 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz) , 6.64 (d, 1 H, J = 8.4 Hz), 6.52 (c I, 1 Η, J = 2.0 Hz), 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H ), 5.10 (s, 2 H), 4.76 (t, 1 H, J = 5.5 Hz), 3.83 (t, 2 H, J = 5.1 Hz), 3.63 (q, 2 H, J =. .3 Hz) , 3.56 (s, 3 H), 2.15 (s, 3 H); MS el m / z 599 (M +). «Example No. 173 5-Natural- 2- (4-octyl-benzyl E ) -1- Γ 3-Methane-4-(2 -Zhang-Z.fluorenyl) -benzyl 1 -3 Dimethyl-yl_ ^ \-P4I Hi Example No. 172 was completed similarly as described in Method 5. Alcohol 3 1 Bromide -1 05- This paper size is applicable to Chinese National Standard (CNS) A4 (210x297 mm) Please read 3 on the back first. Order B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Description (, hour) conversion. Mp = 150-152 ° C; iH NMR (DMSO) 7.48-7.20 (m, 13 H), 7.] 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), ό | 52 (d, 1 H, J = 2.0 Hz), 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H), 5.10 (s, 2 H ), 4.15 (t, 2 H, J = 5.3 Hz), 3.70 (t, 2 H, J = 5.7 Hz), 3. ^ 8 (s, 3 H), 2.15 (s, 3 H); MS el m / z 661 (M +). Example No. 1 Ϊ-benzylpyrene-2-(4-benzylpyridyl-jasmine meal) -3 -methyl-8-7.10 (m, 3 Η),

二 1二_ Γ2 -申氫某-4-(2 -六值 Urtig-I-Z·氫基)]苄基]-1H~_ p^i m 如前述方法6完成以六氫吡聢取代溴化物 1h NMR (DMSO) 7.48 - 7.20 (m, 13 Η), 7.18 - 7.10 (m, Η), 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), 6 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H), 5.10 (s, (t, 2 H, J = 5.7 Hz), 3.55 (s, 3 H), 2.62 - 2.50 (bs, 2 H) (s, 3 H), 1.50 - 1.40 (m, 4 H), 1.40 - 1.35 (m, 2 H); MS F 實施例编號1 7 5 5 -窄氤某-2 - ( 4 -苄氬基-茱蓽)-3 . .- H 2 讀 先 閱 讀 背 面 之 注 意 事 項 再 養 52(d, 1H,J = 2.0 Hz), 2 Η), 3.90 45 - 2.30 (bs, 4 Η), 2.15 訂 ΑΒ m/z 667 (Μ+Η+). 1-「3 -申氳基- 4- (2 -吖康因-Ί-某-乙氬甚) -苄甚1 二丄 如编號1 7 4完成反應,除使用六亞甲胺取fi溴化物置換 六氫枇啶。 Foam; !h NMR (DMSO) 7.48 - 7.20 (m, 13 H), 7.18 - 7.}〇 (m, 3 H), 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), 6, 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H), 5.10 (s, δ H), 3.90 (t, 2 H, J = 5.7 Hz), 3.55 (s, 3 H), 2.85 - 2.70 (bs, 2 H), 2\10 - 2.55 (s, 4 H), 2.10 (s, 3 H), 1.60 - 1.15 (m, 8 H); MS FAB m/z 681 (M+H+) 實施例编號1 6 Ϊ 2 - (4-苄氣基-苯基_).二1_=111· -10 6- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 52 (d, 1 H, J = 2.0 Hz), 田氩甚-4 -1 Η - 經濟部中央橾準局員工消費合作社印製 A7 B7五、發明説明(以) 士 如前述方法7藉由轉移氫化作用K匕實施例 化合物藉由溶解於醚及以1.2當量之1N乙醚/ 理而以鹽酸鹽單離(此為方法8之變化)。 編號173» 'H C 1溶液處 請 先 閲二 一二 _ Γ2 -Hydrogen-4- (2-hexa Urtig-IZ · Hydro)] benzyl] -1H ~ _ p ^ im Complete the replacement of bromide with hexahydropyridine for 1 h as described in Method 6 above (DMSO) 7.48-7.20 (m, 13 Η), 7.18-7.10 (m, Η), 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz) , 6 6.24 (dd, 1 H, J = 1.9 Hz, 8.1 Hz), 5.13 (s, 4 H), 5.10 (s, (t, 2 H, J = 5.7 Hz), 3.55 (s, 3 H), 2.62-2.50 (bs, 2 H) (s, 3 H), 1.50-1.40 (m, 4 H), 1.40-1.35 (m, 2 H); MS F Example No. 1 7 5 5-Narrow -2-(4 -Benzylarginyl-Fructus Corni) -3. .- H 2 Read the precautions on the back and then raise 52 (d, 1H, J = 2.0 Hz), 2 2), 3.90 45-2.30 ( bs, 4 Η), 2.15 Order Αβ m / z 667 (Μ + Η +). 1- "3 -Shenyl- 4- (2 -Acconin-H-A-Ethionium) -Benzyl 1 The reaction was completed as the number 1 7 4 except that hexamethyleneamine was used to replace the fi bromide with hexahydropyridine. Foam;! H NMR (DMSO) 7.48-7.20 (m, 13 H), 7.18-7.} 〇 (m, 3 H), 6.80 (dd, 1 H, J = 2.5 Hz, 8.8 Hz), 6.64 (d, 1 H, J = 8.4 Hz), 6, 6.24 (dd, 1 H, J = 1.9 Hz , 8.1 Hz), 5.13 (s, 4 H), 5.10 ( s, δ H), 3.90 (t, 2 H, J = 5.7 Hz), 3.55 (s, 3 H), 2.85-2.70 (bs, 2 H), 2 \ 10-2.55 (s, 4 H), 2.10 (s, 3 H), 1.60-1.15 (m, 8 H); MS FAB m / z 681 (M + H +) Example No. 1 6 Ϊ 2-(4-benzylamino-phenyl_). 1_ = 111 · -10 6- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 52 (d, 1 H, J = 2.0 Hz), Tian Arqi -4 -1 Η-Central Ministry of Economic Affairs Printed on A7 B7 by the Consumers ’Cooperative of Fifth Bureau of the United States. 5. Description of the invention (in) Method 7 by transferring hydrogenation as described above. Example compounds are dissolved in ether and 1.2 equivalents of 1N ether / dichloromethane. Salt is isolated (this is a variation of method 8). No. 173 »'H C 1 Solution Please read

Mp =: 123 - 127 °C; lH NMR (DMSO) 10.20 (bs, 1 H), 9.72 (s, 1 H), 8.71 (s, 1 H), ? 7.17 (d, 2 H, J = 8.6 Hz), 7.11 (d, 1 H, J = 8.8 Hz), 6.87 (m, 2 H), 6.57 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.55 (d, 1 H (dd, 1 H, J = 1.7 Hz, 8.1 Hz), 5.11 (s, 2 H), 4.23 (t, 2 H,, 3.45 (m, 2 H), 3.35 (m, 2 H), 2.95 (m, 2 H), 2.10 (s, 3 H) (m, 1 H); IR 3500,1500,1275 cm'1; MS (+) FAB m/z 487 (M+H)+; C 30 H 31 N 2 0 4 + 1HC1 + 1 . OH 2 0 之 C H fi 計算 i直 d, 2 H, J = 8.6 Hz), 6.79 ] J = 1.7 Hz), 6.33 J =4.8 Hz), 3.60 (s, 3 H),[ ,1.70 (m, 5H), 1.35 [ 實施例編號1 6 8 2-(4 -猙基-苯基)-1- -甲氣i二丄 庚因-1 -基-乙氣基」羞_1 -5 —醇 如實施例编號167所逑相方法製備。 Mp = 142 - 146 °C; iH NMR (DMSO) 10.36 (s, 1 H), 9.72 (s, 1 Η), 8.71 (s, 1 Η), 7.18 (d, 2 H, J = 8.3 Hz), 7.11 (d, 1 H, J = 8.6 Hz), 6.87 (d, 2 H, J = 8.3 Hz), 6.82 (d, 1 H, J = 8.1 Hz), 6.79 (d, 1 H, J = 2.2 Hz), 6.57 (dd, 1 H, J = 2.2 Hz, 8.6 Hz), 6.55 (d, 1 H, J = 1.8 Hz), 6.33 (dd, 1 H, J = 1.5 Hz, 8.1 H;〇, 5.11 (s, 2 H), 4.24 (t, 2 H, J = 4.6 Hz), 3.60 (s, 3 H), 3.40 (m, 4 H), 3.20 (m, 2 H), 2.10 (s, 3 H), 1.75 (m, 4 H), 1.55 (m, 4 H); IR (KBr) 3300, 1500, 1270,1200 cm-1; MS (+) FAB m/z 5 0 1 ( H + H ) + ; C 3i H 35 N a 0 4 + 1 . 0 H C 1 + 0 . 1 2 C H 計算值。 生 活檢 m—- i ο 7 -Mp =: 123-127 ° C; lH NMR (DMSO) 10.20 (bs, 1 H), 9.72 (s, 1 H), 8.71 (s, 1 H),? 7.17 (d, 2 H, J = 8.6 Hz ), 7.11 (d, 1 H, J = 8.8 Hz), 6.87 (m, 2 H), 6.57 (dd, 1 H, J = 2.4 Hz, 8.8 Hz), 6.55 (d, 1 H (dd, 1 H , J = 1.7 Hz, 8.1 Hz), 5.11 (s, 2 H), 4.23 (t, 2 H ,, 3.45 (m, 2 H), 3.35 (m, 2 H), 2.95 (m, 2 H), 2.10 (s, 3 H) (m, 1 H); IR 3500,1500,1275 cm'1; MS (+) FAB m / z 487 (M + H) +; C 30 H 31 N 2 0 4 + 1HC1 + 1. Calculate CH fi for OH 2 0, d, 2 H, J = 8.6 Hz), 6.79] J = 1.7 Hz), 6.33 J = 4.8 Hz), 3.60 (s, 3 H), [, 1.70 ( m, 5H), 1.35 [Example No. 1 6 8 2- (4 -fluorenyl-phenyl) -1- -methane i-diheptyl-1 -yl-ethanyl "-1 -5 — The alcohol was prepared as described in Example 167. Mp = 142-146 ° C; iH NMR (DMSO) 10.36 (s, 1 H), 9.72 (s, 1 Η), 8.71 (s, 1 Η), 7.18 (d, 2 H, J = 8.3 Hz), 7.11 (d, 1 H, J = 8.6 Hz), 6.87 (d, 2 H, J = 8.3 Hz), 6.82 (d, 1 H, J = 8.1 Hz), 6.79 (d, 1 H, J = 2.2 Hz ), 6.57 (dd, 1 H, J = 2.2 Hz, 8.6 Hz), 6.55 (d, 1 H, J = 1.8 Hz), 6.33 (dd, 1 H, J = 1.5 Hz, 8.1 H; 〇, 5.11 ( s, 2 H), 4.24 (t, 2 H, J = 4.6 Hz), 3.60 (s, 3 H), 3.40 (m, 4 H), 3.20 (m, 2 H), 2.10 (s, 3 H) , 1.75 (m, 4 H), 1.55 (m, 4 H); IR (KBr) 3300, 1500, 1270, 1200 cm-1; MS (+) FAB m / z 5 0 1 (H + H) +; C 3i H 35 N a 0 4 + 1.. 0 HC 1 + 0. 1 2 CH Calculated value. Life check m—- i ο 7-

OH 之 CHN 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X297公釐) 經濟部中央標準局員工消費合作社印製OH's CHN paper size applies to Chinese National Standard (CNS) A4 (2! 0X297 mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閲讀背面之注意事項再填寫本頁) ,-口 ί I. 經 濟 部 中 標 準 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(4) 受體之製備 過度表現雌性受體的CHO細胞於150毫米2 培養冊内於 DMEM+10%葡萄聚糖被覆十炭生長,汽提胎i =血清。平 板以 P B S 洗兩及以 1 0 in Μ T r i - H C 1,p Η 7 . 1, 1 m M EDTA 冼一次。刮擦表面收獲細胞,然後將細胞懸 浮液放置於 水上。細胞以手持馬達加壓組織研磨器]0秒 爆噴二次破 壞。粗製品於1 2,(3 0 0 g離心2 0分鐘,接著於1 0 0,0 0 0 g離 心6 0分鐘獲得不含核糖細胞溶解産物。然後 細胞溶解産 物經由冷凍及儲存於-8 0 °C。使用B C A檢定分 析及蛋白質 參考標準品估計細胞溶解産物之蛋白質濃度 〇 結合檢宁修件 競爭分析傜於96孔平板(聚苯乙烯*)進行, 平板結合 低於2.0%總進量[3fl〕_17_厶—雌二醇,^ 個次料點 重複收集三次。每孔容納1 0 0 A L受體製品。 初步競爭中 評估1 0 0 X及5 0 0 X競爭者加入飽和劑量2 . 5 hi Μ ;3 H) -17- 疗-雌二醇+競爭者(或緩衝液)於50# L體積, 僅使用0 . 8 ffl Μ 〔3 H〕-17-厶-雌二醇。平板置於室溫培育 2 . 5小時。 培育期間結束時150# L冰冷蕕萄聚糖被覆木 炭(5 %活性 炭以0·05% 69K·萄被覆)加至各孔,平板EI 1刻於99g於 4 °C離心5分鐘。然後移出2 0 a L上清液進行 閃爍計數。 樣品計數至2%或計數分鐘(視何者為先而 定)。由於 聚苯乙烯吸收小量[3丨丨〕-1 7 -厶-雌二醇, 含放射性及 細胞溶解産物但未以木炭加工處理的孔用於 定量放射性 同位素數量。又含放射性但不含細胞溶解産 物之孔以木 ~ 1 0 8 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 請 先 閱 讀 背 面 意 事 項 再 填 寫 本 頁 訂 經 濟 部 中 央 標 準 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(、β) 炭加工處理來估計無法去除的〔3 Η〕- 1 7 -, ?-雌二醇之 DPM。使用康寧#35880-96號之96孔平板,其 經證實可結 合最量少量雌二醇。 結—星-之 放射性之毎分鐘數目(C P Μ )由貝克曼L S 7 Ϊ 〇 〇閃爍計數 器自動轉成每分鐘崩解數目(DPM),對各個| 衰品使用一 組淬熄標準品來産Η #。欲計算於1 0 0倍或5 0 [ 倍競爭者存 在下,雌二醇結合百分率,應用下式: ((DMP樣品-未被木炭去除的DPM) /此二醇 -未被木 炭去除的0?«))父100=%雌二醇結合 欲獲得得I C w曲線,將%結合相對於化合 物作匾。於 5 0 0倍競爭者濃度時顯示&gt; 3 0 %競爭作用之化 合物作為I c 。此等方法之説明參見Hulme,E.C.,ed.l992 .Receptor -Ligand Interaction: A Practical Appro a c h . I R L P r e s s ,紐約(待別第8章)。 -1 0 9- 本紙張尺度適用中國國家標準(CNS &gt; A4規格(210 X 297公釐) 請 先 閲 讀 背 意 事 項 再 填 寫 本 頁 訂 五、發明説明( A7 B7 表11 雌激素受體結合 r\(Please read the precautions on the back before filling out this page), I. I. Printed by the Standard Employee Consumer Cooperative in the Ministry of Economic Affairs, printed A7 B7 V. Description of the invention (4) Preparation of receptors CHO cells that overexpress female receptors The 150 mm 2 culture book was grown on DMEM + 10% glucosan-coated ten charcoal, stripping fetus i = serum. The plates were washed twice with P B S and once with 10 in M T r i-H C 1, p Η 7.1, 1 m M EDTA. Scrap the surface to harvest the cells, and then place the cell suspension on water. Cells were pressurized with a handheld motor tissue grinder] 0 sec. The crude product was centrifuged at 1,200 g for 20 minutes, and then centrifuged at 1,000 g for 60 minutes to obtain a ribocyte-free lysate. The lysate was then frozen and stored at -8 0 ° C. Use BCA assay and protein reference standards to estimate the protein concentration of cell lysates. ○ Combining with competitive test kits for competitive analysis. 傜 Performed on 96-well plates (polystyrene *). 3fl] _17_ 厶 -estradiol, ^ times the feed point repeated three times. Each well contains 100 AL receptor products. In the preliminary evaluation, 100 X and 500 X competitors were added to the saturated dose 2. 5 hi Μ; 3 H) -17- Therapeutic-estradiol + competitor (or buffer) in a volume of 50 # L, using only 0.8 ffl Μ [3 H] -17-fluorene-estradiol. The plate was incubated at room temperature for 2.5 hours. At the end of the incubation period, 150 # L of ice-cold glucosan-coated charcoal (5% activated carbon coated with 0.05% 69K · grape) was added to each well, and the plate EI 1 was engraved at 99g and centrifuged at 4 ° C for 5 minutes. Then remove 20 a L of supernatant for scintillation counting. The sample counts to 2% or minutes (whichever comes first). Because polystyrene absorbs a small amount of [3 丨 丨] -1 7- 厶 -estradiol, wells containing radioactive and cell lysate but not treated with charcoal are used to quantify the amount of radioisotopes. Also contains radioactive but does not contain cell lysates ~ 1 0 8-This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) Please read the notice on the back before filling in this page to order the Ministry of Economic Affairs A7 B7 printed by the Central Standards Consumer Cooperative. 5. Description of the invention (, β) Carbon processing is used to estimate the DPM of [3 Η]-1 7-,? -Estradiol. Corning # 35880-96, a 96-well plate, has been shown to bind the smallest amount of estradiol. The number of minutes of radioactivity of the knot-star-radiation (CP Μ) is automatically converted to the number of disintegrations per minute (DPM) by the Beckman LS 7 〇〇 scintillation counter. For each | decay product, a set of quenching standards is used to produce Η #. To calculate at 100 times or 50 [times the presence of competitors, the percentage of estradiol binding, apply the following formula: ((DMP sample-DPM without charcoal removal) / this diol-0 without charcoal removal ? «)) Father 100 =% estradiol binding To obtain an IC w curve, the% binding is compared to the compound as a plaque. At 500 times the concentration of the competitor, a compound showing &gt; 30% competition was used as I c. For a description of these methods, see Hulme, E.C., ed.l992. Receptor-Ligand Interaction: A Practical Appro a c h. -1 0 9- This paper size applies to Chinese National Standards (CNS &gt; A4 size (210 X 297 mm) Please read the intent and then fill out this page to order 5. Description of the invention (A7 B7 Table 11 Estrogen Receptor Binding r \

(請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印^ 資施例蹁獷 Q 議___議_ 受赌結 1C50,suM No. 85 H H O ' 0.45 No. 86 H 4,-OH o 0.12 No. 87 OH H o 0.030 No. 88 OMe 4,-OH o 0.35 No. 89 OH 4,-OMc o 0.30 No. 90 4*-OMe o 0.60 No. 91 OMe 4,*OMe o 0.52 No. 92 OH 4,-OEt o 0.062 110· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) A7 ________B7 五、發明説明(、。*?) 經濟部中央標準局員工消費合作社印製 寘鲍例篇狄; &lt; 十 表 11 (Sf ) 2 7;^^ f受體結i&gt; ^S〇rsuM' No. 93 OH 4f-OEt o 0.090 No. 94 F 4’-0H o 0.20 No. 97 OH 4’-0H o 0.060 No. 98 OH 4,-OH 〇 0.050 No. 99 OH 4,-0H 〇 0.03 No. 100 OH 4,-0H / 0.06 No. 101 OH 4’·0Η 广 Nv_ 0.04 No. 102 OH 4,-0H 〆 N、 0.08 No. 103 OH 4,-OH 0.2 No. 104 OH 4,-0H N)= 0.1 No. 105 OH 4’·0拉 / 0.028 No. 106 OH 4,-OH 1- K 0.1 No. 107 OH 4,·ΟΗ 1- —^ 0.06 nn'm— i m I —^ϋ ml i ·1 ml— a^n 一 π &quot;i (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -111· A7(Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs ^ Q Discuss _ Q _ _ _ Betting End 1C50, suM No. 85 HHO '0.45 No. 86 H 4, , OH o 0.12 No. 87 OH H o 0.030 No. 88 OMe 4, -OH o 0.35 No. 89 OH 4, -OMc o 0.30 No. 90 4 * -OMe o 0.60 No. 91 OMe 4, * OMe o 0.52 No. 92 OH 4, -OEt o 0.062 110 · This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) A7 ________B7 V. Description of Invention (, ... *?) Staff of Central Bureau of Standards, Ministry of Economic Affairs Consumption Cooperative Printed Cases of Di Bao; &lt; Ten Table 11 (Sf) 2 7; ^^ F Acceptor Junction i &gt; ^ S〇rsuM 'No. 93 OH 4f-OEt o 0.090 No. 94 F 4'- 0H o 0.20 No. 97 OH 4'-0H o 0.060 No. 98 OH 4, -OH 〇0.050 No. 99 OH 4, 0H 〇0.03 No. 100 OH 4, 0H / 0.06 No. 101 OH 4 '· 0Η 广 Nv_ 0.04 No. 102 OH 4, -0H 〆N, 0.08 No. 103 OH 4, -OH 0.2 No. 104 OH 4, -0H N) = 0.1 No. 105 OH 4 '· 0 pull / 0.028 No. 106 OH 4, -OH 1- K 0.1 No. 107 OH 4, · ΟΗ 1- — ^ 0.06 nn'm— im I — ^ ϋ ml i · 1 ml— a ^ n a π &quot; i (Please read the precautions on the back before filling in this page) This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) -111 A7

B 五、發明説明(UO ) 經濟部中央標準局員工消費合作社印製 實尨例鱷》 X 表11 α 、、氍 &quot;鑕) τ κ:戀咖 No. 108 OH 4,·ΟΗ h 0.02 No. 109 OH 4’-OH d 0.17 No. 110 OH 4,-OH o- 0.037 No. Ill OH 4,-OH 0.15 No. 112 OH 4,-OH v&gt; 0.07 No. 113 OH 4,-OH ΐγ^-ΟΗ 0.047 No. 114 OH 4,·ΟΗ 0.001 No. 115 OH 4,·ΟΗ 0.15 No. 116 OH 4,-Fl Ο 0.04 No. 117 OH 4,-Fl Ο 0.10 No. 118 OH 3,-OMe,4,-OH ο Ν/Α No. 119 OH 3,,4,-0CH20- ο 0.070 ^^^1 ml ml —^ϋ n^i ml ^1.^1 m· fl^^iB mV nn^i IB^l 一 -λ i (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 寒;UL2 A7B V. Description of the Invention (UO) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, “Exemplary Crocodile” X Table 11 α,, 氍 &quot; 锧) τ κ: Love Coffee No. 108 OH 4, · ΟΗ h 0.02 No 109 OH 4'-OH d 0.17 No. 110 OH 4, —OH o- 0.037 No. Ill OH 4, —OH 0.15 No. 112 OH 4, —OH v &gt; 0.07 No. 113 OH 4, —OH ΐγ ^ -ΟΗ 0.047 No. 114 OH 4, 〇Η 0.001 No. 115 OH 4, 〇Η 0.15 No. 116 OH 4, -Fl Ο 0.04 No. 117 OH 4, -1, 0.1F No. 118 OH 3, -OMe, 4, -OH ο Ν / Α No. 119 OH 3,4, -0CH20- ο 0.070 ^^^ 1 ml ml — ^ ϋ n ^ i ml ^ 1. ^ 1 m · fl ^^ iB mV nn ^ i IB ^ l I-λ i (Please read the precautions on the back before filling this page) This paper size is applicable to China National Standard (CNS) A4 specification (210X 297 mm) Cold; UL2 A7

7 B 五、發明説明(W ) 經濟部中央標準局員工消費合作社印製 xw 表 11 (績) | 受體結合 宵施例绝铽餐 s s * s 1 Ά vlC50*s'W,&quot; No. 120 OH 4,-〇iPr d 0.10 No. 121 OH 4’-0-iPr 〇 0.080 No. 122 OH 4’-OCp o 0.080 No. 123 OH 4,-CF, o 0.17 No. 124 OH 4,-CH3 o 0.11 No. 125 OH 4,-Cl o 0.11 No. 126 OH 2’,4’,-Dimethoxy o N/A No. 127 OH 3’-OH o 0.019 No. 128 OH 3’-OH 〇 0.009 No. 129 OH 4’·ΟΗ,3’-Η o 0.0055 No. 130 OH 4’-OH,3,-Fl O' 0.013 No. 131 OH 3,*OMe o 0.12 No. 132 OH 4’-OCF3 o 0.05 —113— (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(2〖0X 297公釐) 五、發明説明( Μ: 雌激素受體結合 IT掩例编» 2k a7 B V. Description of the invention (W) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs xw Table 11 (Performance) | Recipient Binding Example Exquisite Meal ss * s 1 Ά vlC50 * s'W , 120 OH 4, -〇iPr d 0.10 No. 121 OH 4'-0-iPr 〇0.080 No. 122 OH 4'-OCp o 0.080 No. 123 OH 4, -CF, o 0.17 No. 124 OH 4, -CH3 o 0.11 No. 125 OH 4, -Cl o 0.11 No. 126 OH 2 ', 4', -Dimethoxy o N / A No. 127 OH 3'-OH o 0.019 No. 128 OH 3'-OH 〇0.009 No. 129 OH 4 '· ΟΗ, 3'-Η o 0.0055 No. 130 OH 4'-OH, 3, -Fl O' 0.013 No. 131 OH 3, * OMe o 0.12 No. 132 OH 4'-OCF3 o 0.05 — 113— (Please read the precautions on the back before filling this page) This paper size is applicable to Chinese National Standard (CNS) A4 specification (2 〖0X 297mm) V. Description of the invention Edit »2k a

No. 133 α Η A7No. 133 α Η A7

No. 134 α Η Ο 0.024No. 134 α Η Ο 0.024

No. 135 α Η Ο 0.029No. 135 α Η Ο 0.029

No. 136 α CH, Ο 0.013No. 136 α CH, 〇 0.013

No. 137No. 137

Et Η Ο 0.15 經濟部中央標準局員工消費合作社印製Et Η Ο 0.15 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

No. 138No. 138

No. 139No. 139

CNCN

CN Η Η Ο Ο -114- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 0.011 0.023 五、發明説Μ ( 表13 雌激素受體結合 宵施例说铖 〇. 160 〇. 161 Ιό· 162 合 結 體 受 素 激 frt 0 A7 B7 0CN Η Ο Ο Ο -114- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 0.011 0.023 V. The invention is described in Table M (Table 13 Estrogen Receptor Binding Example Description 铖 160. 〇. 161 Ιό · 162 The complex is stimulated by prime frt 0 A7 B7 0

Z Ζ Β t-Bu t-Bu Ο ο ο 受勝结$/Α λ ! ί.ΊιίΜ (請先閱讀背面之注意事項再填寫本頁) Ν/ΑZ ZZ Β t-Bu t-Bu 〇 ο ο Winning settlement $ / Α λ! Ί.ΊιίΜ (Please read the notes on the back before filling this page) Ν / Α

Does not Bind 14 表 經濟部中央標準局員工消費合作社印製Does not Bind 14 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

—115 — 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) Α7 Β7 五、發明説明(叫) X Q z 受體結合 &quot;ϋδϋβΐι::::- No. 166 OH 4’-OH 0.099 表15 雌激素受體結合—115 — This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) Α7 Β7 5. Description of the invention (called) XQ z receptor binding &quot; ϋδϋβΐι ::::-No. 166 OH 4'-OH 0.099 Table 15 Estrogen receptor binding

Z ----------fk-- (請先閱讀背面之注意事項再填寫本頁)Z ---------- fk-- (Please read the notes on the back before filling this page)

、1T y施例编號 [z „ nSm®, 1T y Example number [z „nSm®

No. 167 經濟部中央標準局員工消費合作社印製No. 167 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

No. 168 ο Ο -116- 0.C8 0.057 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 經 濟 部 中 矣 奉 局 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(”钧) 方法1 7 石川細贿!鹺袢ilSt檢宙分析 細胞之保待與處理:. 石川細胞保持於含酚紅+ 1 f) °/。眙牛血清之E MEM/ F 1 2 (50% : 50%),培養基内補充 2mM Glutamax ,1 % Pen /Strap及1®M焦丙酮酸鈉。實驗(處理細胞)釋 5始前5曰 培養基改成不含酚紅D Μ E M / F 1 2 + 1 0 %葡萄聚 糖被覆木炭 汽提血清。處理前1天。使用〇 . 5 %胰蛋白| i / EDTA收 獲細胞並以5 X〗0 4細胞/孔之密度接種於9 6孔組織培 養平板。試驗化合物之劑量為1 (Γ6, 1 (Τ7及 10'加 1 (Γ6 Μ (化合物)+ 1 (Γ9 iu 1 7乃-雌二醇俥使評估 化合物作為 抗雌性素之能力。檢定分析前處理細胞經歴 4 8小時。各 個9 6孔平板皆含有一個1 7 -雌二醇對照。名 •劑量之樣 品數為η = 8。 鹼性磷酸酶檢定分析: 48小時結束時抽取出培養基,細胞以磷酸 鹽緩衝鹽水 (P B S )洗三次β 5 M L溶解緩衝液(0 . 1 M ) T r i s -HC1 , pH9 . 8 ,0 . 2 % T r i t ο η X - 1 0 0,加至各孔。平板於- δ 0 °C至少放 置】5分鐘。平板於3 7 °C解凍接箸將1 5 (] a L 0 .1M Tris-HCl ,PH9.8,含4®m對硝基苯磷酸酯(pNPP)加至名 ;孔(終濃度 ,3ιΜ pNPP) 0 使用K i n e t i c C a 1 c應用程式(B i 〇 - T e k儀器i 司,維吉 尼亞州,溫努斯基)計算吸收率及斜率。結异 ^偁以於動 態反應曲線(毎5分鐘讀出光密度共30分鐘Qi 5光率)之線 -1 16 - A 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閱 讀 背 之 注 意 事 項 再 填 寫 本 頁 訂 A7 B7 五、發明説明(^) 經 濟 部 中 k 標 準 員 工 消 費 合 作 社 印 製 性 部 分 得 酶 反 應速率 (斜率)平 均 值 之 中 間 值 + / * 標 準 差 表 示 〇 化 合 物 結果傜 以 相對於 1 n Μ 17 β -雌: 二醇之反應 百 分 率 表 示 〇 藉 由 m 性 磷 酸酶方 法 檢定分 析 多 種 化 合 物 之 雌 性 素 活 性 並 求 出 相 對 於 EDS0 值 (95% C .I •) 〇 下 表 列 舉 之 四 種 做 為 標 準 品 * 17 β -雌二醇 0 . 0 3 η Μ 1 7 β -雌二醇 1 . 4 2 η Μ 雌 二 醇 0 . 13 η Μ 雌 m 0 . 36 ηΜ 此 等 方 法 之 説明參 見 Η 〇 1 i n k a . c .F • Ha t, a • Η . 9 Ku r a ffi 0 to ? Η . 及 Gl u r p id e E . ( 1 9 8 6 ) » 於 人 類 子 宮 内 膜 癌 細 胞 (石川種条)上類 固 醇激素 及 抗 類 固 醇 對 m 性 磷 酸 酶 活 性 的 影 響 Ο Cancer R e s e a r c h , 4 6 : 2 7 7 1 -2 7 7 4, 及 Li 11 1 e f i el d, Β . A ., Gu r p i d e , E » ? Ha r k i e w i C Z , L . » Me K i η 1 ey ,B • 及 Η o c h b e r g , R . B . (1 99 0) 3 於 石 川 細 胞 基 於 剌 激 性 磷 酸 酶之簡 tau 早 敏感的 微 力 價 平 板 雌 性 素 生 物 撿 定 分 析 t D , 腎上腺類固醇之雌性素作用β E η ά 0 C r i η 〇 logy 9 6 : 2 7 5 7 - 2 7 6 2 〇 HI 鹺一 η 磷 酸 _檢宙 分 析 -117- 請 閱 讀 背 面 之 注 意 事 項 再 ▲ 寫 本 頁No. 168 ο Ο -116- 0.C8 0.057 This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 × 297 mm) Printed by A7 B7, Consumer Cooperative of Zhongfengfeng Bureau, Ministry of Economic Affairs 5. Description of invention ("Jun") Method 17 7 Ishikawa fine bribes! 鹾 袢 ilSt inspection and analysis of cell preservation and processing :. Ishikawa cells maintained at phenol red + 1 f) ° /. Yam serum E MEM / F 1 2 (50%: 50 %), The medium was supplemented with 2mM Glutamax, 1% Pen / Strap, and 1®M sodium pyropyruvate. The medium was changed to contain no phenol red D EM EM / F 1 2 + 1 before the experiment (treatment of cells). 0% glucosan was coated with charcoal stripped serum. 1 day before treatment. Cells were harvested using 0.5% trypsin | i / EDTA and seeded at 96 cells tissue culture plates at a density of 5 × 0 4 cells / well. The dose of the test compound was 1 (Γ6, 1 (T7 and 10 'plus 1 (Γ6 Μ (compound) + 1 (Γ9 iu 1 7) -estradiol) to evaluate the ability of the compound to act as an anti-estrogens. Test before analysis analysis The cells were treated for 48 hours. Each 96-well plate contained a 17-estradiol control. The number of samples was η = 8. Alkaline phosphatase assay analysis: At the end of 48 hours, the medium was removed, and the cells were washed three times with phosphate buffered saline (PBS) β 5 ML lysis buffer (0.1 M) T ris- HC1, pH9. 8, 0. 2% T rit ο η X-1 0 0, add to each well. Place the plate at-δ 0 ° C for at least 5 minutes. Thaw the plate at 37 ° C and connect it to 1 5 (] a L 0 .1M Tris-HCl, PH9.8, containing 4®m p-nitrophenyl phosphate (pNPP) Add to name; pore (final concentration, 3 μM pNPP) 0 Use Kinetic C a 1 c app (B i 〇-T ek Instrument Division, Winnuski, Virginia) Calculate the absorbance and slope. The difference is based on the dynamic response curve (read the optical density for 5 minutes for 30 minutes Qi 5 Line of light) -1 16-A This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) Please read the precautions before filling in this page to order A7 B7 V. Description of invention (^) Economy The average of the reaction rate (slope) of the printed part of the k-standard employee consumer cooperative in the ministry Value + / * Standard deviation is expressed. Compound results are expressed as a percentage of reaction with 1 n M 17 β-estradiol: 0. Estrogen activity of a variety of compounds is analyzed and analyzed by the m-phosphatase method and calculated relative to EDS Value (95% C.I •) 〇 Four types listed in the table below are used as standards * 17 β-estradiol 0.0 3 η M 1 7 β-estradiol 1.4 2 η Estradiol 0 13 η Μ female m 0. 36 ηΜ For a description of these methods see Η〇1 inka. C .F • Hat, a • Η. 9 Ku raffi 0 to? Η. And Gl urp id e E. (1 9 8 6) »Effect of steroid hormones and anti-steroids on m-type phosphatase activity on human endometrial cancer cells (Ishikawa seed strips) Cancer Reesearch, 4 6: 2 7 7 1 -2 7 7 4 and Li 11 1 efi el d, Β. A., Gurpide, E »? Harkiewi CZ, L.» Me K i η 1 ey, B • and Η ochber g, R. B. (1 99 0) 3 Based on the stimulating phosphatase of tau in the Ishikawa cells. Early sensitive microtiter plate estrogen bioassay analysis t D, estrogen action of adrenal steroids β E η ά 0 C ri η 〇logy 9 6: 2 7 5 7-2 7 6 2 〇HI 鹾 一 η phosphoric acid _ detection analysis -117- Please read the precautions on the back before writing this page

訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) A 7 B7 經濟部中央標準局貝工消費合作社印裝 五、發明説明(^ ) 1 7 /5 -雌二醇 1 0 0 %活性 塔摩思芬(tamoxifen) 0%活性 (4 5% 具有 InM 17疗-瑞羅思芬(r a I o x i f e ίΐ) 5 %活性 (5 % 具有 1 η Μ 1 7 ill 實施例編號9 8 1 %活性 (1 % 具有 1 τι Μ 1 7 办-I VL—.VTT RRR感染榆亩分析 iLilHi 處 i 中國倉鼠卵巢細胞(CH0)已經使用人類性| 轉移感染,維持於D Μ E Μ + 1 0 %胎牛血清(F B S ) 小時生長培養基以缺酚紅D Μ Ε Μ + 1 0 %葡萄聚ft 洗提F B S (處理培養基)替代。細胞以5 0 0 0細街 接種於包含2 0 0 a L培養基/孔之9 6孔平板。 磷酸鈣轉移感染 報告子DNA(Promega質體pGL2於推動發光® 低胸腺核甘激酶促進基因前方含有二套銜接 E R E )與;S -半乳糖甘表現質體p C Η 1 1 0 ( P h a r m a 1) N A ( p T Z 1 8 ϋ )以下列比例組合: 1 〇 A G報告子I) N A 5/iG pCHllODNA 5 μ G p T Z 1 8 U 2 0 a G I〕N A / 1毫升轉移戲染溶液 -1 1 8 - 醇 二 雌 醇 醇 二 I受體穩定 處理前48 ί被覆木炭 /孔密度 丨基因的最 的 vitellogenin c i a )及載體 (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 Α7 Β7五、發明説明() D N A ( 2 0 # G )溶解於 5 0 0 yu L 2 5 0 m Μ 無菌氣 至 500^1」2Χ HeBs(0.28M NaCl,50mM HEP N a 2 Η P 0 4,p H 7 · Q 5 )及於室溫培養2 Q分鐘 合物加至各孔之細胞且於細胞上方維持1 6 間結束時去除沈澱,細胞以培養基洗滌, 培養基及細胞以媒劑,1 η Μ 1 7办-雌二醇, 1 # Μ化合物+ 1 η Μ 1 7办-雌二醇(雌性素拮抗 理。各種處理條件傜於8孔進行(η = 8 ^孔於發光酶 檢定分析之前培育2 4小時 發光酶檢定分析 暴露於化合物2 4小時後,移出培養基,各孔以1 2 5 # 缺 Mg+ 和 Ca+ 之 PBS 洗二次。去除 PBS 後,35;uL Prouega 溶解緩衝液加至各乳及任其於室溫放置1 鐘接箸於 8 0 Ό放置1 5分鐘及於3 7 °C放置1 5分鐘。2 # L溶解産物 移至不透明的9 6孔平板進行發光酶活性評+。其於溶解 産物(5 # L )用於厶-半乳糖甘酶活性評估(F規化轉移感 染)。發光酶基質(Promega)藉發光儀以每^鐘100# L自 動加至各孔並於添加後1 0秒讀出發光(相對 感染發米脑檢宙分枳(捧進品) m— %活件 1 7办-雌二醇 1 0 0 %活性 化鈣及逐滴加 E S , 1 . 5 1 Μ 。各20 # L混 仑時。培育時 哮代新鮮處理 1 # Μ化合物或 作用試驗)處 於發光單位) m·———· ^^^1 ml n —^n Haaiw aaaMa 一,J - T 口 (請先閱讀背面之注意事項再填寫本頁) 此三醇 塔摩思芬 瑞羅思芬 3 8 %活性 〇 %活性(1 0 %具有1 η Μ 1 〇%活性(0%具有ΙπΜ 17 -1 1 9 - 7 -雌二醇 β -雌二醇) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 經濟部中央標準局員工消費合作社印製 五、發明説明(“〇 mi[m.分 1 將4 5 A L之P B S加至其餘5 A L溶解産物,然 P r 〇 in e g a办-半乳糖甘酶2 X檢定分析緩衝液, 於37 °C培育1小時。對各次實驗操作建立含 平板(Q.1至1.5毫單位,重複三次)。平板於 光光度平板閲讓機於41(]nm分析。未知樣品: 準曲線藉數學外推法,轉成活性之毫單位數 絚星之JiA 發光酶數據像以1 0秒测量時間累進的相對 産生且自動轉成JMP(SAS公司)檔,此處扣除 β -半乳糖If酶值自動輸入擋内,此等值分! 使數據正規化。平均值及標準徧差對各處理 得》各板之化合物活性與1 7 /8 -雌二醇活性t 1 7召-雌二醇之活性百分率傷使用下式求出: 二醇-對照組)/ (化合物值))X 1 0 0。該等技 Tzukeriaan, M . T . , E s t y , A. ,Santiso-Mere, 後加入5 # L 徹底混合及 標準曲線之 分子裝置分 ί光度由標 體二 受由 性且 雌 , 類定 人決 C 面 4)層 9 * 9 子 11 ί 進 Ρ 促 D 及 , 而 el層區 nil胞媒 D 細區 MC由内 及傜子 W .力分 見 參 光單位(R L U s ) 背景RLUs。 !j成RLUs而 組由n = 8獲 ;較。比較 % =((雌 術描述於 D ., ,P i k e , J . 轉移活化能 個功能分立 gy,8:21-30)〇 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(2IOX297公釐) A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(Μ ) 表1 6 感染發光酿ί活件 實施例编號 1 Μ Μ Μ+17办-雌二醇 編號85 -2 4 3 编號86 -5 2 编號87 0 0 编號88 4 4 4 编號89 16 18 編號90 3 58 編號91 -3 5 6 編號92 -4 -2 編號93 -3 -2 编號94 -5 15 编號95 -4 -4 编號96 12 8 编號97 -4 -5 編號98 5 5 编號99 5 6 编號100 9 1 0 編號】0 1 14 9 編號1 02 9 10 編號103 13 10 編號104 7 7 编號105 5 5 -12 1- I n^i —^n MW— r mu n^i nn 、一OJ (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) A7 B7 五、發明説明(^) 經濟部中央標準局員工消费合作社印製 表1 6 (鑛) 感染發光酶活性 實施例編號 1 μ Η 1八M + 1 7 yg -雌二酵 编號} 0 6 10 8 1 编號1 07 -1 5 4 编號108 11 10 編號1 〇 9 6 5 編號110 8 10 编號U 1 2 5 2 3 編號1 1 2 10 10 編號1 1 3 14 16 編號1 1 4 1 -1 編號1 1 5 11 10 编號】1 6 -1 1 编號1 1 7 0 1 編號1 1 8 N / A N / A 编號1 1 9 -1 -1 编號1 2 0 - 1 1 編號1 2 1 0 1 编號1 2 2 1 5 編號1 2 3 &quot;1 1 編號1 2 4 - 2 -2 編號1 25 -3 -2 編號]2 6 &quot;1 0 編號1 27 -3 -4 (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS } A4規格'ΙΓΟΧ297公釐) A7 B7 五、發明説明(y )表16 (缠) 經濟部中央標準局員工消費合作社印製 感染發光酶话性&gt; 實施例编號 1 μ Μ 1 yU M + 1 7彡-雌二醇 編號1 32 -5 -2 编號1 3 3 7 9 编號1 3 4 9 5 編號1 3 5 7 3 编號136 16 10 編號137 6 8 编號1 3 8 -2 -1 编號1 3 9 -1 2 -1 3 編號1 6 0 Ν / A N / A 編號1 6 1 N /A N / A 编號1 6 2 -1 4 -1 3 编號1 6 6 2 5 2 3 編號1 6 7 4 10 編號1 6 8 3 7 -12 3- n· ^m· —^n Bn^ nfl^^i m· ml ^ V (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX 297公釐)The paper size of the edition is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) A 7 B7 Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (^) 1 7/5 -estradiol 1 0 0% active tamoxifen 0% active (4 5% with InM 17 therapy-ra I oxife ίΐ) 5% active (5% with 1 η Μ 1 7 ill Example No. 9 8 1% Activity (1% with 1 τι Μ 1 7 Office-I VL—.VTT RRR infection in mu acre analysis iLilHi Department i Chinese hamster ovary cells (CH0) have been used for humanity | metastatic infection, maintained at D Μ E Μ + 10% Fetal bovine serum (FBS) hour growth medium was replaced with phenol-deficient red D Μ Ε Μ + 10% grape poly ft elution FBS (treatment medium). Cells were seeded at 5000 fine streets containing 200 a L medium / Well 9 6-well plate. Calcium phosphate transfer infection reporter DNA (Promega plastid pGL2 contains two sets of adapter EREs in front of Promoting Luminescence® Low Thymokine Promoting Gene) and; Η 1 1 0 (P harma 1) NA (p TZ 1 8 ϋ) is combined in the following proportions: 1 〇AG reporter I) NA 5 / iG pCHllODNA 5 μ G p TZ 1 8 U 2 0 a GI] NA / 1 ml of transfer dyeing solution-1 1 8-Ethanol-estradiol di-I receptor stable before treatment 48 ί coated charcoal / pore density丨 Gene's most vitellogenin cia) and carrier (please read the precautions on the back before filling this page) The size of the paper is applicable to the Chinese National Standard (CNS) M specifications (210X297 mm) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation A7 B7 V. Description of the invention () DNA (2 0 # G) is dissolved in 5 0 0 yu L 2 5 0 m Μ sterile gas to 500 ^ 1 ″ 2 × HeBs (0.28M NaCl, 50mM HEP N a 2 Η P 0 4, p H 7 · Q 5) and incubate at room temperature for 2 Q minutes. The compound was added to the cells in each well and the precipitate was removed at the end of the 16-hour maintenance period. The cells were washed with culture medium, and the culture medium and cells were treated with vehicle. 1 η Μ 1 7 office-estradiol, 1 # Μ compound + 1 η Μ 1 7 office-estradiol (estrogen antagonistic principle. Various processing conditions were performed in 8 wells (η = 8 ^ wells in luminase assay Incubate for 24 hours prior to analysis. Luminase assay assay. After 4 hours of exposure to compound 24, remove medium and remove wells. 125 # lack of Ca + Mg + PBS and washed twice. After removing the PBS, 35L u of Prouega lysis buffer was added to each milk and allowed to stand at room temperature for 1 minute, then at 80 ° C for 15 minutes and at 37 ° C for 15 minutes. 2 # L lysate was transferred to an opaque 96-well plate for evaluation of luminase activity +. Its lysate (5 # L) was used for the evaluation of 厶 -galactosidase activity (F-regulated transfer infection). Luminase substrate (Promega) is automatically added to each well by 100 # L per luminometer by luminometer, and the luminescence is read out 10 seconds after the addition (relative to the infection of the brain and the brain) (m-% activity) Piece 17 7-Estradiol 100% activated calcium and dropwise addition of ES, 1.5 1 Μ. When each 20 # L mixed. When incubating fresh treatment of 1 # Μ compound or action test) Illumination unit) m · ———— · ^^^ 1 ml n — ^ n Haaiw aaaMa I, J-T mouth (please read the precautions on the back before filling this page) this triol tamsin fenrui rosin 3 3 % Activity 0% activity (10% with 1 η Μ 1 〇% activity (0% with 1πM 17 -1 1 9-7 -estradiol β -estradiol) This paper size applies Chinese National Standard (CNS) Α4 Specifications (210 × 297 mm) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. Description of the invention ("〇mi [m. 1) Add 4 5 AL PBS to the remaining 5 AL lysates, but Pr 〇in ega Office -Galactosidase 2 X assay assay buffer, incubate for 1 hour at 37 ° C. Plates for each experimental operation (Q.1 to 1.5 milliunits, repeated three times) Analyze the plate at the photometric plate reader at 41 (nm). Unknown samples: The quasi-curve is converted by mathematical extrapolation to the active milli-unit number of JiA luminase data. The image is generated with a relative measurement time of 10 seconds. And automatically converted to JMP (SAS company) file, where β-galactose If enzyme value is automatically entered into the file, these values are divided! Normalize the data. The average value and standard deviation are processed for each board. Compound activity and 1 7/8-estradiol activity t 1 7-the percentage estradiol activity was calculated using the following formula: diol-control group) / (compound value)) X 1 0 0. Such techniques Tzukeriaan, M. T., Esty, A., Santiso-Mere, and then add 5 #L thorough mixing and standard curve of the molecular device spectrophotometer by the standard body and the female, the person-like person will determine the C face 4 ) Layer 9 * 9 sub 11 ί into P to promote D, and el layer area nil cytoplasm D sub-area MC from the inner and the sub- W. The force can be seen in the background RLUs of the reference light units (RLU s). Groups were obtained by n = 8; compared. Comparison% = ((female surgery is described in D., Pike, J. metastatic activation energy, functionally separate gy, 8: 21-30) 〇 (Please read the notes on the back before filling this page) This paper size applies to Chinese National Standards (CNS) A4 specifications (2IOX297 mm) A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of invention (M) Table 1 6 Examples of live infection infected light No. 1 Μ Μ + 17 Office-estradiol No. 85-2 4 3 No. 86-5 2 No. 87 0 0 No. 88 4 4 4 No. 89 16 18 No. 90 3 58 No. 91 -3 5 6 No. 92 -4 -2 No. 93 -3 -2 No. 94 -5 15 No. 95 -4 -4 No. 96 12 8 No. 97 -4 -5 No. 98 5 5 No. 99 5 6 No. 100 9 1 0 No.] 0 1 14 9 No. 1 02 9 10 No. 103 13 10 No. 104 7 7 No. 105 5 5 -12 1- I n ^ i — ^ n MW — R mu n ^ i nn, one OJ (please read the notes on the back before filling in this page) This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) A7 B7 V. Description of invention (^) Economy Printed by the Consumer Standards Cooperative of the Ministry of Standards of the People's Republic of China 16 (mine) Example of luminescent enzyme activity of infection No. 1 μ Η 18 M + 1 7 yg-estrogenase number} 0 6 10 8 1 No. 1 0 7 -1 5 4 No. 108 11 10 No. 1 〇 9 6 5 No. 110 8 10 No. U 1 2 5 2 3 No. 1 1 2 10 10 No. 1 1 3 14 16 No. 1 1 4 1 -1 No. 1 1 5 11 10 No.] 1 6 -1 1 No. 1 1 7 0 1 No. 1 1 8 N / AN / A No. 1 1 9 -1 -1 No. 1 2 0-1 1 No. 1 2 1 0 1 No. 1 2 2 1 5 No. 1 2 3 &quot; 1 1 No. 1 2 4-2-2 No. 1 25 -3 -2 No.] 2 6 &quot; 1 0 No. 1 27 -3 -4 (Please read first Note on the back, please fill in this page again) This paper size is in accordance with Chinese national standard (CNS) A4 specification 'ΙΓΟχ297mm] A7 B7 V. Description of invention (y) Table 16 Infective luminescent enzyme activity &gt; Example No. 1 μM 1 yU M + 1 7 彡 -estradiol No. 1 32 -5 -2 No. 1 3 3 7 9 No. 1 3 4 9 5 No. 1 3 5 7 3 No. 136 16 10 No. 137 6 8 No. 1 3 8 -2 -1 No. 1 3 9 -1 2 -1 3 No. 1 6 0 Ν / AN / A No. 1 6 1 N / AN / A No. 1 6 2 -1 4 -1 3 No. 1 6 6 2 5 2 3 No. 1 6 7 4 10 No. 1 6 8 3 7 -12 3- n · ^ m · — ^ n Bn ^ nfl ^^ im ml ^ V (Please read the notes on the back of this page and then fill in) this paper scale applicable Chinese National Standard (CNS) A4 size (2 Shu OX 297 mm)

大鼠親子宮 :及 R · L · 熟史帕格拉 驗,動物每 f 0 A G化合物 性質,1 # G 除過量脂肪 部份進行組 A7 B7 五、發明説明l·») 方法19 till王宮1抗1王檢—定il 化合物之雌性素及抗雌素性質傜於未成熟 檢同下分析測定(4日)(如前述於L . J . B 1 a c Goode 1, ife Scienes,26, 1453(1980)未成 利大鼠(雌性,1 8日齡)分成多組每組6隻試 曰腹内注射1 〇 A G化合物,1 0 G # G化合物(1 + 1 17/?-雌二醇)處理來檢查抗雌性素 1 7厶-雌二醇以5 0 % D M S 0 / 5 0 %鹽水做為注射媒劑。第 4曰以二氧化磺窒息動物犧牲,取出子宮剝 ,去除體液,测定濕重。一個子宮角質的小 織及血分析而其餘部份用來分離總R Ν Α裨使_估補體成 份3基因表現。 _______--__ Γ m In·— n-^i ^nfl i^i^i ^ili Ba^m n^— «—^^1 ^ϋ· 1^—B— t !、T (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 -12 4 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(w) 表17 3天鼠未成熟子宮分析 芊宦重暑 罕宵重量 罕宫重昼 芊宮重昼 臺克 mm 豪克 SSL 實施例 lOOytiG 10pG化合 1 yU G Vehicle 编號 化合物 物+ 10&gt;uG 17yg-雌 17/?-雌二醇 二醇 Tamoxifen 74.4毫克 N/A 98.2毫克 42.7毫克 编號85 41.1毫克 92.4毫克 94.4毫克 26.6毫克 編號94 28.1毫克 93.7毫克 88.5毫克 22.3毫克 編號97 27.4毫克 24.3毫克 63.2毫克 30.7毫克 编號98 29.4毫克 27.9毫克 94.1毫克 35· 9毫克 編號100 59· 9毫克 68.7毫克 91.9毫克 23.4毫克 編號101 65.1毫克 71.0毫克 113.7毫克 27.7毫克 編號122 46.7毫克 38.7毫克 103.4毫克 30.3毫克 編號123 39.2毫克 61.4毫克 94.4毫克 26.1毫克 编號138 28.4毫克 37.9毫克 93.9毫克 24.6毫克 編號139 30.4毫克 45.0毫克 82.1毫克 20.5毫克 编號168 43.2毫克 81.7毫克 98.9毫克 25.5毫克 -125- (請先閱讀背面之注意事項再填寫本頁) -丄 、-=&quot; 本紙張尺度適用申國國家標準(CNS ) A4規格(210X 297公釐) 雌性 Sprague 5克&gt; β它們以 所有之治療 己限定之濃 17彡-雌二 输送,〇. 1毫Rat uterine protozoa: and R · L · cooked spaghera test, animal properties per f 0 AG compound properties, 1 # G except excess fat portion for group A7 B7 V. Description of the invention l · ») Method 19 till royal palace 1 antibody 1 Wang Jian—The estrogen and anti-estrogen properties of the il compounds were determined and analyzed under the immature test (4th) (as mentioned in L. J. B 1 ac Goode 1, ife Scienes, 26, 1453 (1980 ) Unfavorable rats (female, 18-day-old) were divided into groups of 6 rats each group. Intraperitoneal injection of 10AG compound and 10G # G compound (1 + 1 17 /?-Estradiol) Check for antiestrogens 17 厶 -estradiol with 50% DMS 0/50% saline as injection vehicle. On the 4th day, the animals were sacrificed with sulphur dioxide to suffocate, the uterus was removed, the body fluid was removed, and the wet weight was measured. A uterine horny tissue and blood analysis while the rest are used to isolate total R Ν Α help _ estimate complement component 3 gene performance. _______--__ Γ m In · — n- ^ i ^ nfl i ^ i ^ i ^ ili Ba ^ mn ^ — «— ^^ 1 ^ ϋ · 1 ^ —B— t !, T (Please read the notes on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs -12 4 This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (w) Table 17 3 Immature Uterus Analysis Hankow weight Kung Palace weight Kung Palace weight Kg day weight mm Hawker SSL Example 100ytiG 10pG combined 1 yU G Vehicle Number Compound + 10> uG 17yg-Es 17 /?-Estradiol Tamoxifen 74.4 mg N / A 98.2 mg 42.7 mg number 85 41.1 mg 92.4 mg 94.4 mg 26.6 mg number 94 28.1 mg 93.7 mg 88.5 mg 22.3 mg number 97 27.4 mg 24.3 mg 63.2 mg 30.7 mg number 98 29.4 mg 27.9 mg 94.1 mg 35.9 mg number 100 59.9 mg 68.7 mg 91.9 mg 23.4 mg No. 101 65.1 mg 71.0 mg 113.7 mg 27.7 mg No. 122 46.7 mg 38.7 mg 103.4 mg 30.3 mg No. 123 39.2 mg 61.4 mg 94.4 mg 26.1 mg No. 138 28.4 mg 37.9 mg 93.9 mg 24.6 mg No. 139 30.4 mg 45.0 mg 82.1 mg 20.5 mg No. 168 43. 2 mg 81.7 mg 98.9 mg 25.5 mg -125- (Please read the notes on the back before filling out this page)-丄 、-= &quot; This paper size applies to the national standard of China (CNS) A4 (210X 297 mm) Female Sprague 5g &gt; β They are delivered in all treatments already defined as 17 彡 -Female II, 0.1 mmol

Atking.WI) A)吸收計測 A7 __B7_ 五、發明説明(丨外) 方法20 6 -週切除啪嚴:&gt; 女菌.堪式 得自Taconic FarM外科手術後1天獲得 Dawley CD鼠,〇vx 或 sharn ovx(重 240-27 3或4隻竄/籠蘭於14/10(光亮/黑暗)軒間表之房間 中且提供食物(Purina 500鼠食)和水及libituau所有 研究於動物到逹後1天開始治療及每週劑飢5或7天, 經6週。對於每一研究符合假装操作之鼠的組別不接受 任何治療,作為完整,雌激素充滿控制組&lt; 製備於1% tween 80於正常生理食鹽水中於 度,以使處理體積為0.1毫升/100克_重&lt; 醇溶解於玉米油(20# G/毫升)中且以皮下 升/鼠。所有劑量根據各組平均重量測量4整於三星期 間隔。 於開始治療之後5遇及在研究結束前一 #,評估各鼠 之骨骼最小密度(BMD)。近鎇脛骨(Proxinal tibae)(PT) 和fourthlumbar vertabre(L4)之BMD係利月丨雙能量X-射Atking.WI) A) Absorption measurement A7 __B7_ V. Description of the invention (outside) Method 20 6-week excision of patella: &gt; Female bacteria. Kansas obtained from Taconic FarM 1 day after surgery. Or sharn ovx (weigh 240-27 3 or 4 panthers / cage orchids in a 14/10 (light / dark) room table and provide food (Purina 500 rat food) and water and libituau all studies on animals to 逹Treatment was started one day after and 5 or 7 days of weekly dosing for 6 weeks. For each group of rats that met the pretend operation, no treatment was received, as complete, the estrogen-filled control group was prepared at 1% tween 80 was mild in normal physiological saline, so that the treatment volume was 0.1 ml / 100 g weight &lt; alcohol was dissolved in corn oil (20 # G / ml) and subcutaneous liter / rat. All doses were averaged according to each group Weight measurement 4 is rounded at three-week intervals. The minimum bone density (BMD) of each rat was evaluated 5 days after the start of treatment and 1 # before the end of the study. Proxial tibae (PT) and fourthlumbar vertabre (L4) BMD is Liyue 丨 Dual Energy X-Ray

線吸收(E c 1 i p s . X R - 2 6,N 〇 r 1 a n d C 〇 r p,F t 測量於麻醉之鼠上。對於各鼠之x射線(DXLinear absorption (E c 1 i p s. X R-2 6, N 0 r 1 an d C 0 r p, F t was measured on anesthetized rats. For each rat x-ray (DX

量僳如下完成:在DXA拥量之前15分鐘,以腹膜内注射 100 毫克 / 公斤酮胺(KetaBine,Bristo1 LThe measurement was done as follows: 15 minutes before the DXA volume, an intraperitoneal injection of 100 mg / kg of ketoamine (KetaBine, Bristo1

Syracuse, NY)及 0.75毫克 / 公斤 acepronazine(Syracuse, NY) and 0.75 mg / kg acepronazine (

Aveco,ft. Dodge,ΙΑ)麻醉β將該鼠置於 在DXA掃描器垂直於其路徑下;延伸1iBbs^ 護試管之表面。於50毫米/秒之掃描速度A -1 2 6 本紙張尺度適用中國國家橾準(CNS ) A4規格(210X 297公楚-)Aveco, ft. Dodge, IA) Anesthetize the beta and place the mouse perpendicular to its path with the DXA scanner; extend the surface of the test tube 1iBbs. Scanning speed at 50 mm / s A -1 2 6 This paper size is applicable to China National Standard (CNS) A4 size (210X 297 cm-)

In n·— n^i In m· ml ml —^ϊ ml、一^ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 aboratoriesIn n · — n ^ i In m · ml ml — ^ ϊ ml 、 一 ^ (Please read the precautions on the back before filling out this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs aboratories

烯酸試管中 以紙膠帶保 1 . 5毫米X 經 部 中 央 標 準 局 員 工 消 費 合 作 社 印 製 A7 B7 五、發明説明(丨?T) 1.5毫米之掃描解析完成首次掃描以測定感 興趣之P T和 L 4的範圍。於10毫米/秒之掃描速度使用0 .5毫米X 0 . 5 毫米解析度之最後DMD測量時使用小標的軟 體。該軟體 允許操作者定義1.5公分之寬度面積以涵蓋 L4之所有長 度。各位置之BMD以從在標的之下和延上述 定義之標的 檢測器之光源而産生之雙束(46.8KeV)和80 KeV X-射線 之衰減函數由軟體計算而得^ BMD值(以克/ &lt;公分表示) 和儲存各別掃描之數據以用於統計分析。B M D評估一週 之後,該等鼠以二氣化磺窒息犧牲及收集ώ [液用於臛固 醇測量。除去子宮及稱重。使用Boehringe r-Mannheiffl Hitachi 911臨床分析器,利用膽固醇/ HP 組套測量。 使用以Dunne t試驗變化之一方式分板比較統 計。 表18 實施例编號98之6週除去卵巢之鼠研究 -1 2 7 - 本紙張尺度適用中國國家標準(CNS ) /VI規格(210X297公釐) 請 先 閲 讀 背 意 事 項 再 t 訂 五、發明説明 治療 研究d 假裝(I n t a e t) 媒液(〇 v x )實施例編號98〇 . 3毫克/公斤 瑞羅思芬 3 毫克/17 &gt;8 -雌二醇 2 # g/鼠,s · c . BMD (m^/cm2)i,h 近側脛骨 0.211“ ±0.003 0.189 ±0.004 0.210· ±0.003 0.207* ±0.006 0.224·' ±0.004 A7 B7 △體重(gr 子宮重量 膽固醇(mg/dl).’ 0.183&quot; ±0.003 0.169 ±0.004 0.173 ±0.003 0.170 ±0.003 0.169 ±0.004 43.0- 士 6.0 62.7±8.2 46.8 土 6.6 25.3· 土 5.4 33.Γ ±4.9 △26.4·· 125.0 18.2 ±7.8 149.3 ±4.4 191.6*· 1:9.3 426.0** 18.4 土 71,6· ±5.0 87.2 ±3.0 59.0&quot; ±2.2 55.0&quot; ±2.4 95.5 ±3.9 (請先閲讀背面之注意事項再填寫本頁) a 平均土 S Ε Μ b 5週治療後 P&lt;〇.i)5#相當之媒液質 P &lt; 〇 · 〇 1謝相當之媒液質 ° 6週治療後 d 每天治療X7天/週X6週 經濟部中央標準局貝工消費合作社印聚 128- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐)1.5mm in paper test tube with X-ray tape. A7 B7 printed by the Ministry of Standards and Staff ’s Consumer Cooperatives. 5. Description of the invention (丨? T) Scanning analysis of 1.5mm. Complete the first scan to determine the PT and L of interest. 4 range. Use a small-size soft body for the last DMD measurement at a scan speed of 10 mm / sec using a resolution of 0.5 mm x 0.5 mm. The software allows the operator to define a 1.5 cm width area to cover all lengths of L4. The BMD of each position is calculated by software using the dual beam (46.8KeV) and 80 KeV X-ray attenuation functions generated from the light source below the target and extending the target detector defined above. BMD value (in grams / &lt; cm) and store the data of each scan for statistical analysis. One week after the BMD evaluation, the rats were sacrificed with disulfonated suffocation and the liquid was collected for the measurement of testosterone. Remove the uterus and weigh. The Boehringe r-Mannheiffl Hitachi 911 clinical analyzer was used to measure with the cholesterol / HP kit. Compare statistics using one of the Dunne t test variations. Table 18 Study of rat with ovarian removal for 6 weeks of Example No. 98-1 2 7-This paper size applies Chinese National Standard (CNS) / VI specifications (210X297 mm) Please read the intent and then t. V. Invention Description Treatment Study d Pretend (Intaet) vehicle (〇vx) Example No. 90.3 mg / kg riprosfin 3 mg / 17 &gt; 8-estradiol 2 # g / rat, s · c. BMD ( m ^ / cm2) i, h Proximal tibia 0.211 "± 0.003 0.189 ± 0.004 0.210 · ± 0.003 0.207 * ± 0.006 0.224 · '± 0.004 A7 B7 △ body weight (gr uterine weight cholesterol (mg / dl).' 0.183 &quot; ± 0.003 0.169 ± 0.004 0.173 ± 0.003 0.170 ± 0.003 0.169 ± 0.004 43.0- ± 6.0 62.7 ± 8.2 46.8 soil 6.6 25.3 · soil 5.4 33.Γ ± 4.9 △ 26.4 ·· 125.0 18.2 ± 7.8 149.3 ± 4.4 191.6 * · 1: 9.3 426.0 ** 18.4 soil 71.6 ± 5.0 87.2 ± 3.0 59.0 &quot; ± 2.2 55.0 &quot; ± 2.4 95.5 ± 3.9 (Please read the precautions on the back before filling this page) a average soil S Ε Μ b 5 weeks treatment After P &lt; 〇.i) 5 # equivalent vehicle fluid P &lt; 〇 · 〇1 Thanks to equivalent vehicle fluid ° After 6 weeks of treatment d X7 daily Day / Week X6 Weeks Printed by the Central Laboratories of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives 128- This paper size applies to China National Standard (CNS) A4 (210X 297 mm)

Claims (1)

六、申請專利範圍 第8 6 1 0 4 9 1 9號「作為雌激素劑之2-苯基-1-苄基-吲哚 化合物」專利菜 經濟部中央標车局員工消費合作社印製Scope of patent application No. 8 6 1 0 4 9 1 9 "2-phenyl-1-benzyl-indole compound as an estrogen agent" Patented dish Printed by the Consumer Cooperative of the Central Standard Vehicle Administration of the Ministry of Economic Affairs (請先閱讀背面之注意事項再填本頁) 裝 、-0(Please read the precautions on the back before filling this page) 六、申請專利範圍 第8 6 1 0 4 9 1 9號「作為雌激素劑之2-苯基-1-苄基-吲哚 化合物」專利菜 經濟部中央標车局員工消費合作社印製Scope of patent application No. 8 6 1 0 4 9 1 9 "2-phenyl-1-benzyl-indole compound as an estrogen agent" Patented dish Printed by the Consumer Cooperative of the Central Standard Vehicle Administration of the Ministry of Economic Affairs (請先閱讀背面之注意事項再填本頁) 裝 、-0 申請專利範圍 R β 為 Η ; X係選自Η、C ^ n為2或3 ; Υ偽選自: 其中 ABCD _ C e保基、氣基、®素; ,Ry 、N Be 及1?8偽選自羥基,鹵素,Ci 或1?7及1?3共同形成六氫吡啶基 庚基,吖雙環辛基,六氫吡哄基 基,且六氫吡啶基可視需要以Ci ,且D丫雙環辛基可視需要由Ci - .s烷基及環己基; 吖庚因基,吖雙環 B丫辛基,及毗咯啶 .6烷基或羥基取代 i院基取代; 及其藥學上可接受鹽。 如申請專利範圍第1項之化合物,其4為5 -千氣基-2 -(4 -乙氧基-苯基)-3 -甲基-卜〔4-(2-六氫毗啶-1~基_ 乙氧基)-千基〕-1H-吲哚或其藥學上可接受鹽。 .如申請專利範圍第1項之化合物,其偽.為5 -苄氧基-2 苯基-3-甲基_1_〔 4-(2-b丫庚因基-乙氣基)-卡基〕 ---------&quot;------&quot;------# (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 -1 Η -吲嵘或其藥學上可接受鹽。 如申請專利範圍第1項之化合物,其 為5-平氧基-2 (4 -苄氧基-苯基)-3 -甲基-卜〔4-(2-Blf庚因-卜基-乙 氣基)-苄基]-1 Η -吲唉或其藥學上可接受鹽。 如申請專利範圍第1項之化合物,其像為5 -苄氣基-2 2 __ ,一 本紙張尺度適用中國國家標準(CNS ) Α4洗格(210Χ297公釐) 經濟部中央標隼局員工消費合作社印製 A8 B8 C8 D8 六、申請專利托圍 (4 -苄氧基-苯基)-3 -甲基-1 -〔 4 - ( 2 -二異 丙胺-1 -基- 乙氣基)-干基〕-1 Η -吲哚或其藥學上可 接受鹽。 6 .如申請專利範圍第1項之化合物,其傜 為5 -苄氧基-2 - (4_节氣越-苯基)-3~甲基~1-〔 4~(2- 丁 基-甲胺-卜基- 乙氣基)-苄基〕-1 Η -吲晓或其藥學上可 接受鹽。 7 .如申請專利範圍第1項之化合物,其像 為5-¥氣基-2- (4-苄氧基-苯基)-3-甲基-1- {4 -〔(二 甲胺基)-乙氣 基〕-苄基)-1 Η -吲哚或其藥學上可接ί 1鹽。 8 .如申請專利範圍第1項之化合物,其偽 為5-苄氧基 -2-U -千氧基-苯基)-3 -甲基-1- {4-〔 2- (2-甲基-六 氫吡啶-1-基)-乙氧基〕-苄基)-1H -吲 咬或其藥學上 可接受鹽。 9 .如申請專利範圍第1項之化合物,其傺 為5 -苄氣基 -2〜(4 -苄氧基-苯基)-3-甲基-1- { 4-〔 2- (3-甲基-六 氫吡啶-1 -基)-乙氧基〕-苄基)-1 Η -吲 晓或其藥學上 可接受鹽。 1 0 .如申請專利範圍第1項之化合物,其傺 為5-苄氧基 ~2~(4·^ 氣基-苯基)-3 -甲基-1- ( 4-〔 2 - ( 4 -甲基-六 氫吡啶-1 -基)-乙氧基〕-吡基)-1 Η -吲 褛或其藥學上 可接受鹽。 η ·如申請專利範圍第]項之化合物,其傜 為5 -苄氣基 -2-(4 -苄氧基-苯基)-3 -甲基-1- { 4-〔 :卜(順)-2 , 6- 二甲基-六氫4 tg -1 -基)-乙氧基〕-千去 % } - 1 Η -吲咬 ~ 3 - ---------訂 备 - ^ (請先閣讀背面之注意事項再填f本頁) 本紙强尺度適用中國國家標準(CNS ) A4規格(21 OX297公釐) A8 B8 C8 D8申請專利範圍 或其藥學上可接受鹽。 1 2 .如申請專利範圍第1項之化合物,其傳為5 -苄氣苺 -2 - ( 4 -干氣基-苯基)-3 -甲基-{ 4 -〔 2 -(1,3,3 甲基-6-BY-雙環〔3.2.1〕辛-6 -基)-乙氧基〕-苄基} -1 Η -吲嵘或其藥學上可接受鹽。 1 3 .如申請專利範圍第1項之化合物,其傑 苄氧基- 2-(4-苄氣基-苯基)-3-甲基--吖-雙環〔2 . 2 . 1〕庚-2 -基)-乙氣基〕 吲唉或其藥學上可接受鹽。 1 4 .如申請專利範圍第1項之化合物,其倒 為(IS , 4R) -5-4 - [ 2-(2--干基} -1H- 為5-苄氣基 -2-(4 -氟-苯基)-3 -甲基-卜〔4-U -吖 庚因-1-基-乙 氣基)-苄基〕-1H -吲晓或其藥學上可接 1 5 .如申請專利範圍第1項之化合物,其侥 受鹽。 為5-苄氣基 2- (4-氟-苯基)-3-甲基-1-〔 4- (2-: _氫毗啶-1-基- 經濟部中央標隼局員工消費合作社印製 乙氧基)-苄基〕-1H -吲哚或其藥學上司接受鹽。 1 6 .如申請專利範圍第1項之化合物,其係為5 -苄氧基 -2-(4-氯-苯基)-3 -甲基-1-〔 4-(2-六i吡啶-卜基-乙氣基)-千基〕-1 Η -吲哚或其藥學上可接受鹽。 1 7 .如申請專利範圍第1項之化合物,其係為5 -苄氧基 -2 - ( 3 , 4 -甲撐二氧基-苯基)-3 -甲基-1 -〔 4 - ( 2 -六氫啦 淀-1-基-乙氣基)-苄基〕-ΙΗ-π引唉或其藥學上可接受 鹽。 1 8 ·如申請專利範圍第1項之化合物,其傜為5 -苄氧基 -4- 本紙張尺度適用中國國家橾準(CNS ) Α4規格(210X 297公釐) ---------g------、1T------@ ^ -(請先閱讀背面之注意事項再填寫本頁) 經 部t 央 標 準 員 工 消 費 A # 社 印 製 Α8 Β8 C8 D8 六、申請專利範圍 -2-(4_異丙氣基-苯基)-3 -甲基-1-〔 4- (2 -六氫毗啶 -:L -基-乙氣基)-干基〕-1 Η -吲唉或其藥 學上可接受鹽。 1 9 .如申請專利範圍第1項之化合物,其係 為5 -苄氧基 -2 - ( 4 -甲基-苯基)-3 -甲基-1 -〔 4 - ( 2 -: \氫吡啶-1 -基- 乙氧基)-苄基〕-1 Η -吲嗓或其藥學上可 接受鹽。 20 .如申請專利範圍第1項之化合物,其偽 為:1 -〔 4 - ( 2 - d 丫庚因-1-基-乙氧基)-苄基〕-5 -苄氧; S -2-(3-苄氧 基-苯基)-3 -甲基-1 Η -吲咬或其藥學上1 ij接受鹽。 2 1 .如申請專利範圍第1項之化合物,其傺 為5 -苄氣基 -2-(4-干氧基- 3- ® -苯基)-3 -甲基-1- 〔4- (2-六氫吡 啶-卜基-乙氧基)-苄基]-1H -吲唉或其 藥學上可接受 鹽。 2 2 .如申請專利範圍第1項之化合物,其係 為5-苄氧基 -2-(4-干氣基-3-氟-苯基)-3 -甲基-卜 〔4 - ( 2 -吖庚因 -:1 -基-乙氧基)-苄基〕-1 Η -吲哚或其藥 學上可接受鹽。 23.如申請專利範圍第1項之化合物,其係 為5 -苄氣基 -2-(3 -甲氣基-苯基)-卜〔4-(2 -六氫毗 啶-卜基-乙氧 基)-千基〕-3 -甲基-1 Η -吲哚或其藥學_ 二可接受鹽。 2 4 .如申請專利範圍第1項之化合物,其傷 為5 -苄氣基 -3 -甲基- 〔4-(2-六氫α比旋- i- 基~乙Ί K基)-苄基〕 -2 - ( 4 -二氟甲氣莪-苯蕋)-1 Η -吲哚或其 藥學上可接受 鹽。 2 5 .如申請專利範圍第1項之化合物,其偽 為(2 - [ 4 -〔 ~ 5 - 本紙張尺度適用中國國家橾準(CNS ) Α4規格(210Χ297公釐) 請 閱 讀 背 ιέ 意 事 項 再 填 寫 本 頁 装 訂 經 系· 部 t A 標 準 Λ 員 工 消 人 社 印 製 六、申請專利範圍 5 -平氣基-2 - ( 4 -干氣基-苯基)-3 -甲1 g -吲咬-1 -基甲 基〕-苯氣基}-乙基)-環己基-胺或_ t藥學上可接受 髒。 2 6 .如申請專利範圍第1項之化合物,其 偽為5 -苄氧基 -2-(4 -干氧基-苯基)-3 -甲基-卜(4- 甲基六氫毗畊-;L - 基)-乙氣基〕-苄基} - 1 Η -吲哚或其9 i學上可接受鹽。 27 .如申請專利範圍第1項之化合物,其 偽為 1_〔 4-(2- 吖庚因-卜基-乙氧基)-苄基〕-5 -苄^ ξ基-2- (3-甲氧基 -苯基)-3 -甲基-1 Η -吲晚或其藥學上ΐ 丁接受鹽。 2 8 .如申請專利範圍笫1項之化合物,其 偽為4 - { 3 -甲 基-1-〔 4 - (2-六氫毗啶-卜基-乙氣基 )-干基〕-1 Η -吲 嗦)(HC 1 )〇 2 9 .如申請專利範圍第1項之化合物,其 偽為4- {3-甲 基-1-〔 4-(2-六氫啦旋-1-基-乙氣基 )-苄基〕-1 Η -吲 唉-基}酚鹽酸鹽(HC1)。 3 0 .如申請專利範圍第1項之化合物,其 像為3 -甲基-2- 苯基-1-〔 4-(2 -六氫吡啶-卜基-乙氧 基)-苄基]-1 Η - 吲嗪-5 -醇(H C 1 )。 3 1 .如申請專利範圍第1項之化合物,其 潞為4 - { 5 -甲 氧基-3 -甲基-1- [ 4〜〔2_(六靈咐症- 1 -基)-乙氧基] -苄基)-1 Η -吲嗓-2 -基} - _或其藥| 1上可接受鹽。 3 2 ·如申請專利範圍第I項之化合物,其 t為2 - ( 4 -甲氧 基-苯基)-3 -甲:S - 1 - ( 4 -〔 2 -(六氫4 i啶-1-基)-乙氧 -δ - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 頁 請 閱 讀 背 1¾ 之 注 意 事 項 再 經 濟 部 中 A 標 準 員 工 消 f 合 作 社 印 製 A8 B8 C8 D8 六、申請專利範圍 基〕-干基} - 1 Η -吲咬-5 -醇或其藥學上 可接受鹽。 3 3 .如申請專利範圍第1項之化合物,其偽 為5 -甲氣基 -2-(4-甲氧基-苯基)-3-甲基-卜〔4-(Σ -六氫吡啶-1 - 基-乙氣基)-苄基〕-1 Η -吲哚(H C 1 )。 3 4 .如申請專利範圍第1項之化合物,其傺 為 1 -〔 4 - ( 2 - 吖庚因-卜基-乙氣基)-苄基〕-5 -甲氧3 S -2-(4-甲氧 基-苯基)-3 -甲基-1 Η -吲哚(H C 1 )。 3 5 .如申請專利範圍第1項之化合物,其係 為2-(4 -乙氣 基-苯基)-3-甲基-1-〔 4 - (2-六氫吡啶- 1-基-乙氣基) -苄基]-1Η-蚓哚-5-醇或其藥學上可接 受鹽。 3 6 .如申請專利範圍第1項之化合物,其偽 為卜〔4- (2- 吖庚因-卜基-乙氣基)-苄基〕-2-(4 -乙 氧基-苯基)-3- 甲基-1H -吲哚-5-醇或其藥學上可接受1 i 〇 37 .如申請專利範圍第1項之化合物,其傷 為4 - [ 5 -氣 一3-甲基-1-〔 4-(2-六氫Π比® -1-基-乙 i基)-苯基〕 -1 Η - D引晚-2 -基}-酚(H C 1 )。 3 8 .如申請專利範圍第1項之化合物,其係 為 1 -〔 4 - (2 - DY庚因-卜基-乙氧基)-千基〕-3 -甲基 -2-苯基-1H-吲 矂-5 -醇(丨1 C 1 )。 3 9 .如申請專利範圍第1項之化合物,其係 為2 - (4-羥基 -苯基)-3 -甲基-1-〔 4-(2 -毗咯啶-1-基 -乙氧基) -干基:〕-1 Η -吲咬-5 -醇或其藥學上可接 受鹽。 4 0 .如申請專利範圍第1項之化合物,其係 為 1 -〔 4 - ( 2 - -7 ~ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 請 先 閱 面 意 事 項 再 ▲ 寫 本 頁 訂 經 濟 部t 標 準 局 員 工 消 合 作 社 印 製 A8 B8 C8 D8 六、申請專利範圍 吖庚因-1 -基-乙氣基)-苄基〕-2 - ( 4 - 徑基-苯基)-3- 甲基-1 Η -1丨引咬-5 -醇(H C i )。 4 1 .如申請專利範圍第1項之化合物,其 偽為卜〔4 - ( 2 - d丫庚因-1 -基-乙氧基)-苄’基〕-2 - ( 4 - 翔基-苯基)-3- 甲基-1 Η -吲唉-5 -醇乙酸鹽。 4 2 .如申請專利範圍第1項之化合物,其 傺為 1- ί 4 - (2- D 丫辛-1-基-乙氧基)-苄基〕-2-(4-羥 基-苯基)-3-甲 基-1 Η -吲哚-5 -醇或其藥學上可接受顆 ! 〇 4 3 .如申請專利範圍第1項之化合物,其 偽為2- (4-羥基- 苯基)-3-甲基-1-〔 4-(2-二甲基-1-1 ;-乙氧基)-干基〕 -1 Η -吲晓-5 -醇或其藥學上可接受鹽。 4 4 .如申請專利範圍第1項之化合物,其 偽為2 - (4 -羥基- 苯基)-3 -甲基-1-〔 4-(2-二乙基-1-3 ;-乙氣基)-苄基〕 -1H-吲晚-5-醇或其藥學上可接受鹽。 4 5 .如申請專利範圍第1項之化合物,其 偽為 1 -〔 4 - ( 2 - 二異丙胺基-乙氧基)-苄基]-2-(4-罗 爸基-苯基)-3-甲 基-1 Η -吲嗪-5 -醇或其藥學上可接受i ί 〇 4 6 .如申請專利範圍第1項之化合物,其 係為卜〔4 - ( 2 - 二丁基胺基-乙氧基)-苄基〕-2 - ( 4 -羊 2基-苯基)-3-甲 基-1 Η -吲哚-5 -醇或其藥學上可接受i 1 〇 4 7 .如申請專利範圍第1項之化合物,其 偽為 〔4-(2_ 二異丙胺基-乙氧莪)-苄基〕-2 - ( 4 - _ 2基-苯基)-3 -甲 基-1 Η -吲嵘-5 -醇或其藥學上可接受? 蓮。 -8 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 請 閱 面 意 事 項 再 玫. 本 頁 裝 訂 镍 經 濟 部 中 標 準 員 工 消 合 作 社 印 製 Α8 Β8 C8 D8 六、申請專利範圍 4 8 .如申請專利範圍第1項之化合物,其偽 為 1 - ( 4 -〔 2 - (丁基-甲基胺基)-乙氣基)-苄基} - 2 -( 4-羥基-苯基) -3 -甲基-1 Η -吲嵘-5 -醇或其藥學上可接 受鹽。 4 9 .如申請專利範圍第1項之化合物,其傜 為2 - ( 4 -羥基 -苯基甲基-1- { 4-〔 2*·(2 -甲基-六I $ 4啶-1 -基)-乙 氧基〕-苄基)-1 Η -吲哚-5 -醇或其藥學 上可接受鹽。 50.如申請專利範圍第1項之化合物,其係 為2- (4-羥基 -苯基-3-甲基-1- { 4-〔 2-(3-甲基-六f $毗啶-1 -基)- 乙氧基]-苄基} -1H-吲哚-5-醇或其藥 學上可接受鹽。 51.如申請專利範圍第1項之化合物,其傲 為2- (4-羥基 -苯基-3 -甲基-1 - ( 4 -〔 2 - ( 4 -甲基-六i $吡啶-卜基)- 乙氧基〕-苄基)-1 Η -吲哚-5 -醇(H C 1 ) c 5 2 .如申諳專利範圍第1項之化合物,其傜 為卜{ 4- 〔 2- (3 , 3 -二甲基-六氫毗啶-:1 -基)乙氣基〕 -干基)-2-(4- 羥基-苯基)-3 -甲基-1 Η -吲咬-5 -醇或其 藥學上可接受 鹽。 5 3 .如申請專利範圍第1項之化合物,其傑 為卜{ 4 -〔 2 - (順)-2 , 6 -二甲基-六氫吡啶-卜基)-乙1 1基〕-干基} -2 - ( 4 -羥基-苯基)-3 -甲基-1 Η -吲哚-5 - 醇或其藥學上 可接受鹽。 5 4 .如申請專利範圍第1項之化合物,其傜 為2 - (4-羥基 -苯基)-1- (4-〔 2-(4-羥基-六氫吡啶- 1 -基)-乙氣基〕 -«比基)-3 -甲基-1 Η -吲晬-5 -醇或其藥1 1上可接受鹽。 -9- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 請 先 閱 讀 背 ιέ 之 注 意 事 項 填 寫 本 頁 訂 經 濟 部 t 央 揉 準 局 員 工 消 f 合 印 製 A8 B8 C8 D8 六、申請專利範圍 5 5 .如申請專利範圍第丨項之化合物,其係 為(1S,4R) + { 4 - ί 2 - (2 - η丫 -雙環〔2 · 2 . 1〕庚 ~ 2 -基 )-乙氧基〕- 苄基)-2 - ( 4 -羥基-苯基)-3 -甲基-1 Η - f 1唉-5-醇或其 藥學上可接受鹽。 5 6 .如申請專利範圍第1項之化合物,其傜 為2 - ( 4 -羥基 -苯基)-3-甲基-1- ( 4-〔 2-(1,3,3-三 E 3 基-6-D丫-雙 環〔3. 2. 1〕辛-6-基)乙氧基〕-苄基) -1 Η ~ 2引 - 5 - 醇或其藥學上可接受鹽。 5 7 .如申請專利範圍第1項之化合物,其像 為2 - ( 4 -氣- 苯基)-3 -甲基-1-〔 4-(2 -六氫吡啶-卜3 S -乙氣基)-苄 基〕-1 Η -吲哚-5 -醇(H C 1)。 5 8 .如申請專利範圍第1項之化合物,其係 為卜〔4- (2- D 丫庚因-1-基-乙氣基)-苄基〕-2-(4 -氟 -苯基)-3-甲 基-1 Η -吲蝾-5 -醇或其藥學上可接受鹽 59.如申請專利範圍第1項之化合物,其傜 為2-(3-甲氣 基-4'蔑基-苯基)-3 -甲基〔 4-(2六 氫吡啶-卜基- 乙氧基)-苄基]-1Η -吲哚-5 -醇(H C 1 )。 60 .如申諳專利範圍第1項之化合物,其侥 為2-苯弁 〔1,3〕二鸣茂-5 ~ 基-3 -甲基-1 -〔 4 -( 2 -六氫吡啶-1 - 基-乙氣基)-苄基〕-1 Η -吲哚-5 -醇(H C 1 ) 〇 6 1 .如申請專利範圍第1項之化合物,其傍 為2 - (4 -異丙 氣基-苯基)-3 -甲基-1 -〔 4 - ( 2 -六氫吡 淀-1 -:基·乙氣 蕋)-苄菽〕-1 Η -吲晬-5 -醇(丨丨C 1 )。 -10- 本紙張尺度適用中國國家梯準(CNS ) Α4说格(2丨0Χ297公釐) 請 閔 面 之 注 意 事 項 再 填 寫 本 頁 訂 經 部 中 央 標 隼 局 員 X. 消 f 合 社 印 製 拈上編 ?88 D8 六、申請專利範圍 6 2 .如申諳專利範圍第1項之化合物,其偽 ^ 1 - [ 4-(2- u 丫庚因-1-基-乙氣基)-苄基]-2-(4 -異 丙氣基-苯基) -3 -甲基-1 Η -吲哚-5 -醇(H C 1 )。 6 3 ·如申請專利範圍第1項之化合物,其係 為2 - ( 4 -環戊 氣基-苯基)-3 -甲基-1-〔 4-(2 -六氫4萌 -1-基-乙氣 基)-苄基〕-1H -吲哚-5 -醇或其藥學上司 接受鹽。 6 4 .如申請專利範圍第1項之化合物,其傜 為3-甲基-1- 〔4-(2-六氫4啶-卜基-乙氣基)-干基〕 -2- (4-三氣 甲基-苯基)-1Η-吲咬-5-醇或其藥學上司 接受鹽。 6 5 .如申請專利範圍第1項之化合物,其偽 為3-甲基-1- 〔4-(2 -六氫吡啶-卜基-乙氧基)-苄基〕 -2 -對-二甲 苯基-1 H -吲哚· - 5 -醇或其藥學上可接受鹽 〇 6 6 .如申請專利範圍第1項之化合物,其係 為2 - ( 4 -氯- 苯基)-3 -甲基-1 -〔 4 - (2 -六氫吡啶-1 -基 -乙氧基)-苄 基〕-1 Η -吲唉-5 -醇(H C 1 )。 6 7 .如申請專利範圍第1項之化合物,其傺 為 2- (2,4-二 甲氣基-苯基)-3 -甲基-1-〔 4-(2-六氫咐 啶-卜基-乙 氧基)-苄基〕-1 ί丨-吲哚-5 -醇或其藥學上 可接受鹽。 6 δ .如申請專利範圍第1項之化合物,其傜 為2 - ( 3 -羥基 -苯基)-3 -甲基-1 -〔 4 - ( 2 -六氫吡啶-1 - S -乙氧基)- 干基〕-1 Η -吲晓-5 -醇或其藥學上可接受 鹽。 6 9 .如申請專利範圍第1項之化合物,其偽 ^ 1~ C 4-(2~* u丫庚因-1 -基-乙氣基)-苄基〕-2 - ( 3 -羥 S -苯基)-3 -甲 -1 1 - 本紙張尺度適用中國國家揉準(CNS &gt; Α4規格(210X297公釐) 請 先 閲 面 冬 意 事 項 再 填 % 本 頁 L 訂 經 濟 部 央 標 隼 局 員 工 消 合 作 社 印 製 A8 S8.iuS3 S D8 六、申請專利範圍 基-1 Η -吲咬-5 -醇或其藥學上可接受彌。 7 0 .如申請專利範圍第1項之化合物,其像 為 2-(3-氣-4- 羥基-苯基)-3 -甲基-卜〔4 - ( 2 -六氫4商 :-1-基-乙氧 基)-苄基〕-1 Η -吲哚-5 -醇或其藥學上百 ‘接受鹽。 7 1 .如申請專利範圍第〗項之化合物,其傜 為 2-(3氣-4- 羥基-苯灌)-3 -甲基-1-〔 4-(α 丫庚因-1- 基)-乙氣基)- 苄基〕-1Η -吲咬-5-醇或其藥學上可接5 :鹽。 7 2 .如申請專利範圍第1項之化合物,其僳 為2 - ( 3 -甲氧 基-苯基)-3 -甲基-1-〔4 -(2-六氫吡啶- 1 -基-乙氯基) -午基]-1H-吲晬-5-醇或其藥學上可接 受鹽。 73 .如申請專利範圍第1項之化合物,其偽 為3 -甲基-1 - 〔4-(2 -六氫吡啶-卜基-乙氧基)-苄基〕 2- (4-三氟甲 氣基-苯基)-1 Η -吲嵘-5 -醇或其藥學上U ί接受鹽。 7 4 .如申請專利範圍第1項之化合物,其像 為 3-氯-2- (4- 羥基-苯基)-1-〔 4-(2 -毗咯啶-卜基-乙 氧基)-苄基〕 -1 Η - d引唉-5 -醇(H C 1 )。 7 5 .如申請專利範圍第1項之化合物,其係 為除去患酯 以産生3 -氛-2 - ( 4 -羥基-苯基)-1 -〔 4 -( 2 -六氫毗啶-1 - 基-乙氣基)-基〕-1 Η -吲哚-5 -醇(H C 1 )〇 7 6 .如申請專利範圍第1項之化合物,其係 為 3-氮- 2- (4- 經基-苯基)~1~ L 4-(2 -η丫庚因-1-基-乙 氧基)-苄蕋〕 -1 Η -吲唉-5 -醇(H C 1 )。 7 7 .如申請專利範圍第1項之化合物,其傜 為 3 -氮-2- (4- -12- 本紙張尺度逋用中國國家標準(CNS ) Α4規格(210Χ297公釐) 請 閱 讀 背 1¾ 之 注 意 事 項 再 填 % 本 頁 % 訂 申請專利範圍 ABCD 羥基-2 -甲苯基)-1 -〔 4 - ( 2 -六氫吡啶-1 -基-乙氣基) 苄基 1 Η-吲咬-5-醇或其藥學上可接受鹽。 7 8 .如申請專利範圍第1項之化合物,其偽 -苯基)-3 -乙基-1 -〔 4 - ( 2 -六氫吡啶-1 - 為2- (4-羥基 基-乙氧基)- 苄基 1 Η -吲咬-5 -醇(H C 1 ) 〇 7 9 .如申請專利範圍第1項之化合物,其係 (4 -羥基-苯基)-1-〔 4-(2 -六氫吡啶-1- 苄基 1 Η -吲唉-3 -甲膳(H C 1 ) 經濟部中央標準局員工消f合作社印$L 8 0 .如申請專利範圍第1項之化合物,其偽 吖庚因-卜基-乙氧基)-苄基〕-5-羥基-基)-1 Η -吲蝾-3 -甲膳(H C 1 )。 8 1 .如申請專利範圍第1項之化合物,其傍 2-(4-苄氣基-苯基)-3-氛-1-〔 4-(2-六 乙氧基)-毗基]-1H-吲蝾或其藥學上可 δ 2 .如申請專利範圍第1項之化合物,其偽 2-(4 -千氧基-苯基)-3 -氛-卜〔4-(2 -吖 氧基)-苄基〕-1 Η -吲哚或其藥學上可接 8 3 .如申請專利範圍第1項之化合物,其係 2 - ( 2 -甲基-4 -苄氣基-苯基)-3 -氛-1 -〔 啶-卜基-乙氣基)-苄基〕-1 Η -吲哚或其 鹽〇 8 4 .如申請專利範圍第1項之化合物,其偽 2 - ( 4 -干氣基-苯基)-3 -乙基-;1 -〔 4 - ( 2 - -13- 為5-羥基-2-基-乙氧基)- 為 卜 〔 4- (2-2-(4 -經基-苯 為5 -苄氧基-氧赴淀_1_基-接受鹽。 為5-苄氧基-庚因-1-基-乙 受鹽。 為5-苄氣基-4 - ( 2 -六氫吡 藥學上可接受 為5-苄氧基-氫4啶-1 - ---------'4^-- (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X 297公釐) 經 部t 標 隼扁 員 工 消 費 合 作 社 印 製 A8 B8 C8 D8 六、申請專利範圍 基-乙氣基)-苄基〕-1 Η -吲哚或其藥學J :可接受鹽。 8 5 .如申請專利範圍第1項之化合物,其偽 為5 -干氧基- 2 - ( 4 -千氣基-苯基)-3 -氰基-1 -〔 4 - ( 2 - 六氫毗啶-1 - 基-乙氣基)-苄基〕-1 Η -吲哚或其藥學」 二可接受鹽。 86 .如申請專利範圍第1項之化合物,其傷 為5 -千氣基- 2-(4 -千氯基-苯ffi卜3 -氡基-卜〔4-(2- 吖庚因-卜基- 乙氣基)-苄基〕-1 Η -吲嵘或其藥學上可 接受鹽。 8 7 .如申請專利範圍第1項之化合物,其偽 為 1- 〔 4-(2- 吖庚因-卜基-乙氣基)-苄基〕-2-(4-羥 基-苯基)-3 - 甲基-1 Η -吲嗓-5 -醇之二丙酸酯(H C 1 )。 88.如申請專利範圍第1項之化合物,其偽 為卜〔4 - (2 - 吖庚因-卜基-乙氧基)-苄基〕-2 - ( 4 -羥 基-苯基)~ 3 - 甲基-1丨丨-吲蝾-5 -醇之二待戊酸酯(H C 1 : 〇 8 9 .如申請專利範圍第1項之化合物,其偽 為5-ΐ氣基 -2-U -苄氧基-苯基)-1-〔 4-(3 -六氫咐 啶-1-基-丙氧 基)-苄基〕-3 -甲基-1 Η -吲哚或其藥學 上可接受鹽。 9 0 .如申請專利範圍第1項之化合物,其傺 為2 - ( 4 -羥基 -苯基)-3_甲基-〔 4_〔 3-(六氣啦症 -1 -基)-丙氣基) -苄基]-1 Η -吲哚-5 -醇或其藥學上可接 受鹽。 9 1 .如申請專利範圍第1項之化合物,其傍 為2- (4-羥基- 苯基)-1 -〔 3 -甲氣基-4 - ( 2 -六氫毗啶- 1 -基-乙氣基)- 千揭〕〜3_甲基- lH-t1引唆醇或其藥學 L上可接受鹽。 9 2 .如申謓專利範圍第1項之化合物,其伤 t為2 - ( 4 -羟基- -14- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 請 閱 讀 背 面 之 注 意 事 項 再 t L 訂 經濟部中央標準局員工消費合作社印製 A8 S8i0^3 a D8 六、申請專利範圍 苯基)-1 -〔 3 -甲氣莲-4 - ( 2 - d丫庚因-卜I -乙氣莲)-苄 基〕-3 -甲基-1 Η -网丨喊-5 -醇.或其藥學上 可接受鹽。 9 3 ,如申請專利範圍第1項之化合物,其偽 為5-干氧基 -2 - ( 4 -千氧基-苯基)-3 -甲基-1 -〔 3 -甲 氧基-4-(2~*六 氫吡啶-1 -基-乙氣基)-苄基]-1 Η -吲哚 或其藥學上可 接受鹽。 9 4 .如申請專利範圍第1項之化合物,其偽 為5-ΐ氧基 -2-(4-千氣基-苯基)-3-甲基-1-〔 2-甲 氧基-4-(2-〇丫 庚因-1-基-乙氧基)-干基〕-1H-吲晬或 其藥學上可接 受鹽。 95.如申請專利範圍第1項之化合物,其偽 為2- (4-羥基 -苯基)-3 -甲基-1-〔4-(2_六氣啦症-1- 基&quot;乙氧基)- 苄基]-1 Η -吲嵘-5 -醇之二特戊酸酯或美 :藥學上可接 受鹽。 96 .如申請專利範圍第1項之化合物,其偽 為5 -苄氣基 -2-U-干氧基-苯基)-3 -甲基-1-〔 4-(2 -六氣(啦淀_1 - 基-乙氧基)-苄基〕-1 Η -吲哚或其藥學J :可接受鹽。 9 7 .如申請專利範圍第1項之化合物,其傜 為5 -苄氧基 -2-(3-干氧基-苯基)-3-甲基-1-〔 4-(2 -六氣吼旋_1- 基-乙氧基)-苄基]-1 Η -吲咬或其藥學_ί :可接受鹽。 9 8 .如申請專利範圍第1項之化合物,其偽 為2- (4-羥 基-苯基)-3 -甲基-1-〔 4-(2 -六氳毗啶- 卜基-乙氧基) -千基〕-1 Η -吲咬-5 -醇或其藥學上可接 受鹽。 -1 5 - (請先閎讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家橾準(CNS ) A4規格(210X 297公釐) &amp;8i0b3 A8 B8 C8 D8 申請專利範圍 9 9.如申諳專利範圍第1項之化合物,其傜為2-(4-^ 基-苯基)-3 -甲基-1 -〔 4 - ( 2 -六氫吡啶 -干基]_ 1 H _ b引晚_ 5 _ S?甲碘化物。 1 -基)-乙氧基 1 0 0 .如申請專利範圍第1項之化合物,其偽為2 - ( 4 -羥 基-苯基)-3 -甲基-1-〔 4-(2-二甲基 午基〕_1H -〇引晚-5-醇.甲碘化物。 -基-乙氣基) 經濟部中央標準局員工消費合作社印製 1 0 1 . —種治療或預防哺 含一有效量之如申 學上可接受鹽作為 1 0 2 . —種治療或預防哺 狀態或症候群之醫 專利範圍第1項之 性成份及一種醫藥 1 0 3 . —種治療或預防哺 包含一有效量之如 藥學上可接受鹽作 1 0 4 . —種治療或預防哺 子宮内膜異位或似 ,作用或生長所造 圍第1項之化合物 及一種翳藥可接受 乳類骨質 請專利範 活性成份 乳類中因 藥組成物 化合物, 可接受載 乳類心與 申請專利 為活性成 乳類疾病 子宮内膜 成,其包 ,或其藥 載體。 疏鬆之醫_組成 圍第1項化合 及一種翳_可接 激 含 學 或與雌 ,其包 或其藥 體。 血管疾病 物,其包 物,或其藥 受載體。 _有關之疾病 有效景之如申請 上可接受鹽作為活 (請先閱讀背面之注意事項再填寫本頁) 範圍第 份及一 之醫藥 異位組 含-有 學上可 種 組 織 效 接 之醫藥 項之化 醫藥可 成物, 之增生 景之如 受鹽作 組成物,其 合物,或其 接受載體。 該疾病像由 ,異常發展 申請專利範 為活性成份 本紙張尺度逋用中國國家梯準(CNS ) Α4規格(210Χ297公釐)(Please read the precautions on the back before filling this page). The scope of the patent application for -0 R β is Η; X is selected from Η, C ^ n is 2 or 3; Υ is selected from: where ABCD _ C e Ry, N Be and 1-8 pseudo-selected from hydroxyl, halogen, Ci or 1-7 and 1-3 together to form hexahydropyridylheptyl, azabicyclooctyl, hexahydropyridine An acyl group, and hexahydropyridyl can be Ci, and D y bicyclooctyl can be Ci-. S alkyl and cyclohexyl; azepine, azabicyclo B octyl, and pyrrolidine. 6 alkyl or hydroxy substituted i-substituted radicals; and pharmaceutically acceptable salts thereof. For example, for the compound in the first item of the scope of patent application, its 4 is 5 -thienyl-2-(4-ethoxy-phenyl) -3 -methyl-bu [4- (2-hexahydropyridine-1 ~ Yl_ethoxy) -kiloyl] -1H-indole or a pharmaceutically acceptable salt thereof. . For example, the compound in the scope of the application for the first item, which is pseudo 〕 --------- &quot; ------ &quot; ------ # (Please read the notes on the back before filling this page) -1 Thallium-indox or a pharmaceutically acceptable salt thereof. For example, the compound in the first item of the scope of patent application is 5-pentoxy-2 (4-benzyloxy-phenyl) -3-methyl-bu [4- (2-Blf (Gasyl) -benzyl] -1 fluorene-indionium or a pharmaceutically acceptable salt thereof. For example, the compound in the first scope of the patent application, its image is 5 -benzyl-2-2 __, a paper size applies the Chinese National Standard (CNS) Α4 wash grid (210 × 297 mm) staff consumption of the Central Bureau of Standards, Ministry of Economic Affairs A8 B8 C8 D8 printed by the cooperative 6. Application for patent support (4-benzyloxy-phenyl) -3 -methyl-1-[4-(2 -diisopropylamine-1 -yl -ethoxy)- Dry group] -1 fluorene-indole or a pharmaceutically acceptable salt thereof. 6. The compound according to item 1 of the scope of patent application, wherein fluorene is 5-benzyloxy-2-(4-solenyl-phenyl) -3 ~ methyl ~ 1- [4 ~ (2-butyl- Methylamine-butyl-ethoxy) -benzyl] -1H-indol or a pharmaceutically acceptable salt thereof. 7. The compound according to item 1 of the scope of patent application, the image of which is 5- ¥ amino-2- (4-benzyloxy-phenyl) -3-methyl-1- {4-[(dimethylamino ) -Ethoxy] -benzyl) -1 hydrazone-indole or a pharmaceutically acceptable salt thereof. 8. The compound according to item 1 of the scope of patent application, which is pseudo-5-benzyloxy-2-U-thyloxy-phenyl) -3-methyl-1- {4- [2- (2-methyl -Hexahydropyridine-1-yl) -ethoxy] -benzyl) -1H-indene or a pharmaceutically acceptable salt thereof. 9. The compound according to item 1 of the scope of patent application, wherein fluorene is 5-benzylamino-2 ~ (4-benzyloxy-phenyl) -3-methyl-1- {4- [2- (3- Methyl-hexahydropyridine-1 -yl) -ethoxy] -benzyl) -1 fluorene-indiox or a pharmaceutically acceptable salt thereof. 10. The compound of item 1 in the scope of patent application, wherein fluorene is 5-benzyloxy ~ 2 ~ (4 · ^ amino-phenyl) -3 -methyl-1- (4- [2-(4 -Methyl-hexahydropyridine-1 -yl) -ethoxy] -pyridyl) -1 fluorene-indionium or a pharmaceutically acceptable salt thereof. η · The compound as described in item [Scope of the patent application], wherein 傜 is 5-benzyloxy-2- (4-benzyloxy-phenyl) -3 -methyl-1- {4- [: b (cis) -2, 6-dimethyl-hexahydro 4 tg -1 -yl) -ethoxy] -thousands of%}-1 Η -indine bite ~ 3---------- Order-^ (Please read the precautions on the back before filling in this page.) The paper's strength scale applies to the Chinese National Standard (CNS) A4 specification (21 OX297 mm) A8 B8 C8 D8 patent application scope or its pharmaceutically acceptable salt. 1 2. The compound according to item 1 of the scope of patent application, which is referred to as 5-benzyl berry-2-(4-dry gas-phenyl) -3 -methyl- {4-[2-(1,3 , 3-methyl-6-BY-bicyclo [3.2.1] oct-6-yl) -ethoxy] -benzyl} -1 Η-indionium or a pharmaceutically acceptable salt thereof. 1 3. The compound according to item 1 of the scope of patent application, wherein its benzyloxy-2- (4-benzylamino-phenyl) -3-methyl-azepine-bicyclo [2.2.1] heptan- 2-yl) -ethoxy] indol or a pharmaceutically acceptable salt thereof. 1 4. If the compound in the scope of patent application No. 1 is (IS, 4R) -5-4-[2- (2--dry basis) -1H- is 5-benzylamino-2- (4 -Fluoro-phenyl) -3 -methyl-bu [4-U-azepine-1-yl-ethoxy) -benzyl] -1H-indox or pharmaceutically acceptable 1 5. If applied The compound of the scope of patent No. 1 is subject to salt. 5-benzylamino 2- (4-fluoro-phenyl) -3-methyl-1- [4- (2-: _hydropyridin-1-yl-printed by the Employees' Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs Preparation of ethoxy) -benzyl] -1H-indole or a pharmaceutically acceptable salt thereof. 16. The compound according to item 1 of the scope of patent application, which is 5-benzyloxy-2- (4-chloro-phenyl) -3-methyl-1- [4- (2-hexaipyridine- Benzyl-ethoxy) -kisyl] -1 hydrazone-indole or a pharmaceutically acceptable salt thereof. 17. The compound according to item 1 of the scope of patent application, which is 5-benzyloxy-2-(3, 4-methylenedioxy-phenyl) -3 -methyl-1-[4-( 2-Hexahydroline-1-yl-ethynyl) -benzyl] -lΗ-π 唉 or its pharmaceutically acceptable salt. 1 8 · If the compound in the scope of application for the first item of the patent, its content is 5 -benzyloxy-4- This paper size is applicable to China National Standard (CNS) A4 specification (210X 297 mm) ------- --g ------, 1T ------ @ ^-(Please read the precautions on the back before filling out this page) Department of Economics and Trade Standards Staff Consumption A # 社 印 Α8 Β8 C8 D8 六2. The scope of the application for a patent-2- (4-isopropylamino-phenyl) -3-methyl-1- [4- (2-hexahydropyridine-: L-yl-ethoxy) -dry] -1 Thallium-indox or a pharmaceutically acceptable salt thereof. 19. The compound according to item 1 of the scope of patent application, which is 5-benzyloxy-2-(4-methyl-phenyl) -3 -methyl-1-[4-(2-: \ hydrogen Pyridine-1 -yl-ethoxy) -benzyl] -1H-indol or a pharmaceutically acceptable salt thereof. 20. The compound according to item 1 of the scope of patent application, which is pseudo: 1-[4-(2-d aheptin-1-yl-ethoxy) -benzyl] -5 -benzyloxy; S -2 -(3-benzyloxy-phenyl) -3-methyl-1 fluorene-indene or a pharmaceutically acceptable salt thereof. 2 1. The compound according to item 1 of the scope of patent application, wherein fluorene is 5-benzyloxy-2- (4-dryoxy-3- 3- -phenyl) -3 -methyl-1- [4- ( 2-hexahydropyridine-butyl-ethoxy) -benzyl] -1H-indox or a pharmaceutically acceptable salt thereof. 2 2. The compound according to item 1 of the scope of patent application, which is 5-benzyloxy-2- (4-dry-gas-3-fluoro-phenyl) -3 -methyl-bu [4-(2 -Azepine-: 1-yl-ethoxy) -benzyl] -1 fluorene-indole or a pharmaceutically acceptable salt thereof. 23. The compound according to item 1 of the scope of patent application, which is 5-benzylamino-2- (3-methylamino-phenyl) -bu [4- (2-hexahydropyridine-buyl-B (Oxy) -kiloyl] -3 -methyl-1 hydrazone-indole or a pharmaceutically acceptable di-acceptable salt thereof. 24. The compound according to item 1 of the scope of patent application, wherein the damage is 5-benzylamino-3 -methyl- [4- (2-hexahydroα specific rotation-i-yl ~ acetamidine K-)-benzyl Group] -2-(4-difluoromethan-phenylhydrazone) -1 hydrazone-indole or a pharmaceutically acceptable salt thereof. 2 5. If the compound in the first item of the scope of patent application, its pseudo is (2-[4-[~ 5-This paper size applies to China National Standard (CNS) A4 specification (210 × 297 mm) Please read the notes Fill in this page again. Binding Department · Department t A Standard Λ Printed by the Consumer News Agency 6. Scope of Patent Application 5-Flat Gas Based-2-(4-Dry Gas Based-Phenyl)-3-A 1 g- Indine-1 -ylmethyl] -benzyl} -ethyl) -cyclohexyl-amine or -t is pharmaceutically acceptable. 2 6. The compound according to item 1 of the scope of patent application, which is pseudo-5-benzyloxy-2- (4- dryoxy-phenyl) -3 -methyl-bu (4-methylhexahydropyridine) -; L -yl) -ethylamino] -benzyl}-1 fluorene -indole or a 9 i scientifically acceptable salt thereof. 27. The compound according to item 1 of the scope of patent application, which is pseudo- 1- [4- (2-azepine-butyl-ethoxy) -benzyl] -5 -benzyl ^ ξ-2--2- (3- Methoxy-phenyl) -3-methyl-1 fluorene-indox or its pharmaceutically acceptable sulfonium salt. 28. If the compound in the scope of item 1 of the application for a patent, it is pseudo-4-{3-methyl-1- [4-(2-hexahydropyridine-b-yl-ethoxy) -dry] -1 Η-Indene) (HC 1) 〇 2 9. If the compound of the scope of application for the first item of the compound, its pseudo is 4- {3-methyl-1- [4- (2-hexahydrolacyclo-1-yl -Ethoxy) -benzyl] -1 fluorene-indio-yl} phenol hydrochloride (HC1). 30. The compound according to item 1 of the scope of patent application, whose image is 3-methyl-2-phenyl-1- [4- (2-hexahydropyridine-butyl-ethoxy) -benzyl]- 1 hydrazone-indazin-5-ol (HC 1). 3 1. The compound according to item 1 of the scope of patent application, wherein 潞 is 4-{5 -methoxy-3 -methyl-1- [4 ~ [2_ (六 灵 令 症 -1 -yl) -ethoxy []]-Benzyl) -1 fluorene-indan-2 -yl}-_ or its medicinal | 1 acceptable salt. 3 2 · If the compound in the scope of application for the first item of the patent, its t is 2-(4-methoxy-phenyl)-3-A: S-1-(4-[2-(hexahydro 4 i-pyridine- 1-based) -Ethoxy-δ-This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 × 297 mm). Please read the note on the back of 1¾. A Standard in the Ministry of Economic Affairs. Employees printed by cooperatives. A8 B8 C8 D8 VI. Patent application scope] -Dry basis}-1 Η-indene-5 -ol or a pharmaceutically acceptable salt thereof. 3 3. If the compound in the patent application scope item 1 is pseudo-5-methyl gas 2- (4-methoxy-phenyl) -3-methyl-bu [4- (Σ-hexahydropyridine-1 -yl-ethylamino) -benzyl] -1 hydrazone-indole ( HC 1). 3 4. The compound according to item 1 of the scope of patent application, wherein 傺 is 1-[4-(2 -azepine-butyl-ethoxy) -benzyl] -5 -methoxy 3 S -2- (4-methoxy-phenyl) -3 -methyl-1 fluorene-indole (HC 1). 3 5. If the compound in the scope of patent application No. 1 is 2- (4- Ethylamino-phenyl) -3-methyl-1- [4-(2-hexahydropyridine-1 -yl-ethanyl) -Benzyl] -1 pyrene-earthol-5-ol or a pharmaceutically acceptable salt thereof. 3 6. The compound as claimed in item 1 of the patent application, which is pseudo- [4- (2-azepine-butyl -Ethoxy) -benzyl] -2- (4-ethoxy-phenyl) -3-methyl-1H-indole-5-ol or pharmaceutically acceptable 1 i 〇37. The compound of the first item whose damage is 4-[5 -Ga-3-methyl-1- [4- (2-hexahydroII ratio ® -1-yl-ethiyl) -phenyl] -1 Η-D is a late -2-yl} -phenol (HC 1). 3 8. If the compound in the scope of the application for the first item of the patent, it is 1-[4-(2-DY heptane-bukey-ethoxy (Yl) -kiloyl] -3 -methyl-2-phenyl-1H-indio-5 -ol (丨 1 C 1). 3 9. If the compound in the scope of patent application No. 1 is 2- (4-Hydroxy-phenyl) -3-methyl-1- [4- (2-pyrrolidin-1-yl-ethoxy)-dry:]-1 吲 -indine-5 -ol or Its pharmaceutically acceptable salt. 40. For example, the compound in the scope of patent application No. 1 is 1-[4-(2--7 ~ This paper size applies to China National Standard (CNS) A4 specification (210 × 297 mm) ) Please read me first Matters again ▲ Write this page to print the A8 B8 C8 D8 printed by the Consumers' Cooperatives of the Standards Bureau of the Ministry of Economic Affairs 6. The scope of the patent application azepine-1 -yl-ethane-benzyl] -2-(4- -Phenyl) -3-methyl-1 Η -1 丨 bite -5-ol (HC i). 4 1. The compound as claimed in item 1 of the scope of patent application, which is pseudo- [4-(2-d-heptane-1 -yl-ethoxy) -benzyl'yl] -2-(4-Xiangyl- Phenyl) -3-methyl-1 fluorene-indionium-5-ol acetate. 4 2. The compound according to item 1 in the scope of patent application, wherein 傺 is 1-ί 4-(2- D yacryl-1-yl-ethoxy) -benzyl] -2- (4-hydroxy-phenyl ) -3-methyl-1 fluorene-indole-5 -ol or its pharmaceutically acceptable particles! 〇 4 3. As the compound of the scope of application for the first item, it is pseudo 2- (4-hydroxy-phenyl) ) -3-methyl-1- [4- (2-dimethyl-1-1; -ethoxy) -dry group] -1 fluorene-indio-5-ol or a pharmaceutically acceptable salt thereof. 4 4. The compound according to item 1 of the scope of patent application, which is pseudo 2-(4-hydroxy-phenyl) -3 -methyl-1- [4- (2-diethyl-1-3; -ethyl (Gasyl) -benzyl] -1H-indlate-5-ol or a pharmaceutically acceptable salt thereof. 4 5. The compound according to item 1 of the scope of patent application, which is pseudo 1- [4-(2-diisopropylamino-ethoxy) -benzyl] -2- (4-ropato-phenyl) -3-methyl-1 fluorene-indazine-5 -ol or its pharmaceutically acceptable i 〇 4 6. If the compound in the scope of the application for the first item of the patent, it is [4-(2-dibutyl Amine-ethoxy) -benzyl] -2-(4-sep 2-yl-phenyl) -3-methyl-1 fluorene-indole-5 -ol or its pharmaceutically acceptable i 1 〇 4 7 . For example, the compound in the first scope of the application for a patent, which is pseudo- [4- (2-diisopropylamino-ethoxy] -benzyl] -2-(4-_ 2yl-phenyl) -3 -methyl -1 Η-Indene-5 -ol or is it pharmaceutically acceptable? lotus. -8-This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 × 297 mm) Please read the subject matter and reprint. This page is bound to be printed by Standard Employees ’Cooperatives in the Ministry of Economic Affairs of Nickel. Α8 Β8 C8 D8 Scope of patent application 48. The compound according to item 1 of the scope of patent application, which is pseudo- 1-(4-[2-(butyl-methylamino) -ethoxy) -benzyl}-2-(4-hydroxy- Phenyl) -3 -methyl-1 fluorene-indio-5-ol or a pharmaceutically acceptable salt thereof. 4 9. The compound according to item 1 in the scope of patent application, wherein 傜 is 2-(4-hydroxy-phenylmethyl-1- {4- [2 * · (2-methyl-hexa I $ 4 pyridine-1 -Yl) -ethoxy] -benzyl) -1 fluorene-indole-5-ol or a pharmaceutically acceptable salt thereof. 50. The compound according to item 1 of the scope of patent application, which is 2- (4-hydroxy-phenyl-3-methyl-1- {4- [2- (3-methyl-hexaf 1-yl) -ethoxy] -benzyl} -1H-indole-5-ol or a pharmaceutically acceptable salt thereof. 51. The compound according to item 1 of the patent application scope is 2- (4- Hydroxy-phenyl-3 -methyl-1-(4-[2-(4 -methyl-hexai $ pyridine-pyl) -ethoxy] -benzyl) -1 fluorene -indole-5- Alcohols (HC 1) c 5 2. As the compound in the scope of the patent application of item 1, the compound is [4- [2- (3, 3-dimethyl-hexahydropyridine-: 1-yl) ethyl Gas group] -Dry group) -2- (4-Hydroxy-phenyl) -3-methyl-1 fluorene-indole-5 -ol or a pharmaceutically acceptable salt thereof 5 3 The compound of the above item is its compound {4-[2-(cis) -2, 6 -dimethyl-hexahydropyridine-byl) -ethyl 1 1yl] -dry group} -2-(4 -hydroxy -Phenyl) -3 -methyl-1 fluorene-indole-5 -ol or a pharmaceutically acceptable salt thereof. 5 4. The compound according to item 1 of the scope of patent application, wherein 傜 is 2-(4-hydroxy-phenyl) -1- (4- [2- (4-hydroxy-hexahydropyridine-1 -yl) -ethyl [Gasyl]-«Bibyl) -3 -methyl-1 fluorene -indio-5 -ol or an acceptable salt thereof. -9- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 × 297 mm). Please read the precautions below and fill in this page to order the Ministry of Economic Affairs, the Central Bureau of Standards and Staff, and the combined printing A8 B8 C8 D8 Six 5. The scope of application for patent 5 5. For the compound of scope 丨 of the application for patent, it is (1S, 4R) + {4-ί 2-(2-η 丫 -bicyclo [2 · 2. .1] hept ~ 2- Group) -ethoxy] -benzyl) -2-(4-hydroxy-phenyl) -3 -methyl-1 fluorene -f 1fluor-5-ol or a pharmaceutically acceptable salt thereof. 56. The compound according to item 1 in the scope of patent application, wherein 傜 is 2-(4-hydroxy-phenyl) -3-methyl-1- (4- [2- (1,3,3-triE 3 Phenyl-6-Damma-bicyclo [3. 2. 1] oct-6-yl) ethoxy] -benzyl) -1 Η 2-5-alcohol or a pharmaceutically acceptable salt thereof. 5 7. The compound according to item 1 of the scope of patent application, the image of which is 2-(4-gas-phenyl) -3 -methyl-1- [4- (2-hexahydropyridine-bu 3 S -ethane Group) -benzyl] -1 fluorene-indole-5 -ol (HC 1). 58. The compound according to item 1 of the scope of patent application, which is [4- (2-D yaheptin-1-yl-ethoxy) -benzyl] -2- (4-fluoro-phenyl ) -3-methyl-1 fluorene-indio-5-ol or a pharmaceutically acceptable salt thereof 59. As for the compound in the scope of patent application, the fluorene is 2- (3-methylamino-4 ' -Phenyl) -3-methyl [4- (2hexahydropyridine-butyl-ethoxy) -benzyl] -1H-indol-5-ol (HC 1). 60. The compound as claimed in claim 1 of the scope of patent application, wherein the fluorene is 2-phenylhydrazine [1,3] dimingo-5 ~ yl-3 -methyl-1-[4-(2 -hexahydropyridine- 1-yl-ethoxy) -benzyl] -1 fluorene-indole-5 -ol (HC 1) 〇 6 1. If the compound in the scope of patent application No. 1, its side is 2-(4- isopropyl Carbo-phenyl) -3 -methyl-1-[4-(2 -Hexahydropyridine-1 :: yl · ethanegasoline) -benzylhydrazone] -1 Η -indio-5 -alcohol (丨丨 C 1). -10- This paper size is applicable to China National Standards of Standards (CNS) Α4 grid (2 丨 0 × 297 mm) Please fill in the notes on this page before filling in this page. Member of the Central Standards Bureau of the Bookkeeping Department X. Consumer f. ? 88 D8 6. Application scope of patent 6 2. For the compound in the scope of patent application item 1, its pseudo ^ 1-[4- (2- u yaheptene-1-yl-ethoxy) -benzyl Group] -2- (4-isopropylamino-phenyl) -3-methyl-1fluorene-indole-5 -ol (HC 1). 6 3 · The compound according to item 1 of the scope of patent application, which is 2-(4-cyclopentylamino-phenyl) -3 -methyl-1- [4- (2 -hexahydro 4 Meng-1- -Ethoxy) -benzyl] -1H-indole-5 -ol or a pharmaceutically acceptable salt thereof. 64. The compound according to item 1 of the scope of patent application, wherein hydrazone is 3-methyl-1- [4- (2-hexahydro4pyridinyl-ethyl-ethyl) -dry] -2- (4 -Trifluoromethyl-phenyl) -1H-indole-5-ol or a pharmaceutically acceptable salt thereof. 65. The compound according to item 1 of the scope of patent application, which is pseudo 3-methyl-1- [4- (2-hexahydropyridine-b-yl-ethoxy) -benzyl] -2-p-di Tolyl-1 H-indole · -5 -ol or a pharmaceutically acceptable salt thereof 06. As for the compound in the first item of the patent application, it is 2-(4-chloro-phenyl) -3- Methyl-1-[4-(2-hexahydropyridin-1 -yl-ethoxy) -benzyl] -1 fluorene-indio-5-ol (HC 1). 67. The compound according to item 1 of the scope of patent application, wherein fluorene is 2- (2,4-dimethylamino-phenyl) -3 -methyl-1- [4- (2-hexahydropyridine- Benzyl-ethoxy) -benzyl] -1 indole-5 -ol or a pharmaceutically acceptable salt thereof. 6 δ. As for the compound in the first item of the patent application scope, the hydrazone is 2-(3-hydroxy-phenyl) -3 -methyl-1-[4-(2 -hexahydropyridine-1 -S -ethoxy Group) -dry group] -1 fluorene-indio-5-ol or a pharmaceutically acceptable salt thereof. 6 9. The compound according to item 1 of the scope of patent application, which is pseudo ^ 1 ~ C 4- (2 ~ * uheptane-1 -yl-ethyloxy) -benzyl] -2-(3-hydroxyS -Phenyl) -3 -A-1 1-This paper size is applicable to Chinese national standard (CNS &gt; Α4 size (210X297mm) Please read the winter notes before filling% A8 S8.iuS3 S D8 printed by the Bureau ’s Consumer Cooperatives 6. Application for a patent scope of -1 Η-indole-5 -ol or a pharmaceutically acceptable compound thereof. 7 0. If the compound in the first scope of the patent application, its The image is 2- (3-Ga-4-hydroxy-phenyl) -3 -methyl-Bu [4-(2 -Hexahydro 4 quotient: -1-yl-ethoxy) -benzyl] -1 Η -Indole-5 -alcohol or its pharmacologically acceptable salt. 7 1. As the compound in the scope of the patent application, its hydrazone is 2- (3-gas-4-hydroxy-benzene irrigation) 3-methyl -1- [4- (α Yaheptin-1-yl) -ethoxy) -benzyl] -1Η-indole-5-ol or a pharmaceutically acceptable 5: salt thereof. 7 2. The compound according to item 1 of the patent application, wherein 僳 is 2-(3-methoxy-phenyl) -3 -methyl-1- [4--(2-hexahydropyridine-1-yl- Ethyl chloride) -amyl] -1H-indio-5-ol or a pharmaceutically acceptable salt thereof. 73. The compound according to item 1 of the scope of patent application, which is pseudo-3-methyl-1-[4- (2-hexahydropyridine-butyl-ethoxy) -benzyl] 2- (4-trifluoro Methenyl-phenyl) -1 hydrazone-indio-5-ol or its pharmaceutically acceptable salt. 74. The compound according to item 1 of the scope of patent application, the image of which is 3-chloro-2- (4-hydroxy-phenyl) -1- [4- (2-pyrrolidin-butyl-ethoxy) -Benzyl] -1 Η-d to fluoren-5 -ol (HC 1). 75. The compound according to item 1 of the scope of patent application, which is to remove the affected esters to produce 3 -anhydro-2-(4-hydroxy-phenyl) -1-[4-(2 -hexahydropyridine-1 -Yl-ethoxy) -yl] -1 fluorene-indole-5 -ol (HC 1) 〇 7 6. The compound according to item 1 of the patent application scope is 3-nitro-2- (4- Transyl-phenyl) ~ 1 ~ L 4- (2-η-Aheptane-1-yl-ethoxy) -benzylhydrazine] -1 Η-indio-5-ol (HC 1). 7 7. If the compound in the scope of application for the first item of the patent, its content is 3 -nitro-2- (4- -12- This paper size uses the Chinese National Standard (CNS) A4 specification (210 × 297 mm) Please read the back 1¾ Note for re-fill %% on this page% Patent application scope ABCD hydroxy-2 -tolyl) -1-[4-(2 -hexahydropyridine-1 -yl-ethoxy) benzyl 1 fluorene-indole- 5-ol or a pharmaceutically acceptable salt thereof. 7 8. The compound according to item 1 of the scope of patent application, its pseudo-phenyl) -3 -ethyl-1-[4-(2 -hexahydropyridine-1-is 2- (4-hydroxy-ethoxy ) -Benzyl 1 fluorene-indole-5 -ol (HC 1) 〇 7 9. As the compound of the scope of application for the first item, which is (4-hydroxy-phenyl) -1- [4- (2 -Hexahydropyridine-1-benzyl 1 Η -Indene-3-formazan (HC 1) The staff of the Central Standards Bureau of the Ministry of Economic Affairs printed $ L 8 0. If the compound in the scope of patent application is applied, its pseudo Acetyl-buyl-ethoxy) -benzyl] -5-hydroxy-yl) -1 hydrazone-indionium-3-formyl (HC 1). 81. The compound according to item 1 of the scope of patent application, wherein 2- (4-benzylamino-phenyl) -3-an-1- [4- (2-hexaethoxy) -pyridyl]- 1H-indionium or pharmaceutically acceptable δ 2. As the compound in the scope of application for the first item of the patent, its pseudo 2- (4-thenyloxy-phenyl) -3 -ambiol-bu Group) -benzyl] -1 fluorene-indole or its pharmaceutically acceptable 8 3. For example, the compound in the scope of application for the first item of the patent, which is 2-(2-methyl-4 -benzyl-phenyl-phenyl) -3 -Homo-1-[pyridinyl-ethyl-ethoxy) -benzyl] -1 hydrazone-indole or its salt 〇 4 4. If the compound in the scope of patent application item 1, its pseudo 2-(4 -Dry-air-phenyl) -3 -ethyl-; 1-[4-(2--13- is 5-hydroxy-2-yl-ethoxy)-is [4- (2-2- (4-Bycyl-benzene is 5-benzyloxy-oxyl yodo_1-yl-accepting salt. It is 5-benzyloxy-heptin-1-yl-ethyl accepting salt. It is 5-benzyloxy- 4-(2-Hexahydropyridine is pharmaceutically acceptable as 5-benzyloxy-hydro 4pyridine-1---------- '4 ^-(Please read the precautions on the back before filling in this Page) The size of the paper is applicable to China National Standard (CNS) A4 (210X 297 mm) A8 B8 C8 D8 printed by the Bing Employees' Cooperatives 6. Applicable patent scope-Ethyl)-benzyl]-1-Indole or its pharmaceutical J: Acceptable salt. 8 5. If the scope of patent application is item 1 Compound, which is pseudo- 5 -dryoxy-2-(4 -thienyl-phenyl) -3 -cyano-1-[4-(2 -hexahydropyridin-1 -yl-ethoxy) ) -Benzyl] -1 hydrazone-indole or a pharmaceutically acceptable second salt thereof. 86. If the compound of the scope of application for item 1 of the invention, the wound is 5-kisylamino- 2- (4-kischloroyl- Benzene 3 -fluorenyl-bu [4- (2-azepine-b-yl-ethenyl) -benzyl] -1 hydrazone-indionium or a pharmaceutically acceptable salt thereof 8 7. If a patent is applied for The compound of the scope item 1, which is pseudo-1- [4- (2-azepine-buyl-ethyloxy) -benzyl] -2- (4-hydroxy-phenyl) -3 -methyl- 1 Η-indox-5-alcohol dipropionate (HC 1). 88. For example, the compound in the scope of patent application item 1, which is pseudo [4-(2-azepine-butyl-ethoxy] Group) -benzyl] -2-(4-hydroxy-phenyl) ~ 3-methyl-1 丨 -indio-5-ol dipentovalerate (HC 1: 08 9 The compound of the first range is pseudo-5-fluorenyl-2-U-benzyloxy-phenyl) -1- [4- (3-Hexahydropyridin-1-yl-propoxy) -Benzyl] -3 -methyl-1 fluorene-indole or a pharmaceutically acceptable salt thereof. 90. The compound according to item 1 in the scope of patent application, wherein 傺 is 2-(4-hydroxy-phenyl) -3_methyl- [4 -_ [3- (hexaqiera-1-yl) -propane ) -Benzyl] -1 fluorene-indole-5 -ol or a pharmaceutically acceptable salt thereof. 91. The compound according to item 1 of the scope of patent application, which is 2- (4-hydroxy-phenyl) -1-[3 -methylamino-4-(2 -hexahydropyridin-1 -yl- Ethyl group)-Qianjie] ~ 3-methyl-lH-t1 fluorenol or a pharmaceutically acceptable salt thereof. 9 2. If the compound in the first item of the patent application scope, the damage t is 2-(4 -hydroxy--14-) This paper size is applicable to China National Standard (CNS) A4 specification (210 × 297 mm) Please read the note on the back Matters should be ordered by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs and printed by A8 S8i0 ^ 3 a D8 6. The scope of patent application phenyl) -1-[3 -Katrine-4-(2-d 丫 庚 因-卜I-ethacene) -benzyl] -3 -methyl-1 Η-net 喊 y -5-alcohol. Or a pharmaceutically acceptable salt thereof. 9 3. If the compound in the scope of the application for the first item of the patent, it is pseudo 5-dryoxy-2-(4-thenyloxy-phenyl) -3 -methyl-1-[3 -methoxy-4 -(2 ~ * hexahydropyridine-1 -yl-ethoxy) -benzyl] -1 hydrazone-indole or a pharmaceutically acceptable salt thereof. 94. The compound according to item 1 of the scope of patent application, which is pseudo-5-methoxy-2- (4-thienyl-phenyl) -3-methyl-1- [2-methoxy-4 -(2-〇AHeptin-1-yl-ethoxy) -dry] -1H-indox or a pharmaceutically acceptable salt thereof. 95. The compound according to item 1 of the scope of patent application, which is pseudo-2- (4-hydroxy-phenyl) -3 -methyl-1- [4- (2_hexaqila syndrome-1-yl &quot; B (Oxy) -benzyl] -1 fluorene-indio-5-ol divalerate or melamine: a pharmaceutically acceptable salt. 96. The compound according to item 1 of the scope of patent application, which is pseudo-5-benzylamino-2-U-dryoxy-phenyl) -3 -methyl-1- [4- (2-hexadecane (la Yodo_1-yl-ethoxy) -benzyl] -1 hydrazone-indole or its pharmacological J: acceptable salt. 9 7. If the compound in the scope of patent application item 1, its hydrazone is 5-benzyloxy -2- (3-dryoxy-phenyl) -3-methyl-1- [4- (2-hexafluorocyclo-1--yl-ethoxy) -benzyl] -1 hydrazone-indene Or its pharmaceutics: acceptable salt. 9 8. The compound as claimed in item 1 of the scope of application, which is pseudo 2- (4-hydroxy-phenyl) -3 -methyl-1- [4- (2- Hexamidine-pyridine-boxy-ethoxy) -thylyl] -1 hydrazone-indole-5 -ol or a pharmaceutically acceptable salt thereof. -1 5-(Please read the precautions on the back before filling in this (Page) This paper size applies to China National Standards (CNS) A4 (210X 297 mm) &amp; 8i0b3 A8 B8 C8 D8 Patent Application Scope 9 9. If you apply for the compound in item 1 of the patent scope, its value is 2- (4- ^ yl-phenyl) -3 -methyl-1-[4-(2 -hexahydropyridine-dry basis) _ 1 H _ b _ 5 _ S? Meodide. 1 -yl) -Ethoxy 1 0 0. Such as The compound in item 1 of the patent scope is pseudo-2- (4-hydroxy-phenyl) -3-methyl-1- [4- (2-dimethylamyl] _1H-〇 引 晚 -5- Alcohol. Methyl iodide. -Base-Ethyl Gas) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. It is a type of treatment or prevention that contains an effective amount of a scientifically acceptable salt as 102. — A sexual ingredient and a medicine 10 in the scope of medical patents for treating or preventing feeding status or syndromes. — A treatment or preventing feeding includes an effective amount such as a pharmaceutically acceptable salt as 104. — Treatment or prevention of endometriosis or ectopic uterine uterus, a compound created around item 1 and a peony that accepts milk osteoporosis Xinxin and the patent application for endometrial formation of active milk-forming diseases, its package, or its drug carrier. The doctor of loosening _ composition around the first compound and a kind of _ can be stimulated to contain science or with female, its package or Its drug body. Vascular disease substance, its inclusions, or its drug carrier. _ Related diseases If the effect of the application is acceptable, please accept the salt as a living (please read the notes on the back before filling this page). The first and the first of the scope of the medical ectopic group include-a chemical medicine with a medically acceptable tissue. It can be made into a substance, and its proliferation scene is subject to salt as a composition, a composition thereof, or a carrier for receiving the same. The disease like, abnormal development, patent application for the active ingredient, this paper size uses the Chinese National Standard (CNS) A4 specification (210 × 297 mm)
TW86104919A 1996-04-19 1997-04-16 2-phenyl-1-benzyl indole compounds as estrogenic agents TW381093B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63397496A 1996-04-19 1996-04-19

Publications (1)

Publication Number Publication Date
TW381093B true TW381093B (en) 2000-02-01

Family

ID=24541937

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86104919A TW381093B (en) 1996-04-19 1997-04-16 2-phenyl-1-benzyl indole compounds as estrogenic agents

Country Status (5)

Country Link
BR (1) BR9701895B1 (en)
CA (1) CA2203079C (en)
ID (1) ID16604A (en)
TW (1) TW381093B (en)
ZA (1) ZA973302B (en)

Also Published As

Publication number Publication date
BR9701895A (en) 1998-11-10
CA2203079A1 (en) 1997-10-19
CA2203079C (en) 2006-12-05
ID16604A (en) 1997-10-23
ZA973302B (en) 1998-10-19
BR9701895B1 (en) 2010-08-10

Similar Documents

Publication Publication Date Title
DE69707189T2 (en) Estrogenic compounds
US6787538B2 (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
JP5872624B2 (en) 2-Phenyl-1- [4- (2-aminoethoxy) benzyloxy] indole combined with estrogen
US20070142361A1 (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
TW381093B (en) 2-phenyl-1-benzyl indole compounds as estrogenic agents
DE60011401T2 (en) N-SUBSTITUTED INDOLINE AS ESTROGENIC AGENT
CA2203078C (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
CA2558821A1 (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
MXPA00011178A (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent